Biochemical and Structural Changes in Response to Abomasal Nematode Infections in Ruminants by Scott, Ian
BIOCHEMICAL AND STRUCTURAL CHANGES IN 
RESPONSE TO ABOMASAL NEMATODE INFECTIONS IN
RUMINANTS
Ian Scott, B.V.M.S., M.R.C.V.S.
A thesis submitted for the degree of Doctor of Philosophy 
Faculty of Veterinary Medicine, University of Glasgow
© Ian Scott, September 1996
ProQuest Number: 13818581
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13818581
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
IOWCry
GLASGOW™!
x jn iv er sitt  I
i.re sARY _ l
2ABSTRACT
Four methods for estimating plasma pepsinogen concentrations were compared to determine 
the most suitable assay for routine use. Three of the methods were colorimetric assays which 
used glycine-buffered albumin, albumin, or haemoglobin as their substrates. The fourth 
method was a radial diffusion assay which used casein in agarose as its substrate. All four 
methods gave reproducible results when replicates were assayed on the same day. However, 
the first method had the least day-to-day variation and was the only method which gave a 
linear relationship with different concentrations of pepsinogen in a plasma pool.
Two artificial pepsinogen containing solutions were created, the first was an entirely aqueous 
solution of porcine pepsinogen and the second was plasma with an identical pepsinogen 
concentration, achieved by adding an identical amount of porcine pepsinogen to ovine plasma 
instead o f water. The ovine plasma chosen had zero intrinsic peptic activity. When the peptic 
activities of the two solutions were compared the activity o f pepsinogen in plasma was 
significantly reduced. This was due either to an interference in enzyme reaction rates by the 
presence o f plasma proteins, or to a more specific interference with activated pepsin by an 
inhibitor, as yet unknown, present in plasma. Either way this phenomenon represented a 
potentially significant source of variation when recording plasma pepsinogen concentrations 
by assays measuring proteolytic activity.
The effects of excretory/secretory products (ES) of Ostertagia circumcincta on the release of 
pepsinogen and on smooth muscle function in vitro was investigated. ES was prepared by 
culture o f O. circumcincta adults. Methods to monitor pepsinogen release from isolated, intact 
mucosal sheets and isometric contractions in abomasal smooth muscle were successfully 
developed and were both adequately responsive with the muscarinic agonist, carbachol. The 
addition of ES to tissues consistently resulted in the release of pepsinogen from mucosae and 
in smooth muscle contraction, but only in tissues obtained from animals with a history of 
previous exposure to helminth parasites. Tissues from known parasite-naive animals did not 
respond to the presence of ES. These responses were therefore considered to be 
hypersensitivity responses to antigens present in ES.
The distribution of pepsinogen in abomasal tissues was investigated immunohistochemically 
and biochemically in the abomasa of parasite-naive cattle and sheep, and in animals with
3ostertagiasis and haemonchosis. In the parasite-naive animal the fundic chief cell was the 
major source of pepsinogen, as indicated by intensity o f staining. Mucous neck cells also 
contained pepsinogen, but in lesser amounts. The pepsinogen content of surface mucous cells 
was variable in the bovine however this cell type did not contain pepsinogen in the normal 
ovine. Ostertagiasis was associated with focal hyperplasia around parasitised gastric glands 
and increased tissue pepsinogen content was detected within nodules. Normal epithelial cells, 
including chief cells, were replaced by hyperplastic mucous-type cells. These cells contained 
pepsinogen and hyperplasia resulted in an expanded population of cells producing the 
zymogen. Individual cells of the hyperplastic population contained less pepsinogen than did 
mature chief cells, but their greater numbers accounted for the increase in tissue pepsinogen 
content. In haemonchosis hyperplasia was generalised, and increased numbers o f cells were 
positive for pepsinogen. However, overall tissue pepsinogen content was not increased by 
infection and it was observed that chief cell content was again reduced. Thus helminth 
infections were associated with an expanded zymogenic population and the inference was that 
pepsinogen secretion in infected animals was at least maintained in infection, if not increased. 
Some sheep were shown to produce little or no pepsinogen, but the consequences and 
significance of this finding remain unknown.
The role of the mucosal growth regulator, Transforming Growth Factor-alpha (TGF-a), in the 
development of hyperplasia in ostertagiasis was investigated. The immunohistochemical 
localisation of TGF-a in various gastrointestinal tissues of parasite-naive sheep was 
determined and compared to that of the related peptide, Epidermal Growth Factor (EGF). In 
normal fundus TGF-a immunoreactivity was confined to the differentiated, non-proliferative 
compartment, to parietal cells and to surface mucous cells, and the distribution of EGF was 
identical. In other gastrointestinal tissues, such as oesophageal mucosa, the distribution of the 
two growth factors was not the same and this was taken as evidence that the antisera used 
were able to recognise distinct peptides, i.e. the ovine equivalents of TGF-a and EGF. Within 
the nodular tissue obtained from animals with ostertagiasis, the greater numbers of mucous- 
type cells were associated with an increase of intensity of staining in the superficial mucosa, 
but the concomitant depletion of parietal cell number was associated with reductions of 
staining in deeper gland structures. Given the known effects of TGF-a these results strongly 
suggested that TGF-a may be important in the development of hyperplasia in infections with 
Ostertagia spp. parasites.
4These studies have investigated the causes of elevated plasma pepsinogen concentrations that 
occur in animals infected with parasites of the genera Ostertagia and Haemonchus, and have 
shown that variations in plasma pepsinogen concentration between animals may be due to a 
number of causes. Amongst these causes inaccuracies inherent to the assay methods used may 
be important. Further these studies have shown that complementary to previous hypotheses 
concerning the mechanisms behind elevated plasma pepsinogen concentrations, such as 
changes in mucosal permeability, and the direct stimulation of pepsinogen secretion by 
parasites, must be added hypotheses concerning mucosal hypersensitivity responses to 
antigens released by parasites stimulating pepsinogen secretion indirectly and changes in the 
populations o f cells secreting pepsinogen, which may even result in an enhanced zymogenic 
population.
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1: GENERAL INTRODUCTION
The nematodes and other Metazoans are thought to have evolved, under anoxic conditions, in 
the sulphide-rich layer that is present at the bottom of all major bodies of water and is still rich 
in nematode species today (Bryant, 1982). Vertebrate ancestors, the chordates, were oceanic 
bottom-dwellers, almost certainly mud-sifters, and were likely to contact the sulphide layer. 
The redox potential, the availability of oxygen and carbon dioxide, and the pH are very 
similar in the marine sulphide layer and the gastrointestinal tract of vertebrate hosts (Bryant, 
1982). Nematodes, like many organisms, developed the ability to detoxify oxygen, yet they 
have retained their great capacity for anaerobiosis.
O f all described nematodes (Phylum: Nemathelminthes; Class: Nematoda), 40 per cent are 
parasites of animals, mostly of vertebrates, and the majority of parasitic species belong to one 
large sub-class, the Secernentea (Anderson, 1984). Nematodes are one of the most successful 
animal groups and, in the course o f evolving, may have made the transition from a free-living 
existence to a parasitic one many times. It is interesting therefore to consider the potentially 
long co-evolution of nematodes and their vertebrate hosts.
The compartmentalisation of the forestomach of ruihinants is an evolutionary adaptation to 
enable utilisation of the bacterial products of the breakdown of tough plant matter otherwise 
indigestible in the mammalian gut. The final chamber, the abomasum, is analogous to the true 
stomach of monogastric animals. Conditions within the abomasum and stomach are unique to 
these organs; secretion of hydrochloric acid begins the breakdown of foodstuffs by hydrolysis 
and assists the acid-stable enzyme pepsin in the breakdown of protein. Host tissues are by no 
means resistant to these destructive elements and secrete copious mucus and bicarbonate 
which act as a barrier.
The hostility of conditions prevalent in the gastric compartment would seem an adequate 
deterrent against parasitism of this organ, yet numerous viral, bacterial and multicellular 
pathogens are accomplished colonists. In some instances an initial injury is required, allowing 
opportunistic spread of the invading organism, for example in Braxy in sheep where 
consumption of frozen pasture or fodder can predispose to overgrowth o f the bacterium
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Clostridium septicum (Barker et al, 1993a). Other infectious agents are quite capable of 
penetrating the uncompromised gastric environment and surviving and these include many 
species of nematode parasites that afflict a wide variety of hosts (Urquhart et al, 1987). 
Amongst monogastric host animals, Trichostrongylus axei and Habronema spp. are gastric 
parasites of horses (Leland et al, 1961; Barker et al, 1993b), Hyostrongylus rubidus affects 
pigs (Stockdale, 1974), and Ollulanus tricuspis (Hargis et al, 1983; Reindel, 1987) and 
Gnathostoma spp. (Kirkpatrick, 1987) are parasites o f carnivores. The nematode Nochtia 
nochti causes gastric adenomatous tumours in the stomach of Javanese monkeys (Bonne and 
Sandground, 1939). In ruminant hosts, abomasal nematodes are o f great economic importance 
and constrain animal production world-wide. Important nematode parasites of ruminant 
abomasa include Ostertagia spp., Trichostrongylus spp. and Haemonchus spp.
1.1: Nematode parasites of ruminants.
The predominant pathogenic nematodes of the ruminant gastrointestinal tract are all 
representatives of the family Trichostrongylidae. In temperate areas of the world the cattle 
parasite Ostertagia ostertagi is the most economically important parasite (Armour, 1970), 
accounting for considerable losses in animal production. The disease in cattle is, principally, a 
parasitic abomasitis. In sheep, parasitic gastroenteritis is generally attributed to a mixed 
spectrum of parasites, including; Trichostrongylus, Cooperia and Nematodirus genera. 
Ostertagia circumcincta (Teladorsagia circumcincta) is often the predominant and most 
pathogenic nematode species present (Armour et al, 1966). In sheep with mixed infections, 
the disease may be attributed to the abomasitis caused by O. circumcincta (and to a lesser 
extent Trichostrongylus axei) and enteritis caused by several enteric parasites, such as 
Trichostrongylus colubriformis. Haemonchus spp. parasites have a widespread geographical 
distribution, but are of greatest importance as abomasal parasites of ruminants in tropical and 
subtropical areas (Allonby, 1973).
Parasitic infection is, generally, of greatest importance in young ruminants. The adverse 
effects of parasitism on productivity are legion. Reductions of liveweight gain in young 
growing stock can be as high as 60 to 100 per cent (Sykes and Coop, 1976, 1977; Abbott et al, 
1986; Fox et al, 1989a). These changes are accompanied by alterations in body composition; 
changes in soft tissue components and in bone (Sykes et al, 1977; Wilson and Field, 1983; 
Holmes, 1986). The quantity and quality of wool production in sheep can be affected (Steel et
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al, 1982). Other production parameters such as milk production and reproductive performance 
may also be affected. Numerous studies have reported reduced milk production in infected 
animals (Bliss and Todd, 1973; 1976; Leyva et al 1982), however milk production is 
necessarily an activity of mature animals that may be more resistant to parasites (Parkins and 
Holmes, 1989). Ovulation rates have been shown to be consistently lower in sheep infected 
with O. circumcincta, but this did not translate into reduced reproductive performance 
(Jeffcoate et al, 1988). Mortality in heavy infections and the premature culling o f affected 
stock are obvious and further sources of economic loss and are welfare concerns. Added to 
productivity losses are the costs of anthelmintic treatments and the cost and inconvenience of 
pasture and stock management to minimise exposure to infection.
1.2: The life cycle of Ostertagia spp. affecting bovine and ovine hosts.
The life cycle is direct, following a typical trichostrongylid pattern. Development involves 
progression from egg to sexually active adult via five larval stages; transitions are 
accomplished by moulting. Unembryonated eggs passed in the faeces o f infected animals 
hatch and develop to the infective third larval stage (L3) in two weeks given optimal 
conditions (Rose, 1961; Pandey, 1972 a, b; Young et al, 1980; Gibson, 1981). With adequate 
moisture the L3 migrate onto the herbage and are consumed by grazing animals. Third stage 
larvae, retaining the cuticle of the second stage, exsheath in the rumen and may penetrate the 
gastric glands within 6 hours of ingestion (Osborne et al, 1960). After two further moults L5 
emerge onto the abomasal surface and become adult. The life cycle is slightly faster in sheep 
(Armour et al, 1966), but eggs generally appear in the faeces of both bovine and ovine hosts 
21 days after initial infection. In certain instances (vide infra) development can arrest at the 
early stage of L4 (EL4), to resume at up to six months later.
1:3: Inhibited or arrested larval development (Hypobiosis).
Seasonal and immunological mechanisms of inhibition of the larval development of 
Ostertagia spp. have been proposed (Anderson, 1988; Eysker, 1993). Inhibition occurs at a 
precise stage in early parasitic development (EL4). Hypobiotic larvae have lowered metabolic 
rates and there is cessation of growth. Winter inhibition, seen in colder climates such as 
northern Europe, has been associated with the chilling of larvae prior to ingestion. The 
climatic factors responsible for the summer/dry season inhibition of warmer climes are less
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well known. There can be marked variations in the susceptibility of different parasitic strains 
to become inhibited (Armour et al, 1967; Borgsteede and Eysker, 1987). In field trials, 
towards the end of the grazing season, the extent o f inhibition was greater in permanently 
grazed stock than in previously naive, tracer animals, demonstrating a potential influence of 
host resistance (Eysker, 1993). At least in northern Europe the onset of adverse climatic 
conditions favouring inhibition is often at the same time as host resistance is building. Factors 
or stimuli causing the resumption of development are unknown. The time course of inhibition 
may be set by the parasites themselves (Armour and Bruce, 1974). The synchronous 
development of large numbers of inhibited larvae giving rise to Type II ostertagiasis (vide 
infra), and the low prevalence, although this may be due in part to efficient prophylaxis, and 
variable onset of this condition point to the involvement of specific host factors.
1.4: Parasitic gastritis.
At the turn of the last century and in the early parts of this century reports of the biology of, 
and disease seen in association with, trichostrongyle parasites of ruminants were sporadic, but 
reflected the world-wide distribution of these parasites (Ostertag, 1890; Stiles, 1900-1901; 
Gardner, 1911; Ransom, 1911; Ackert and Moldoon, 1920, Stewart and Crofton, 1941). 
Abomasal parasitism was seen as a significant cause of diarrhoea, anorexia, weight 
loss/failure to thrive and mortality in affected animals.
It was not until the late 1950’s that studies began to relate aspects of the biology of parasites 
to disease and to distinguish between separate disease syndromes. Douvres (1956) described, 
in detail, the morphology of the parasitic stages of O. ostertagi, and the concept of larval 
inhibition and the delayed onset of disease was noted (Martin et al, 1957).
In 1965, Anderson et al classified bovine ostertagiasis on the basis of three phases of disease: 
Type I, Pre-type II and Type II. Of these only Types I and II were clinically apparent. Type I 
disease was as seen in calves at grass for the first time, from late July until the end of the 
grazing season and arose from the development of sufficient parasite burden to cause disease, 
with minimal inhibition of larval development. The disease is generally a high morbidity, low 
mortality scour with accompanying anorexia and weight loss (Armour et al, 1973). Large, 
clinically inapparent populations of inhibited larvae characterise the Pre-type II phase. Up to 
80 per cent of the total worm population may be inhibited (Armour, 1970) and animals appear
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healthy unless the numbers of emergent larvae, having resumed development, are sufficient to 
produce clinical signs. Type II disease has been described by some workers as atypical 
gastritis (Martin et al, 1957), and arises with the resumption o f larval development in 
outwintered or housed stock after their first grazing season. The synchronous resumption of 
development by many larvae can be catastrophic, with very rapid loss of condition in affected 
animals. Type II is predominantly of low morbidity, but potentially high mortality (Armour et 
al, 1973).
It is generally accepted that similar disease classifications apply to ovine ostertagiasis (Reid 
and Murray, 1973), Although type II disease in sheep is not necessarily associated with high 
mortality.
1.5: Pathogenesis and pathophysiology of infections with Ostertagia spp.
Several key studies elucidated the pathogenesis of ostertagiasis. Gross and histopathological 
changes were demonstrated as a consequence of single experimental infections in cattle (Ross 
and Dow, 1965; Ritchie et al, 1966) and sheep (Armour et al, 1966) and experimentally 
induced lesions were entirely consistent with those found in the field (Anderson et al, 1965). 
Studies of the secretory changes in the abomasum, as well as changes in biochemical, 
serological and haematological parameters, were also made (Anderson et al, 1965; Ross and 
Todd, 1965; Jennings et al, 1966). Murray et al (1970) identified the key lesion of bovine 
Type I ostertagiasis as a hyperplastic gastritis and defined the progression of a single 
experimental infection in three phases;
Phase 1 (from the point of infection to the seventeenth day after infection); during this phase 
developing larvae occupied the glands and cellular changes were more or less confined to the 
parasitised gland.
Phase 2 (day 17 to day 35 after infection); more severe lesions were associated with the 
maturation and emergence of adults - changes initially confined to the parasitised gland had 
spread.
Phase 3 (day 35 after infection onwards); changes following the loss of the worm burden - 
essentially the return o f the mucosa to normal.
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In phase 1, the normal, mature fundic glandular epithelium, consisting principally of parietal 
cells, mucous neck cells and chief cells, was replaced by a poorly differentiated epithelium. 
Initially stretched by the physical presence of the larvae, this epithelium became hyperplastic 
and cells were eventually recognisable as tall, mucus producing cells. The chief, grossly- 
apparent lesion of phase 1 was a pale nodule, with an umbilicated centre. Nodules grew in 
size as the parasites enlarged and in heavy infection nodules coalesced (the “Morocco-leather” 
effect; Ritchie et al, 1966).
Phase 2 was characterised by the loss of differentiation and hyperplasia of cells in the 
surrounding, non-parasitised glands. Emergence o f the parasites was seen as critical in the 
spread of these changes. Phase 2 was also characterised by considerable epithelial cytolysis 
and loss of superficial epithelium. Initially epithelial loss simply enhanced the umbilicated 
appearance o f each nodule, but where larger areas were lost it was observable grossly as 
“thumb-print” lesions and diphtheresis (Ritchie et al, 1966). In sheep, hyperplastic changes 
spread out from the central parasitised gland as early as day 8 (Armour et al, 1966), in 
association with the emergence of young adults, so that disease progression was observed to 
be faster in sheep.
Ritchie et al (1965) and Murray et al (1970) reported exponential worm loss between days 16 
and 35 in cattle, but phase 2 was still dominated by the continued emergence o f the remaining 
parasites and their associated pathology. With eventual worm loss phase 3 was characterised 
by a gradual return to normal appearance and function, and the return of recognisable parietal, 
mucous neck and chief cells.
The hyperplastic nature of lesions was underlined by the presence of more mitotic figures than 
normal. Murray et al (1970) described the hyperplastic cell population ultrastructurally as 
cells showing none of the features of mature epithelial cells. The cytoplasm and often quite 
large nucleus were relatively electron-lucent and rough-surfaced endoplasmic reticulum 
(RSER) was conspicuously absent. However a sizeable Golgi complex often encircled the 
nucleus. As cell differentiation proceeded RSER accumulated and secretory granules appeared 
towards the apex of cells which were themselves increasingly columnar. The granules were 
positive for Periodic Acid Schiff (PAS) in light-microscopical studies, but generally 
heterogeneous in terms of electron densities and reflected differentiation of cells to a mucus- 
secretory type.
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Pathological changes of the Pre-type II phase were considered to be minimal (Anderson et al,
1965). Changes were confined to larval-occupied glands, with mucous cell replacement of the 
gland lining; mucous cell metaplasia. Areas of cytolysis were uncommon and rarely 
extensive. The switch to Type II disease can be dramatic, with the sequential development of 
numerous larvae, and hyperplasia in these circumstances has been shown to be marked 
(Murray, 1969; Snider et al, 1983) and the confluence of hyperplastic nodules depleted the 
mucosa of functionally differentiated cells and “thumb-print” lesions and areas of diphtheresis 
were extensive.
Mucous cell hyperplasia invariably results in derangements of abomasal secretory function in 
both Type I and Type II disease. When much of the abomasum is affected the ability to 
acidify the abomasal contents can be lost. Abomasal pH rises as the functional activity of 
parietal cells is lost. This has been implicated in the development of a rise in plasma 
pepsinogen, since pepsinogen is not converted to pepsin when pH is elevated (Jennings et al,
1966). Pepsinogen has also been thought to leak into the plasma through the impaired cell 
junctions that have been demonstrated between hyperplastic and immature cells (Murray, 
1969, Murray et al, 1970). Loss of junctional integrity has also been considered responsible 
for the hypoalbuminaemia of infection. Murray (1969) demonstrated, in ultrastructural studies 
of Type II bovine ostertagiasis with associated severe hypoproteinaemia, that epithelial cells 
were uncharacteristically separated by spaces filled with electron-dense material. The 
electron-dense material was thought to be either- plasma proteins leaking towards the 
abomasal lumen or pepsinogen travelling in the opposite direction, or perhaps both.
1.5.1 Enhanced epithelial permeability and hypoalbuminaemia.
Ostertagiasis is well characterised as a protein-losing gastropathy (Murray, 1969; Holmes and 
Maclean, 1971). Protein loss probably occurs via a paracellular mechanism; through the 
widened tight junctions existing between hyperplastic epithelial cells. In studies conducted by 
Murray (1969) between 50 and 90 per cent of the zonulae occludentes, a component of the 
tripartite junctional complex normally existing between cells (Farquhar and Palade, 1963; 
Murray, 1970), were partially or completely separated. This separation was not fully 
explained and existed between quite mature, better differentiated cells where the contentions, 
that cells were pulled apart or that the junctions were incomplete due to immaturity, are less 
likely. Areas of significant cytolysis and epithelial shedding are also likely to contribute to
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plasma losses. Inflammatory changes in the microvasculature may also contribute (Murray,
1969).
Significant Nitrogen losses, reflecting overall protein loss, accrue due to the loss of plasma, 
epithelial cytolysis, the increased exfoliative rate of a hyperplastic mucosa and enhanced 
mucus production and secretion. Following oral inoculation of 9 to 13 month old lambs with 
300,000 or 900,000 O. circumcincta larvae mean serum albumin concentration declined 
similarly in both infected groups after 1 week of infection and remained lower than that of 
uninfected controls for at least four weeks (Holmes and Maclean, 1971). Faecal plasma losses 
and catabolic rates of albumin were also estimated. These values rose between the fifth and 
ninth days after infection and reached peaks at about one to two weeks, but declined to near 
normal values by the fourth week. Although faecal plasma losses were similar in both groups, 
albumin turnover was more marked in animals given the 900,000 larval dose and only these 
animals developed clinical signs. Taylor et al (1989) also demonstrated significant loss of 
albumin into the gastrointestinal tract of Ostertagia-infected calves, but detected no rise in 
faecal nitrogen. Lost protein may therefore be broken down and reabsorbed more distally in 
the gut. Urinary Nitrogen was, however, increased suggesting failure to utilise what was 
reabsorbed. Infected animals respond with increased de novo synthesis of albumin, but 
production may not match loss and plasma albumin remains lowered (Symons, 1989; Fox, 
1993).
1.5.2: Changes in abomasal pH.
Abomasal pH becomes elevated as hyperplastic changes become confluent. Elevation of 
abomasal pH in the bovine is therefore associated with the emergence of O. ostertagi from the 
mucosa at about 20 days after infection (Jennings et al, 1966) and in sheep elevation of pH 
may arise earlier (Armour et al, 1966), from day eight. As hydrogen ion concentration falls 
Na+ increases, whilst K+ and CF fall.
The loss o f mature parietal cells is not the sole cause of reduced acid secretion. Remaining 
and recognisable parietal cells may show morphological changes indicative of reduced, even 
negligible, parietal cell activity (Murray et al, 1970; McLeay et al, 1973). Features of normal 
parietal cells include extensive intracellular canaliculi lined by numerous microvilli (Murray,
1970). In the ultrastructural studies of Murray et al (1970) these features were often reduced,
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even absent. Such changes are similar to those seen in parietal cells subjected to strong 
chemical inhibition (Vial and Orrego, 1963). Stringfellow and Madden (1979) showed 
reductions of staining specific for the parietal cell enzyme carbonic anhydrase following the 
oral inoculation of 3 month old calves with O. ostertagi L3. Parietal cells in the vicinity of 
parasitised glands showed reduced staining and this reduction became widespread throughout 
the abomasum from 26 days following initial infection.
Bueno et al (1982a) suggested that elevation of abomasal pH in sheep infected with H. 
contortus was due, at least initially, to increased secretion o f bicarbonate, but that eventually 
parietal cell inactivity predominated. Similar early changes in H C 03' secretion may occur in 
ostertagiasis (Dakkak and Khallaayoune, 1984).
The bacteriostatic effect of the abomasal environment is likely to be diminished by elevated 
pH. Jennings et al (1966) detected increased numbers of viable bacteria in the abomasa of 
infected calves once the pH had risen to 7.0, and equated the severity of diarrhoea to the 
duration of the elevation of pH.
The exact mechanisms of the loss of mature parietal cells and of the inhibition of the activity 
of remaining parietal cells are unknown. It is possible that an inhibitory factor, that may 
facilitate parietal cell loss as well as inhibition of hydrogen ion secretion, is released from 
either the parasites themselves or from damaged host tissues. This inhibitory factor may 
potentially have different effects related to its concentration. Close to its proposed site of 
production in the parasitised gland, higher concentrations may cause the loss o f recognisable 
parietal cells, but at a greater distance and with lower concentrations, effects may manifest 
solely as the inhibition of parietal cell activity. It has been considered that parietal cell loss is 
due to the replacement of the normal gland lining by metaplastic mucous cells in response to 
the stretching of the gland by the motile parasite, it is unlikely that this itself would account 
for the inactivity of distant parietal cells.
Acid secretion in ostertagiasis was studied further by McLeay et al (1973), who monitored 
secretion from the main body of the abomasum in sheep in the presence of infection with O. 
circumcincta, whilst simultaneously measuring secretion from surgically separated fiindic 
mucosal pouches that were free of infection. Pouch hypersecretion of acid occurred in the face 
of the normal hyposecretion in the infected abomasum. The inhibition of parietal cell activity
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in the main body of the abomasum did not affect pouch activity, thus the putative inhibitory 
factor was not active systemically, only locally. Pouch hypersecretion was seen, rather, as 
evidence of a second mechanism operating in infected animals. An increase in the plasma 
concentration of the gut hormone gastrin (vide infra) was likely to be responsible.
The hypothesis that acid pH is deleterious to parasite survival, and that the worms would 
actively seek to increase abomasal pH, is attractive. It was perhaps not surprising that O. 
ostertagi parasites rapidly died in vitro at highly acidic pH (Eiler et al, 1981). Further, Eiler et 
al (1981) inhibited gastric acid production in rats in-vivo with a somatic extract of adult O. 
ostertagi. There are also rather scant reports of small molecular weight peptides, isolated from 
“in-vitro products of O stertagid\ which inhibited the respiration of isolated gastric glands in- 
vitro and enhanced mucus production and secretion in rat stomachs in-vivo (Rikihisa and 
Hammerberg, 1982). Since mitochondria occupy 30 to 40 per cent of parietal cell volume, in 
comparison to just 5 per cent in chief cells, 0 2 utilisation by gastric glands is highly correlated 
with acid production (Soil and Berglindh, 1987). Excretory/secretory (ES) products of 
Ostertagia ostertagi did not alter basal acid production, as measured by aminopyrine 
accumulation in isolated and dispersed, bovine gastric glands (McKellar et al, 1990a), but 
basal accumulation of aminopyrine was significantly reduced by cimetidine, omeprazole and 
thiocyanate. However some parietal cell inhibitors, e.g., Epidermal Growth Factor (Finke et 
al, 1985), do not alter basal secretory rates but do suppress stimulation by, e.g., histamine. The 
results of in-vitro experiments must be interpreted carefully as the conditions used for culture 
of worms may be vastly different from those prevalent in the abomasum.
In experiments, where parasites were transplanted directly into the uncompromised abomasal 
environment of previously parasite-naive animals, worms became established and were viable 
for a number of days (as evinced by positive faecal egg counts)(Anderson et al, 1985; 
McKellar et al 1986; McKellar et al, 1987). Worms may survive by exploiting the mucus 
layer, where conditions are markedly different from the highly acidic lumen; indeed, during 
necropsy, the majority of worms can be found closely adherent to the abomasal surface 
(Eysker and Kooyman, 1993).
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1.5.3: Hypergastrinaemia.
Acid hypersecretion, occurring in separated fundic pouches in the presence of infection of 
sheep with O. circumcincta in the main part of the abomasum, could be abolished by 
antrectomy (Anderson et al, 1981). The abomasal antrum is the major gastrointestinal source 
o f gastrin (in sheep: Reynolds et al, 1979; and in cattle: Fox et al, 1993). Specialised 
endocrine cells, the G-cells, store and secrete gastrin in response to changes in lumenal pH, 
lumenal amino acids and fatty acids, and a presumed neural input (Titchen and Anderson, 
1977). Hypergastrinaemia has been demonstrated directly by the radioimmunoassay of plasma 
gastrin in experimental infections of both cattle and sheep (Anderson et al, 1981; Fox et al,
1987) and in field studies of naturally-arising infections in grazing cattle (Entrocasso et al, 
1986a). In normal animals circulating gastrin is a 17 amino acid polypeptide (G-17), however 
the gastrin form associated with parasite-induced hypergastrinaemia is the 34 amino acid form 
(G-34)(Anderson et al, 1988; Fox et al, 1993). Incomplete post-translational processing of 
gastrin precursors (progastrins) probably accounts for this difference. G-cells may store 
gastrin as G-34 or even as larger forms and the sudden release o f stored gastrin in response to 
the stimulus of infection may prevent the completion of polypeptide splitting to the mature G- 
17. Elevated plasma gastrin occurs at the expense of G-cell stores, which are depleted, and it 
is likely that G-cell numbers are not changed, at least in the case of the lifespan of single 
experimental infections (Fox et al, 1993).
In cattle, hypergastrinaemia may well be caused solely by elevations of lumenal pH (Fox et al, 
1987; Fox et al, 1993). However in studies of infections in sheep (Anderson et al, 1981) mild 
hypergastrinaemia occurred in advance of any elevation in pH. When pH was markedly 
elevated at the time of parasite emergence then plasma gastrin was further increased. This 
favoured, therefore, an alternative hypothesis; that parasites stimulated gastrin release 
themselves. Indeed gastrin rapidly returns to normal following anthelmintic treatment and 
worm removal (Anderson et al, 1981). Cellular changes in infected abomasa spread to 
surrounding glands earlier in sheep than in cattle. It could therefore be argued that the putative 
inhibitory factor for parietal cell activity (vide supra) was released earlier in sheep and 
initially exerted incomplete control over parietal cells, hence early increases in circulating 
gastrin were able to maintain the acidity of the abomasum. This assumes that the stimulus for 
enhanced gastrin release is subtle and that initial reductions of parietal cell activity do not 
translate as significant or detectable increases in abomasal pH. Eventually inhibition of
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parietal cells becomes complete, or as in cattle the onset of inhibition is rapid and immediately 
total, so that abomasal pH can no longer be controlled and hypergastrinaemia becomes 
massive. As yet there is insufficient evidence to confirm either hypothesis.
Plasma gastrin became elevated within 24 hours of the direct transplantation of larval and 
adult stages of O. circumcincta into the abomasa of previously naive sheep (similar changes 
were observed with transplant of mainly adult populations)(Anderson et al, 1985). Elevation 
of plasma pepsinogen and reduced feed intake were associated with hypergastrinaemia. 
Reduced feed intake has also been seen with experimentally induced hypergastrinaemia 
consequent to parietal cell inhibition with omeprazole (Fox et al, 1989b). There may therefore 
be a close link between hypergastrinaemia and the anorexia of parasitic gastritis with 
Ostertagia spp. in ruminants.
The mechanisms of hypergastrinaemia in cattle and sheep in response to infection with 
Ostertagia spp., whilst superficially similar, may still prove to be different.
1.5.4: Plasma pepsinogen.
The mechanism of elevation of plasma pepsinogen concentration has been hotly debated. The 
“leak” theory expounded initially, whilst attractive, could not account for elevated blood 
zymogen at all times. Holmes and Maclean (1971) demonstrated plasma loss as a transient 
feature, but elevation of plasma pepsinogen was prolonged. In experiments where epithelial 
permeability was assessed using a marker of similar molecular weight to pepsinogen - 
Horseradish peroxidase - permeability was shown to be similar in infected calves and in 
uninfected controls (Stringfellow and Madden, 1979). Given that, after 26 days of infection, 
plasma pepsinogen in these animals was raised, that chief cells were denuded o f granules and 
that abomasal fluid had no peptic activity, these workers argued that pepsinogen secretion had 
occurred directly into the plasma and that the half-life of pepsinogen in plasma was long. 
Plasma pepsinogen declined rapidly in sheep infected with O. circumcincta following 
anthelmintic treatment (Anderson et al, 1981), and in calves with patent infections of
O. ostertagi, derived by larval inoculation or by transplantation of adults, plasma pepsinogen 
was elevated, but declined rapidly following antimuscarinic therapy with atropine, reaching 
lowest levels within four hours of treatment (Mostofa and McKellar, 1989). Where plasma 
pepsinogen had been elevated by the experimental hypergastrinaemia induced by repeat
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treatments with omeprazole (Fox et al, 1989b), plasma pepsinogen concentrations declined to 
approximate those of placebo treated animals within days of the cessation of omeprazole 
treatments. Thus the half-life of pepsinogen appears to be relatively short and 
hypergastrinaemia itself may result in elevated plasma pepsinogen concentration, presumably 
without affecting abomasal permeability. Gastrin is a known stimulant of pepsinogen 
secretion by chief cells in-vitro and in-vivo (Hersey, 1987). Hypergastrinaemia may therefore 
contribute to the elevated plasma pepsinogen concentrations associated with ostertagiasis, but 
this can only be of significance if a sufficient cell population is synthesising the zymogen and 
is still responsive.
Estimations of abomasal peptic activity have indicated reduced output (Ross and Todd, 1965). 
In calves fitted with abomasal cannulae and infected with O. ostertagi, abomasal peptic 
activities were maintained (Jennings et al, 1966), although levels varied widely. The dry 
matter content of abomasal contents has been shown to be reduced from 7 to 8 per cent to less 
than 3 per cent in sheep infected with O. circumcincta (Dakkak and Khallaayoune, 1984). 
Fluid loss or secretion into the abomasum may result in lower enzyme concentrations. 
Interpretation of lumenal peptic activities should therefore be made with caution; the stability 
of pepsinogen/pepsin in abomasal fluid has not been adequately researched and other factors 
such as the total volume of all secretions must be taken into account.
Elevated plasma pepsinogen in sheep in response to transplant o f mixed parasite populations 
(Anderson et al, 1985) and in calves transplanted with adult parasites (McKellar et al, 1986; 
McKellar et al, 1987) could be interpreted as a consequence of direct or indirect stimulation of 
chief cells by parasites. A parasite pro-secretory factor was associated with 
excretory/secretory (ES) products of both O. ostertagi and O. circumcincta and stimulated 
pepsinogen release from dispersed bovine and ovine abomasal glands (McKellar et al, 1990b).
Plasma pepsinogen is thus potentially influenced by many factors. A tripartite mechanism of 
enhanced permeability, which may only be a transient feature, stimulation of remaining chief 
cells by host factors, such as gastrin, and stimulation of the same cells by parasites, could best 
explain the wide range of responses seen.
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1.5.6: Gastrointestinal motility and the onset of diarrhoea.
There is little information on changes of gastrointestinal motility in infections with Ostertagia 
spp. The rate of passage of digesta of calves infected with O. ostertagi parasites was reduced 
and part of this reduction could be explained by the reduced feed intake of these animals (Fox 
et al, 1989a). In sheep infected with T. axei and Chabertia ovina (Bueno et al, 1975) abomasal 
emptying rates were reduced within 4 to 6 hours after infection. Diarrhoea occurred after 
about 23 days, but the major changes in motility actually preceded it. The electrical activity 
most responsible for propulsion in ruminant gut - the Migrating Myoelectric Complex 
(MMC)(Gregory, 1985) - was severely disrupted and reticular and abomasal activity also 
declined. After recovery from diarrhoea MMC’s returned to normal. In studies of sheep 
infected with H  contortus (Bueno et al, 1982a), infected animals did not develop diarrhoea, 
but the water content of faeces did increase. The duration of the abomasal antral motor cycle 
was reduced by infection, the frequency of duodenal MMC’s was increased and the rate of 
duodenal flow was also increased. It was suggested that reduced duodenal acidification, 
associated with a less acid abomasal outflow in infected animals, may have reduced inhibition 
of duodenal activity. Motor disturbances were recorded within 4 hours of an intra-venous 
injection of a larval extract o f H. contortus (Bueno et al, 1982b), and this suggests a direct 
chemical mechanism of stimulation of muscle activity by parasites.
Many parasites, including O. circumcincta, secrete acetylcholinesterase (Ogilvie et al, 1973; 
Douch et al, 1988; Oppermann and Chang, 1992). Acetylcholinesterase could potentially 
modulate intestinal muscle activity by destroying acetylcholine - the biological holdfast. 
However Ostertagia spp. do not secrete as much enzyme as other nematodes such as 
Trichostrongylus spp. (McKeand, J., personal communication). Recent work favours the 
hypothesis that secretion of acetylcholinesterase has important anti-inflammatory, and 
immune-modulatory effects (vide infra).
Increased abomasal pH in calves infected with O. ostertagi was associated with the onset and 
severity of diarrhoea (Jennings et al, 1966). Presumably the bacteriostatic effect of the mucosa 
was lost in these animals since increased numbers of viable rumen microflora were detectable 
in the abomasa. The potential consequences of bacteria and protozoa surviving the abomasum 
has not been adequately researched.
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In diarrhoeic animals water turnover can be increased (Holmes and Bremner, 1971). 
Surprisingly, in some studies in O. ostertagi infected calves there were increases in both 
faecal and urinary water losses (Parkins et al, 1982). However in Cooperia pectinata infected 
calves urine losses were considerably reduced and total water loss was less in infected animals 
when compared to controls (Bremner, 1982). Water intake and retention are often increased in 
parasitised cattle and sheep, the latter arising due to increased tissue water and expanded 
plasma volume (Parkins et al, 1982; Entrocasso et al, 1986 b).
At present our knowledge of the likely causes of diarrhoea in parasitised ruminants is 
speculative and poor in general, perhaps more so than for any other aspect of the 
pathophysiology of trichostrongyle infections.
1.6: Immunity to ostertagiasis and the acquisition of host resistance.
Acquired, immune-mediated resistance to ostertagiasis develops slowly, and generally is most 
evident after the second grazing period under natural conditions (Holtenius et al, 1983; 
Entrocasso et al, 1986a). This immunity is usually not sterile. Single monospecific 
experimental infections of calves with O. ostertagi did not protect against subsequent 
challenge (Herlich and Tromba, 1982); only after sustained or repeated infection can effects 
attributable to acquired resistance be detected (Michel et al, 1973; Smith et al, 1983; Klesius,
1988).
In contrast to many viral and bacterial infections, where B cell memory may be sufficient for 
the provision of sterile immunity, responses to protozoal and helminth pathogens involve a 
complex T cell response (Reiner, 1994). Present understanding of T cell responses involves 
the Thl/Th2 dichotomy. Naive T helper cell precursors are stimulated via cytokines to 
develop either phenotype in response to input from a variety of other cells (e.g. T and B cells, 
macrophages, mast cells and eosinophils). Such activation can predict the efficacy of 
subsequent immune responses. Thl responses, associated with Interferon-y expression, confer 
greater resistance to protozoal infection, whereas Th2 responses are linked to helminth 
expulsion via an effector arm linked by Interleukins 4, 5 and 9. The resistance or susceptibility 
of certain strains of mice to Trichuris muris infection, has been shown to be due to whether 
responses are driven primarily by Thl (susceptible) or Th2 (resistant) pathways (Else et al,
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1992). Thus the quality of T cell recall may be just as important as other factors, such as the 
immunogenicity of a particular protein.
Manifestations of acquired immunity to many trichostrongyloses include; reduced magnitudes 
of pathological change and reduced pathophysiological reactions, lower worm burdens, 
decreased egg output, shorter adult worms and the absence of vulval flaps in female worms, 
implying impaired worm development (Klesius, 1988, 1993). Reduced faecal egg counts may 
be achieved in some instances, not by reduced worm burden, but by the reduced fecundity of 
individual female worms (Wallace et al, 1995). Effects may be manifest therefore as 
interference in worm development rather than worm expulsion.
Inflammatory cells are important in ostertagiasis, and reactions are characterised by the 
infiltration of numerous eosinophils into the mucosa and circulating eosinophilia (Ross and 
Dow, 1964; Ritchie et al, 1966; Wiggin and Gibbs, 1987; Snider et al, 1988). Other 
infiltrating cell types include lymphocytes, plasma cells, mast cells and globule leukocytes. 
Increases in the weights of local lymph nodes also occur with increased mitotic activity in 
germinal centres (Curtain and Anderson, 1971; Gasbarre, 1986; Wiggin and Gibbs, 1990).
Recent work has shown that of sheep infected with O. circumcincta, those that had higher 
mast cell numbers also had higher globule leukocyte and eosinophil numbers and had higher 
numbers of plasma cells and greater parasite-specific antibody responses (Stear et al, 1995b). 
The same workers argued that resistance to O. circumcincta, was due at least in part to local 
mucosal antibody responses, which regulate individual worm development and fecundity, and 
to local immediate hypersensitivty responses which regulate worm burdens. This resistance 
develops in three phases. During the first phase animals are susceptible and host effector 
mechanisms are developing. In the second phase antibody-mediated responses are manifest 
and suppress egg production. The generation of globule leukocytes, and of immediate 
hypersensitivity, is more prolonged and either prevents the establishment of incoming larvae, 
or expels established worms. The third phase is therefore associated with lower worm burdens 
and continued reduction of the fecundity of worms that do establish.
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1.6.1: Antibody production.
Studies of antibody in infected animals show that antibody responses develop slowly and to a 
variety of somatic and metabolic (ES) antigens from different parasitic stages (reviewed by 
Klesius, 1993). The greatest antibody responses accompany the transition of L4 to adults 
(Kloosterman et al, 1984; Entrocasso et al, 1986a). Studies have shown increases in IgGl, 
IgM and IgA (Jensen and Nansen, 1978, Smith et al, 1983, 1984; Canals and Gasbarre, 1990). 
Different studies have differed in the predominant antibody detected, but IgG2 levels are 
usually low. Canals and Gasbarre (1990) showed a peak in IgGl after 35 days of a primary 
infection and an anamnestic response to a challenge infection. The kinetics of an IgA response 
were similar, but lower levels were recorded. Jensen and Nansen (1978) showed that antibody 
levels of a number of subclasses were correlated with worm burdens.
As a cautionary note plasma IgA responses may not correlate well with local mucosal IgA 
responses (Sinski et al, 1995) and an association has been observed between the numbers of 
fourth-larval stages of O. circumcincta and the local IgA and IgGl responses in the mucosae 
of infected sheep (Stear et al, 1995b). Smith and coworkers (1995) showed that worm length 
was associated with peak IgA responses in gastric lymph and sheep with higher IgA responses 
had shorter worms.
Immunoglobulin E is recognised as an important isotype elevated by helminth parasites. 
Levels o f IgE paralleled worm burden in lightly infected calves but in heavily afflicted 
animals IgE was inversely proportional to burden (Thatcher et al, 1989; Baker and Gershwin, 
1993). Baker and Gershwin (1993) suggested that lowered IgE may be due to binding of IgE 
to mast cells and subsequent mast cell turnover. One function of IgE is the initiation of 
immediate hypersensitivity reactions (anaphylaxis) by binding to mast cells (Ward and 
Wagland, 1990).
Ostertagia specific antibody present in calf sera prior to turnout, when exposure to parasites 
has not occurred, may be ascribable to maternally-derived antibody, but clearly is not 
protective (Entrocasso et al, 1986a; Gasbarre et al, 1993).
37
1.6.2: Cellular immunity.
Eosinophils may act as immune effector cells in responses to helminth parasitism (Rothwell 
and Dineen, 1972; Dawkins et al, 1989). Grove et al, (1977) showed antibody and 
complement dependant killing of Trichinella spiralis larvae. Klesius (1993) refers to studies 
contained in the thesis o f Washburn (1984), who was said to have demonstrated binding of 
eosinophils to O. ostertagi larvae, but their consequent actions, and potential for parasite 
damage, were unknown. There is some doubt as to whether eosinophils have direct effector 
activity against Ostertagia spp. (Huntley et al, 1995).
Hypersensitivity is a likely component of the cellular response to Type I ostertagiasis (Snider 
et al, 1985a; Wiggin and Gibbs, 1987, 1990; Cross et al, 1987; Klesius, 1988, 1993), and both 
eosinophils and mast cells may be involved. Both immediate (Cross et al, 1987) and delayed 
(Snider et al, 1985a) hypersensitivity reactions may occur. Eosinophils produce hydrogen 
peroxide, in a respiratory burst akin to that of neutrophils, and this as well as eosinophil major 
basic protein may account for the eosinophil as a potent effector of cell damage. Mast cells 
contain eosinophil chemotaxins and a variety of potent mediators of inflammation 
(Wasserman, 1979; Paul et al, 1993) and are considered to be the precursors of globule 
leukocytes (Huntley et al, 1984). Globule leukocytes are situated intraepithelially and have 
been associated with the acquisition of resistance to infection (Jarrett et al, 1967; Miller et al, 
1983; McClure et al, 1992). These cells were also, thought to be responsible for an anti- 
parasitic activity detected in the abomasal mucus layer (Douch et al, 1986).
1.6.3: Modulation of immune responses by Ostertagia spp. parasites.
There is a wealth of accumulated evidence suggesting that modulation o f immune responses 
by parasites occurs in ostertagiasis (Klesius, 1993). Modulation is thought to occur in five 
areas:
1. Transient and non-specific suppression of lymphocyte reactivity. This suppression 
has been seen in both naturally and experimentally infected animals. Lymphocyte reactivities 
to larval (L3) antigen and stimulation with phytohaemagglutinin or concanavalin-A have been 
seen to be suppressed (Klesius et al, 1984; Cross et al, 1986; Snider et al, 1986; Wiggin and
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Gibbs, 1990). Suppression occurs in the pre-patent period, associated with the maturation of 
L4 through to the adult stage (Klesius et al, 1984; Cross et al, 1986).
2. Suppression of antibody. Antibody responses in parasitised animals develop slowly. 
Soluble larval extracts reduced the antibody responses of mice to O. ostertagi antigen and to 
Keyhole limpet haemocyanin and sheep erythrocytes (Cross and Klesius, 1989).
3. Eosinophil chemotaxis. There are two potential mechanisms of eosinophil 
chemotaxis in infection. Ostertagia ES contains Eosinophil Chemotaxis Factor (ECF) - a 
lectin - which may be released by larvae into the abomasal tissues (Washburn and Klesius, 
1984; Klesius et al, 1985, Klesius et al, 1989). Eosinophil chemotaxis also occurs after 
intradermal injection of ECF-lectin. Mast cell activation may also result in release of 
eosinophil chemotaxins (Marom and Casale, 1983). Both mechanisms may explain the 
accumulation of these immune cells around parasitised glands. Any advantage this may confer 
on the parasite is unknown.
4. Enhanced lymphocyte blastogenesis. Larval extracts stimulated blastogenesis in 
lymphocytes from parasite-naive calves (Cross et al, 1986; Wiggin and Gibbs, 1990) and 
abomasal lymph nodes from infected animals are larger and show increased mitoses compared 
to those from uninfected control animals (Curtain and Anderson, 1971; Gasbarre, 1986; 
Wiggin and Gibbs, 1990).
5. The secretion of acetylcholinesterase may also be an important mechanism of 
immune-modulation for nematode parasites. This enzyme could prevent the cholinergic 
stimulation of leukocytes. This process is thought to be of greater importance for those 
parasites that establish long-lasting infections with little associated pathology (Pritchard, 
1993), and may therefore be of little importance in ostertagiasis.
Gastrointestinal nematode parasites may initially occupy immunologically privileged sites in 
the host, separated from host immune cells by epithelial barriers. Immune responses may rely 
therefore on diffusion/uptake o f ES products or upon inflammation and tissue damage. 
Immune modulation by soluble factors released by parasites may form the first interactions 
between the host and parasite. Tissue and parasite damage due to hypersensitivity reactions, 
with associated release of parasite antigens, and the eventual development of antibody to
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immunomodulatory factors may enable more effective responses to parasites to develop that 
are capable of expelling the parasite, or curtailing its development/activity.
1.6.4: Hypersensitivity reactions.
Following challenge exposure of previously exposed animals, that have some degree of 
acquired immunity, certain pathophysiological reactions have been demonstrated. Amongst 
these is the rapid elevation of plasma pepsinogen, seen in immune grazing sheep (Anderson, 
1973), in immune dairy cows (Armour et al, 1979) and in immune sheep challenged after 
housing (Yakoob et al, 1983). Yakoob et al (1983) demonstrated concomitant elevation of 
plasma pepsinogen concentration and mucosal permeability, the latter evinced by albumin 
loss into the gut. Hypersensitivity responses are thought to be the likely cause, although 
treatment with the mast cell stabilising drug, sodium cromoglycate did not affect the 
magnitude of the pepsinogen response in immune ewes challenged with O. circumcincta 
(McKellar and Bogan, 1987). Hertzberg et al (1995) demonstrated rapid increases in both 
plasma pepsinogen and plasma gastrin in animals previously exposed to Ostertagia 
leptospicularis and given challenge infections, although abomasal pH was not measured. 
Hypersensitivity reactions were seen as the likely cause.
A syndrome of oedematous ostertagiasis has been described in two to three year old cattle 
(Raynaud and Bouchet, 1976), where the abomasal folds were grossly oedematous at 
necropsy, it is likely that this syndrome is a consequence of the larval challenge of immune 
animals.
The continual triggering of hypersensitivity responses in immune grazing animals, ingesting 
larvae may have detrimental effects on production (Anderson, 1973).
1.7: Comparative pathology.
In man three syndromes of hyperplastic gastropathy are recognised (Komorowski and Caya, 
1991); all are relatively rare. The syndromes have been classified on the basis o f either gastric 
acid hypersecretion or hyposecretion, the existence o f normal gastrin levels or of 
hypergastrinaemia, and the pathological changes seen. The gastric glandular mucosa 
comprises two parts: the pit (foveolus) and the gland itself (containing parietal, chief and
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mucous neck cells), and relative structural changes in the pit and gland characterise each 
syndrome. Each of the three syndromes represent morphologically unique hyperplastic 
gastropathies, accompanied by specific clinical and biochemical features:
1. Zollinger-Ellison (Z-E) syndrome arises due to neoplasia of gastrin-producing G- 
cells usually of the pancreas (McGuigan, 1983). Zollinger-Ellison syndrome is characterised 
as a hyperplastic, hypersecretory gastropathy with recurrent/intractable ulcer disease. Acid 
hypersecretion is secondary to hypergastrinaemia. Glandular hyperplasia and parietal cell 
hyperplasia occur in the face of a normal foveolar compartment, and glandular changes are 
entirely consistent with those seen, in experimentally induced hypergastrinaemias (Waldum et 
al, 1991).
2. Hyperplastic, hypersecretory gastropathy (HHG), without hypergastrinaemia. A 
gastropathy of unknown aetiology that is clinically and pathologically similar to Z-E 
syndrome, but gastrin secretion is normal.
3. Hyperplastic, hyposecretory gastropathy (Menetrier’s Disease). Giant thickening of 
the mucosal folds is achieved by massive foveolar hyperplasia and gland atrophy. There is 
acid hyposecretion, even achlorhydria, and reduced acid secretory responses to 
histamine/pentagastrin stimulation. The hypergastrinaemia accompanying Menetrier’s disease 
occurs secondarily to elevated gastric pH. Consequent to the presence of enlarged pits there is 
often mucus hypersecretion. Menetrier’s disease is seen in three distinct forms. Menetrier’s 
disease accompanies gastric cytomegalovirus infections in children (Coad and Shah, 1986; 
Oderda et al, 1990; Occena et al, 1993). In adults it is generally idiopathic, “a gastropathy 
associated with massive foveolar hyperplasia but minimal inflammation” (Wolfsen et al,
1993), but a distinct form does exist that is associated with an underlying lymphocytic 
gastritis (Haot et al, 1991; Wolfsen et al, 1993). The cellular and biochemical features of 
Menetrier’s disease are very similar to those seen in ostertagiasis, especially Type II disease 
(Snider et al, 1983). Diarrhoea is not a consistent feature of Menetrier’s disease although 
features such as reduced acid secretion are common to both Menetrier’s and ostertagiasis. 
Rather the principal clinical signs of Menetrier’s disease are weight loss, epigastric pain and 
vomiting. It is often difficult to distinguish the three human hyperplastic gastropathies on 
clinical signs alone (Komorowski and Caya, 1991), and enlarged mucosal folds per se are 
generally asymptomatic.
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All hyperplastic gastropathies may be accompanied by loss of plasma and cellular protein, as 
well as blood, into the gastrointestinal tract. Plasma protein loss is thought to occur in an 
identical manner as for ostertagiasis, i.e. through the widened tight junctions between 
hyperplastic epithelial cells (Kelly et al, 1982).
Recent work has implicated overproduction of the peptide growth factor Transforming 
Growth Factor-alpha (TGF-a) in the development of Menetrier’s disease (Dempsey et al,
1994). Transforming Growth Factor-a has potent mitogenic effects for gastric epithelial cells, 
affects end-stage differentiation of gastric epithelial cells, inhibits acid production and 
enhances mucus secretion (Rhodes et al, 1986; Derynck, 1988; Dempsey et al, 1994, 
Bockman et al, 1995; Lee et al, 1995).
Foveolar hyperplasia and gland atrophy are frequently seen in gastric responses to a wide 
variety of insults (Barker et al, 1993c). Chronic trauma due to foreign bodies may be the 
triggering stimulus, as may some chemical irritants (Lushbaugh, 1947). Foveolar hyperplasia 
can often be found at the margins of ulcers (Barker et al, 1993c). Chronic abomasal 
involvement in mucosal disease or herpes rhinotracheitis, which are both viral diseases of 
cattle, (and some other viruses) can result in similar pathological changes. An autosomal 
recessive gene may be responsible for the hyperplastic changes seen in an in-bred mouse 
strain (Stewart and Andervont, 1938; Andervont, 1939a,b; Stewart, 1941). Intracellular, 
Campylobacter-1 ike organisms were associated with this kind of pathology in a Beagle dog 
(Leblanc et al, 1993), but no direct cause could be demonstrated for the condition arising in 
Basenji dogs (Van Kruiningen, 1977) or in occasional case reports in Boxers and Bull Terriers 
(van der Gaag et al, 1974, 1976).
The commonest, specific causes of pathological change leading to foveolar hyperplasia and 
gland atrophy are the helminth parasites of either the stomach/abomasum itself or even those 
of other tissues. Hyperplastic lesions similar to those seen in ostertagiasis have been 
associated with many nematode infections including: T. axei infections of cattle (Ross et al, 
1967; Ross et al, 1968; Snider et al, 1985b) and horses (Leland et al, 1961), H. rubidus in pigs 
(Stockdale, 1974), habronemiasis in horses (Nair and Damodaran, 1969), and the massive 
hyperplasia resulting in large adenomatous plaques in the stomachs of primates caused by the 
nematode N. nochti (Bonne and Sandground, 1939). Following intestinal infection o f sheep 
(and minimal abomasal involvement) with T. colubriformis (Barker and Titchen, 1982)
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abomasal acid secretion was reduced and there were mild signs of hyperplasia of primarily 
mucus producing cells. Ultrastructural features of inactivity were seen in parietal cells, which 
were also less prominent in light microscopical study. Infection with T. colubriformis is not 
the only non-gastric helminthosis to result in hyperplastic change. Development of the 
metacestode Taenia taeniaformis in the livers of rats resulted in massive hyperplasia in the 
stomach and small intestine (Cook and Williams, 1981). Stomach changes closely resembled 
Menetrier’s disease and hypergastrinaemia developed as a consequence of the loss of parietal 
cells and acid secretory activity (Cook et al, 1981). Hyperplasia also occurred in the 
uninfected partners of parabiotic pairs (surgically prepared rat pairs sharing blood supply). In 
antrectomized rats hyperplasia still developed, but hypergastrinaemia did not.
Gastric mucosal hyperplasia (specifically foveolar hyperplasia and gland atrophy) develops as 
a consequence of usually chronic insult. The commonality of cell changes in response to a 
variety of helminth parasites, viruses, chemical irritants and genetic factors suggests that 
hyperplasia is primarily a host response, although the possibility exists that parasites might 
seek to initiate, or enhance such a response, ostensibly to improve their survival in the gastric 
environment. Transforming Growth Factor-a has been identified as a possible mediator of this 
common pathway, but the precise stimuli for its increased expression, or enhanced effects, are 
largely unknown.
1.8: The excretory/secretory system of nematodes.
Nematodes possess what has been termed a Secretory-Excretory (S-E) system (Bird and Bird, 
1991). The Secementean S-E system, although differing widely between different taxonomic 
groups, generally comprises an H-shaped tubular canal system with the two lateral canals 
running in the lateral cords. The S-E cell nucleus is commonly associated with the connecting 
transverse canal and the lateral canals are extensions of this cell. There is also an A-shaped bi- 
nucleate S-E gland cell, the nuclei situated in opposing arms. The lateral canals and the S-E 
gland cell may connect at a sinus or ampulla, from here a duct leads to the exterior, and is 
formed by a duct cell and a pore cell. The S-E pore generally opens in an anterior, mid-ventral 
position on the worm. The S-E systems of Caenorhabditis elegans and H. contortus are quite 
similar and the accessory S-E gland cells are packed with electron-dense granules (Nelson et 
al, 1983; Wharton and Sommerville, 1984). The ampulla and S-E cells are thought to be 
important for osmoregulation), since worms quickly fill with fluid following laser ablation of
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the ampulla, S-E cell, or duct and pore cells, but not following ablation of the gland cell (Bird 
and Bird, 1991).
Lee (1970) demonstrated histochemically the presence of various enzymes, esterases, 
acetylcholinesterases and aminopeptidases, in the gland celh When T. colubriformis worms 
were placed on substrate gels protease activity was demonstrable, but restricted to the area 
around the S-E pore (McLaren et al, 1974). S-E gland activity may therefore have a role in 
feeding. The gland cell in H. contortus decreased in volume in response to C 0 2 stimulation, 
and might therefore be involved in exsheathment (Davey and Sommerville, 1982). S-E gland 
function may also include the secretion of protective or lubricating glycoproteins that may 
bind to the nematode cuticle (Bird and Bird, 1991). Any substance released in vitro or in vivo 
from parasites could be from a number of sources; the S-E system itself, the mouth, anus, 
reproductive organs, or a number of other structures with external communication. The term 
Excretory/Secretory (ES) products for in vitro released substances is therefore somewhat 
misleading. However there is some evidence to suggest that products are released by parasites 
to exert effects externally. The nervous co-ordination and control o f the S-E system of 
nematodes is poorly understood. The precise spectrum of secretions, their chemical natures 
and functions, is unknown. The control of secretion may be vastly different in vivo, in the 
natural worm habitat, than in in vitro worm cultures.
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1.9: Study objectives.
The studies presented in this thesis were intended to cover four main areas;
1. An evaluation of four different methods for assay of plasma pepsinogen concentration, 
ostensibly to find a method suitable for use in the subsequent studies reported in this thesis.
2. The effects of Excretory/secretory (ES) products of O. circumcincta on pepsinogen 
secretion and gastrointestinal smooth muscle activity were assessed. In vitro methods were 
used in the study of substances present in ES capable of stimulating pepsinogen secretion and 
gastrointestinal smooth muscle activity. Responses were compared in parasite-naive and 
previously exposed animals to assess whether they were the result o f hypersensitivity to 
antigens present in ES.
3. The fate of cells producing pepsinogen in the abomasa of ruminant animals with abomasal 
nematode infection was determined. Immunohistochemical techniques for the localisation of 
pepsinogen in bovine and ovine mucosae were used to compare the staining patterns in 
normal, parasite-naive animals and those with ostertagiasis and haemonchosis. Changes 
observed in the distribution of pepsinogen were then compared to the cellular changes 
observed in conventionally stained histological sections.
4. The role of Transforming Growth Factor-alpha in the pathogenesis o f ostertagiasis was 
investigated. The potential involvement of TGF-a in the development of hyperplasia was 
investigated initially by an examination of the distribution of the growth factor in normal and 
parasite-affected mucosae. These studies utilised immunohistochemical techniques to 
compare the distributions of both TGF-a and the related peptide Epidermal Growth Factor in 
the same tissues.
2: GENERAL MATERIALS AND METHODS.
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2.1: Chemicals.
All chemicals used in the studies reported in this thesis were obtained from Sigma Chemical 
Co. (Poole, England), unless otherwise stated.
2.2: The estimation of the pepsinogen concentrations of plasma and other samples.
Pepsinogen concentrations were assayed using a modification o f the method o f Paynter (1992) 
which will be discussed fully in Section 3.2.
2.3: The measurement of tissue pepsinogen concentration.
Tissue pepsinogen concentrations were estimated by measuring the total peptic activity of 
tissue homogenates. Basson et al (1990) extracted pepsinogen from intact guinea pig gastric 
mucosa by homogenisation and freeze thawing in 0.1 per cent Triton X-100, a non-ionic 
surfactant. A similar method was used to extract pepsinogen from ovine abomasal mucosa 
before assay o f pepsinogen concentration by the modified method of Paynter (1992).
Small sections of abomasal mucosa were cut using a cylindrical punch, thus all sections were 
of identical area. Tissues obtained in this way were generally less than 0.2 g in weight of wet 
tissue. The tissues were gently washed clean of gastric contents and blotted dry and the wet 
weight of individual tissues was recorded. The tissues were then thoroughly homogenised in 
up to 10 ml of detergent solution. The detergent solution was composed of 0.1 per cent Triton 
X-100 (BDH Chemicals, Poole, England), in 0.01 M Hydrochloric acid, pH 2.0. Pepsinogen 
concentration was then determined in the supernatant produced after centrifugation (2,000 g 
for 30 mins). This method was not assessed for its reliability, precision or accuracy, but an 
assessment of the short term stability of peptic activity in solution, using this technique, was 
made. Five abomasal mucosal pieces (of identical area) from one sheep were homogenised 
separately and the individual homogenates were then incubated at 37°C in a water bath for 2 
hours. Aliquots of each homogenate were removed at 0, 30 mins, and at 1 and 2 hours and the
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peptic activity measured following centrifugation. The results in terms of total tissue 
pepsinogen per mucosal cut at each time point and the mean values of all five tissues are 
displayed in Table 2.1.
The results were analysed by one-way analysis of variance, to test for the effect of time, and 
this was not found to be significant (p=0.846) although the mean values did increase slightly 
with time. These preparations were therefore considered adequately stable over two hours and 
since the degree of homogenisation was equivalent for all tissues the method was considered 
reliable.
Table 2.1: Total pepsinogen content (iU) of homogenates of individual mucosal pieces 
over time.
Time (mins)
Tissue
1 2 3 4 5 mean±S.E.
0 2937.86 2297.87 2268.80 2966.93 4683.06 3030.92
±439.35
30 4201.80 1816.94 2697.12 3151.30 3577.18 3088.84
±403.27
60 3922.15 2228.46 3298.19 2941.61 4100.44 3298.19
±339.45
120 4309.57 2304.39 2992.79 3770.83 3980.40 3471.62
±363.47
2.4: Assay of Lactate Dehydrogenase.
Lactate dehydrogenase (LDH) concentration in the mucosal bathing fluid of intact abomasal 
mucosae, maintained in vitro, was measured using a commercial assay kit (Sigma 
Diagnostics, catalogue no. 288-10, procedure no.288-UV). The kit was based on the 
interconversion of lactate and pyruvate, a reaction catalysed by Lactate dehydrogenase:
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Lactate + NAD <=> Pyruvate + NADH + H+
The oxidation of lactate to pyruvate is accompanied by the reduction of Nicotinamide adenine 
dinucleotide (NAD) and the formation of NADH results in an increase in absorbance at 340 
nm and this increase is directly proportional to the LDH concentration.
The test reagent contained 50 mM Lactate and 7 mM NAD, buffered to pH 8.9. The reagent 
was warmed to 30°C and 1.0 ml was pipetted into a clean cuvet before the addition of 50 pi of 
the sample to be assayed. The contents of the cuvet were then mixed by inversion and then 
placed into the cuvet compartment (warmed to 30°C) of the spectrophotometer (Pye-Unicam 
Sp8-500). The absorbance at 340 nm was read after 30 seconds and then again after a further 
minute. The initial value was subtracted from the final value to give the change in absorbance 
in one minute. Results were expressed as U/L, given that one unit of LDH activity would 
catalyse the formation of one micromole of NADH per minute under assay conditions.
2.5: Assay of total protein concentration.
The determination of protein concentrations was carried out using a modification (Maizels et 
al, 1991) of the method of Bradford (1976). The presence of phenol red in the incubation 
medium used for parasite culture in the present studies was incompatible with the use of other 
methods of protein estimation (such as those using Bicinchoninic acid or Folin and 
Ciocalteu’s reagent). Bradford’s method utilises the binding of dye (Coomassie brilliant blue) 
to protein and the concomitant change in dye peak absorption from 465 nm to 595 nm.
Bradford’s reagent was made by dissolving 100 mg of Coomassie brilliant blue in 50 ml of 95 
per cent ethanol, and this was further dissolved in 100 ml of 30 per cent perchloric acid and 
then made up to 1 litre with distilled water. Final reagent composition was therefore as 
follows; 0.01 per cent Coomassie brilliant blue, 4.7 per cent ethanol and 3 per cent perchloric 
acid.
A 1 mg/ml bovine serum albumin (fraction V) solution was prepared with distilled water, 
which was then diluted to provide standards in the range 0 fig/ml to 1 mg/ml. Five protein 
standards (0, 1, 10, 100 pg/ml and 1 mg/ml) were treated in a manner identical to the
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unknown samples. One hundred microlitres of sample/standard was added to 0.9 ml of 
Bradford’s reagent and the mixture was then vortexed. Optical densities were measured after 5 
minutes at 595 nm using a Pye-Unicam Sp8-500 spectrophotometer and using 1 ml plastic 
cuvets. Plastic cuvets were not supposed to bind die (Maizels et al, 1991), but some degree of 
die retention was noted so that cuvets were rinsed with methanol and then water after each 
reading. Optical densities from the standards were used to construct a standard line from 
which the protein concentration (in pg/ml BSA equivalents) could be calculated.
2.6: Faecal egg counts.
Except where otherwise stated faecal egg counts were measured by a modification of the 
McMaster method (MAFF/ADAS, 1984b). Faecal samples were collected directly from the 
rectum of each animal, and counts were done that same day. Two grams of faeces was placed 
in a plastic 50 ml tube and water was added to make a total volume of 25 ml. The tubes were 
then shaken vigorously. Twenty five millilitres of saturated salt solution was then added and 
shaken, and the mixture was then passed through a 250 pm mesh screen (Endecotts Ltd., 
London, England). The strained fluid was kept, whereas the debris materials were discarded. 
The filtrate was shaken and sufficient volume was withdrawn using a Pasteur pipette to fill 
one chamber o f a McMaster egg counting slide (Gelman Hawksley Ltd., Northampton, 
England). A second volume was then withdrawn to fill the second chamber. In the half 
saturated salt solution strongyle eggs floated to occupy a position just below the coverslip, 
debris sinking. By focusing a dissecting microscope just below the coverslip only eggs were 
in focus. The total number of eggs counted in the two squares of the McMaster slide 
represented the eggs present in 0.3 ml of filtrate (2 x 0.15 cm x 1.0 cm x 1.0 cm). This figure 
multiplied by 83.33 gave the faecal egg count per gram of faeces.
In many instances a faecal egg count was done to confirm the absence of eggs (as in parasite- 
naive animals) to facilitate this the entire area of the McMaster slide was examined.
2.7: The preparation of Ostertagia circumcincta ES products.
Parasite naive and, in some cases, previously exposed sheep, o f predominantly the Scottish 
Blackface breed, and generally 6 to 9 months old, were infected with O. circumcincta L3 to 
allow the harvest of adult worm populations. Worms were also collected from sheep with
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naturally acquired, patent infections of predominantly O. circumcincta. These sheep had 
grazed pasture in south-west Strathclyde, where nematode infections have been shown to be 
predominantly of O. circumcincta (Stear et al, 1995a).
Experimental infection of sheep was accomplished by the oral administration of infective O. 
circumcincta L3 maintained in an aqueous suspension (usually 15,000-25,000 larvae per 
sheep). Donor sheep were killed at approximately 21 days post-infection when faecal egg 
counts confirmed the patency of infection and thus the presence of adult parasites in the 
abomasal lumen. At necropsy abomasa were collected and transported back to the laboratory. 
The abomasa were then opened along the greater curvature and the loose contents emptied 
into a 2 gallon container, many parasites were seen closely applied to the mucosal surface at 
this stage, so abomasa were thoroughly rinsed with sterile Phosphate-buffered Saline (PBS, 
pH 7.4) and if necessary worms still stuck to the mucosa were picked off individually. The gut 
contents and saline were then passed through a bed of several gauze sheets, which were then 
folded around the remaining solid contents and tied off. The gauze bags were then immersed 
in warm (37°C) PBS and left for two hours until the majority of worms had migrated free of 
the bags.
The worms were washed several times in final RPMI-1640 culture medium (Gibco BRL) 
supplemented with 1 per cent Glucose, 500 U/ml Penicillin and 500 pg/ml Streptomycin - 
replaced by 10 pg/ml Gentamicin in later incubations - and 0.001 per cent Di-thiothreitol (an 
anti-oxidant). Worms were incubated in 20 ml of final culture medium, in sterile containers at 
j7°C. The presence of antibiotics was to reduce contamination of ES with products of 
bacterial metabolism and help prevent any subsequent bacterial overgrowth of the cultures. 
Preparations were monitored regularly for the motility o f parasites, as an indication of 
viability, and were successfully incubated for 18 to 24 hours at which time the culture fluid 
was collected. If motility was still good the worms were then incubated for a further period in 
r.ew medium. Collected medium was passed through a 0.22 pm, low protein binding filter 
(Millex - GV, 0.22pm, Millipore S.A., Molsheim, France) to eliminate any contaminating 
organisms. Total protein concentrations of ES batches were determined by the method quoted 
ii section 2.5. Batches of ES were stored at -20°C, or in some instances -70°C. Worms were 
fxed in 20 millilitres of Brunnefs fixative, at the end of the incubations and worm numbers 
v/ere estimated by counting the total number of worms present in five 1.0 ml aliquots. Each 
aliquot was added to a pettri-dish (9 cm in diameter) which had been scored by equidistant
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vertical and horizontal lines, dividing the base into 16 non-equal areas, and the number of 
worms was then calculated from the total worm numbers in all areas.
2.8: Statistical analyses.
All statistical analyses reported in this thesis, unless otherwise stated, were carried out using 
the SAS system (SAS Institute, Cary, North Carolina, U.S.A.) or Minitab (Releases 8.2 and 
10, Minitab Inc., State College, Pennsylvania, U.S.A.). Reported mean values were arithmetic 
means, unless otherwise stated, and probability (p) values of less than 0.05 were considered as 
significant. Probability values of between 0.05 and 0.10 were considered to be of borderline 
significance.
2.9: Photomicrography.
Light microscopical examinations and the photomicrography of histological specimens were 
accomplished using an Olympus AHBT Research Photomicrographic Microscope System 
(Olympus, Tokyo, Japan), unless stated otherwise.
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EXPERIMENTAL STUDIES - PART 1: PEPSINOGEN ASSAYS 
3: THE ASSAY OF PEPSINOGEN CONCENTRATION.
3.1 Introduction:
The measurement of plasma pepsinogen concentration has been recommended as an aid in the 
diagnosis of parasitic gastritis of ruminants since the technique was first applied by Anderson 
et al (1965) and Ritchie et al (1966) to cattle infected with Ostertagia ostertagi. A large 
number of methods for pepsinogen estimation have now been published and this probably 
reflects a degree of dissatisfaction with existing techniques since the assays are generally 
laborious and cumbersome (Berghen et al 1993). Plasma pepsinogen concentration is however 
still considered to be a valuable diagnostic parameter in abomasal nematode infection 
(Hilderson et al 1989).
The majority of assays estimate plasma pepsinogen concentration by measuring the total, 
acid-stable, proteolytic activity of plasma. Pepsinogen becomes converted to active pepsin at 
acid pH (1-4) and peptic digestion of protein substrates yields small peptide fragments, which 
can be measured spectrophotometrically by their ability to reduce complexed metal ions 
resulting in colour changes. Comparison is usually made to standards containing the phenolic 
amino acid tyrosine and results are then expressed as International Units (1 iU = lpmol 
tyrosine released/min/litre of plasma). The results are influenced by variations in temperature, 
assay pH and incubation times, as well as by variations in substrate and enzyme 
concentration. The method first employed in veterinary studies of abomasal parasitism, that of 
Edwards et al (1960), utilised an albumin substrate and a 24 hour incubation. A modified 
method has recently been described which uses a glycine-buffered albumin substrate and 
requires only a three hour incubation period (Paynter, 1992). Simpler assay methods have also 
been developed based on the radial diffusion of pepsinogen into acidified and opaque 
substrate gels where peptic activity clears the gel. The dimensions of the clear zone are 
dependant on the original pepsinogen concentration and comparison has to be made to active 
pepsinogen standards (Thode-Jensen, 1977; Ishaque and Bardhan, 1978).
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The following studies were conducted to determine the most appropriate assay method for 
routine use and included a limited assessment of the biochemistry of pepsinogen in different 
experimental situations, namely a comparison of the activities of pepsinogen dissolved in 
plasma and in entirely aqueous solution.
3.2: A comparison of four methods for the determination of plasma pepsinogen 
concentration.
In the present method development four methods were compared to determine the most 
appropriate for routine use. Three methods were based on the enzymatic digestion of an 
acidified substrate in solution and used tyrosine standards, whilst the fourth was a radial 
diffusion method in which peptic activity was measured in an agarose gel containing casein 
and compared to activated pepsinogen standards.
For each method an assessment was made of the precision (variability) of each method, based 
on the measurement of within-assay (intra-assay) variation, and the reproducibility of the 
methods, based on an examination of between-assay (inter-assay, or day-to-day) variation. In 
addition, the relationship between observed differences of pepsinogen concentration and 
actual differences of the quantities o f pepsinogen present, was also examined.
3.2.1: Materials and methods.
3.2.1.1: Method 1.
This method was based on the method of Paynter (1992) and used glycine-buffered albumin 
as a substrate (3.2 per cent Bovine serum albumin (BSA), fraction V in 1 per cent glycine 
buffer, adjusted to pH 1.6 with 1M hydrochloric acid). Duplicate tubes containing 0.5 ml of 
plasma added to 0.75 ml of substrate were prepared for each sample. Both tubes were 
incubated at 37°C, one for thirty minutes, the other for an additional three hours (total 
incubation time 210 minutes). Undigested substrate was precipitated by the addition to each 
tube of 2.5 ml of 10 per cent (v/v) perchloric acid (BDH Chemicals, Poole, England). The 
undigested substrate was then separated with Whatman No. 50 filter papers (Maidstone, 
England). No controls were included to assess the rate of non-enzymatic hydrolysis of 
substrate, as this was assumed to be negligible in method 1 (Paynter, 1992).
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A stock solution of L-tyrosine (10 mM) was prepared in 2 per cent (v/v) perchloric acid. From 
the stock solution five tyrosine standards were prepared at concentrations of 0.0, 0.9, 1.8, 3.6 
and 5.4 millimolar, being diluted from the stock with 2 per cent perchlorate. Standards were 
added to substrate, instead of plasma, and were processed in an identical manner to samples, 
each standard tube was incubated for only thirty minutes before the precipitation of substrate. 
The tyrosine standards were then equivalent to plasma with pepsinogen concentrations of 0, 5, 
10, 20 and 30 iU (Paynter, 1992).
The concentration of acid soluble peptide fragments in test solutions was estimated with a 
solution of bicinchoninic acid (BCA) and copper sulphate (50 parts of 10 per cent (w/v) BCA 
solution to 1 part o f a 4 per cent (w/v) Cu(ii)S04-pentahydrate solution), 100 p.1 o f filtrate was 
added to 2.0 ml of the colour reagent and incubated at 37°C for 30 minutes. The optical 
density was then measured with a Pye-Unicam sp8-500 spectrophotometer at 560 nm, blanked 
with distilled water. Optical density measurements were converted to iU using the standard 
curve prepared from the tyrosine standards.
Paynter (1992) had reported that reaction rates were only linear after the first thirty minutes of 
incubation, hence pepsinogen concentration in this method was estimated by subtracting the 
concentration of tyrosine-like substances present after thirty minutes of incubation from that 
present after 210 minutes.
3.2.1.2: Method 2.
This method was based on the method of Edwards et al (1960) and used 0.667 per cent bovine 
serum albumin, fraction V, at pH 1.5. As with method 1 duplicate tubes were required per 
sample, with 0.5 ml of sample added to 2.5 ml of substrate. One tube was not incubated, the 
substrate immediately precipitated with 5.0 ml of 4 per cent (w/v) trichloroacetic acid then 
separated using Whatman No. 44 filter paper and the filtrate was stored overnight at 4°C. The 
remaining tube was incubated at 37°C for 24 hours before the precipitation and filtration of 
undigested substrate.
This method required the incubation of substrate blanks (BSA-blanks) to assess the rate of 
non-enzymatic hydrolysis of substrate. Half a millilitre of distilled water, instead of plasma,
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was therefore added to each of two tubes containing substrate, and one tube was immediately 
precipitated, whilst the other was incubated for twenty four hours.
The concentration of acid soluble peptide fragments was estimated using Folin and 
Ciocalteu’s reagent (BDH Chemicals, Poole, England), 0.5 ml o f filtrate was added to 4.0 ml 
of 0.25M sodium hydroxide and 0.75 ml of diluted colour reagent (Folin and Ciocalteu’s 
reagent diluted 1:2 with distilled water) and incubated at room temperature for 30 minutes 
before the measurement o f optical density at 725 nm. A reagent blank, which was 0.5 ml 
distilled water added to 4.0 ml NaOH and 0.75 ml colour reagent, was treated similarly. The 
optical density of the reagent blank was subsequently subtracted from all other 
spectrophotometer readings.
Comparison was made to standards containing 0.0, 0.1 and 0.2 mM L-tyrosine (diluted using 
distilled water from a lOmM stock solution originally prepared in 0.1M HC1). All other 
spectrophotometer readings were then converted into micromoles of tyrosine. Pepsinogen 
concentration was finally calculated by the following formula;
Pepsinogen concentration (iU) = [(A-B)-(C-D)] multiplied by 22.24
Where A was the amount o f tyrosine equivalents (in pmols) released in the 24 hour incubated 
samples, B was the amount present in unincubated samples, C the amount in the incubated 
BSA-blank and D that of the unincubated BSA-blank. The figure of 22.24 was a correction 
factor to convert tyrosine released by the activity of 0.03125 ml of plasma in 24 hours to that 
which would be released by a litre of plasma in one minute (i.e. to international units).
3.2.1.3: Method 3.
This method was based on that published by MAFF and ADAS (1984a). A 2 per cent solution 
of horse haemoglobin (pH 1.7) was used as the substrate. Half a millilitre of plasma was 
added to each of two duplicate tubes containing 2.5 ml of haemoglobin substrate, but to one at 
the start of a three hour incubation at 37°C and to the other plasma was added at the end of the 
three hours, substrate having been incubated alone in this tube, and both tubes were 
precipitated with 2.5 ml of 10 per cent (w/v) trichloroacetic acid. Separation of precipitated 
substrate was achieved using Whatman No. 50 filter papers.
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Folin and Ciocalteu’s reagent was used in colour development and activity compared to 
standards with 0.0 and 0.138 millimolar tyrosine (equivalent to 0 and 50 pg of tyrosine per 2.0 
ml). Two millilitres of filtrate/standard were added to 4.0 ml of 0.5M NaOH and 1.2 ml of 
Folin and Ciocalteu’s reagent (again diluted 1:2 with distilled water). For a reagent blank 2.0 
ml of water was substituted for the filtrate/standard. Incubation of the colour reaction was at 
room temperature for 20 minutes and the optical density (O.D.) was read at 560 nm. The first 
step in the calculation of pepsinogen concentration was the determination of the tyrosine (in 
pg) present in each 2.0 ml filtrate, T;
T = fOD incubated-OD nonincubated') x 50 
OD standard
To convert T to iU;
iU = [T (pg) x Total incubation volume(5.5 ml)] divided by [plasma volume (0.5 ml) x 
filtrate volume (2.0 ml) x incubation time (180 mins)x MW tyrosine(181.2)]
3.2.1.4: Method 4.
This method was based on the radial diffusion of pepsinogen into an acidic and opaque 
substrate gel (Thode-Jensen, 1977; Mostofa, 1989a).. Two grams of agarose (type 1-A) was 
dissolved by boiling in 100 ml of Tris1 buffer (final concentration 0.05M TrisHCl, 0.107M 
Tris base, pH 8.2), the solution was then cooled to 50°C. Half a gram of casein was dissolved 
in a further 100 ml Tris buffer at 50°C and then the agarose and casein solutions were mixed 
and poured onto a 530 cm microbiological assay plate (A/S NUNC, Kamstrup, Denmark) 
and allowed to cool. After the gels had solidified the plates were soaked in glycine buffer 
containing barium chloride (26 mM glycine, 25 mM sodium chloride, 60 mM barium 
chloride, pH 2.4) until the gels became uniformly opaque, after approximately three hours.
Wells were cut into the gel (7.72 mm diameter) and 0.5 ml of plasma or pepsinogen standard 
added, the plates were then incubated at 37°C for 24 hours. Peptic activity cleared the gel and 
the dimensions of the clear zone were proportional to the original pepsinogen concentration 
(see Fig. 3.1). Measurement of zone size was done with an electronic, digital calliper (Max-
1 Tris - Tris[hydroxymethyl]aminomethane
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Cal 0-6”, CP. Instruments, Bishop Stortford, England) and recorded on a printer/calculator 
(QC-Printer, CP. Instruments). Pepsinogen standards were prepared by dissolving porcine 
pepsinogen in water at concentrations of 0.15, 0.3, 0.6, 1.2 ng/ml.
3.2.1.5: Samples.
Uninfected sheep were bled by jugular venepuncture into heparinised containers. After 
centrifugation at 2,000g for 10 minutes the plasma was pooled to form a stock with low 
intrinsic plasma pepsinogen concentration. The stock was divided into five aliquots and 
porcine pepsinogen was added to produce five spiked pools with 0, 0.15, 0.30, 0.60 and 0.90 
ng/ml of added pepsinogen. These values were chosen to produce concentrations similar to 
those found in infected animals. The aliquots were then sub-divided and stored at -20°C.
3.2.1.6: Experimental design.
In experiment one, the five spiked pools were each tested five times with each of the four 
methods to give a total of 100 tests. The data were then analysed to compare the variability 
(precision) of the different tests. The data were also compared against the standards to 
determine if the relationships were linear. In experiment two, the five spiked pools were each 
tested with each of the four methods on four consecutive days to give a total of 80 tests. The 
data were then analysed to determine the extent of day-to-day variation in the different tests.
3.2.1.7: Statistical analyses.
Bartlett’s test for the homogeneity of variance (Steel and Torrie, 1980) was applied to the data 
in experiment one (day one data) to test for differences among the spiked pools measured by 
the same method. One-way analysis of variance was applied separately to each method to 
determine the proportion of the total variance that was due to differences among pools and to 
differences within pools. The model fitted was pepsinogen = pool. Type III sums of squares 
were used to calculate the proportion of variance attributable to each effect. The accuracy of 
each method was assessed by multiple regression where the observed value was fitted as 
covariate and the squared value was fitted to test for departures from linearity (Snedecor and 
Cochran, 1980). Differences between days were assessed in a two-way mixed model analysis 
of variance with day fitted as a random effect and the spiked pool fitted as a fixed effect, the
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model was pepsinogen = day + pool. Intra and inter-assay coefficients o f variation were 
calculated for purposes of comparison. Coefficients of variation were calculated as the ratio of 
the standard deviation to the mean, multiplied by 100.
3.2.2: Results.
Appendices 1A to ID contain the assay results for each replicate of each plasma standard on 
each day. Table 3.1 gives the mean and standard error for each method separately for each 
spiked plasma pool. Although methods 1, 2 and 3 purport to measure plasma pepsinogen 
concentrations in international units (one iU = 1 pmol tyrosine liberated/ min/ litre of plasma), 
they are clearly not giving the same results. In particular method 1 gives values approximately 
five-fold greater than method 2.
Bartlett’s test for the homogeneity of variance showed no significant differences in the 
amount of variation between different pools measured by the same method, therefore the 
methods do not show increased variability as the plasma pepsinogen concentration rises. 
However variance was significantly different between methods for pools 1 (p<0.005), 3 
(p<0.01), 4 (p<0.025) and 5 (p<0.025). In separate analyses method 1 was not significantly 
different from either methods 2 or 3 for any pool, but demonstrated less variance than method 
4 for plasma pools 3,4 and 5 (p<0.025, 0.025 and 0.05 respectively).
One-way analyses of variance for each method showed that differences between the spiked 
pools accounted for the vast majority of variation in each test when replicates were tested on 
the same day. For methods 1, 2, 3 and 4, variation among the pools accounted for 99.3, 99.6, 
98.7 and 93.1 per cent of the variation; variation within pools was only 0.7, 0.4, 1.3 and 6.9 
per cent of the total. Coefficients of intra-assay variation were also low. For methods 1, 2, 3 
and 4 they were only 5.6, 2.9, 7.9 and 13.7 per cent respectively.
Regression analysis showed that, as expected, each method was highly associated with 
differences in the plasma pools (p<0.0001 for each method). For method 1 there was no 
evidence for a non-linear relationship; the effect of fitting the squared covariate was not 
significant (p=0.68). In contrast fitting the squared covariate was of borderline significance 
(0.05<p<0.10) for methods 2, 3 and 4. Given the relatively small number o f tests (n=25) for 
each method, these results suggest, but do not prove, that methods 2, 3 and 4 do not give
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linear responses. Regression lines fitted by the method of least-squares for each method were 
0.23 + 0.03(x) for method 1, 0.30 + 0.16(x) + 0.0037 (x2) for method 2, 0.14 + 0.087(x) + 
0.0076 (x2) for method 3 and 0.40 + 0.90(x) - 0.13(x2) for method 4. If confirmed, these 
results would suggest that methods 2, 3 and 4 would need correction factors if pepsinogen 
concentrations are to be estimated accurately, especially in animals with relatively high 
values.
Variation among days was tested separately for each assay in a two-way analysis of variance. 
To avoid possible problems with non-linear relationships, the spiked plasma pools were fitted 
as a fixed effect rather than as a covariate. The results showed that the variation among days 
was highly significant for methods 2, 3 and 4 (pO.OOOl) but of only borderline significance 
for method 1 (p=0.048). Day-to-day variation accounted for 0.4 per cent o f the variation in 
method 1 and 0.7, 8.2 and 30 per cent of the variation in methods 2, 3 and 4 respectively. For 
comparison the inter-assay coefficient of variation were 9.8, 9.3, 15.6 and 36.8 per cent for 
methods 1, 2, 3 and 4.
Table 3.1: Mean pepsinogen values (± S.E.) for each method when five replicates were 
compared on one day at each of five concentrations.
Amount o f  
Pepsinogen added
Method 1 Method 2 Method 3 Method 4
ng/ml iU iU iU ng/ml
0.00 6.39 (0.26) 1.83 (0.02) 1.61 (0.10) 0.54 (0.04)
0.15 11.88 (0.47) 2.66 (0.05) 3.01 (0.16) 0.64 (0.03)
0.30 15.12(0.26) 3.53 (0.04) 3.57 (0.09) 0.92 (0.07)
0.60 24.03 (0.29) 5.10(0.07) 5.97 (0.12) 1.47 (0.08)
0.90 32.66 (0.54) 6.57 (0.07) 7.18(0.10) 1.95 (0.11)
Fig. 3.1: The appearance of a casein-agarose plate at the end of the incubation period.
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3.2.3: Discussion.
3.2.3.1: The comparison of the four methods.
A comparison of four methods for estimating plasma pepsinogen concentrations showed that 
all four methods gave reliable results when replicates were assayed by the same person on the 
same day. All the assay methods showed day-to-day variation but the method of Paynter 
(1992)(method 1) showed less variation than the other three methods. Paynter’s method was 
the only method which showed a linear relationship with the spiked plasma pools and this 
method appears to be the method of choice for routine plasma pepsinogen determination.
The observation that all methods gave acceptable levels of variation within days, but not 
between days suggests that more effort is needed to minimise day-to-day variation. Possibly 
the use of a buffered substrate for method 1 was responsible for the reduced day-to-day 
variation with this method. Another possibility is to incorporate internal standards such as 
plasma pools o f high and low activity.
The addition of porcine pepsinogen to simulate naturally elevated concentrations in ovine 
plasma allowed an assessment of method linearity. Graded dilutions o f naturally high plasma 
could have been used, however this would have diluted other plasma proteins which at acid 
pH contribute to the total substrate present. Porcine pepsinogen is active over a similar pH 
range as ruminant group I pepsinogens and is essentially an equivalent protease (Mostofa, 
1989b).
An assessment o f method specificity for pepsinogen was not made. All four methods 
estimated plasma pepsinogen concentration from the total acid-stable, proteolytic activity in 
plasma and may be equally specific. In humans, the correlation between total proteolytic 
activity and pepsinogen measured by immunoassay is good (Hirschowitz, 1984). This is likely 
to be the same in ruminants were pepsinogen subtypes are elevated equally in parasitic 
infection and peptic activity has been shown to be confined to peaks, separable by gel 
filtration, representing only pepsinogen subtypes (Mosofa et al, 1990a, 1990b).
Immunological methods (Axelsson et al, 1983, Turner and Shanks, 1982) and a recently 
developed colourimetric assay which uses /7-nitroanilides as substrates (Heinova et al, 1992) 
may be more specific, although none of these methods has been fully assessed for routine use.
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Although the results were expressed in international units for Paynter’s method, and for 
methods 2 and 3, the results were quite different and care must be exercised to avoid 
confusion between the results obtained by different methods. Using method 1 Paynter (1992) 
established that plasma pepsinogen concentrations of up to 5.0 iU were indicative of minimal 
and insignificant abomasal damage. This is in comparison with studies using the assay 
method of Edwards et al (1960) where plasma pepsinogen concentrations of greater than 3.0 
iU are considered indicative o f severe clinical ostertagiasis (Armour, 1970). The five-fold 
differences between the results measured by methods 1 and 2 would mean that a plasma 
pepsinogen value o f 3.0 iU, measured by method 2 (Edwards et al, 1960) would be equivalent 
to a value of approximately 15.00 iU when measured by method 1, and this latter value was 
found by Paynter (1992) to be indicative of severe abomasal damage in animals with 
ostertagiasis.
The main role for the estimation of plasma pepsinogens in ruminants lies in the detection of 
subclinical or clinical infections with abomasal nematodes such as O. ostertagi in cattle and
O. circumcincta in sheep. As pointed out by Michel (1978) while plasma pepsinogen 
concentration cannot establish categorically whether an animal is suffering from ostertagiasis 
(especially subclinical infection), it is distinctly useful when considered alongside other pieces 
of evidence. The value of plasma pepsinogen concentration will also depend upon the 
proportion of the variation between tests that is due to variation in the test itself and the 
proportion that is due to variation in the ability of animals to respond to the same level of 
infection; as well as the proportion that is due to variation among animals in the level of 
infection. Methods with the lowest intrinsic variability are likely to be the most useful.
In conclusion all methods tested gave acceptable levels of variation when replicates were 
tested on the same day, but method 1 showed less variation when replicates were tested on 
different days and was the only test which showed a linear relationship with plasma 
pepsinogen concentrations in spiked plasma pools. Method 1 was simple and quick, but 
differed from the published method of Paynter (1992) who further simplified the assay 
procedure by using centrifugation to separate undigested substrate. Suitable equipment was 
unavailable at the time this study was carried out thereby necessitating the filtration step. 
Overall the method developed by Paynter was therefore the method of choice for routine 
estimations of plasma pepsinogen concentration.
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3.2.3.2: Final modifications to Paynter’s method for the routine assay of plasma pepsinogen in 
the laboratory.
The plasma pepsinogen assay was required to assay pepsinogen in a number of experiments 
reported in this thesis; the assay of pepsinogen in the plasma of experimental animals, the 
assay of pepsinogen in the secretions of in vitro abomasal glands or intact abomasal mucosa, 
and finally, the assay of pepsinogen in abomasal mucosal homogenates. To facilitate these 
measurements and speed the assay procedure, a number of modifications to the method 
quoted earlier (section 3.2.1.1) were made. As reported earlier, Paynter (1992) separated 
undigested substrate by centrifugation and not by filtration. This step was adopted in the 
present studies when suitable equipment became available. Following the arrest of the peptic 
reaction and the precipitation of undigested substrate, samples were centrifuged at 10,000g in 
a bench-top microcentrifuge (MSE). The use of the centrifugal separation o f substrate also 
allowed the considerable reduction of reagent volumes (ten-fold). Instead of 500 pi of plasma, 
50 pi was added to 75 pi o f BSA substrate and the reaction stopped with 250 pi of 
perchlorate. This volume reduction allowed the use of 1.5 ml, conical Eppendorfs for the 
reaction step. Following the addition of sample and substrate to the Eppendorf, and before 
incubation, the tubes were vortexed briefly and then flash spun in the centrifuge, this ensured 
that the entire mixture returned to the base of the Eppendorf and would therefore be under the 
surface when the tubes were placed in the 37°C waterbath.
The colour reaction step using BCA/ Copper sulphate was transferred from test tubes to 98 
well, flat bottomed, microtitre plates (Greiner Labortechnik Ltd., Dursley, England). It was 
found that the colour reagent was very sensitive to dust and other contaminants, giving 
erroneously high optical densities, and the use of multiple replicates permitted the elimination 
of any abnormally high data suspected to result from contamination. With four wells used for 
the addition of supernatant from each Eppendorf, a 98 well plate was sufficient for 6 tyrosine 
standards (with the inclusion of a 9 mM tyrosine standard, equivalent to 50 iU, in addition to 
the five listed earlier) and nine samples (Fig. 3.2).
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Fig. 3.2: Set up of microtitre plate to measure 6 standards and 9 samples.
Tyrosine Standards (iU) | Samples
1 2 3
0 5 10 20 30 50 30 210 30 210 30 210
1 2 3 4 5 6 7 8 9 10 11 12
A 0 O 0 O O O O O O 0 0 O
B 0 O 0 O O O O O O 0 0 0
C 0 0 0 0 0 O 0 O O 0 0 0
D 0 0 0 0 0 O 0 O O 0 0 0
E 0 0 0 0 o O 0 O O 0 0 0
F 0 0 0 0 0 O 0 O O 0 0 0
G 0 0 0 0 0 O 0 O O 0 0 0
H 0 0 0 0 0 O 0 0 O 0 0 0
4 5 6 7 8 9
Samples
[30 and 210 refer to the duplicate tubes per sample incubated for 30 and 210 minutes 
respectively]
Each well contained 200 pi o f the BCA and CuS04 mixture to which 10 pi of supernatant was 
added. Plates were then covered with adhesive plate sealers (Greiner Labortechnik Ltd.) and 
were then incubated at either 37°C for 30 minutes or at room temperature for 2 hours. Plates 
were then read using a Dynatech MR 5000 microplate reader, measuring at 562 nm and 
blanked on air.
Active pepsinogen standards may reduce inter-assay variation, by compensating for 
fluctuations in assay pH, temperature, etc. In some instances therefore the six tyrosine 
standards were replaced by three pepsinogen standards that were processed in an identical 
manner as were samples, i.e. with duplicate tubes per sample, one incubated for 30 minutes 
the other for 210 minutes. The pepsinogen standards then occupied the six rows of wells, used 
ordinarily in the plate for the colour reaction, for the tyrosine standards. The standard curve 
for the pepsinogen standards was prepared from the differences between the optical densities 
of the 210 and 30 minute incubated duplicates of each standard.
64
For the majority of pepsinogen assays, pepsinogen concentrations were compared in a small 
number of samples that were processed together in a single day, hence inter-assay variation 
was o f no importance. However when a large number of samples had to be analysed over 
several days, active pepsinogen standards were used to reduce this variation. A single set of 
tyrosine standards could be run on one of the days to allow the conversion of the results to iU, 
if so desired. If data sets from an experiment did not require direct comparison with those 
from other experiments then conversion to iU was not necessary. Aqueous pepsinogen 
standards were not used in the assay of plasma samples.
Pepsinogen concentrations, in in vitro studies of pepsinogen secretion, were rarely within the 
range o f values seen in plasma and the technique was further adjusted to allow measurements 
over a greater concentration range. This resulted in two methods that could be used 
independently according to the range of concentrations found:
1. The first method involved reagent quantities and procedures unchanged from those listed 
earlier in this section. Three pepsinogen standards were obtained by dissolving porcine 
pepsinogen in water at concentrations of 0.00, 0.75 and 1.50 ng/ml.
2. The modified method used porcine pepsinogen standards of 0.00, 1.50 and 3.00 ng/ml. To 
allow for higher concentrations of pepsinogen the volume of the standard/sample added to the 
substrate was reduced to 20 pi (from 50 pi) and the volume of the BSA substrate increased to 
100 pi (from 75 pi). The volume of perchlorate used to stop the reaction was kept at 0.25 ml 
and the assay procedure was otherwise identical.
To ascertain the appropriate standard range for each separate experiment a small, 
representative number of samples were processed, along with standards in the 0.00 to 3.00 
ng/ml range, and using the reagent volumes of the modified method procedure. Single tubes 
were used per sample or standard and incubated for three hours before the addition of 
perchlorate and subsequent centrifugation. The quantity of pelleted, undigested substrate was 
assessed visually, and compared to the standards, to decide the approximate concentration 
range covered by the samples. Samples with lower concentrations could then be analysed with 
the original method (standard range 0.0 to 1.5 ng/ml), or if the concentrations were outwith 
the higher standard range (0.0 to 3.0 ng/ml) then samples could be diluted accordingly.
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For routine use of the pepsinogen assay BSA/glycine substrate as well as tyrosine and 
pepsinogen standards were prepared fresh each month, then refrigerated at 0 to 4°C. 
Pepsinogen standards were prepared from a stock solution of porcine pepsinogen (30 ng/ml) 
maintained at -20°C. From repeat experiments it was calculated that 1 ng/ml of porcine 
pepsinogen had peptic activity equivalent to 35.50 ± 1.70 iU (mean ± S.E., from 21 separate 
experiments performed over two years - see Appendix 2). It was more usual to quote the 
activities of the porcine pepsinogen standards using the peptic activity reported by the 
manufacturers (Sigma Chemical Co.). One unit (u) of peptic activity, measured as 
trichloroacetic acid-soluble products using haemoglobin as substrate, was that which produced 
a change in optical density at 280 nm of 0.001 per minute at pH 2.0 at 37°C. One nanogram of 
porcine pepsinogen was therefore equal to approximately 3.2 units. Quoting the peptic activity 
of pepsinogen standards in this way (u/ml rather than ng/ml) allowed for variation in batches 
of pepsinogen where the peptic activities of identical masses of compound might vary. Based 
on the multiple comparisons of pepsinogen and tyrosine standards quoted earlier (Appendix 2) 
one u/ml was equivalent to 11.0 ± 0.50 iU (mean value ± S.E., based on 21 measurements).
3.3: Assessment of Method 1 (Paynter, 1992) using plasma with naturally elevated 
pepsinogen concentrations.
To ensure adequate assay performance in all experimental situations, the precision/reliability 
of Paynter’s method was determined with plasma obtained from sheep with plasma 
pepsinogen concentrations elevated in response to infection, rather than by the addition of 
exogenous zymogen.
3.3.1: Materials and methods.
Plasma was obtained from a group of 11, six month old Scottish Blackface lambs some of 
which (8/11) had been infected with an oral dose of 15,000 O. circumcincta. Animals were 
killed by electrical stunning followed by exsanguination, blood was collected as the animals 
were bled out and processed as described in section 2.2.5. Plasma was stored in aliquots at 
-20°C until used.
Five replicates per animal were analysed simultaneously on day one to ascertain the degree of 
intra-assay variation and single replicates were performed on four subsequent days to
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establish inter-assay variance. Data were analysed by Bartlett’s test (day one data only) and by 
a two-way analysis of variance using a General Linear Model (Minitab, Release 8, Minitab 
Inc., State College, PA). The model used was plasma pepsinogen = animal + day.
3.3.2: Results.
Plasma pepsinogen concentrations ranged from 0.35 iU to 13.58 iU (mean values of the five 
replicate analyses of plasma from individual sheep performed on day one - see Appendix 3). 
Bartlett’s test detected no significant inequalities of variance between the variances recorded 
for the replicate estimates of individuals (0.25<p<0.50). Analysis of variance showed that 
differences between the pepsinogen concentrations recorded for different sheep were highly 
significant (p<0.001) and that between day variation was also significant (0.025<p<0.05).
3.3.3: Discussion.
Similar results were obtained with the naturally elevated plasma pepsinogen samples as had 
been obtained with the spiked pools tested previously. As shown for the spiked pools, within- 
assay variation was not significant when compared to the differences that existed between the 
pepsinogen concentrations of individual animals and day-to-day variation was marginally 
significant. Pepsinogen concentrations were high given the relatively light level of infection 
and this also suggests that method 1 is likely to give higher results than other methods.
3.4: Comparison of peptic activity in the presence and absence of plasma.
A problem encountered with the casein-agarose, radial diffusion assay in the method 
comparison study was the poor clarity of zone border. This feature may have led to inaccurate 
measurement of the zone diameter and might therefore account for the higher degree of intra­
assay variation seen with this method. This was only a problem for the zones associated with 
the plasma samples, the aqueous pepsinogen standards produced well defined clear zones and 
therefore there may be some interference due to the presence o f plasma. This phenomenon 
was reported by Thode-Jensen (1977), but was not seen as any hindrance to the routine use of 
the assay.
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The present experiment was performed to compare the zones produced in the casein-agarose 
method by different types of pepsinogen-containing sample, and thus to further investigate the 
poor performance of this assay in the method comparison study.
3.4.1: Materials and methods.
Plasma was obtained from a parasite-naive, 9 month old Hampshire Down lamb that had zero 
intrinsic plasma pepsinogen activity (assayed by Paynter’s method and confirmed in the radial 
diffusion assay). Added to this plasma was a known amount o f porcine pepsinogen (1.5 
ng/ml) and a second, entirely aqueous, solution was made with an identical concentration of 
porcine pepsinogen. Both solutions and the original plasma were then added to wells cut in a 
casein-agarose plate and incubated according to the method previously described (section
3.2.1.4). All solutions were also assayed by Paynter’s method. Zone dimensions were 
calculated as the diameter of the cleared zone minus the well diameter.
3.4.2: Results.
All results for pepsinogen concentration, zone diameters for the plate method and optical 
densities for the colourimetric assay, are given in Appendix 4. Despite identical pepsinogen 
concentrations the zones produced by the pepsinogen/water solution (Fig. 3.3) were larger 
(mean (± S.E.) zone dimension 6.60 (0.08) mm, n = 10) than those produced by the 
pepsinogen/plasma solution (mean 5.80 (0.12) mm, n = 10) and this difference was significant 
when analysed by a two-sample T-test (p<0.001). Referring to Fig. 3.3 it can also be 
appreciated that the aqueous zones (wells 1, 3 and 5) were clearer and more sharply defined 
than the plasma zones (wells 2, 4 and 6). The original, blank plasma was added to well 7 and 
there was no proteolytic activity associated with it (mean 0.00 (0.00) mm, n=5).
Assayed by Paynter’s method replicates of the pepsinogen/plasma samples again gave lower 
results than the pepsinogen/water solution (mean (± S.E.) O.D. at 562nm of 0.19 (0.005), 
n=10, versus a mean of 0.28 (0.01), n=10), this difference was again significant by two- 
sample T-test (p<0.001).
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3.4.3: Discussion.
Both methods clearly demonstrated that the presence of plasma affected the activity of 
pepsinogen, and reduced peptic activity significantly. This study also demonstrated that the 
use of aqueous porcine pepsinogen standards to assay plasma pepsinogen concentration by 
either method, is inappropriate. Entirely aqueous standards may yet have a role in assay of the 
peptic activity of experimental solutions, such as tissue culture supernatants, which are 
uncontaminated with plasma. These findings together with the lack of clarity of zone border in 
the casein-agarose assay are probably sufficient grounds for the abandonment of the radial 
diffusion method for routine assay of plasma samples at least for diagnostic or experimental 
purposes.
Thode-Jensen (1977) reported that “the lysed zones were not quite as clear and well-defined” 
for plasma, or for solutions supplemented with albumin, when compared to pure pepsinogen 
and pepsin standards. However the addition of albumin at concentrations of zero to five per 
cent did not alter peptic activities (zone-sizes) when compared to entirely aqueous pepsinogen 
at the same concentration. Some factor present in plasma may be inhibitory to pepsinogen, but 
at present this factor remains unidentified. At acid pH plasma proteins contribute to the total 
substrate present, but increasing substrate concentration would be expected to increase peptic 
activity, at least until the substrate was in excess. Thus indirect assays of plasma pepsinogen 
concentration that measure total peptic activity may also be affected by the concentration of 
any possible inhibitory factor and this represents a further and potentially significant source of 
assay variation.
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Fig. 3.3: Com parison of the zones produced by proteolytic activity in a casein-agarose 
gel, by plasma and by an aqueous solution, both of identical pepsinogen concentration.
Well 7 contained plasma with an intrinsic pepsinogen concentration of zero and wells 2,4 and 
6 contained the same plasma fortified with 1.5 ng/ml of porcine pepsinogen. Wells 1,3 and 5 
contained distilled water with 1.5 ng/ml added porcine pepsinogen.
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EXPERIMENTAL STUDIES - PART 2: IN VITRO METHODS. 
4: PEPSINOGEN SECRETION.
4.1: Introduction.
Continual exocrine secretion into the abomasum in ruminants reflects the relatively 
uninterrupted passage of digesta along the gastrointestinal tract and thus differs from the 
intermittent secretion which occurs in monogastric species. Apart from short quiescent 
periods, of 15-20 minutes duration which occur every 1 to 2 hours, abomasal outflow is 
effectively continuous (Bueno and Fioramonti, 1979). McLeay et al (1973) demonstrated 
continuous output of both pepsin and acid from separated pouches of abomasal fundus, which 
was reduced, but not abolished, by a period of restricted food intake. Basal secretion of both 
acid and pepsinogen occurs in man and is thought to be cholinergically mediated, and can be 
inhibited by very small doses of atropine (Hirschowitz et al, 1984). However basal secretion 
does not occur in dogs or cats (Hirschowitz, 1984). Total daily abomasal exocrine secretions 
have been estimated at 5 litres for an adult sheep and 30 litres for a 2-year old heifer (Hill, 
1968).
Neural and hormonal stimuli (endocrine and paracrine) are undoubtedly involved in the 
maintenance of abomasal secretion. Vago-vagal reflexes in response to chemical and physical 
stimuli are likely to be involved (Titchen and Anderson, 1977) and the vagus operates in the 
psychic response to teasing with food and in the buccal response to the physical presence of 
food. Local neural reflex arcs may also operate. Gastric distension in dogs causes increased 
acid output that is partially abolished by vagotomy, due to loss of vago-vagal reflexes, and 
completely blocked by atropine, via blockade of local cholinergic reflexes (Debas et al, 1974). 
Local responses may also be controlled by enteric hormone release.
Cells of the abomasum which secrete pepsinogen include; the chief or zymogenic cells, the 
mucous neck cells and possibly even mucous cells lining the gastric pits (Andren et al, 1982; 
Yamada et al, 1988; Cybulski and Andren, 1990). The tissue distribution of pepsinogen and 
the existence of different pepsinogen subtypes are discussed in section 7.1.2.
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Although in many circumstances pepsinogen and acid secretion occur in concert, this is not 
universal (vide infra). A great many endogenous and exogenous substances have been 
identified as secretagogues (stimulants) for pepsinogen secretion in vivo and in vitro, but not 
all are likely to be important in the physiological regulation o f secretion. Cholinergic 
stimulation of pepsinogen secretion occurs in intact animals (Samloff, 1971a) and in vitro, in 
dispersed gastric glands (Koelz et al, 1982; McKellar et al, 1990b) and in intact mucosal 
sheets (Basson et al, 1990). Cholinergic activity reflects the endogenous neural control, which 
occurs via vagal innervation of the mucosa, or via internal plexi existing within it. In intact 
animals vagal stimulation results in secretion of aqueous fluid and gastrin and a number of 
other effects which might lead to the stimulation of pepsinogen secretion, however there is 
also ample evidence for a direct action on chief cells (Koelz et al, 1982; Kaskebar et al, 1983; 
Sanders et al, 1983). Beta-adrenergic agonists stimulate pepsinogen release (Koelz et al, 
1982), but do not always affect acid secretion. Isoprenaline did not stimulate acid secretion in 
isolated rabbit gastric glands (Hersey et al, 1983b), but did in whole rat stomach in vitro, in 
the latter situation it was thought to be acting via atypical p-adrenoceptors (Canfield and 
Paraskeva, 1992). Chief cell adrenergic stimulation is direct and can be inhibited by 
propranolol, but not by atropine or the histamine receptor antagonist cimetidine. Alpha2- 
adrenoceptor agonists inhibit pepsinogen release indirectly (Tazi-Saad et al, 1992). The 
influence of adrenergic stimulation in the intact animal is not as well defined. Histamine has 
variable action depending on the species investigated. Acidification of the gastric lumen in 
response to histamine may also result in increased pepsinogen output due to local cholinergic 
reflex (Johnson, 1972) and further adds to the perceived complexity of the controlling 
mechanisms of gastric secretion.
Several enteric, peptide hormones are reported stimulants of pepsinogen secretion. There is 
increasing evidence that many endocrine molecules also serve as neurotransmitters. Members 
of the peptide family which includes gastrin and cholecystokinin (CCK) have been reported as 
secretagogues, but CCK is generally more potent in this respect (Hersey et al, 1983a; Hersey, 
1987). The effects of gastrin on chief cells may be largely indirect. Guinea pig chief cells 
possess two receptors for CCK/gastrin-related peptides, one has greater affinity for CCK and 
produces a marked response, the other binds gastrin and provides a weaker stimulus to 
secretion (Chemer et al, 1988). Whilst gastrin also stimulates acid production, CCK may be 
an important negative regulator of acid and an inhibitor of postprandial release of gastrin in 
humans (Schmidt et al, 1994). Other peptides reported to stimulate pepsinogen secretion
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include the Vasoactive Intestinal Polypeptide (VIP)/secretin family (Raufman et al, 1983, 
1984) and bombesin-like peptides which act by causing gastrin release (Hirschowitz and 
Molina, 1983). Glucagon inhibits acid and pepsinogen secretion (Konturek et al, 1975), as 
does somatostatin (Barros et al, 1978; Hirst et al, 1982; Vagne et al, 1982).
The coupling of stimulus and secretion is achieved by one of two intracellular mechanisms 
induced by the binding of agonist to membrane receptors (Hersey, 1987). Receptors for 
secretin/VIP-like peptides and p-adrenergic agents interact with adenylate cyclase and cause
increased levels of cyclic adenosine monophosphate (cyclic AMP), whereas cholinergic
2+  •agonists and CCK-like peptides cause increases in intracellular Ca via production of inositol
triphosphate. Ultimately both mechanisms cause elevations of intracellular Ca2+, since
2+forskolin, which activates adenylate cyclase directly, stimulates a slow, transient rise in Ca 
(Chew, 1986). Calcium may be important in granule exocytosis (Hersey et al, 1984).
Secretion of pepsinogen by chief and other cells in response to stimulus involves the prompt 
release of stored granules, the synthesis and sustained secretion of new pepsinogen and the 
uptake of amino acids and the metabolic activity to support the synthetic process 
(Hirschowitz, 1984; Hersey, 1987). Thus secretion can be considered as biphasic with an 
initial burst due to degranulation followed by sustained secretion not involving granule 
formation. The exact mechanism of degranulation is unknown, but is thought to be similar to 
exocytosis in other cells.
Historically, studies of pepsinogen secretion involved studies of the intact animal, e.g. dogs 
fitted with gastric fistulae or pouches, or in studies of anaesthetised animals. Advantages of 
these methods include the retention of neural and humoral regulation, and the ability to study 
the main secretory stimulus for monogastric animals, food itself. Disadvantages are the very 
complexity of the regulatory mechanisms themselves due to the plasma clearance and 
metabolism of agents under investigation, and the potential for stimuli to act through indirect 
pathways. Recently much work has involved enzymatically dispersed gastric glands and it 
was in such a preparation that McKellar et al (1990b) demonstrated pepsinogen release in 
response to Ostertagia spp. excretory/secretory products (ES) in bovine and ovine glands. 
Advantages of methods employing dispersed glands include the loss of external neurohumoral 
control, but the retention of glandular architecture. The disadvantage o f this, and of the less 
commonly applied technique utilising intact mucosal preparations, is the presence of a diverse
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number of cell types, especially in the latter preparations. This may be advantageous in some 
instances, as pepsinogen and acid secretion might both be studied using the same preparation. 
Their advantages over other methods, in terms of the ease of preparation, probably account for 
their popularity.
The following work was intended to develop and investigate two methods for the in vitro 
monitoring of pepsinogen secretion (by dispersed and isolated gastric glands and by intact 
preparations of mucosal sheets), to assess the utility and responsivity of each method with the 
aim of using one method in later studies of the effects of parasite ES on pepsinogen secretion. 
Assessment would be made o f the viability of preparations made by either method and their 
responsivity, in terms o f pepsinogen secretion, to stimulation with the cholinergic agonist 
carbachol.
4.2: Pepsinogen Secretion by Isolated Gastric Glands.
Dispersed, isolated gastric glands have been used to study secretion of acid and pepsinogen in 
a variety of mammalian species (Berglindh and Obrink, 1976; Koelz et al, 1982; Hersey, 
1987; Soil and Berglindh, 1987). Their preparation requires a less thorough enzymatic 
digestion than is involved in the liberation of single cells. Dispersed glands have only ever 
been used for short term cultures, the duration measured in hours rather than days and do not 
provide immortal cell lines that are characteristic of single cell culture methods.
Previous work has demonstrated pepsinogen secretion in response to ES products from 
Ostertagia spp. parasites using isolated bovine and ovine gastric glands (McKellar et al, 
1990b) and the same method was used in the present studies. The responsivity of dispersed 
gastric glands was checked using the cholinergic agonist carbachol. Carbachol was used at 
either multiple, increasing doses or as a single dose calculated to give maximal stimulation.
4.2.1: Materials and methods.
4.2.1.1: Preparation of ovine dispersed gastric glands.
The abomasa of sheep were collected at Sandyford Abattoir, Paisley, Scotland and no more 
than 15 minutes elapsed between the time of death of donor sheep and the collection of
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tissues. Abomasa were opened along the greater curvature and the mucosa was then washed 
with Hank’s balanced salt solution (Gibco BRL, Life Technologies, Ltd., Paisley, Scotland.) 
supplemented with 25 mM HEPES (N-2-Hydroxyethylpiperazine-N’-2-ethanesulphonic acid) 
pH 7.3, 0.2 per cent (w/v) bovine serum albumin (fraction V) and 0.2 per cent (w/v) glucose, 
gassed with 100 per cent Oxygen. The mucosal folds were then removed from the main bulk 
of the abomasal wall and these were transported back to the laboratory in the same 
supplemented medium on ice (0-4°C).
Mucosal pieces were then minced finely and placed in Leibovitz medium (Gibco BRL) with 
identical supplementation as that added to the Hank’s balanced salt solution (vide supra). The 
solution was gassed prior to the addition of minced mucosa with 100 per cent Oxygen, and 
vigorous gassing was continued throughout a subsequent 10 minute incubation at 37°C, this 
also served to stir the mucosal fragments. After 10 minutes the contents were allowed to 
settle, mucosal fragments quickly sank, whereas fatty debris and any other floating materials 
were decanted and discarded. The mucosal pieces were then resuspended in supplemented 
Leibovitz medium further supplemented with 0.1 per cent (w/v) collagenase, Type 1A and 0.1 
per cent (w/v) Soyabean trypsin inhibitor, Type 1-S, gassed with 100 per cent Oxygen. The 
mucosal fragments were then incubated for 45 minutes at 37°C. At the end of this period the 
suspension was passed through a fine nylon mesh and the glands in the filtrate were 
resuspended in Leibovitz medium, supplemented only with 0.2 per cent (w/v) albumin and 0.2 
per cent (w/v) glucose. In the only significant departure from the method employed by 
McKellar et al (1990b) the gland suspension was not centrifuged, but glands were allowed to 
sediment instead, this is thought to be a less deleterious procedure for glands than 
centrifugation (Soli and Berglindh, 1987). In order to clean the glands old medium was 
discarded following sedimentation and glands were then resuspended in 30 to 50 ml of fresh, 
oxygenated Leibovitz medium, supplemented with 0.2 per cent albumin and 0.2 per cent 
glucose. Washing was repeated at least five times. Yield of glands varied between 
preparations so that the volumes available for subsequent incubations varied accordingly.
4.2.1.2: Gland counts and assessment of viability.
Counts of glands were made using a Modified Fuchs Rosenthal Haemocytometer, and 
viability was assessed using a Trypan Blue Dye Exclusion test (Berglindh and Obrink, 1976). 
Equal volumes of a 0.4 per cent (w/v) solution of Trypan Blue and of glandular suspension
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were mixed and then immediately examined by light microscope. Living cells are able to 
prevent dye uptake, whereas dead cells stain blue strongly. Viability was assessed at the start 
and finish of each experiment.
4.2.1.3: Carbachol dose response studies.
Dose response curves for pepsinogen secretion in response to carbachol were prepared using 5 
doses of carbachol (at final concentrations of 10'7, 10‘6, 10'5, 10'4 and 10*3 M carbachol, 0.1 
micromolar to 1 millimolar) and a control dose (distilled water). Glandular suspensions were 
prepared from the fundic mucosa of six animals killed at Sandyford abattoir. The experiments 
covered a period of six non-consecutive days, in which glands from each sheep were 
processed in a single day.
Carbachol (carbamylcholine chloride) was prepared as a 0.1 molar stock solution using 
distilled water. One to five millilitres of glands were aliquoted into capped vessels, the exact 
volume depended on the total yield from each animal. Glands were then pre-incubated in a 
shaking water bath at 37°C for 30 minutes, at the end of which either a dose of carbachol or 
an equivalent volume of distilled water (vehicle for carbachol) was added. Multiple aliquots 
of glands from each animal were set up to receive each carbachol/vehicle dose. Agent/vehicle 
addition was never in excess of 1 per cent of total volume. Glands were then incubated for a 
further 60 minutes. Small samples (0.1 to 0.2 ml) were taken at the end of the pre-incubation 
period and at the end of the experiment. Samples were then diluted 1:4 with distilled water 
and centrifuged at 10,000 g  in a bench-top Eppendorf centrifuge (MSE) to pellet glands/cells. 
Supernatants were then stored at -20°C to await analysis. Assay of pepsinogen concentration 
in supernatants was performed using the modified pepsinogen assay (section 3.2).
The pepsinogen concentrations in the pre-samples were subtracted from the final sample 
concentrations and then a mean value was obtained for each separate dose for each animal. To 
compare the mean values obtained from all six sheep, where the individual pepsinogen 
concentrations involved varied widely, data were expressed as an increase over secretion in 
control samples, and then as a percentage of the maximal response obtained in each animal. 
Non-normal data distribution required analysis by non-parametric tests. The pepsinogen 
concentrations obtained in response to different doses of carbachol were therefore compared 
using a Kruskall-Wallis test.
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4.2.1.4: Studies involving supramaximal doses of carbachol.
Other experiments simply tested pepsinogen secretion in response to a dose of carbachol 
greater than that likely to be required to give maximal stimulation (extrapolated from other 
studies), versus basal unstimulated secretion. Glands were prepared from the abomasa of two 
sheep, both obtained from Sandyford abattoir. Different yields of glands meant that the total 
number of gland aliquots per treatment was ten with the first sheep, but six with the second. 
The one-tenth molar stock solution of carbachol was again used. The final concentration of 
carbachol in the culture medium for half the gland aliquots from each sheep was 1 mM, the 
other half remained unstimulated, with only an equivalent volume of carbachol vehicle 
(distilled water) added. Pepsinogen concentration was measured in the culture supernatants at 
the end of the thirty minute equilibration period, prior to the addition of carbachol/vehicle, 
and after a further thirty minutes. The pepsinogen concentration of the pre-samples (0 
minutes) was then subtracted from that of the final samples (30 minutes). The mean 
pepsinogen concentrations in control and carbachol-treated glands for each sheep were 
compared by two-sample T-test.
4.2.2: Results.
4.2.2.1: Results of assessments o f viability.
Gland counts per millilitre of final incubation medium are given in Appendices 5 A and 5B. 
Because of the three-dimensional nature of glands, cells on the far side o f glands could not be 
seen, it was therefore felt that absolute counts o f viable and non-viable cells were 
inappropriate. Viability was, however, empirically very good when glands were prepared by 
the above method, an estimate of viability indicated that 70 per cent of all cells were viable 
and remained so during subsequent experiments (agreeing with the studies of McKellar et al, 
1990b). Fig. 4.1 shows cross sections of dispersed glands harvested prior to the 
commencement of an experiment, following fixation in Brunnel’s Fixative. Paraffin- 
embedded glands were sectioned at 2 pm thickness and stained with Haematoxylin and Eosin. 
Parietal and chief cells can be seen in normal apposition to each other. The apical cytoplasm 
of the chief cells is filled with eosinophilic granules. Chief cell nuclei show quite dense 
chromatin, but otherwise cells appear viable.
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4.2.2.2: Results o f dose response studies.
Pepsinogen concentration data from gland preparations from each animal are shown in 
Appendix 5A. Fig. 4.2 shows the overall mean results of all six separate dose response 
experiments. Although the gland preparations showed increased pepsinogen secretion at 
higher carbachol concentrations, and the curve approximates the sigmoid shape typical of 
other dose response experiments, the very high degree of variation encountered (illustrated by 
the extent of the standard error bars) meant that differences in pepsinogen secretion in 
response to different carbachol doses were not necessarily greater than that which might 
simply arise between preparations treated identically. The Kruskall-Wallis test showed that 
differences in secretion between the different carbachol doses were not significant (p>0.150).
4.2.2.3: Results of supramaximal stimulation studies.
The pepsinogen concentrations in control and carbachol-treated gland preparations are shown 
in full in Appendix 5B. Fig. 4.3 details the results from the two experiments and shows that 
each failed to produce a significant response to stimulation with a 1 millimolar concentration 
of carbachol, and in one (Fig. 4.3a) mean secretion in the presence of carbachol was in fact 
less than that of controls. Pepsinogen concentrations in control and carbachol-treated glands 
were not significantly different in either experiment (p>0.05, by Student’s two-sample T- 
Test).
4.2.3: Discussion.
Dispersed abomasal glands prepared by the above method were inadequately responsive to 
carbachol, despite apparently good viability of the glands. Other workers have shown that 
significant responses to stimulation occur rapidly, within 30 minutes (Hersey et al, 1983a,b; 
McKellar et al, 1990b) and it is unlikely that insufficient time had been allowed for the 
generation of responses in the present studies. Possibly the doses of carbachol were too low to 
provoke responses or ovine glands in general do not respond, or respond only weakly, to 
carbachol stimulation. Both these arguments are unlikely given the wealth o f information 
obtained from gastric gland studies from other species and the one study of bovine and ovine 
glands where cholinergic stimulation was successful (McKellar et al, 1990b). The major 
difference between the method used by McKellar et al (1990b) and the method adopted here
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was the use o f abattoir-derived abomasal tissue that had been transported in cold media. Cold 
transport/storage (0-4°C) of gastrointestinal muscle in parallel studies did not abolish 
responsivity (results not shown), however cold storage of gastric glands at the same 
temperatures has been associated with the subsequent poor performance of glands, with 
failure o f acid secretion in particular (Soil and Berglindh, 1987). Other workers (Sack and 
Spenney, 1982) have shown that the exact culture conditions are crucial to the magnitude of 
responses obtained using dispersed gastric glands, at least for monitoring acid secretion via 
the intracellular accumulation of aminopyrine. The same workers listed a variety of factors, 
which included the shape of the incubation vessel, and the rate and direction of shaking, 
important in the determination of the magnitude of responses. Further work would therefore 
be required to enable the routine use of dispersed abomasal glands. Eventually this method 
was abandoned in favour of a more straightforward technique which utilised intact mucosal 
sheets (section 4.3).
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Fig. 4.1: Cross sections of dispersed abom asal glands. (H&E) viewed with oil immersion 
and x250 magnification.
Fig. 4.2: Pepsinogen  release from  dispersed abom asal glands in response to C arbachol.
Data was expressed as the ratio o f stimulated secretion to control secretion in each experiment and 
then as a percentage o f the maximal response obtained in each experiment, and is displayed as the 
overall mean, +/- SE, o f experiments in glands derived from 6 animals.
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Fig. 4.3: Failure of maximal doses of carbachol to elicit significant increases of pepsinogen 
release from dispersed abomasal glands in two separate experiments.
3a: mean data +/- SE, o f  10 preparations per treatment.
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4.3: Pepsinogen secretion by intact mucosal sheets.
Intact mucosal sheets mounted in Ussing chambers have been used extensively in recent years 
and can be utilised to monitor the secretion of both pepsinogen and acid simultaneously (Forte 
et al, 1975; Finke et al, 1985; Rhodes et al, 1986; Basson et al, 1990; Patel and Spraggs, 
1992). The preparation of intact gastric mucosal sheets involves minimal processing of tissue, 
with no requirement for enzymatic digestion. An Ussing chamber is one where luminal and 
submucosal surfaces o f the mucosal sheets face separate compartments and are therefore 
bathed by fluids that do not communicate except for a potential exchange through the tissue 
itself. Measurements o f transmucosal potential difference as well as those of acid and 
pepsinogen secretion can be made using these preparations if suitable equipment is available. 
Luminal pH has generally been measured by pH-Stat technique involving auto-titration with 
sodium hydroxide. Pepsinogen secretion can be measured simply by assaying the pepsinogen 
concentration of samples o f luminal fluid, collected at specific intervals.
The initial studies reported in this section were to establish the length of time required for the 
full development of secretory responses to stimulation and thus identify an appropriate 
sampling interval for routine experimentation. The method was further validated by 
establishing dose response curves for increasing concentrations of carbachol, these latter 
studies assumed that the twenty minute sampling interval used by other workers (Basson et al, 
1990) was appropriate.
4.3.1: Materials and methods.
4.3.1.1: Preparation of intact mucosal sheets to monitor pepsinogen secretion.
Ovine abomasa were obtained from the abattoir, as described previously (section 4.2.1) and 
opened along the greater curvature and the contents discarded. The mucosa was then rinsed 
with warm (approximately 30°C) Ringer’s solution (122 mM NaCl, 25 mM N aHC03, 5 mM 
KC1, 1.3 mM M gS04, 2.0 mM CaCl2, 1.0 mM KH2P 0 4 and 20 mM glucose), that had been 
gassed with 95 per cent 0 2 and 5 per cent C 0 2. The abomasa were then placed mucosal side 
down and a volume of Ringer’s solution (approximately 50 ml per site) was injected between 
the muscle layer and the mucosa to form a blister. The muscle coat was then cut away and the
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freed mucosa was collected and placed in warm Ringer’s for transport back to the laboratory. 
Mucosal pieces were later trimmed to a suitable size for mounting in tissue chambers.
The tissue chambers themselves were hand-crafted from 2.5 ml polystyrene syringes (see Fig.
4.4). The plunger was removed and the tip of the syringe was cut away using a small hacksaw. 
With a fine file a groove was cut behind the tip, to give a raised lip, and the cut edges were 
smoothed. To seal the smoothed surfaces the tip was immersed briefly in acetone and then 
allowed to dry.
The mucosa was tied in place over the chamber and secured by strong thread, with the luminal 
surface facing into the chamber, having an exposed surface area of 0.64 cm2. The tissue- 
chamber assembly was then placed in a 15 ml tissue bath and the submucosal surface was 
bathed with 10 ml of Ringer’s bubbled vigorously with 95 per cent 0 2, 5 per cent C 0 2. The 
luminal surface was bathed with 2.0 ml Ringer’s supplemented with 0.3 per cent Casein Acid 
Hydrolysate, and gassed with the same mixture as the submucosal fluid. The gas flow rate on 
the luminal side was kept high to better stir the bathing Ringer’s. The full experimental 
apparatus is illustrated in Fig. 4.4.
Both luminal and submucosal solutions were maintained at pH 7.4 by the presence of 
bicarbonate and 5 per cent C 0 2 in the gas mixture. Circulating water in the bath jackets was 
maintained at 37°C. The presence of casein hydrolysate in the luminal solution has been used 
by others (Basson et al, 1990) to improve the recovery of pepsinogen. It acts by saturating 
protein binding sites and acting as an alternative substrate to prevent autodigestion of 
pepsinogen if activated pepsin is present. Basson et al (1990) recorded a 30 per cent increase 
in yield of peptic activity in this way.
For at least the first two hours after set-up, tissues were allowed to equilibrate, with no 
additions of agonists/ES in this period. Luminal and submucosal solutions were replaced 
every 20 minutes, and old solutions were discarded.
Fig. 4.4: Experim ental set-up for the in vitro m onitoring of pepsinogen release from 
intact inueosal sheets. The inset details the tissue-tube assembly where the mucosa is 
stretched over the tube end and secured behind a raised lip with strong thread.
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4.3.1.2: Time course of the response to cholinergic stimulation.
To confirm the appropriateness of the twenty minute sampling interval, tissues were obtained 
from three animals at Sandyford abattoir and pepsinogen release in response to cholinergic 
stimulation was closely monitored. Tissues were allowed to equilibrate for two hours before 
the experiments were begun. The submucosal bathing fluid was then replaced at 0, 15 and 30 
minutes and then at twenty minute intervals until the end of the experiment. Thirty minutes 
after the end of the equilibration period and immediately after the submucosal bathing fluid 
had been changed, a dose of carbachol was added to the submucosal Ringer’s. The dose was 
extrapolated from other studies and calculated to give a final bath concentration of 0.1 
millimolar, i.e. a likely supramaximal dose of carbachol. The carbachol dose was repeated 20 
minutes later when the mucosal fluid was again replaced. After a further twenty minutes the 
mucosal Ringer’s was replaced for the last time, but this time with no further additions. 
Tissues were therefore exposed to carbachol for a total period of forty minutes. Throughout 
the experiment the luminal fluid (2.0 ml) was collected and replaced at five minute intervals. 
Immediately after collection of luminal fluid, the samples were acidified to a pH of 
approximately 5.0 with the addition of 20 pi of 1 molar hydrochloric acid, since pepsinogen 
and pepsin are stable at pH 5.0, but the activation of pepsinogen to pepsin at this pH will be 
minimal (Hirschowitz, 1984). Samples were stored at -20°C until the assay of pepsinogen 
concentration could be performed using the modification of Paynter’s method (section 3.2). 
The volume of carbachol added to the submucosal bathing fluid did not exceed 1.0 per cent of 
total bath volume (i.e. 100 pi). The experiments used the same 0.1 molar carbachol stock 
solution as used earlier (section 4.2.1.3) Five mucosal tissue preparations were set up for each 
of two o f the animals (sheep 2 and 3). Three preparations were set up for the third animal 
(sheep 1), however one tissue was ruptured accidentally in the course of the experiment and 
luminal fluid could only therefore be collected from the remaining two intact tissues.
4.3.1.3: Carbachol Dose Response studies.
Dose response studies were carried out in tissues from five animals (five tissues from each 
animal) and pepsinogen release was measured in response to increasing concentrations of 
carbachol. All solutions were replaced and the luminal fluid samples collected at twenty 
minute intervals. After the first two time points, during which tissues remained untreated, 
carbachol was added initially to give a final bath concentration of 10*9 M (1 nanomolar). The
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concentration o f carbachol in the mucosal bathing solution was then increased in ten-fold 
increments, in each subsequent twenty minute interval, to reach a maximum of 105 M (10 
micromolar). Tissues were therefore exposed to each concentration of carbachol for twenty 
minutes. The 0.1 molar stock solution of carbachol (see section 4.2.1.3) was diluted to 
produce a series o f working concentrations so that the volume of each necessary to achieve 
the required bath concentration would not exceed 100 pi. An examination of the pepsinogen 
released during the first two, untreated time points was used to confirm whether basal 
secretion was steady-state. Luminal samples were again acidified by the addition of 20 pi of 
hydrochloric acid prior to their storage at -20°C.
4.3.1.4: Statistical analysis of pepsinogen release data.
From the pepsinogen concentrations present in the luminal samples, pepsinogen secretion was 
calculated as the total pepsinogen released per 5 or 20 minute period. For the time course data 
separate one-way analyses of variance (ANOVA) were performed for each animal, this was to 
indicate whether any time points were associated with greater mean pepsinogen release than 
others. Subsequent to ANOVA, Dunnett’s test was used to compare mean pepsinogen release 
for the treated timepoints (i.e. the response to carbachol) to a control mean, in this case the 
last untreated time point. Dunnett’s test was also used to confirm that pepsinogen release 
during all untreated time points at the beginning of the experiments did not vary significantly 
and that steady-state conditions had indeed been reached by the end of the equilibration 
period. For the dose response data mean values were calculated for each animal for each time 
point, these data were then expressed as the ratio of the secretion in each time interval to that 
of the last untreated interval. This was to allow the comparison of the results from all five 
animals where the individual pepsinogen concentrations varied widely. The ratio data was 
then analysed by one-way ANOVA and Dunnett’s test. The above analyses were preceded by 
Bartlett’s test for homogeneity of variance, and if variance was significantly heterogeneous 
then data were log]0-transformed, then resubmitted for Bartlett’s test. Differences of the 
degree of variance were generally not detected after this transformation, and ANOVA and 
Dunnett’s test could then be applied to the transformed data.
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4.3.2: Results.
4.3.2.1: Results of investigations into the time course of the response to cholinergic 
stimulation.
The full results of experiments in tissues from the three animals are given in Appendices 6A 
to 6C. The results expressed as the mean pepsinogen release over basal for each animal over 
time are shown in Fig. 4.5. Pepsinogen release was at a steady rate during the first thirty 
minutes o f the experiments in all animals. In two animals pepsinogen release became maximal 
within twenty minutes of exposure to carbachol. Pepsinogen concentrations in the luminal 
fluid rose rapidly in the first five minutes to become maximal by 10 minutes in sheep 3 and 15 
minutes in sheep 1. In the remaining animal maximal pepsinogen release was only achieved 
25 minutes after carbachol addition. Based on Analysis of Variance and Dunnett’s test of 
log10-transformed data, pepsinogen secretion in the first thirty minutes in tissues from all three 
animals did not vary significantly (p>0.05). In tissues from sheep 1 pepsinogen release was 
significantly greater than basal (p<0.05) from the 35th minute until the 60th, and, in sheep 3, 
from the 35th minute until the end of the experiment (80 minutes). In sheep 2 pepsinogen 
release was significantly greater than basal only from the 41st minute, and remained so until 
the end of the experiment (75 minutes).
4.3.2.2: Results of dose response studies.
The full results for the dose response studies are given in Appendices 7A to 7E. The overall 
mean results are expressed in Fig. 4.6, and ED50 and ED100 values, which were assessed by 
visual examination of individual dose response curves, are given in Table 4.1. The dose 
response curve shows a typical sigmoid shape. Based on Dunnett’s test of log10-transformed 
data from all six experiments, only the responses to 10‘6 and 10"5 M carbachol were 
significantly greater than basal (p<0.05). Maximal stimulation of pepsinogen release was 
generally achieved by carbachol concentrations of at least 3 micromolar.
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Fig. 4.6: Carbachol Dose Response Curve, showing pepsinogen release from mucosal 
preparations in response to increasing doses of drug
(mean values, + /- SE, o f  5 separate experiments on different animals, each com prising 5 tissues 
from a single animal)
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■£co
CQ
"3u
CAa<up*
0
0 20 40
A N O V A  p< 0.001  
([Carbachol], log molar dose)
60 80 100
Time (mins)
(-9) (-8) (-7)
120 140 160
(-6) (-5)
Table 4.1: Concentrations giving 50 per cent and 100 per cent of the maximal response 
to Carbachol in studies of mucosal pepsinogen release in individual animals, based on 
visual examination of individual dose response curves, (molar concentrations).
e d 50 ED100
Animal 1 
2
3
4
5
Mean (± S.E.)
1.0 X 10"'
1.2 x 10'6
3.0 x 10'7
2.0 x 10'7
6.0 x 10'8
3.0 x 10'7 (1.0x 10'7)
1.0 x 10'°
1.0 X 10‘5
1.0 X 10'6
1.0 X 10‘6
1.0 X lO-6
2.8 x 10‘6 (1.7 x 10'6)
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4.3.3: Discussion.
A twenty minute sampling interval would have been adequate for two of the three animals in 
the time course experiments. The slower rise to peak pepsinogen output in tissues from sheep 
2 is important. Tissues from this animal appeared grossly thicker than those of other animals, 
although an examination of mucosal wet weights revealed that they were not significantly 
heavier than those of sheep 1 and 3 (p>0.08, by balanced ANOVA, fitting sheep as a random 
effect). In other experiments, exceptionally thick mucosae often failed to give increases in 
secretion in response to cholinergic or other stimulation (results not shown). In these cases it 
is possible that secreted pepsinogen was unable to diffuse, or was delayed from diffusing, out 
of the mucosa. Alternatively, agonists may not have adequately penetrated into the tissues, or 
a failure of diffusion of oxygen or electrolytes may have caused significant tissue 
degeneration. It is likely that in most cases twenty minute sampling intervals will allow 
responses to stimulation to be fully expressed. Abomasa were selected from lighter, smaller 
sheep at the abattoir for use in subsequent experiments.
Pepsinogen release declined more rapidly in tissues from sheep 1, this might have been due 
to the gradual depletion of pepsinogen granules from cells. Since the tissues were bathed 
only in electrolytes, it is unlikely that much de novo synthesis o f pepsinogen occurred in 
these preparations. Because of the potential for decline of pepsinogen granule content in 
intact mucosae, these preparations are unsuitable for repeat experiments testing more than 
one treatment.
From the dose response studies any dose of carbachol giving a concentration of at least 3 
micromolar can be considered to be supramaximal, that is greater than the ED]00. Maximal 
responses to carbachol were generally in the order of three to five times greater than basal 
secretion. The magnitudes of the responses were substantially less than those reported by 
Basson et al (1990), who recorded increases of up to forty times basal rates in response to 
cholinergic stimulation using intact guinea pig mucosae. The same workers reported that 
basal secretion in guinea pig mucosa was at the rate of 0.3 per cent of the total mucosal 
pepsinogen content per hour. This compared with 0.4 to 3.0 per cent per hour in isolated 
rabbit gastric glands, and guinea pig gastric glands and chief cells (Kaskebar et al, 1983; 
Raufman et al, 1984; Berger and Raufman, 1985). Shirakawa and Hirschowitz (1986) 
reported that basal pepsinogen secretion from frog oesophageal mucosa mounted in Ussing
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chambers was between 16 and 19 per cent of the total pepsinogen content. In the present 
studies the total pepsinogen content remaining in the mucosae at the end of experiments was 
measured in mucosal homogenates from some experiments. From these values the total 
pepsinogen content present at the start o f the experiment could be calculated (i.e. by adding 
the total of all pepsinogen released during the experiment). Basal secretion was then 
expressed as a percentage of the total present at the start of the experiment. In this manner, 
from a series of ten experiments, basal secretion was calculated as 7.06 ± 1.76 per cent of 
total pepsinogen content (mean value ± S.E.) with a range of 1.34 to 16.01 per cent. These 
values were recorded in tissues giving maximal responses to stimulation o f4 .3 0 ± 0 .5 6  times 
basal (mean value ± S.E.) with a range of 2.50 to 8.03. Thus basal secretion was higher than 
in the studies of Basson et al (1990), and maximal responses in comparison were perhaps 
correspondingly lower. In the present studies it was thought that tissues with higher basal 
secretory rates generally had lower maximal responses to stimulation, when this was 
calculated as an increase over basal, but this has not been confirmed.
Fig. 4.7 shows a section of an intact mucosal preparation, placed in fixative at the end of an 
experiment. The architecture of the pits and glands is well preserved, some glands appear 
slightly dilated. The muscularis mucosa can be seen, intact at the base of the tissue. Most 
epithelial cells appeared viable with nuclei containing chromatin apparently normal in 
appearance. Chief cells contained few granules, supporting the theory that they had depleted 
during these experiments, and parietal cells showed less cytoplasm than normal, with some 
containing cytoplasmic vacuoles. In the lamina propria, there was evidence of some tissue 
destruction with the presence of some pyknotic nuclei, with fragments of dense chromatin. 
The above findings are consistent with the maintenance of the viability o f the chief cell 
elements of the preparations over the length o f incubation normally used.
The intact mucosal sheet preparation was simpler in comparison to the dispersed gastric 
gland method, but was also the only one of the two methods to prove responsive to 
cholinergic stimulation, and as such was preferred for use in the subsequent studies of the 
effects of ES (section 6).
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Fig. 4.7: Photom icrograph of a section of an intact mucosal sheet preparation , placed in 
fixative at the end of the experimental incubation, (original magnification x 50).
9 ?
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5: GASTROINTESTINAL SMOOTH MUSCLE.
5.1: Introduction.
The control of visceral smooth muscle function and motility is no less complex than that of 
gastrointestinal secretion and involves many of the same regulatory components including 
the sympathetic and parasympathetic branches of the peripheral nervous system, local nerves 
of the enteric nervous system and endocrine/paracrine hormonal input. Visceral smooth 
muscle activity in the gastrointestinal (GI) tract is also regulated by the muscle cells 
themselves. Gastrointestinal smooth muscle cells have a characteristically oscillatory 
membrane potential, giving rise to slow waves in membrane potential. Slow waves are the 
likely result o f variability in the activity of sodium/potassium pumps in muscle cell 
membranes (Grundy, 1985a), and do not themselves result in contractions. They do however 
elevate resting membrane potential nearer the threshold required for the generation of major 
depolarisations, action or spike potentials. The overall result is the rhythmic contraction of 
GI smooth muscle due to spontaneous waves of depolarisation (Caprilli et al, 1982). Smooth 
muscle cells act in co-ordination with each other and there are recognised pacemaker areas 
where the frequency of slow waves is greatest. In the small intestine the longitudinal muscle 
of the proximal duodenum fulfils this function (Ruckebusch, 1981), communicating with the 
circular muscle and generating a regular cycle of activity, the Migrating Myoelectric 
Complex (MMC)(Ruckebusch, 1970). Phase I of the MMC lacks contractile activity, and 
slow waves are the predominant myoelectric activity. In phase II intermittent spiking activity 
occurs (ISA) as spike potentials become superimposed on the slow waves, these are 
accompanied by irregular contractions and the frequency of spike potentials increases until 
the onset of regular spiking activity (RSA) or phase III of the MMC. Migrating myoelectric 
complexes are propagated aborally and this is associated with the function o f the MMC in 
monogastric animals as an interdigestive housekeeper (Szurszewski, 1969). In monogastric 
animals the passage of digesta is associated with supervening peristaltic contractions and 
intestinal contents are mixed by a variety of other activities of smooth muscle such as 
segmenting contractions. In the ruminant, however, the MMC is uninterrupted by feeding 
and serves to maintain an almost continuous flow of digesta along the GI tract (Grivel and 
Ruckebusch, 1972).
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Innervation of the GI tract is both intrinsic (via the enteric nervous system) and extrinsic (the 
autonomic nervous system). Axons from ganglia of the intramural (Auerbach’s) plexus, 
situated between the circular and longitudinal muscle layers, penetrate into both muscle 
layers. Input to these ganglia include autonomic efferents and axons from chemoreceptors 
and mechanoreceptors in the muscles and mucosa. A further plexus (Meissner’s) situated in 
the submucosa is mainly involved with secretion and the relay of sensory information from 
the mucosa. The majority of neurones in the enteric nervous system are intemeurones which 
integrate and assimilate sensory input and mechanical output.
Autonomic control of gastrointestinal smooth muscle is via parasympathetic and sympathetic 
supply. While it is considered that parasympathetic effects are generally stimulatory for 
contractile activity and that the sympathetic system has opposite effects, it is probably wrong 
to view them as simply mutually antagonistic (Gershon and Erde, 1981; Grundy, 1985b). 
The parasympathetic innervation to the proximal GI tract originates in the brain stem and the 
preganglionic fibres are contained in the vagus nerve and acetylcholine is the 
neurotransmitter in virtually all of these fibres (Gershon and Erde, 1981). The preganglionic 
fibres innervate local ganglia in the GI tissues and the postganglionic fibres may have 
excitatory or inhibitory effect. Sympathetic innervation of the most proximal parts of the GI 
tract is via postganglionic and noradrenergic fibres from the cervical and coeliac prevertebral 
ganglia. Most sympathetic nerves innervate pre-synaptic a 2-adrenoceptors on cholinergic 
neurones of the intramural plexus, sympathetic activity thereby preventing the release of 
acetylcholine (Gershon and Erde, 1981; Grundy, 1985c; Mamber and Gershon, 1979). 
Sympathetic innervation of sphincter areas is however direct and this direct stimulation of 
visceral smooth muscle cells generally results in hyperpolarisation of the cell membranes, 
preventing the formation of action potentials. The importance of extrinsic control of GI 
smooth muscle is dependant on the activity of brain stem nuclei and that o f other central 
areas, and the baseline activity of vagal efferents in ruminants appears to be lower than that 
o f monogastric species (Clark, 1990). In addition to this there is a discrepancy between the 
number of vagal efferents and the number of enteric ganglion cells such that many intramural 
cell bodies receive no direct vagal innervation (Weyns et al, 1987).
A striking feature of the enteric nervous system is the abundance of different 
neurotransmitters involved in signalling and control of visceral smooth muscle activity. In 
addition to the classical neurotransmitters acetylcholine and noradrenaline, there is ample
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evidence that other substances, such as 5-hydroxytryptamine (5-HT, also known as 
serotonin), many peptides such as VIP, gastrin and CCK, and a variety o f other agents such 
as Adenosine triphosphate and substance P, are present in enteric neurones. Many peptides 
such as gastrin and CCK function as part of the endocrine regulation of muscle function in 
addition to their neurotransmitter roles.
Parasites are known to cause anatomical and functional changes in the smooth muscle layers 
of the gut wall (Castro, 1989). Many parasitic infections have been shown to cause increases 
of intestinal muscle mass and other studies have demonstrated a non-specific increase in 
responsiveness o f muscle to cholinergic and serotonergic stimuli in rat jejunum following 
Trichinella spiralis infection (Vermillion & Collins, 1988). Similarly in rats with primary 
nippostrongylosis an increase in muscle mass was accompanied by hyper-responsivity to 5- 
HT and to electrical stimulation (Farmer and Laniyonu, 1984). In sheep experimentally given 
concurrent T. axei and C. ovina infection, disturbances of the MMC, accompanied by the 
onset of diarrhoea, were detected 3 weeks after initial infection (Bueno et al, 1975), similar 
findings were found in T.spiralis parasitised rats (Castro et al, 1976) and dogs (Schanbacher 
et al, 1978). Unusual myoelectric activity was seen in T. spiralis infected rats as normal 
MMC frequency became reduced (Palmer et al, 1984). An abnormal but still highly 
organised electrical event was rapidly propagated aborally along the intestine; referred to as 
the Migrating Action Potential Complex (MAPC). The MAPC may be associated with more 
rapid intestinal transit and attempts by the host to eliminate pathogens.
Morphological and functional changes in smooth muscle function in response to infection 
may be the result of inflammatory reactions, but some workers have postulated the existence 
of chemical factors released by parasites with direct effects on motility. The intra-venous 
administration to sheep of an extract of crushed H. contortus larvae immediately reduced 
reticular contractions, followed by a prolonged reduction in abomasal and duodenal motility 
(Bueno et al, 1982a). Excretory/secretory products from Nippostrongylus brasiliensis have 
been shown to reduce spontaneous contractions in isolated sections of rat intestine (Foster et 
al, 1994) and a direct effect of ES from the dog heartworm {Dirojilaria immitis) on blood 
vasculature, the depression of endothelium dependant arterial relaxation, has been attributed 
to a filarial prostaglandin, prostaglandin D2 (Kaiser et al, 1992). Intestinal transit was 
prolonged in calves with infections of 0. ostertagi (Fox et al, 1989a).
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Anamnestic and stimulus-specific responses occur as a result of challenge infections of 
immune animals with parasites. Secondary infection of rats with T. spiralis larvae resulted in 
myoelectric disturbances within 15 minutes of larval administration (Palmer and Castro,
1986). Changes occurring included the appearance of MAPC’s and were associated with the 
rapid expulsion o f larvae. Changes could not be elicited by the administration of killed 
larvae, larval ES or by inoculation with a heterologous parasite such as the coccidian 
Eimeria nieschulzi. Similar mechanisms may have been operating in studies carried out by 
Stewart (1953, 1955) into the self-cure phenomenon of ovine haemonchosis. Direct intra- 
abomasal inoculation of sheep already infected with H. contortus larvae resulted in increased 
muscle activity within ten minutes. These responses have been seen as the in vivo 
equivalents of an in vitro phenomenon, the Schultz-Dale reaction (Schultz, 1910; Dale, 1913; 
Chand and Eyre, 1978). The Schultz-Dale phenomenon is the contraction elicited in in vitro 
maintained smooth muscle preparations in response to antigenic stimulation, and only occurs 
in tissues from animals that have previously been actively or passively sensitised to the 
antigen. The central event of the Schultz-Dale reaction is thought to be the degranulation of 
mast cells in the presence of antigen. Antigen cross-linking of bound immunoglobulin, of 
subclasses IgE and IgGl, themselves already attached via FcsRI receptors at the mast cell 
surface, stimulates the exocytotic release of chemical mediators from mast cell granules 
(Plaut et al, 1989; Bissonnette and Befiis, 1993; Perdue and McKay, 1993). Mast cell 
granules in a variety o f species are thought to contain numerous mediators including 
histamine, 5-HT, leukotrienes, platelet-activating factor, prostaglandin D2. a variety of 
proteases and nitric oxide (Bissonnette and Befus, 1993; Schwartz, 1984; Tamura et al,
1987). Chand and Eyre (1978) recognised several characteristics of the contractile reaction 
typical o f the Schultz-Dale phenomenon in smooth muscle;
1. The response is anamnestic and stimulus specific, and tissues are sensitive to small 
doses of antigen. Antigen has no direct action on smooth muscle cells.
2. A latent period exists between the addition of antigen and the onset of the 
contractile response. This period is of variable length and may be due to the requirement for 
a build up of released products to effective concentrations.
3. Tachyphylaxis occurs, i.e. the diminishment of the response to a repeated yet 
identical antigen dose, without affecting the responses to other agents. Tissues recover if
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rested for a period of hours and it is thought that tachyphylaxis is due to the depletion of 
mast cell granules and that time is required for their repletion.
Mast cells are not the only cells mediating manifestations of gastrointestinal anaphylaxis. 
Neurones of the enteric nervous system have also been implicated. In studies of ionic current 
changes in immune guinea pig colonic epithelium in response to T. spiralis antigen (Wang et 
al, 1991) mast cell products were thought to stimulate cholinergic nerve activity directly. 
Frieling et al (1994) also reached the conclusion that signalling between mucosal mast cells 
and the enteric nervous system was involved in colonic anaphylactic reactions to sensitising 
antigens. Other studies have shown that in nematode-sensitised animals many mast cells 
migrate to lie in close proximity to enteric neurones (Stead et al, 1987, 1991).
An investigation of the effects of ES on smooth muscle activity would be an invaluable 
adjunct to the studies of pepsinogen secretion. The following work was performed to develop 
a method for the in vitro maintenance of gut smooth muscle, and to test muscle preparations 
with cholinergic, histaminergic and serotonergic stimulation.
5.2: Isolated smooth muscle preparations.
The following studies were to assess the utility and responsivity of smooth muscle 
preparations.
5.2.1: Materials and methods.
5.2.1.1: Tissue collection.
The ballooning method used to separate abomasal mucosa from the underlying muscle 
during the preparation of intact mucosal sheets served a dual purpose since muscle could also 
then be collected. Muscle cuts were transported back to the laboratory in the same, warmed 
Ringer’s as were the mucosal pieces. The muscle was then transferred to cold (0-4°C) Krebs- 
Henseleit solution (95 mM NaCl, 25 mM NaHC03, 4.7 mM KC1, 2.5 mM CaCl2, 1.2 mM 
M gS04, 1.2 mM KH2P 0 4 and 11 mM glucose) and stored refrigerated until used. The larger 
smooth muscle pieces were later pinned to a cork board kept moist by drenching with cold 
Krebs, the muscle layers were not separated, but by cutting thin strips (up to one millimetre
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in width by half to one centimetre in length) in line with the . fibres o f one muscle layer, the 
effects of that layer could be studied in isolation. Although the circular muscle layer of the 
abomasum was thicker the longitudinal layer was generally used as this tended to give less 
spontaneous activity. Thread was tied securely to each end of the muscle strips and these 
were then placed in 10 ml jacketed water baths (kept at 37°C) containing Krebs-Henseleit 
solution bubbled with the 95 per cent 0 2 and 5 per cent C 02 mixture.
5.2.1.2: Isometric measurements of muscle tension.
Tissues were anchored distally to secured metal hooks via the thread. The proximal end of 
each tissue was attached to an isometric force-transducer (FT03, Grass Instrument Co., 
Quincey, Mass., U.S.A.), itself mounted on a sliding rack to allow the height of the 
transducer, and hence the resting tension in the tissue to be altered. The transducer fed to a 
Low Level D.C. Pre-amplifier (7P1G, Grass Instrument Co.) which in turn led to a 
Polygraph D.C. Driver Amplifier (7DAG, Grass Instrument Co.). Amplifier output was 
recorded as displacement of an ink trace, recorded on chart paper. The system was calibrated 
by the suspension of 1 to 5 gram weights from the transducer arm, and pen displacement was 
shown to be in direct relationship to the mass of the suspended weights. The experimental 
set-up is represented schematically in Fig. 5.1. Tissues were left for 20 minutes before being 
pretensioned by stretching the muscle strips until a tension equivalent to one gram was 
registered. The muscles invariably relaxed after initial stretch so that they were retensioned 
until resting tension was steady at one gram.
5.2.1.3: Carbachol Dose Response studies.
When tissues had been stable at one gram of resting tension for at least twenty minutes, the 
experiments were begun. Cumulative dose response studies to cholinergic stimulation with 
carbachol were carried out in muscle strips from four animals. Four muscle strips were tested 
from each of sheep 1 and 2, three from sheep 3 and six from sheep 4. Unlike dose response 
studies performed with the mucosal sheets, the bathing fluid was not changed between 
individual doses of carbachol. Instead the response to each dose was monitored on the trace 
and when the response to the previous dose had reached a plateau, the next dose was added. 
Six doses of carbachol were employed, in ten-fold increments of concentration from 1 
nanomolar to 0.1 millimolar (10‘9 M to 10"4 M). A similar 0.1 molar carbachol stock solution
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and working dilutions as used in section 4.2.1 were prepared for these studies, and the 
volume of each dose added to the baths did not exceed 100 pi. Data were expressed as 
increases in grams tension above basal and then as the percentage of the maximal response to 
carbachol obtained in each tissue. The mean values from each animal were compared by a 
Kruskall-Wallis test (non-parametric data) to see if responses to any doses of carbachol were 
greater than others.
5.2.1.4: Studies of histaminergic and serotonergic stimulation.
Similar studies as those of the previous section were performed with longitudinal smooth 
muscle strips for the addition of histamine and serotonin (5-HT). Both chemicals were 
prepared as stock solutions in distilled water, both at concentrations o f 10 millimolar, from 
which working, ten-fold dilutions were prepared to facilitate the generation of dose response 
curves. Investigations measured the responses to cumulative drug doses in tissues from three 
animals for histamine (sheep 1 to 3) and from two of the three animals for serotonin (sheep 2 
and 3). Two tissues were obtained from sheep 1, and four muscle strips were obtained from 
both sheep 2 and 3. Both agonists were added initially at 1 nanomolar concentrations and 
increased in ten-fold increments to concentrations of 10 micromolar (serotonin) and 100 
micromolar (histamine). The conduct of these experiments was as for section 5.2.1.3, but the 
responsivity of each muscle strip was checked with a 0.1 millimolar dose of carbachol at the 
beginning and end of each experiment. Responses to doses o f histamine and serotonin were 
expressed as increases in grams tension above basal and then were expressed as a percentage 
of the maximal response o f each tissue to the final 0.1 millimolar dose of carbachol. A mean 
was then taken for the response of all tissues from each animal to each dose and a final, 
overall mean value was obtained to compare all animals. Because of the low number of 
animals in this study the data were not subjected to further statistical analysis.
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5.2.2: Results.
5.2.2.1: Results of Carbachol Dose response experiments.
Responses to carbachol addition developed rapidly, and reached the plateau of contraction 
within a few minutes. Full data from these experiments are recorded in Appendices 8A to 
8D. The overall mean values of the responses from the four animals can be seen in Fig. 5.2. 
Maximal responses were obtained at carbachol concentrations of close to 10 micromolar. 
Responses to the different doses were significantly different (p<0.002). The ED50 and ED100 
values for the responses to carbachol are shown in Table 5.1. These values were obtained by 
the visual examination of the dose response curves for tissues from individual animals. From 
this data doses of at least 100 micromolar carbachol were likely to give supramaximal 
stimulation.
Fig. 5.2: Mean carbachol dose response curve of tissues from four sheep.
(mean, +/- SE).
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Table 5.1: Carbachol concentrations giving 50 per cent and 100 per cent of the 
maximal response in dose response studies with abomasal smooth muscle, (molar 
concentrations).
e d 50 ED ioo
Animal 1 
2
3
4
Mean (± S.E.)
3.8 x 10''
4.3 x 10'7
1.0 x 10‘7
2.3 x 10'7
2.8 x 10'7 (7 x 10‘8)
1 x 10“*
1 x 10'5 
1 x 10'5 
1 x 10-4 
5.5 x 10‘5 (2.6 x 10'5)
5.2.2.2: Results of histaminergic and serotonergic stimulation.
When responses to either agonist were seen these usually developed as rapidly as responses 
to carbachol. Full data from these experiments are shown in Appendices 9A to 9E. The 
results from these experiments are shown in Fig. 5.3. Tissues from two animals (sheep 1 and 
3) did not respond to histamine at any concentration, tissues from the third sheep only 
responded to high concentrations (10 and 100 pM). Responses to both agonists were 
considerably less than those to carbachol. The response of the tissues from sheep 2 to 100 
pM histamine cannot be considered maximal as this would have required that the response to 
a higher histamine dose be no greater. The responses to serotonin concentrations of 1 and 10 
pM were similar in tissues from both sheep tested, but were slightly greater to the higher 
dose, it is therefore likely that the response to 10 micromolar serotonin is at least close to 
maximal.
5.2.3: Discussion.
Abomasal longitudinal smooth muscle preparations proved consistently responsive to 
cholinergic stimulation. Unlike the intact mucosal sheet method where granule pepsinogen 
content was likely to deplete with time, smooth muscle preparations gave repeatable
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responses to repeated agonist doses (results not shown). That carbachol was a consistent 
stimulus of smooth muscle contraction supports the hypothesis that cholinergic stimulation 
of abomasal smooth muscle is an important component of the physiological control of 
gastrointestinal motility in the normal ovine. The results for stimulation with histamine and 
serotonin suggest that these agents may not be important in the physiological control of 
ovine abomasal smooth muscle function. A significant advantage of smooth muscle 
preparations over the intact mucosal sheet studies was the immediacy of the results, 
contractions to stimulation were seen immediately in the pen trace. For example, when 
tissues were unresponsive to even carbachol they could be discarded and new tissues set up 
in their stead. In this way the success rate for this technique, the frequency with which this 
technique yielded meaningful data, was much higher. There was no need for a time- 
consuming second assay, such as the pepsinogen assay of luminal samples.
Fig. 5.3: Histamine and Serotonin dose response curves,
mean values, ± S.E., n = 3 animals (histamine), n = 2 animals (serotonin.
50 1
40"
cn
■3 2 3 0 -
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6: THE EFFECTS OF ES ON PEPSINOGEN SECRETION AND SMOOTH 
MUSCLE FUNCTION.
6.1: Introduction.
The potential influence of excretory/secretory products of Ostertagia spp. on pepsinogen 
secretion and smooth muscle function has already been discussed (sections 1.5 & 5.1), and 
was investigated in this series of experiments using the in vitro methods developed 
previously, and described in sections 4 and 5. Samples of ES prepared from cultured adult O. 
circumcincta parasites were tested on mucosal tissues and smooth muscle preparations 
obtained from the abomasa of animals that had prior experience of infection and also on 
tissues from animals that were known to be parasite-naive. This would determine whether 
responses to ES were the result of the direct stimulation of glandular secretion or of smooth 
muscle contraction by ES, or whether responses were hypersensitivity reactions due to the 
substances present in ES acting as antigens. Given the prevailing animal husbandry systems 
in the West of Scotland, most sheep in commercial flocks are kept outdoors, and will 
consequently have grazed nematode-contaminated pastures. Such animals will therefore have 
developed some degree of immunity to parasitism by nematode genera. Ostertagia 
circumcincta has been shown to be the predominant nematode species associated with 
parasitic gastroenteritis in sheep in this region of Britain (Stear et al, 1995a). Parasite-naive 
individuals would only be those that had been reared since birth in conditions likely to 
eliminate exposure to helminth parasites.
Further experiments would investigate some of the mechanisms of tissue responses to ES. 1) 
Comparison would be made between the time courses of pepsinogen release and smooth 
muscle responses to ES and to those due to cholinergic stimulation. 2) Release of the enzyme 
Lactate dehydrogenase is considered to be an indication o f the rates of cell damage in 
gastrointestinal tissue culture (Koelz et al, 1982) and monitoring the release of LDH would 
therefore ascertain whether pepsinogen release in response to stimulation was due to; non- 
cytotoxic degranulation of chief cells, or due to accelerated rates o f cell death. 3) An 
examination would also be made of the role of cyclooxygenase pathways in the generation of
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responses to ES, by comparing responses in the presence and absence of Indomethacin (vide 
infra).
6.2: Responses to ES in tissues obtained from sheep with a history of likely exposure to 
ostertagiasis.
Experiments in this section tested the actions of adult Ostertagia circumcincta ES on tissues 
from animals that had experienced exposure to the parasites prior to their deaths.
The non-steroidal, anti-inflammatory drug Indomethacin has been used by some workers to 
enhance the overall responsivity of intact gastric mucosal preparations to stimulation 
(Reeves and Stables, 1985; Patel and Spraggs, 1992), and the ability o f Indomethacin to 
enhance the responsivity of ovine abomasal mucosal preparations was to be investigated in 
the present studies. By blocking the production of prostanoids by cyclooxygenase, 
Indomethacin inhibits responses to agents which act by prostanoid pathways. Such a 
pathway is known to be involved in the physiological response of gastrointestinal smooth 
muscle to Epidermal Growth Factor (Hollenberg, 1994). Indomethacin might therefore 
interfere with the mechanism of any response to parasite ES, and this potential was therefore 
investigated. Comparison was made of the responses to ES in mucosal sheet and smooth 
muscle preparations treated with Indomethacin at doses similar to those used by Patel and 
Spraggs (1992), against those obtained in control tissues not given Indomethacin.
The release of Lactate dehydrogenase (LDH) has been used as an index of cell damage in 
studies of pepsinogen secretion from isolated gastric glands (Koelz et al, 1982). 
Measurement of LDH concentrations in the luminal collection fluid from mucosal 
preparations under basal conditions was therefore used to assess the viability of preparations 
in the present studies. Observation of changes in LDH concentrations following the addition 
of ES or carbachol was used to confirm that pepsinogen release in response to stimulation 
was not due to cell damage.
6.2.1: Materials and methods.
Adult parasite ES was prepared using the methods outlined in section 2.7
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Tissues were obtained from sheep killed at Sandyford Abattoir. The ages, sexes, and exact 
histories, of these animals were not ascertained. The majority of animals killed at Sandyford 
Abattoir were of the Scottish Blackface breed or its crosses, and were either fattened lambs, 
bom in the previous spring, or surplus stock, such as cast ewes. Intact abomasal mucosal 
preparations and smooth muscle strips were set up as described previously (sections 4.3. & 
5.2). Four or five mucosal preparations and four smooth muscle strips were generally 
obtained from each animal. In some instances the responses to ES were examined in both 
tissue sets, set up from the same animal, but this was not so in every case, tissues being 
collected from some animals for study in only one system.
For the intact mucosal sheet preparations the mucosal bathing fluid was changed every 
twenty minutes and the luminal solution was collected at the same time to allow the 
determination of the rates of pepsinogen secretion. Experimental design allowed two twenty 
minute time periods at the start of each experiment (0 to 40 minutes), with no additions to 
the baths, to assess whether basal, unstimulated secretion was stable. After this time agents 
were added, immediately post-washing, to the submucosal bathing fluid. The responses to 
ES were investigated using a standard dose of any ES batch of 100 pi. Tissues were exposed 
to ES for twenty minutes (40 to 60 minutes). To ensure the viability of mucosae in these 
studies all experiments were completed with a final and supramaximal dose of carbachol 
(100 pM) given at 60 minutes. Experiments were therefore completed after a total of 80 
minutes. The carbachol dose served as a positive control to confirm that if there was no 
response to ES then this was a valid result and not due to a more general failure of tissues to 
secrete. Acidified luminal samples were stored at -20°C until assay of their pepsinogen 
concentrations could be performed using the modified method reported earlier (section 3.2).
Experiments involving abomasal smooth muscle strips were conducted in the following way. 
After the muscle strips had equilibrated to one gram of resting tension, the tissues were given 
a supramaximal dose of carbachol (final bath concentration of 100 pM) to check that they 
were responsive. Tissues were then washed, several times, with fresh Krebs and left until the 
tension developed had returned to basal levels. Tissues were later tested with ES and the 
paper trace observed to see if contractions resulted. In common with all other agent 
additions, ES was added at the rate of one per cent or less of the total bath volume (i.e. a 
maximum of 100 pi per 10 ml baths). Tissues were washed and finally tested with carbachol 
(supramaximal dose) to ensure that they were still responsive.
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The effect of the addition of blank RPMI culture medium on pepsinogen secretion from 
mucosal sheets and smooth muscle activity was investigated in tissues from four sheep. 
Equilibrated tissues in both in vitro systems were tested with the addition o f 100 pi of blank 
medium, instead of the dose of ES. Tissues were then given an ES dose and then 
experiments were completed with a supramaximal dose of carbachol.
Dose response curves were prepared using smooth muscle strips involving serial, ten-fold 
dilutions of ES (1 in 10,000 to undiluted, raw ES). Dilutions were prepared using distilled 
water and were added to baths at the rate of 100 pi per 10 ml baths. Tissues from a number 
of animals (six) were tested in this way, although not all were tested with all ES dilutions. 
Following ES addition ample time was allowed for the full generation of responses before 
the next dose was given. Because experiments were performed at different times, different 
batches of ES were used in individual experiments, this was due to the depletion of the 
different ES batches with time.
Some experiments in both mucosal sheets and smooth muscle strips were performed in the 
presence of 3 micromolar Indomethacin. Indomethacin was prepared as a 100 millimolar 
stock solution in absolute alcohol. Intact mucosal sheets were bathed throughout the 
experiment with Ringer’s solution supplemented with 3 micromolar Indomethacin. Smooth 
muscle strips were preincubated in the presence of Indomethacin before the addition of ES. 
Using only smooth muscle preparations the effect of Indomethacin was examined by pre­
incubating half the tissues in one experiment (4/8 muscle strips from one animal) with 3 pM 
Indomethacin, the other half were given the vehicle for Indomethacin (absolute alcohol) at an 
equivalent dose volume. A dose of ES was then added and the responses to ES in the 
presence and absence of Indomethacin were compared by a two-sample Student’s T-test.
In an initial experiment to assess LDH release, mucosal preparations from one animal were 
exposed to ES and then carbachol. The luminal fluid was collected in this experiment at the 
end of each twenty minute period, as per normal, but was not immediately acidified by the 
addition of hydrochloric acid. Instead assay of LDH was performed soon after sample 
collection, samples were then acidified to await pepsinogen assay. Assay of LDH 
concentration was performed using the method detailed in section 2.4.
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Pepsinogen secretion for individual mucosal sheets was calculated as the total pepsinogen 
released in each twenty minute interval. To see if the addition of ES or blank medium in each 
experiment resulted in greater pepsinogen release, untransformed or log10-transformed data 
were compared by one-way ANOVA, followed by Dunnett’s test. As for the cholinergic 
studies reported earlier (section 4.3), Dunnett’s test determined whether pepsinogen release 
in the time period when tissues were exposed to ES (or blank medium) was greater than that 
in the preceding interval when tissues were unstimulated. The mean response to ES per 
animal was finally expressed as the ratio of the response to basal secretion, i.e. stimulated 
secretion divided by basal secretion.
For the smooth muscle strips, tension was monitored on the paper trace for the immediate 
period after the addition of any agents. If the tissues maintained zero spontaneous activity 
then the pen trace showed no deflections over time and the method was therefore sensitive to 
very small tension changes in response to agent addition, but if  there was any spontaneous 
muscle activity then responses had to be of sufficient strength to exceed the magnitude of the 
spontaneous activity. Responses were measured as the distance the pen was deflected beyond 
the basal line and were then calculated as increases in grams of tension above basal activity. 
Responses to ES were finally expressed as a percentage of the maximal response obtained to 
carbachol in the same tissue. Statistical analysis was generally not performed on the data 
from the studies of smooth muscle, as comparisons would be being made between the 
tension developed in response to the agent (a positive number) and the basal activity of 
tissues, which had been arbitrarily set at zero. An appropriate method of statistical analysis 
would involve the construction of a confidence interval for basal activity, and responses to 
agents would need to exceed this to be significant, but this would be too cumbersome for 
routine use without the ability to analyse traces by computer. The mean responses of each 
animal to ES in the dose response experiments, expressed as the percentage of the maximal 
response to carbachol, and then as a percentage of the maximal response to ES, were 
however analysed by a Kruskall-Wallis test, to see if the responses to the different ES 
dilutions were different.
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6.2.2: Results.
The numbers and source of worms used in the preparation of batches o f ES, the times of 
duration of incubations and the final protein concentrations of each batch are given in Table 
6 . 1.
No effect in either in vitro system was observed in response to the addition of blank medium 
(the relevant data are recorded in Appendices 10A to D). The mean response of all four 
animals to the addition of blank medium was 0.84 (± 0.04), expressed as an increase of 
pepsinogen secretion over basal. A figure of 1.0 would indicate pepsinogen release the same 
as basal, and the figure of less than one indicates that pepsinogen release in the presence of 
blank medium was in fact less than basal. The addition of blank medium to smooth muscle 
preparations did not cause any alteration in recorded muscle tension.
The addition of ES consistently resulted in increased pepsinogen release from mucosal sheet 
preparations and ES consistently stimulated smooth muscle contractions. The results of all 
experiments testing the effects of ES on pepsinogen secretion and smooth muscle function 
are summarised in Table 6.2 (full data is listed in Appendices 10A to R, and Appendices 
11A to Q). Not included in the list of experiments for pepsinogen release from isolated 
abomasal mucosal preparations are those experiments were basal, unstimulated secretion did 
not achieve a steady-state (i.e. pepsinogen release in the first two untreated time points in the 
experiment were significantly different when analysed by Dunnett’s test), and also those 
experiments were tissues, that did not respond to ES, also failed to respond to the carbachol 
dose given at the end of each experiment.
The results from a typical experiment examining pepsinogen release in response to the 
addition of blank medium, an ES batch and then the carbachol control dose, are shown in 
Fig. 6.1. Pepsinogen release did not increase in response to the addition of blank medium, 
yet the responses to ES and then to carbachol were significantly greater than basal 
pepsinogen release.
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Table 6.2: The magnitudes of responses to ES in studies of mucosal pepsinogen secretion 
and of smooth muscle contraction, (mean data (± S.E.), n refers to the number of animals 
from which tissues were obtained and tested with each ES batch).
Batch Pepsinogen release (increase 
over basal) n
Smooth muscle contraction 
(% maximal response to 
carbachol)
n
27/10-1 1.80 (0.30) 4 35.00(12.10) 5
85.00* 1
27/10-2 2.53 (0.58) 5
28/10-1 2.88 1 8.00 (0.70) 2
03/11-1 2.25(1.18) 3 0.00 1
05/10-1 6.40* (4.90) 2 17.00* (9.20) 2
06/10-1 1.54 (0.20) 3 85.00*(27.80) 6
* - Experiments performed in the presence of 0.3 p.M Indomethacin
Fig. 6.1: Pepsinogen release from intact mucosal sheets in response to the addition of blank 
medium, an ES batch and carbachol.
(mean +/-SE, 5 tissues from one animal).
50
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E
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0.1 mM Carb 
*
0.1ml ES
0.1 ml RPMI
blank
Time (mins)
ANOVA p<0.001, * sig. diff from basal (t40) by Dunnett's test.
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Fig. 6.2 details a trace typical of experiments involving ES addition to smooth muscle strips. 
Muscle strips contracted to ES after a lag-period of variable length, the maximal tension 
developed was typically less than that seen in response to carbachol, and the tissues gradually 
relaxed and returned to basal tension, whereas tension was generally maintained in carbachol- 
contracted tissues until they were washed.
Fig. 6.2: Com parison of the responses to Carbachol (a) and ES (b) in abomasal smooth 
muscle strips. Time of agent addition is indicated by a solid arrow. Note the delay in onset of 
the response to ES and that the response to carbachol is immediate and larger (note change of 
vertical scale between a and b).
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Despite the use of different ES batches in the preparation of dose response curves for ES, the 
results were sufficiently similar to allow the direct comparison of all experiments. The results 
are shown in Fig. 6.3 (full data is shown in Appendices 11 A, B, F, J, N and P). Responses to 
different ES doses were significantly different by Kruskall-Wallis test (p<0.02), yet the 
responses to undiluted ES and to the one in ten dilution were not significantly different in a 
separate Mann-Whitney U-test (p=0.08).
The addition of the vehicle for Indomethacin, absolute ethanol, had no effect on baseline 
smooth muscle tension. The addition of Indomethacin was occasionally associated with a 
slow decline in the amount o f spontaneous activity exhibited by smooth muscles, but mostly 
Indomethacin had no effect on basal or spontaneous activity. In tissues from one animal the 
presence of Indomethacin, added approximately 5 minutes before the addition of ES, was 
associated with significantly greater responses to ES (p<0.02, by two-sample T-test). The 
results from this experiment are shown in Fig. 6.4. (full data is shown in Appendix 11H). In 
contrast there was no difference between the contractile responses to a supramaximal dose of 
carbachol in the presence and absence of Indomethacin. Tissues were stimulated with 100 pM 
carbachol and once the response had fully developed, the tissues were washed. The tension 
declined to baseline levels and the tissues were then treated with 0.3 pM Indomethacin, five 
minutes before the carbachol dose was repeated. The mean (± S.E.) response to carbachol, in 
terms of grams tension per gram of tissue wet weight, before the addition of Indomethacin 
was 802.00 (61.00), and after Indomethacin, 741.00 (45.00). These values were not 
significantly different by two-sample T-test (p>0.40). There is insufficient data to examine the 
responses to ES, in terms of pepsinogen release from intact mucosal sheets, with or without 
Indomethacin, but Indomethacin did not prevent responses to ES occurring in this system.
The results of an experiment investigating LDH release, mean (± S.E.) values for both 
pepsinogen release and LDH release, are shown in Fig. 6.5 (full data in Appendix 12). Basal 
rates of pepsinogen release were widely different in the individual tissues and for this reason 
data were expressed as pepsinogen release over basal (secretion in the second twenty minute 
period) for each tissue. Non-normal data distribution required non-parametric analysis. 
Pepsinogen release during the first two, unstimulated time intervals was acceptably constant 
and all tissues responded to ES with a small increase in release of the zymogen (median 
response; 1.50 times basal, n=5). Pepsinogen release did not rise further in response to 
carbachol, but declined slightly. In contrast LDH release remained fairly constant and at low
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levels throughout. A Kruskall-Wallis test showed that pepsinogen release was significantly 
different (p<0.01) at some time points. The same test applied to untransformed data for LDH 
release detected no significant differences (p>0.50).
Fig. 6.3: Dose response curve showing smooth muscle contraction to serially diluted and raw 
ES batches.
(mean data, +/- SE, tissues from n = l animal (ES 1:10,000), 2 (ES 1:1,000), 4 (ES 1:100), 6 (ES  
1:10 & ES raw).
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Fig. 6.4: Comparison of the response to ES in smooth muscle strips in the presence and 
absence of Indomethacin.
(mean +/- SE, 4 m uscle strips per treatment).
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Fig. 6.5: Comparison of pepsinogen and LDH release from mucosal preparations from 
one animal in response to the addition of ES and then Carbachol, mean values (± S.E.), n 
= 5 tissues (the durations of exposure to ES and then carbachol are indicated by bars).
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6.2.3: Discussion.
The addition of ES repeatedly resulted in increased secretion of pepsinogen from intact 
mucosal sheets and the stimulation of contraction in smooth muscle preparations. It was not 
possible to say from these results whether this reflected a direct stimulation of host cells by 
pharmacologically active substances present in ES or whether the effects were simply 
manifestations of hypersensitivity reactions in animals that were previously exposed to O. 
circumcincta parasites. The lag period of the response to ES in smooth muscle strips 
suggested that the mechanism of effect of ES relied upon the formation or release of a second 
chemical, and this is a characteristic of the Schultz-Dale response (see section 5.1). However 
it is equally a characteristic of physiological responses to agents such as Epidermal Growth 
Factor (Hollenberg, 1994). The response to ES in terms of pepsinogen release from mucosal 
tissues, was less than the response to the following carbachol dose (Fig. 6.1), and generally 
ES responses were less than those to carbachol. A better comparison of the mucosal secretory 
responses to ES and carbachol would have required that pepsinogen secretion be allowed to
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return to basal levels before the addition of the carbachol dose, but here the gradual depletion 
of pepsinogen content of the tissues might lessen the response to carbachol. A more correct 
method to compare the two responses would be to treat half of a larger number of tissues with 
ES and the other half with carbachol, but to be of sufficient value such an experiment would 
need larger numbers of tissues than could be easily processed together in the present studies. 
If the responses to ES in mucosal preparations are genuinely smaller than those to carbachol 
then this agrees with the results of the smooth muscle studies, but this is not to say that the 
mechanism of the response in both in vitro systems is the same.
The magnitude of the contractions to ES in Indomethacin-treated tissues was greater than in 
control smooth muscle strips, and Indomethacin did not block the development of responses 
in intact mucosal preparations. Indomethacin occasionally reduced the extent of spontaneous 
muscle activity in muscle tissues, but this was not consistently observed. Prostanoid 
molecules released in response to ES stimulation might have antagonised the development of 
the smooth muscle contractile response, and the inhibition of their production by 
Indomethacin might then have allowed the generation of a stronger contraction. Indomethacin 
had no effect on the response to carbachol, but the dose of carbachol used was supramaximal, 
and therefore in excess of the minimal effective dose required for a maximal response (the 
E.D.100). Indomethacin may have shifted the dose response curve for carbachol (as well as ES) 
to the left, resulting in a lower concentration for the E.D.50, but with the response to 
supramaximal carbachol concentrations remaining unchanged. Further work is clearly needed 
to not only confirm these results, but also to assess the effects of Indomethacin in intact 
mucosal preparations and to assess the physiological role of prostanoids in ovine abomasal 
mucosa and smooth muscle tissues.
Pepsinogen secretion in response to ES appeared to be unrelated to the release of LDH and 
any potential loss o f viability of mucosal preparations. The one experiment investigating LDH 
release involved tissues that eventually proved poorly responsive to ES and carbachol. The 
concentration of LDH was calculated from the change in absorption at 340 nm (AA340) per 
minute of the kit reagent to which the sample had been added. The range of AA340 min'1 
values in this experiment were low, from 0.000 to 0.004 and were likely to be close to the 
limit of detection for this assay. The limit of detection was not assessed in the present studies 
and is not listed by the kit manufacturers. It is possible that LDH was not measurable in the 
buffering system of the luminal Ringer’s solution used.
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6.3: The mechanism of the response to ES: the release of Lactate dehydrogenase.
To assess LDH release by mucosal sheet preparations tissues were monitored under steady- 
state conditions and in response to ES and carbachol, but at the end of the experiment the total 
remaining tissue LDH and pepsinogen were measured, using this data the rates of release of 
both LDH and pepsinogen were expressed as percentages of the totals present in tissues at the 
time.
6.3.1: Materials and methods.
Six mucosal sheet tissue preparations, all from the same animal, were set up, three in group 
one and three in group two. At the end of the equilibration period the collection of luminal 
fluid every twenty minutes was begun. After forty minutes ES (100 pi) was added to group 
one tissues, but not group two tissues. After a further twenty minutes all tissues received a 
supramaximal dose of carbachol (final bath concentration of 100 pM). To complete the 
experiment the preparations were disassembled and the mucosal sheets were then 
homogenised in 4.0 ml of fresh luminal Ringer’s and then centrifuged (see section 2.3 for 
fuller details). In the present experiment Ringer’s replaced the Triton X-100 buffer normally 
used in the preparation of homogenates for the assay of tissue pepsinogen. The concentration 
of LDH in the luminal samples was assayed and also that o f the mucosal homogenate 
supernatants, after which all were acidified with hydrochloric acid prior to pepsinogen assay.
6.3.2: Results.
The results are shown in Table 6.3. (full data in Appendix 13). The addition of ES did not 
result in any significant increase in pepsinogen release (p>0.05, by ANOVA and Dunnett’s 
test of log10-transformed data). During the period when group one tissues were exposed to ES, 
mean pepsinogen release increased by 1.30 times basal, whereas in unstimulated, group two 
tissues during the same period, pepsinogen release also increased slightly over the preceding 
rate, by 1.10 times basal. All tissues subsequently responded to carbachol, and did so to a 
similar extent. The mean response of all tissues to carbachol was 8.40 times basal release 
rates. LDH concentrations were very low at all time points examined during the experiment, 
the A A 34o min'1 values ranged from -0.001 to +0.002, yet considerable activity was recorded
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for the mucosal homogenates where the mean AA340 min’1 value of all tissues was 0.231. 
There were no significant differences in LDH release for any time points.
From the amount of pepsinogen released in the second, unstimulated incubation period, basal 
pepsinogen release for all tissues was calculated as 8.50 peptic units per hour. Taking the 
figure of 201.40 peptic units as the mean total pepsinogen still present in the tissues at the end 
of the experiment and adding the mean amounts released during the experiment, it was 
calculated that 210.50 units would have been present 20 minutes after the start of the 
experiment. Based on these figures it was possible to calculate the percentage of the total 
pepsinogen present that would be secreted at basal rates in one hour, as 4.03 per cent. The 
same calculation was done for LDH release and the figure obtained was 1.50 per cent.
6.3.3: Discussion.
Values for LDH release were again very low and close to a theoretical limit of detection. 
However, LDH was measurable in this system as the analysis of mucosal homogenates clearly 
showed. Hourly basal pepsinogen release exceeded that of LDH release, which implied that 
pepsinogen secretion by tissues under steady-state conditions, and in response to carbachol at 
least, was not due to significant tissue damage or degeneration.
Table 6.3: Mean (± S.E.) pepsinogen and LDH release from mucosal tissues: basal 
release and the responses to the addition of ES and carbachol.
Time (mins)
Group 1 
Pep (u) LDH (U)
Group 2 
Pep LDH
20 3.02 (0.40) 0.005 (0.002) 2.64 (0.43) 0.005 (0.002)
40 2.70 (0.55) 0.007 (0.004) 2.96 (0.24) 0.009 (0.002)
60 3.56(0.13) 0.002 (0.002) 3.34 (0.66) 0.005 (0.005)
80 25.73* (1.81) 0.002 (0.002) 21.85* (2.44) 0.005 (0.002)
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Table 6.3 (continued from previous page) - Notes
Group 1; given ES, batch 27/10/93 (2nd culture), after 40 minutes.
Group 2; controls, not given ES.
All tissues given 100 pM carbachol after 60 minutes.
* - Sig. different from basal, t40 (p<0.05), by ANOVA and Dunnett’s test, on log10- 
transformed data.
6.4: The influence of the Non-steroidal Anti-inflammatory Drug, Indomethacin, on 
mucosal responsivity.
The effect of Indomethacin on the responsivity of intact mucosal sheets was further 
investigated in tissues obtained from one animal. The rates o f basal secretion of pepsinogen 
and LDH were monitored in tissues exposed to Indomethacin and in tissues not exposed to the 
drug, the responses to ES and carbachol were also monitored.
6.4.1: Materials and methods.
Six mucosal tissue preparations, all from one animal, were set up, three of which were bathed, 
during a three hour equilibration period and during the experiment proper, with Ringer’s 
solution supplemented with 3 pM Indomethacin, the others in normal Ringer’s. After the forty 
minute period without additions to the baths all tissues received 100 pi of ES (Batch 27/10/93 
- 2nd culture). At the end of the subsequent twenty minute period the tissues were washed and 
then left for a further twenty minutes before carbachol (final bath concentration of 100 pM) 
was added. The luminal fluid samples, collected as usual every twenty minutes, were not 
immediately acidified, but were analysed for LDH activity. At the end of the experiment all 
tissues were homogenised in 4.0 ml of luminal Ringer’s solution, to allow the total tissue 
LDH to be measured. Acidified samples and homogenate supernatants were then frozen until 
pepsinogen concentration was assayed. Data for Indomethacin-treated and control tissues 
were analysed separately by ANOVA and Dunnett’s test, after log ^ -transformation.
6.4.2: Results.
The results for pepsinogen release with time are shown in Fig. 6.6. (full data in Appendix 14). 
Based on ANOVA and Dunnett’s tests the responses to carbachol were significantly greater
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than basal (secretion in the second, twenty minute time interval) in both tissue sets, however 
only the response to ES in Indomethacin-treated tissues was significantly greater than basal. 
Basal secretion was at a greater rate in control tissues than in Indomethacin-treated tissues. 
The hourly rate of basal secretion for control tissues was calculated as 7.94 ± 0.21 (mean ± 
S.E.) per cent of the total pepsinogen present and this figure was significantly greater 
(p<0.001, by two sample T-test) than that obtained for Indomethacin-treated tissues, i.e. 3.74 
±0.14 per cent.
As in previous investigations the AA340 min’1 values for estimates of LDH in the sampled 
luminal collection fluid were close to zero, values ranged from -0.001 to 0.002, the values for 
mucosal homogenates were again much larger, and the mean (± S.E.) value for the total LDH 
contained in all six tissues was calculated as 1.76 (0.12) U. Assuming a maximum AA340 
min’1 value of 0.002 for the analysis of samples from the second twenty minute period, giving 
total hourly basal release of LDH of 0.040 U, hourly LDH release would still only be 2.30 per 
cent of the total LDH contained in tissues, a figure smaller than both rates of pepsinogen 
release. There were no differences in LDH release between the two tissue groups (control and 
Indomethacin-treated) and no differences at any time point. The results for release of LDH 
with time are shown in Table 6.4.
6.4.3: Discussion.
In the present experiment basal release of pepsinogen exceeded the release of LDH and basal 
pepsinogen secretion again appears to be a physiological property of intact mucosal 
preparations that is unrelated to rates of cell death/damage.
Treatment with Indomethacin lowered basal pepsinogen secretion. The assumption must be 
that cyclooxygenase products contributed to the maintenance of higher basal rates of 
secretion. In general, if  responses to agents are expressed as the ratio of the secretion in 
response to the agent, to basal secretion (x/y), then preparations with lower basal rates of 
secretion (y) will give greater responses, even when the actual difference between the 
magnitude of responses and basal secretion (x-y) remains the same. This was the case in the 
present experiment, but the differences in the responses to ES expressed as increases over 
basal between control and Indomethacin-treated tissues were still not significantly different.
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Indomethacin treatment may indeed enhance the responsivity of mucosal preparations, but 
further work is needed to confirm these findings.
Table 6.4: Mean (± S.E.) values for LDH release per twenty minute periods in 
Indomethacin-treated and control tissues (n = 3 tissues per treatment).
Time (mins) Control tissue LDH (U) Indo-treated LDH
20 0.005 (0.002) 0.005 (0.002)
40 0.000 (0.000) 0.002 (0.002)
60 0.007 (0.004) 0.002 (0.002)
80 0.005 (0.005) 0.002 (0.002)
100 0.002 (0.002) 0.002 (0.002)
Fig. 6.6: Comparison of the pepsinogen released from mucosal tissues from one animal 
in the presence and absence of 3 pM Indomethacin, mean values (± S.E.), n = 3 tissues (the 
durations of exposure to ES and carbachol are indicated by bars).
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6.5: The time course of the response to ES in intact mucosal preparations.
Initial experiments of the effects of ES on smooth muscle function had shown that there was 
generally a delay, or lag period, between the addition of ES and any increase in recorded 
muscle tension. Responses to carbachol in the same tissues were however more immediate. It 
was proposed to see if a similar lag period existed between the addition of ES to intact 
mucosal preparations and the release of pepsinogen.
6.5.1: Materials and methods.
The time course of the pepsinogen release response to ES was investigated in tissues from 
two animals. Tissues were maintained in the presence of 3 pM Indomethacin throughout the 
experiments. Tissues were left unstimulated for thirty minutes, with the mucosal bathing 
fluid replaced every fifteen minutes, but the luminal fluid was collected every ten minutes. 
At the end of the thirty minutes and after the mucosal bathing fluid had been changed, ES 
(100 pi) was added to the tissues. The dose of ES was repeated after a further twenty 
minutes. After the initial thirty minutes the mucosal bathing fluid was changed at twenty 
minute intervals, but the luminal solution was still collected at ten minute intervals. Tissues 
were in the presence of ES for forty minutes, at the end of which the tissues were washed 
and then left untreated for the next ten minutes before the experiments were completed with 
supramaximal doses of carbachol (100 micromolar). Tissues from the two animals were not 
tested with the same ES batch, the 27/10/93 (2nd. culture) batch being used with tissues from 
sheep 1 and the 05/10/94 (1st. culture) batch used with tissues from sheep 2. Data were 
finally expressed as the mean pepsinogen released over basal (30 minutes) for each time 
point for each animal.
6.5.2: Results.
The results are shown in Fig. 6.7. (full data in Appendices 15A and B). The mean response 
to ES in sheep one tissues was large and immediate, occurring in the first ten minutes after 
ES addition. In sheep two however the response was delayed to the second ten minute 
interval and the magnitude o f the response was much less. The response to carbachol in both 
animals was rapid, occurring within ten minutes, but declined as rapidly as the response to 
ES in sheep one tissues.
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6.5.3: Discussion.
The two sets of tissues from the two animals behaved quite differently in their responses to 
the addition of ES, but behaved similarly with carbachol. Either the different animals 
differed in their ability to respond to the same stimulus (the addition of ES) or the different 
batches of ES used meant that the stimuli were not directly comparable. However as smooth 
muscle contractions generally occurred within five minutes of the addition of ES, the 
response in tissues of sheep 1 might still have been delayed. Earlier experiments examining 
the time course of the responses to only carbachol have shown that the intact mucosal 
preparations are variable in the speed with which responses develop, yet in smooth muscle 
studies responses to carbachol were always immediate. In the present study, in the tissues of 
sheep 2, the response to ES was delayed, but that to carbachol given subsequently was 
immediate, there is therefore some evidence that, like the responses in smooth muscle strips, 
a lag-period may be a feature of the mucosal tissue responses to ES.
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6.6: Responses to ES in tissues obtained from parasite-naive animals.
To test the hypothesis that responses to ES, observed previously in both in vitro systems, 
were immune manifestations, analogous to the Schultz-Dale response, mucosal and smooth 
muscle tissues were obtained from the abomasa of parasite-naive animals and were tested 
with ES.
6.6.1: Materials and methods.
6.6.1.1: Animals.
A total of eight parasite-naive animals were used. The first four were pure-bred Hampshire 
Down female lambs of approximately six months of age (animals 1 to 4). These animals had 
been reared indoors in conditions likely to eliminate the risk of exposure to nematodes. 
Faeces was collected from the rectum of each animal for faecal egg counts to confirm the 
abscence of patent infection. The four further parasite-naive animals were Scottish Blackface 
lambs of mixed sex, all were of less than one week of age (animals 5 to 8). The lambs had 
been orphaned soon after birth, and fed milk-replacer until they were killed. All eight 
animals were killed by either electrical stunning, or captive bolt, followed by exsanguination, 
abomasal mucosal and smooth muscle tissues were then collected.
6.6.1.2: Experimental procedure.
The experiments involving the intact mucosal preparations and smooth muscle strips of the 
parasite-naive animals in this section were conducted in an identical manner as the 
experiments involving tissues obtained from animals killed at Sandyford Abattoir (section 
5.2). In studies o f pepsinogen secretion from intact mucosal sheets, tissues were stimulated 
with ES (100 pi) in the third twenty minute period and then the preparations were checked 
with the carbachol control dose in the fourth period. Muscle strips that had equilibrated to 
resting tension levels and then checked by a supramaximal carbachol dose were given the 
standard dose of ES and then ample time was allowed to see if any contractions resulted, all 
tissues were then checked at the end of the experiments with a final dose of carbachol. The 
responses of longitudinal and circular smooth muscle from the abomasum of sheep 1 were 
tested, and tissues from sheep 1 and 2 were examined for the response to ES in the presence
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and absence of 3 micromolar Indomethacin. Indomethacin was not used in any of the 
experiments involving the intact mucosal preparations.
The experiments in this section used a newly collected batch of ES (Batch 06/10/94). The 
only exception to the procedure adopted for the experiments using the mucosal preparations 
was that involving tissues from animal 1. The tissues of animal one, the mucosae and the 
muscle strips, were tested with the new ES batch on the same day as the ES had been 
harvested, and because this new batch had not been tested before all the tissues from animal 
1 were also given a second dose of ES (Batch 27/10/94 - 1st. culture) that had already been 
shown to stimulate responses in tissues from animals from the abattoir population. The 
mucosal preparations from animal 1 were left unstimulated for a full hour before the addition 
of the new ES batch at the start of the fourth twenty minute time period, after a further 
twenty minutes all the tissues were then given the second ES batch, and were finally tested 
with carbachol in the sixth and last twenty minute period. Because of the depletion of the 
new ES batch experiments involving the mucosal preparations of the last animal tested 
(animal 8) and the muscle strips of the last two animals (7 and 8) had to be accomplished 
using a further ES batch (05/10/94 - 1st culture).
The data from the intact mucosal experiments for individual animals were analysed by 
ANOVA and Dunnett’s test following appropriate transformations. The responses of all 
muscle strips to ES were expressed as the percentage , o f the maximal responses to carbachol 
occurring in the same tissues.
6.6.2: Results.
The results of the experiments involving the mucosal preparations and smooth muscle strips 
of all animals are given in Tables 6.5 and 6.6 respectively (full data in Appendices 16 A to H 
and 17 A to H). The intact mucosal preparations from sheep 1 did not respond to either ES 
batch and sheep 2 tissues did not respond to the new ES batch. Tissues from both sheep 1 
and 2 did respond however to carbachol. The responses to carbachol in sheep 1 and 2 tissues 
were 5.59 and 3.87 times basal respectively. The data from the experiments with the mucosal 
tissues of animals 3 and 4 were rejected because tissues from these animals failed to achieve 
a steady basal secretory rate and did not respond to either ES or carbachol. The addition of 
ES to the mucosal tissues from the lambs did not result in any significant increase in
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pepsinogen release. The mean (± S.E.) value for all lambs of pepsinogen release in the 
presence of ES was 1.00 (0.13) times basal release (release in the second twenty minute 
period). All tissues were however highly responsive to the subsequent carbachol dose, the 
mean response being 15.70 (5.90) times basal. The 95 per cent confidence interval for the 
mean response of mucosal tissues of all parasite-naive animals to ES (calculated from the 
ratios of secretion in response to ES to basal secretion), was 0.78 to 1.22. The figure of 1.00 
clearly lies within this range so that the mean response to ES is not significantly different 
from basal, unstimulated secretion. In comparison the 95 per cent confidence interval for the 
mean response o f all mucosal tissues from previously-exposed animals (Table 6.2) to various 
ES batches was 1.39 to 3.80.
Smooth muscle strips from all eight animals were responsive to cholinergic stimulation. 
However none responded to any ES batch tested. Circular smooth muscle strips from animal 
1 also did not respond to ES and the presence of Indomethacin had no effect on the response 
to ES in circular muscle of sheep 1 and in longitudinal muscle from sheep 2. The addition of 
ES did not affect the frequency or the amplitude of the spontaneous contractile activity 
manifest in tissues from sheep 4, the same tissues did subsequently respond to carbachol 
(lOOpM), see Fig. 6.8. In comparison the 95 per cent confidence interval for the mean 
response of all muscle strips from previously-exposed animals (Table 6.2) to ES was 19 to 
73 per cent of the responses to carbachol occurring in the same tissues.
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Table 6.6: Mean (± S.E.) responses of smooth muscle strips from parasite-naive animals 
to various ES batches. Responses expressed as a percentage of the response to 0.1 
millimolar carbachol in the same tissues (see Appendices 17A to H).
Animal
Tissue
type
±
Indomethacin
(3pM)
ES batch no. of 
tissues
Response
1 long. - 06/10/94 4 0.00 (0.00)
- 27/10/93 (1st) 4 0.00 (0.00)
- 05/10/94 (2nd) 4 0.00 (0.00)
circ. - 06/10/94 4 0.00 (0.00)
- 05/10/94 (1st) 4 0.00 (0.00)
+ 06/10/94 4 0.00 (0.00)
2 long. - 06/10/94 6 0.00 (0.00)
+ 4 0.00 (0.00)
3 long. - 06/10/94 4 0.00 (0.00)
4 long. - 06/10/94 4 0.00 (0.00)
5 long. - 06/10/94 4 0.00 (0.00)
6 long. - 06/10/94 4 0.00 (0.00)
7 long. - 05/10/94 (1st.) 4 0.00 (0.00)
8 long. - 05/10/94 (1st.) 4 0.00 (0.00)
Notes;
long. - longitudinal smooth muscle, circ. - circular smooth muscle.
Fig 6.8: The lack of effect of ES on the spontaneous muscle activity in tissues from a 
parasite-naive Hampshire, (point of ES addition indicated by solid arrows, that of 
carbachol. by open arrows).
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6.6.3: Discussion.
The most important finding of the present studies was the complete lack o f effect, in both in 
vitro systems, of O. circumcincta ES on tissues from parasite-naive animals. All batches of 
ES tested in parasite-naive animals were shown to elicit responses in tissues from animals 
from the abattoir population, animals that were likely to have been previously exposed to 
abomasal parasitism. Therefore the simplest and likeliest explanation o f the results of the 
present studies is that responses to ES in tissues from animals previously exposed to 
parasites, were hypersensitivity responses to antigens present in ES. The mechanism of the 
response may have involved mast cell degranulation in response to antigen cross-linking of 
immunoglobulin bound to mast cell membranes, and the release of bioactive compounds 
from the mast cells. The excretory/secretory products of adult O. circumcincta have been 
shown to contain a number of different molecular weight substances (Wedrychowicz, 1986) 
many of which reacted with immune sera, and thus many substances present in ES could be 
responsible for the hypersensitivity responses seen.
The nature of the bioactive substances released by mast cells in sheep are not well known 
and in the present studies neither histamine nor serotonin were effective at stimulating 
smooth muscle contraction at likely physiological concentrations. The non-steroidal anti­
inflammatory drug, Indomethacin, actually enhanced the response to ES, so it is unlikely that 
the responses to ES are due to the production of a prostaglandin by mast cells or other 
immune cells. Investigations into the mechanism of response will not be straightforward. 
The mast cell stabilising drugs Quercetin (Fewtrell and Gomperts, 1977) and Cromoglycate 
(Altounyan, 1967), may prevent mast cell degranulation by interfering with intracellular Ca2+ 
and these agents will therefore also interfere with smooth muscle responses to stimulation 
which are sensitive to changes in calcium (Fanning et al, 1983) and may also interfere with 
the exocytosis of pepsinogen granule contents.
Using dispersed bovine and ovine gastric glands obtained from parasite-naive animals, 
McKellar et al (1990b) demonstrated stimulation of pepsinogen release in response to 
Ostertagia spp. ES. Worm culture in the study of McKellar et al (1990b) used a different 
method from that used in the present experiments, since worms were cultured in distilled 
water for thirty minutes and antibiotics were not included. Some bacteria, for example 
Escherechia coli, are known to liberate toxins capable of stimulating mammalian tissues (De
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Jong and Vaandrager, 1986) and their presence in worm cultures would complicate any 
subsequent conclusions about the effects of ES. McKellar et al (1990b) achieved partial 
block of the response to ES with the antimuscarinic drug, atropine, and therefore postulated 
that the agent was cholinergic in nature. It would be expected that both in vitro preparations 
in the present studies would have responded to such an agent if  it had been present, and in 
sufficient concentration. The worm culture technique employed in the present studies was 
chosen to maximise the yield from the available worms by culturing worms for at least 24 
hours. It is possible that the culture conditions in the present studies may have prevented the 
release of the agent that was previously present in ES from worms maintained in distilled 
water. The stimuli for the release of any ES component from Ostertagia spp. worms remain 
unknown.
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EXPERIMENTAL STUDIES - PART 3: PEPSINOGEN 
IMMUNOHISTOCHEMISTRY.
7: THE IMMUNOHISTOCHEMICAL LOCALISATION OF PEPSINOGEN IN 
RUMINANT ABOMASA AND THE EFFECTS OF OSTERTAGIASIS.
7.1: Introduction.
7.1.1: Abomasal cell populations.
Exocrine secretion in the ruminant forestomachs is confined to the fundic and pyloric areas 
of the abomasal mucosa. The surface area of the fundic mucosa is increased by the presence 
of numerous folds, lying roughly in-line with the longitudinal axis o f the abomasum. Fundic 
mucosa is the site of the majority of abomasal acid and peptic secretory activity. Cells of 
both fundic and pyloric areas are situated in one of two structures (represented schematically 
in Fig. 7.1). Invaginated from the mucosal surface are the pits (foveoli), at the base of which 
arise usually two or three, blind-ending tubular glands which penetrate deeper into the 
mucosa. The pit-gland junction is called the isthmus. The glands can be subdivided into 
neck, adjacent to the isthmus, and base regions. Pits in the fundus are shallow and glands are 
long and straight, whereas in pyloric mucosa the pits are often deeper with correspondingly 
shorter glands that are coiled. The greatest diversity of cells is found in fundic mucosa. 
Murray (1970) identified five main cell types in bovine fundic mucosa; the surface epithelial 
cells, lining the mucosal surface and the pits, the mucous neck cells, the parietal cells, the 
chief cells and the endocrine cells. In pyloric mucosa Murray (1970) noted four cell types, 
the surface epithelial cells, the pyloric gland cells, parietal cells, albeit in fewer numbers in 
pyloric areas, and the endocrine cells. Surface epithelial cells have also been called surface 
mucous cells (Cybulski and Andren, 1990; Karam and Leblond, 1993b).
Karam and Leblond (1992) distinguished eleven morphologically distinct cell types in 
mouse gastric corpus (equivalent to bovine fundus). In addition to those already described 
they identified other cells as more intermediate in nature from one type to another, and in 
further work traced the progression of all cell types from undifferentiated stem cells in the
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isthmus (Karam, 1993; Karam and Leblond, 1993a,b,c,d). Karam and Leblond (1993a) 
identified three undifferentiated and granule free cell types present in the isthmus in mouse 
corpus. The first (subtype I) was identified as the pluripotential stem cell. This cell 
reproduces to renew itself and to give rise to two other granule free, precursor cells (subtypes 
II and III), and the granule-free pre-parietal cell (variant 1). Granule-free cells of subtypes II 
and III were distinguishable by the type of pro-secretory vesicles present adjacent to the 
golgi apparatus and were regarded as pre-pit cell precursors and pre-neck cell precursors 
respectively. In the mouse subtype II precursors may also give rise to a small number of 
variant 2 pre-parietal cells, named because of their possession of a small number of granules 
similar to those of pre-pit cells. Subtype III precursors give rise to pre-neck cells with 
granules similar to those of mucous neck cells and also give rise to variant 3 pre-parietal 
cells. Pre-neck cells migrate down the gland and become mucous neck cells and then 
zymogenic (chief) cells. Cells that have undergone some differentiation may still undergo 
mitotic cell division so that all cells of the pit/gland can be classified into one of four groups 
based on the frequency that each cell divides (Karam and Leblond, 1993a). Parietal and pre- 
parietal cells (all variants) do not divide. Zymogenic cells, pre-zymogenic cells (cells 
intermediate between mucous neck cells and zymogenic cells) and entero-endocrine cells 
divide only occasionally. Mucous neck cells and pit cells divide regularly, but at a low rate. 
Granule-free precursor cells and the pre-pit cell precursors and pre-neck cell precursors have 
the highest rates of cell divisions.
In the mouse pre-pit cells migrate towards the gastric lumen, and reach it as mature mucous 
cells in approximately 3 days (Karam and Leblond, 1993b). Initially a few secretory granules 
are scattered in the pre-pit cell cytoplasm, these granules increase in number and become 
aligned at the apical margin, thus marking the transition to mature pit cells. Granule number 
and size increase further in mid and higher pit levels, but cell organelles begin to show signs 
of degeneration, the mitochondria and nucleoli diminish in size and the number of free 
ribosomes decreases. By the time pit cells reach the free surface the cells produce fewer and 
smaller granules and degeneration of organelles is more advanced. The cells become spindle 
shaped, with the greatest cell volume, including the nucleus, situated apically, but also with 
fewer granules, and there are often spaces between the basal cytoplasm of neighbouring 
cells. Cells are eventually lost into the gastric lumen or are phagocytosed by a neighbouring 
cell that is itself eventually shed.
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In mice, developing parietal cells migrate from the isthmus to both the pit and the gland. 
(Karam, 1993). The upward migration of pre-parietal cells presumably does not occur in the 
bovine as no parietal cells were present in the pits of bovine fundic mucosa (Murray, 1970). 
The average turnover time of parietal cells at different levels of the pit/gland units in the 
mouse was 54 days (Karam, 1993), that of parietal cells in the gland, 189 days. In the gland 
base 75 per cent of parietal cells were histologically normal, the remainder showed signs of 
degeneration and two per cent were dead (Karam, 1993). Parietal cell death occurs by 
necrosis, whereby parietal cells are shed from the gland base into the lumen, and by 
apoptosis, which is followed by phagocytosis of parietal cells by zymogenic cells, or an 
invading macrophage from the lamina propria (Karam, 1993).
Approximately two thirds of neck cells arise due to the migration and differentiation of pre­
neck cell precursors, the remaining neck cells arising from their own mitoses (Karam and 
Leblond, 1993c). Turnover time for mucous neck cells has been calculated as between one 
and two weeks, at the end o f which neck cells have become pre-zymogenic cells, which in 
turn become chief cells after a further month. The turnover time for chief cells in the gland 
base was calculated to be almost half a year. Dead chief cells are lost by the same 
mechanisms as parietal cells. The granules of neck, pre-zymogenic and chief cells illustrate 
the maturational changes taking place. The ultrastructural appearance o f the granules varies 
with the fixation and post-fixation techniques used in tissue preparation (Murray, 1970; 
Karam and Leblond, 1992), but many studies show a. similar pattern. The mucous neck cell 
granule has a core, usually situated eccentrically, and this feature is common to the bovine 
(Murray, 1970; Yamada et al, 1988), the guinea pig (Bouhours et al, 1981) and the mouse 
(Karam and Leblond, 1993c). The core represents pepsinogens (Yamada et al, 1988), the 
outer material being mucins. The granule of the chief cell is almost entirely pepsinogen, 
however a thin rim of mucin may remain (Bouhours et al, 1981). Karam and Leblond 
(1993c) showed a progression of granule appearance from neck cells to chief cells, 
characterised by gradually diminishing mucin content.
The granules o f surface mucous cells may be more heterogeneous in appearance. Electron- 
dense and electron-lucent granules coexisted in mucous cells in the studies of Murray (1970). 
The appearance of pyloric gland cell granules was similar. Some surface mucous cell 
granules contain cores (Karam and Leblond, 1993b). In immunofluorescence studies of 
bovine fundus, surface mucous cells contained pepsinogen as well as the related zymogens
prochymosin and progastricsin (Cybulski and Andren, 1990). Pepsinogen was not 
demonstrated to be present in surface mucous cells of young calves by electron 
immunohistochemistry (Yamada et al, 1988).
Fig. 7.1: Schematic representation of a pit and gland from fundic mucosa.
Surface m ucous cellPIT
(F o v eo iu s)
IS T H M U S
M ucous neck cell
P arie ta l cellGLA N D
C hief (zymogenic) cell
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7.1.2: Immunology of pepsinogens and their tissue distributions.
Up to seven, electrophoretically-distinct mammalian pepsinogens/pepsins have been 
identified (Hirschowitz, 1984; Hersey, 1987). The similarity of primary and tertiary structure 
of all the carboxyl (aspartyl) proteases, a group that includes pepsinogens, chymosin (the 
neo-natal, milk-clotting enzyme), renin and some cathepsins, implies that they may have 
evolved from a common ancestral peptide (Tang, 1979). Pepsinogens are further separable 
into two groups, pepsinogens of types I and II, on the basis o f the commonality of major 
antigenic determinants, the pH optima for the proteolytic activity of the corresponding 
pepsins and the distribution of pepsinogens in tissues.
Using specific antibodies, pepsinogens of groups I and II (PG I and PG II) are distinct. 
Molecular weight estimates of pepsinogens from a wide range of species, including 
amphibians, fish and mammals, range from 29 to 65 kD. Much of this weight variation is 
accounted for by differences in the N-terminal sequence that is lost upon activation to pepsin 
(Foltman and Pederson, 1976; Ichihara et al, 1982; Schugerman et al, 1982), however there 
are differences in the catalytic peptide as well (Schugerman et al, 1982). Despite such 
differences the major antigenic determinants and the structure o f the active site are consistent 
across species and indeed across phyla. One human pepsinogen gene encodes a 373 amino 
acid peptide with 82% homology to a porcine pepsinogen (Sogawa et al, 1983). The low 
molecular weight pepsinogen of frogs is immunologically indistinguishable from human PG 
I (Schugerman et al, 1982).
The distinction between pepsinogens of groups I and II is also present when their 
biochemistry and that of the corresponding pepsins is examined. The pH optima of the five 
human group I pepsins lie between pH 1.5 and 2.0 and for the two group II pepsins, the pH 
optimum is 3.2 (Samloff, 1983). Group I pepsinogens are more susceptible to denaturation in 
alkali than those of group II since denaturation occurs at pH 7.2 and pH 8.0 respectively, but 
they are less susceptible to heat (PG I, 16 per cent, after 15 minutes at 62 °C at pH 2.4, 
versus PG II, 80 per cent) (Samloff, 1983). Their peptide bond specificities with artificial 
dipeptide substrates and their rates of hydrolysis of different protein substrates also differ 
(Hirschowitz, 1984).
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The distribution of PG I and PG II within tissues has been studied using immunofluorescent 
techniques. All studies have confirmed the original hypothesis of Langley (1881) that the 
chief cell o f the gastric fundus is the major source of pepsinogen in mammals, but 
demonstrate that it is not the only cell type synthesising pepsinogen. Chief and mucous neck 
cells of the human fundic gastric gland were shown to contain both PG I and PG II (Samloff, 
1971b, Samloff and Liebman, 1973). However cells of the cardiac and pyloric glands of the 
stomach and the Brunner’s glands of the duodenum produced only PG II (Samloff and 
Liebman, 1973). The human prostate secretes PG II into the seminal fluid, although the 
significance o f this is unknown (Samloff and Liebman, 1972). It is thought that all 
pepsinogens are filtered by the kidneys, but that PG II is reabsorbed, so that only PG I is 
present in urine, and PG II is consequently present in serum at a slightly higher level than its 
abundance in gastrointestinal and other tissues would suggest (Hirschowitz, 1984).
In the bovine, four group I pepsinogens, and one of group II, have been identified (Eckersall 
et al, 1987; Mostofa et al, 1990a). Only three pepsinogen subtypes, all group I, were 
identified in the sheep and goat (Mostofa et al, 1990a). The distributions of PG I and PG II in 
the bovine abomasum have recently been studied immunohistochemically and the pattern is 
similar to that observed in human gastric mucosa. In the milk-fed calf, prochymosin, the 
zymogenic precursor of chymosin, and PG I co-localised to mucous neck cells and chief 
cells. In concentrate fed calves and older cattle the distribution o f pepsinogen remained 
similar whereas expression of prochymosin declined and the number of prochymosin 
producing cells was highly correlated to the level of milk-feeding (Andren et al, 1982). In 
further studies (Cybulski and Andren, 1990), prochymosin, PG I and PG II all co-localised to 
similar cell populations in both fundic and pyloric mucosae. Chymosin was the predominant 
zymogen present in 17 day old, suckling calves and was present in chief and mucous neck 
cells of the fundus and in pyloric gland cells. At this stage PG I was mostly confined to 
mucous neck cells. PG II immunostaining was minimal at 17 days, but by 45 days prominent 
staining could be seen in surface mucous cells of fundic and pyloric mucosa and in deep cells 
of pyloric glands. Calves were still milk fed to some degree at 45 days. In 180 day old, 
entirely concentrate-fed calves chymosin-specific staining had declined with slight staining 
only present in mucous neck cells and in pyloric glands. Type I pepsinogens were widely 
distributed in many epithelial cells, including surface mucous cells in the pits o f both fundic 
and pyloric mucosae and PG II was prominent in surface mucous cells and in pyloric glands. 
The presence of PG I in pyloric mucosa was the one significant departure from the pattern
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observed in humans (Samloff, 1971; Samloff and Liebman, 1972). In electron 
immunohistochemical studies of the mucosae of 1 month old, milk-fed calves, PG I and 
prochymosin were demonstrable in the same individual granules of chief and mucous neck 
cells and in cells intermediate in appearance between the two (Yamada et al, 1988).
There are no reports of the immunohistochemical localisation of pepsinogens in sheep, or of 
the distribution of pepsinogens in any ruminant animals infected with abomasal nematode 
parasites. In studies of Haematoxylin and Eosin stained sections, Stringfellow and Madden 
(1979) noted that chief cells of calf abomasa were entirely depleted of granules by 26 days 
after infection with O. ostertagi larvae, yet plasma pepsinogen concentrations were still high. 
They argued that pepsinogen was no longer being synthesised in the abomasum, indeed 
abomasal pepsin concentrations were zero at this time, and hypothesised that pepsinogen was 
retained in the circulation due to a long elimination half-life. However the half-life of 
pepsinogen is likely to be short (vide supra) and there may have been some continuing 
source of pepsinogen in these calves. Prolonged stimulation o f pepsinogen secretion may not 
involve granule formation (see section 4.1), however Stringfellow and Madden (1979) 
reported that chief cells showing reduced granule content, had degenerative features and did 
not give the appearance of cells actively secreting pepsinogen.
Mucous cell hyperplasia is a recognised feature of the pathology of abomasal and gastric 
helminthoses and cell types other than chief cells can potentially provide a vast reserve of 
cells capable of producing pepsinogens if production by chief cells ceases. The following 
studies were initiated to assess the distribution of pepsinogen in normal, parasite-naive cattle 
and sheep, using a commercially available and polyclonal, anti-bovine PG I antiserum. It 
was assumed that, using this antiserum, bovine and ovine PG I would cross react and cross­
reaction was assessed by a parallel study of the staining patterns o f bovine and ovine 
abomasal mucosa. It was further proposed to investigate the distribution of PG I in 
parasitised animals; to ascertain whether changes in the mucosal cell population due to 
parasitism would result in changes in the number of cells producing pepsinogen, or changes 
in the zymogen content of individual cells. Biochemical studies o f the peptic activity present 
in mucosal tissues were designed to support the immunohistochemical findings.
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7.2: Preliminary investigations of bovine and ovine mucosae.
The following studies were primarily to test the suitability of using antibody raised against 
the bovine zymogen in the detection of its ovine counterpart, and to compare the staining 
patterns of abomasal mucosae from parasite-naive cattle and sheep for pepsinogen. It was 
further proposed to assess whether changes in the immunohistochemical localisation of 
pepsinogen, in response to parasitic infections of cattle and sheep, were readily apparent.
In the in vitro studies of abomasal secretion in section 5.6, tissues from lambs less than one 
week old were used. Tissues from these animals responded to cholinergic stimulation by 
releasing material with pepsin-like activity, i.e. acid stable proteolytic activity. Only small 
amounts of pepsinogen are produced in the abomasa of young calves (Andren et al, 1980), 
but significant amounts of pepsinogen have been detected in the mucosae of three day old 
lambs (Baudys et al, 1988). The cellular source of pepsinogen in the neonatal animal was 
therefore investigated using abomasal tissues from neonatal lambs.
7.2.1: Materials and methods.
7.2.1.1: Animals.
Sections o f abomasal fundic mucosa were taken from four, six month old Holstein-Friesian 
calves and sections of fundic and pyloric mucosae were collected from two, nine month old 
Scottish Blackface lambs, and three Hampshire Down lambs of approximately the same age. 
Both the calves and lambs had been reared indoors since birth in conditions likely to 
minimise helminth exposure. Fundic and pyloric tissues were also obtained from seven, one 
week old Scottish Blackface lambs. The lambs had been fed artificial milk-replacer by 
stomach tube for the short period until they were killed.
Tissues were also obtained from cattle and sheep which had been infected with abomasal 
parasites, although faecal egg counts and total worm burdens were not assessed. These 
animals were; a group of eight yearling cattle, which were known to have patent, but sub- 
clinical infections of O. ostertagi following single, experimental, larval infections, and two, 
six month old Scottish Blackface lambs that had been grazing infected pasture for a number 
of months and were killed for humane reasons when clinical signs of gastroenteritis became
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severe. Animals were killed by captive bolt (calves), or electrical stunning (sheep), followed 
by exsanguination. Tissues were collected as soon after death as possible and placed in 
Bninnel’s fixative.
7.2.1.2: Histological methods.
Tissue sections, were prepared for pepsinogen immunostaining, and were also stained with 
Haematoxylin and Eosin (H&E), and Periodic Acid Schiff (PAS). Immunolocalisation of 
pepsinogen was determined on 2 pm paraffin sections of abomasal mucosae, previously 
fixed using Brunnel’s fixative (Laboratory Supplies and Instruments Limited, Antrim, 
Northern Ireland). Endogenous peroxidase was blocked with 0.5 per cent hydrogen peroxide 
in methanol for thirty minutes, and sections were then treated with 0.1 per cent trypsin 
solution at 37°C for a further thirty minutes. Pepsinogen was visualised using a commercial 
antiserum from rabbits immunised with highly purified bovine pepsinogen type I (Chris 
Hansen’s Laboratory Limited, Reading, England) and the appropriate Vectastain, Avidin 
Biotinylated enzyme Complex (ABC) kit (Catalogue number, PK-4001, Vector Laboratories 
Limited, Peterborough, England). The primary antiserum, used at a one in ten thousand 
dilution, was incubated on the sections overnight at 4°C, after which the secondary, 
biotinylated and peroxidase complexed antibody was incubated on the sections for a further 
30 minutes. Bound peroxidase was then visualised using 0.1 per cent diaminobenzidine 
tetrahydrochloride (BDH Chemicals Limited, Poole, England). Sections were counterstained 
with Haematoxylin. Pepsinogen was localised as a brown stain, against a blue background. 
Two types of negative staining control were performed, the first by omitting the primary 
antiserum and the second by replacing the primary antiserum with normal (non-immune) 
rabbit serum (Catalogue number, S-5000, Vector Laboratories Limited).
In addition to the two negative-staining controls. Negative tissue controls were also obtained; 
tissues were taken from two sheep, from sub-mandibular salivary gland, trachea and large 
intestine and were stained immunohistochemically for pepsinogen.
7.2.2: Results.
Examination of parasite-naive calf abomasal fundus in H&E stained sections (Fig. 7.2) 
showed that pit and gland architecture was normal. Inflammatory cell infiltrates were
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minimal and the few intra-mucosal lymphoid follicles present were discrete and appeared 
wholly non-reactive (i.e. there were no germinal centres). Pepsinogen-specific staining could 
be detected in epithelial cells at all levels of the mucosae of all calves with the exception of 
parietal cells (Fig. 7.3). Staining in chief cells was strongest and these cells bore numerous 
dark staining granules in their apical cytoplasm. The basal cytoplasm of the chief cells was a 
uniform light brown. The apical granularity exhibited by mucous neck and surface mucous 
cells was considerably finer and paler than that of chief cells. The histological appearance of 
all the parasite-naive sheep in H&E stained sections was similar to that o f the calves. The 
pits appeared slightly shallower and the glands were correspondingly longer (Fig. 7.4). In 
PAS-stained sections mucins were confined to the neck of the fundic glands and to cells 
lining the pits (Fig. 7.5). Examination of multiple sections of sheep mucosa from each 
animal showed that the immunostaining for pepsinogen was consistent, qualitatively and 
quantitatively, from section to section. In the ovine fundus the immunostaining pattern for 
pepsinogen was similar to that in the calf tissues, but with one major difference, in that the 
surface mucous cells of the sheep were free of stain (Fig. 7.6). The pyloric mucosae of the 
sheep, examined in H&E stained sections, were unremarkable (Fig. 7.7), and the pepsinogen 
distribution was similar in all animals, with staining confined to deeper cells of the pyloric 
glands (Fig. 7.8).
Examination of H&E stained sections of the neonatal lamb fundic mucosa revealed a shallow 
mucosa in which the pits were short and lined by mucous cells with a voluminous mucus 
cap, which was foamy in appearance (Fig. 7.9). A major difference between these animals 
and those of other age groups lay in the population of the neck regions o f the fundic glands, 
the majority of cells in this region resembling the surface mucous cells. Cells recognisable as 
chief and parietal cells were confined to deeper gland areas. Parietal cells were generally few 
in number and appeared to have lower cytoplasmic volume than parietal cells in tissues from 
older animals. Some chief cells had accumulated eosinophilic granules in their apical 
cytoplasm, but many had not. Pits in the pyloric mucosa were deep and lined by tall mucous 
cells with voluminous apical mucus (Fig. 7.10). The very short glands o f the pylorus were 
lined by more cuboidal mucous cells and the gland lumen was often wide. Numerous mitotic 
figures were in evidence in the pyloric mucosa, but were rarer in the fundus. 
Immunohistochemical studies (Figs. 7.11 and 7.12) localised pepsinogen to the chief cells of 
the fundus, with a further group of cells staining at the level of the isthmus and lower pit. 
The staining of the cytoplasm of chief cells was still strongest despite their apparent lack of
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much granular material. In the pylorus, pepsinogen immunoreactivity was detected, albeit 
weakly, in the basal and also the more apical cytoplasm of some of the mucous cells of the 
pits.
Figures 7.13, 7.14 and 7.15 show sections of fundic mucosa from two of the eight cattle of 
the infected group. In Fig. 7.13 (higher magnification in Fig. 7.14) a collapsed gland left 
after larval emergence was noted, the overlying mucosa appears depressed in comparison to 
the hyperplastic edges o f the nodule (arrows). Epithelial cells lining collapsed glands were 
irregular in height and width, varying from tall, columnar to low cuboidal. Cells also varied 
in the intensity o f staining for pepsinogen, with some cells demonstrating considerable apical 
staining, whilst adjacent cells stained more weakly. Epithelial cells lining slightly dilated 
structures above the collapsed gland stained only weakly for pepsinogen. In comparison, at 
either side of the centre of the nodule (arrows), at mid-mucosal levels and towards the 
surface, hyperplastic and hypertrophied mucous cells stained more strongly for pepsinogen 
than cells at corresponding levels of adjacent, more-normal mucosa, cells which had more 
abundant apical cytoplasm with larger mucus caps. At deeper mucosal levels some glands 
adjacent to the central, formerly-parasitised gland were mildly dilated, and were lined by low 
cuboidal and poorly differentiated cells that stained weakly for pepsinogen. Parietal cells 
were not present in these glands, but were still prominent in other glands in close proximity 
to them. No parasitised gland could be seen in the section shown in Fig. 7.15, however the 
raised outline of a nodule was discernible at the mucosal surface and there were associated 
accumulations o f lymphocytes in the lamina propria and sub-mucosa. Deeper gland 
structures appeared normal and parietal cells were plentiful across the lesion. More obvious 
changes existed closer to the surface where hyperplastic and hypertrophied mucous cells 
showed increased staining for pepsinogen in comparison to cells at this level in normal areas 
adjacent to the lesion. Fig. 7.16 shows a section of a parasitised gland from another animal 
from this group. The gland was occupied by a large worm that was seen to be partly 
emergent from the mucosa in a different section. There was minimal change around this 
gland when compared to more distant areas, and although adjacent glands showed mild 
dilatation, parietal cells were still present in them. The epithelial lining of the parasitised 
gland was irregular with some hyperplastic fronds, and pepsinogen-specific staining in the 
cells was poor or absent. Parasites themselves did not stain, except for slight accumulations 
of positive material lining what could well correspond to the worm’s gut.
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Figure 7.17 shows an area of massively thickened fundic mucosa from one of the infected 
sheep, stained by Periodic Acid Schiff (PAS). Mucins, identified as PAS-positive material 
(violet coloration), were present in cells at all levels of the mucosa, although many cells, 
especially those deeper within glands, contained only small amounts. At higher 
magnification few parietal cells could be seen in this area of mucosa. The same tissue stained 
for pepsinogen (Fig. 7.18) revealed a very mixed pattern, with many cells at the gland base 
showing less staining and possessing fewer granules than chief cells in other, histologically 
normal, parts o f the mucosa. However, in other areas, pepsinogen-specific staining was 
detected in cells at all levels o f the mucosa. Similar changes were seen in mucosal sections 
taken from the other infected sheep (results not shown), but were generally less marked.
Pepsinogen-specific staining was not observed in any of the control sections and no 
pepsinogen-specific staining could be detected in the salivary gland, tracheal or large 
intestinal tissues from the two animals examined.
7.2.3: Discussion.
The immunohistochemical localisation of type I pepsinogen in parasite-naive calf mucosa in 
the above studies agreed closely with the reported distributions of pepsinogen in fundic 
mucosa of calves in other studies (Cybulski and Andren, 1990). Assuming that the antiserum 
employed recognised ovine type I pepsinogen equally well, the pattern of distribution of 
pepsinogen in normal sheep may differ from that of cattle since the surface mucous cells in 
the ovine do not appear to contain pepsinogen. The concentrations of pepsinogen in sheep 
surface mucous cells may have been below the sensitivity of the antibody method, however 
in studies of bovine mucosa, the antiserum could be diluted from a normal working dilution 
of 1:10,000, to at least 1:80,000 and staining in surface mucous cells was still apparent 
(results not shown). Staining of ovine pyloric mucosa for pepsinogen produced a similar 
pattern to that reported by others for the bovine pylorus (Cybulski and Andren, 1990) and 
disagreed with studies in humans where PG I was not present in the pylorus (Samloff, 1971).
The quality o f staining for pepsinogen in both cattle and sheep was excellent, with no 
staining detected in other non-epithelial cells. The anti-bovine pepsinogen antiserum 
recognised ovine pepsinogen well. The antiserum may have recognised epithelial 
components other than pepsinogen, but the distribution in the bovine was similar to that
reported for other studies, and in the sheep at least attempts to localise pepsinogen-specific 
immunoreactivity to a variety of non-abomasal tissues were entirely without success,
Fig. 7.2: Photom icrograph of a section of the fundic mucosa from a parasite-naive calf.
(H&E stain, original magnification x25).
Fig. 7.3: Photom icrograph of parasite-naive calf fundic mucosa stained for pepsinogen.
(Haematoxylin counterstain, x 25).
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Fig. 7.4: Photom icrograph of a section of parasite-naive ovine fundus.
(H&E stain,x 25).
Fig. 7.5: Photom icrograph of parasite-naive ovine fundic mucosa. (PAS stain; mucins 
appear violet, x 25).
r  SfiS
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Fig. 7.6: Section of parasite-naive ovine fundic mucosa im m unostained for pepsinogen.
(Haematoxylin counterstain, x 25).
Fig. 7.7: Photom icrograph of a section of parasite-naive ovine pyloric mucosa. (H&E 
stain, x 25).
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Fig. 7.8: Section of ovine pyloric mucosa im m unostained for pepsinogen. (Haematoxylin 
counterstain, x 13.2)
Fig. 7.9: Photom icrograph of the fundic mucosa of a lam b of less than one week of age.
The upper gland levels are lined by cells bearing voluminous mucus caps (H&E stain, x 50).
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Fig. 7.10: Pyloric mucosa from a Iamb of less than one week of age. (H&E stain, x 50).
Fig. 7.11: The immunohistochemical localisation of pepsinogen in the fundic mucosa of 
a lamb. (Haematoxylin counterstain, x 50).
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Fig. 7.12: Pyloric mucosa of a lamb of less than one week of age. (Immunostained for 
pepsinogen, x 50).
Fig. 7.13: The immunohistochemical localisation of pepsinogen in fundic mucosa of a 
calf with a patent O. ostertagi infection. Reduced staining can be seen immediately above 
the collapsed gland left after parasite emergence, but the hyperplastic edges of the nodule 
(arrows) show increased levels of staining (Haematoxylin counterstain, x 10).
Fig. 7.14: H igher magnification of the collapsed nodule featured in Fig. 7.13.
(Pepsinogen immunostain, x 40).
Fig. 7.15: Section of a presum ed nodular lesion from a calf with a patent O. ostertagi 
infection. There is hyperplasia and hypertrophy of more superficial mucous cells and an 
apparent increase in pepsinogen-specific stain (x 10).
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Fig. 7.16: Section of an area of mucosa from a calf of the same group as those featured 
in Figs. 7.13 and 7.15. Note the presence of a large parasite within the confines of a gland 
and that there is minimal change in the structures around it and consequently little change in 
the distribution of pepsinogen (x 10).
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Fig. 7.17: Section of ovine fundic mucosa with massive hyperplasia due to parasitic 
gastritis. Note the presence of numerous parasite larvae (p) and the presence of PAS- 
positive material deep in the mucosa (arrows)(x 10).
Fig. 7.18: The same tissue as in Fig. 7.17 im m unostained for pepsinogen. A mixed 
pattern of staining is present with some deep glandular structures showing little stain (small 
arrows) and in other areas pepsinogen is present in numerous surface mucous cells (large 
arrows)(x 10).
These studies confirmed the presence of a PG I-like substance in the abomasa of young 
lambs. Despite the observed differences between the architecture of the lamb mucosae at a 
few days of age and those of older animals, the chief cell remained the major source of 
pepsinogen, as indicated by the intensity of staining. Although the exact control of 
pepsinogen secretion in the chief cells of neonatal animals may ultimately differ from that of 
older animals, it is however likely that cells of the neonate and adult respond similarly to 
many of the same secretagogues.
The preliminary results for infected animals strongly suggested that ostertagiasis resulted in 
changes in the pattern of distribution of pepsinogen in fundic mucosae, changes that were 
observable by immunohistochemical means. In the bovine examples studied the results were 
suggestive of increased amounts of pepsinogen present within parasitic nodules, but also 
indicated that the stage of infection might be important, with greater changes associated with 
older lesions. The mixed pattern observed in the parasitised ovine tissues might have resulted 
from differences in the maturation of the hyperplastic epithelial cells that had replaced the
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normal gland components. The rapid amplification of very poorly differentiated cells may 
have resulted in the presence of large numbers of cells that possessed little synthetic 
machinery for the production of pepsinogen. These cells subsequently underwent some 
differentiation and a synthetic capability was then achieved, but it is possible that as cells 
differentiated to resemble fully mature mucous cells, which in the ovine do not contain 
pepsinogen, the ability to produce pepsinogen was finally lost.
7.3: Examination of tissue pepsinogen concentrations at multiple sites of the abomasa 
of sheep and cattle.
The degree of variation in pepsinogen concentration encountered within the abomasa of 
individual animals was assessed, to see whether tissue pepsinogen concentrations were 
consistent in different areas of the abomasum as had been suggested by the preliminary 
immunohistochemical studies.
7.3.1: Materials and methods.
Tissues were obtained from a group of five, six month old female calves, of mixed breeds 
(three Hereford-Friesian crosses, one Charolais cross and one Limousin cross) that had been 
reared indoors to minimise exposure to helminth infection. Ten sections o f fundic and two 
sections of pyloric mucosa were collected from each animal for the measurement of mucosal 
wet weight and the assay of tissue pepsinogen. Sections were also taken for pepsinogen 
immunohistochemistry. Sections were taken in a similar pattern for all animals (Fig. 7.19), 
and cut using a 13.5 mm diameter punch biopsy. Sections were therefore o f identical cross- 
sectional area, and fundic sections incorporated two mucosal layers, that is the opposing 
sides of the mucosal fold. Pyloric mucosal sections, consisting of one mucosal layer, had to 
be dissected free of the sub-mucosa, which was a relatively easy task. To allow a limited 
comparison with sheep, tissue was taken in a similar pattern from each of three Scottish 
Blackface, female lambs, all less than one year old. These animals had an incomplete history 
and may have been previously exposed to parasites. Sections were not taken for 
immunohistochemistry and due to a degree of difficulty in dissecting the pyloric mucosa 
free, the core punch was not used for the pyloric mucosal pieces and sections were therefore 
of non-standard area, and not directly comparable. Pepsinogen concentrations could however 
be compared, when expressed as peptic units per gram of tissue. Weighed tissues were
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processed and tissue pepsinogen was assayed as described earlier (see section 2.3). From the 
values o f pepsinogen concentration present in the supernatants of the processed tissue 
homogenates, the total pepsinogen present in each mucosal cut was calculated. Tissue 
pepsinogen concentrations were then expressed as peptic units per mucosal cut (all identical 
areas) or as peptic units per gram of tissue. The amount of variation in tissue pepsinogen 
concentration from site to site within the abomasa of individual animals was assessed by 
calculating the coefficient of variation (C.V.) for each animal. The C.V. was obtained by 
dividing the mean tissue pepsinogen concentration (iU/g) for each animal by the 
corresponding standard deviation and multiplied by 100 to obtain the per cent value. Tissue 
wet weights, total tissue pepsinogen values (iU/standard area) and tissue pepsinogen 
concentrations (iU/g) were compared by one-way analysis of variance to see if  individual 
animals were different. The model test parameter (wet weight, tissue pepsinogen) = 
animal, was used.
Fig. 7.19: Schematic representation of the abomasal luminal surface, the abomasum was 
opened along the greater curvature and the approximate location and sequence of mucosal 
sections is shown.
FUNDUS
Q  Section for Tissue 
Pepsinogen Assay
£  Section for Immuno­
histochem istry
PYLORUS
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7.3.2: Results.
None of the calves showed any evidence of any abomasal pathology, however a few parasitic 
nodules and adult parasites were seen in the abomasum of one sheep (No. 3). The results of 
tissue pepsinogen concentrations expressed as iU per gram of tissue (iU/g) are given in Table 
7.1. The mean (± S.E.) values for fundic wet weights (g) and total tissue pepsinogens (iU per 
standard mucosal area) and individual values for pyloric measurements, are given in Table 
7.2 (full data for fundic mucosal tissue total pepsinogen (iU/ standard area) and for fundic 
wet weights are contained in Appendices 18A and B). In all animals the pepsinogen content 
of pyloric mucosa was lower than that found in the fundus, mean values for cattle fundus 
ranged from 28,900 iU/g to 48,200 iU/g, whereas pyloric pepsinogen concentrations ranged 
from 800 iU/g to 10,000 iU/g. The sheep gave similar results. In all animals fundic 
pepsinogen concentrations were consistent between areas and variation calculated as 
coefficients of variation was generally low. The overall mean C.V. of all 8 animals was 19.5 
per cent with individual values ranging from 14 to 25 per cent. For the three parameters of 
tissue wet weights, total tissue pepsinogen (iU/ area) and tissue pepsinogen concentration 
(iU/g), animals were highly significantly different from each other (p<0.001), i.e. within- 
animal variation was negligible in comparison to that already existing between animals. 
Immunohistochemical localisation of pepsinogen in the calf mucosae demonstrated no 
staining of the surface mucous cells, but otherwise staining was typical of that seen 
previously in parasite-naive animals.
7.3.3: Discussion.
Cuts of the fundic mucosal folds incorporated two mucosal layers, whereas those of the 
pylorus, only one. Assuming that tissue densities did not vary then tissue wet weights were 
directly proportional to the thickness of the mucosa, which would be affected by the vertical 
heights of the pits and glands. Some contribution to tissue weights would undoubtedly derive 
from submucosal structures, such as adipose tissue and larger calibre blood vessels, but 
judging from histological sections these features accounted for only a small proportion of 
total tissue mass and were fairly consistent from tissue to tissue. It is therefore likely that wet 
weights give a good indication of the size of the pit/gland units. The number of animals in 
this study was too small to allow a proper comparison of the pepsinogen concentrations of 
cattle and sheep, but both species contained pepsinogen concentrations of similar orders,
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although there was the suggestion that there was greater variation between concentrations of 
the individual sheep. In comparison with earlier investigations of the distribution of 
pepsinogen in ruminants these results indicate similar staining patterns as well as similar 
tissue pepsinogen concentrations in both cattle and sheep.
Age is known to influence the pattern of pepsinogen staining in animals (Cybulski and 
Andren, 1990), but the possible effects of other factors, such as diet, are not known. Many 
factors may have accounted for the apparent presence of pepsinogen within the surface 
mucous cells in some cattle as reported earlier, and its absence in surface mucous cells of the 
calves in the present study. The present study has shown that abomasal fundic pepsinogen 
distribution is remarkably consistent from area to area in parasite-naive calves, and is likely 
to be the same in sheep. As a consequence, a single mucosal sample from a normal animal 
would give good information on the amount and distribution of pepsinogen present in the 
abomasum overall. The distribution of pathological changes during nematode parasitism may 
not be spread so evenly throughout the abomasum.
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Table 7.1: Tissue pepsinogen concentrations (iU/g tissue wet weight) of multiple sites of 
the abomasa of cattle and sheep.
Site
Calf
1 2 3 4 5
Sheep
1 2 3
Fundus
1 37,754 72,749 37,088 30,236 26,241 8,635 26,394 101,732
2 67,764 56,442 33,682 27,459 22,576 14,186 28,401 71,662
3 50,331 59,964 40,956 23,984 30,017 11,318 17,301 97,500
4 62,243 66,851 39,766 30,339 19,056 11,641 28,589 80,428
5 57,536 66,048 34,902 34,519 32,049 9,775 21,977 96,671
6 36,228 55,546 43,902 34,406 37,359 8,076 28,931 100,529
7 36,406 53,239 32,726 32,058 21,244 6,855 37,481 72,240
8 56,026 46,160 47,432 36,382 29,252 10,343 31,932 62,810
9 38,072 54,995 41,389 34,693 38,569 9,831 29,898 95,303
10 39,976 81,015 49,050 49,109 32,302 12,543 26,463 99,858
Mean 48.234 61.301 40.089 33.319 28.866 10.320 27.737 87.873
(± SD) (3,793) (3,275) (1,771) (2,120) (2,083) (692) (1,712) (4,609)
C.V. % 24.87 16.90 13.97 20.12 22.82 21.19 19.57 16.59
Pylorus
1 10,444 525 1,417 3,473 1,469 9,840 5,530 10,434
2 8,551 1,011 1,971 1,996 1,203 7,096 2,009 5,660
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Table 7.2: Mean (± S.E.) tissue wet weights (g) and total tissue pepsinogen (iU per 
standard area) of multiple sites of the abomasa of cattle and sheep (values for pyloric 
mucosae are not mean values)
Calf
1 2 3 4 5
Sheep
1 2 3
Wet wts 
Fundus 0.1231 0.1119 0.0933 0.0956 0.0988 0.0819 0.0929 0.0672
(± S.E.) (0.0033) (0.0065) (0.0056) (0.0033) (0.0035) (0.0035) (0.0039) (0.0020)
Pylorus
1 0.0897 0.1208 0.1112 0.0747 0.0694 0.1282* 0.1527* 0.0363*
2 0.0947 0.1256 0.1223 0.1300 0.1309 0.1076* 0.1292* 0.1060*
Tot. Peps. 
Fundus 5875 6788 3710 3149 2857 844 2535 5887
(± S.E.) (389) (384) (221) (159) (240) (66) (112) (338)
Pylorus
1 937 64 158 259 102 1261* 844* 379*
2 810 127 1464 259 157 763* 259* 600*
* - Ovine pyloric pieces were not cut using the core punch, therefore wet weights and total 
tissue pepsinogens are not directly comparable, however tissue pepsinogen concentrations 
(see previous table) are.
7.4: The effects of natural infections of sheep, with predominantly O. circumcincta, on 
the distribution and quantity of abomasal tissue pepsinogen.
In the initial studies presented earlier in this thesis changes in pepsinogen distribution in the 
abomasa of animals with ostertagiasis were associated principally with the nodules caused by 
larval development and emergence and tissue pepsinogen content could have been increased 
in nodules as a consequence of the hyperplasia of immature, mucous-type cells. The 
following studies were designed to further investigate the nature of changes occurring in 
ovine tissues and to compare the pepsinogen content of nodular tissues to that of intervening 
areas of non-nodular mucosa in the same animals, and to assess the extent o f any changes 
that might be present within infected mucosae.
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7.4.1: Materials and methods.
7.4.1.1: Animals.
The sheep in this study had grazed pasture contaminated with parasitic nematode larvae on a 
commercial, upland farm in the west of Scotland. The group comprised twenty six, spring- 
born, male, Scottish Blackface lambs that were monitored monthly during the grazing 
season, from May to October, for faecal egg counts. With the exception o f the last sampling 
date in October, the lambs were dosed with a broad-spectrum anthelmintic (Albendazole 
sulphoxide: Rycoben, Youngs Animal Health, Leyland, England), given at the time of 
sampling, at the recommended dose rate o f 5 mg/kg body weight, based on the body weight 
of the heaviest lamb.
7.4.1.2: Procedure at necropsy.
The sheep were killed by exsanguination following electrical stunning. Blood was collected 
into heparinised containers, as the sheep were bled out, and samples were later centrifuged at 
2,000 g  in a Beckman GS-6R centrifuge for 10 minutes, plasma was then separated and 
stored at -20°C. Before the abomasal mucosa was washed (for the quantitation of parasite 
numbers), tissue from multiple sites was taken into Brunners fixative for 
immunohistochemical studies. Tissue was also collected from the first five animals killed for 
the estimation of the amounts of tissue pepsinogen present in nodular and non-nodular 
mucosa, cuts were made using the biopsy punch tool (see section 7.4.1) to take sections of 
identical area. Four sections containing parasitic nodules (the nodule comprising the majority 
of the whole cut, with a thin rim of normal mucosa) and four sections o f the immediately 
adjacent, apparently normal mucosa, were taken from each animal. In one animal (Y27), 
because of a generalised thickening of much of the mucosa, areas relatively normal in 
appearance were too small to be cut separately from changed mucosa, changed tissue was 
however collected from this animal, and sections cut for histology incorporated some 
apparently normal mucosa.
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7.4.1.3: Parasitological and biochemical examinations.
Faeces was collected from the rectum of each lamb at necropsy for faecal egg counts. Faecal 
egg counts were accomplished using a modification of the McMaster procedure (Gordon and 
Whitlock, 1939). Each egg counted represented 50 eggs per gram of faeces. Abomasal 
contents and washings were made up to 2 litres, from which ten, 4 ml samples were 
examined to estimate the size of the worm population at the abomasal surface. One half of 
the abomasum was digested in pepsin-hydrochloric acid for six hours at 42°C, after which 
the digest was made up to 2 litres from which ten, 4 ml samples were examined to estimate 
the numbers of the population of tissue-dwelling worm stages (Armour et al, 1966). Plasma 
pepsinogen was assayed using Paynter’s method (1992).
7.4.1.4: Histological procedures.
Tissues, taken initially into Brunnel’s fixative, were later processed for routine histological 
examination (H&E and PAS techniques) and for the immunohistochemical localisation of 
pepsinogen.
7.4.1.5: Assay of tissue pepsinogen.
The mucosal pieces were gently cleaned to remove remaining abomasal contents and were 
then blotted dry and the wet weights recorded. Tissue pepsinogen was measured using the 
method described earlier (section 2.3). The wet weights of mucosal pieces, the total 
pepsinogen content of the pieces and their pepsinogen concentrations were compared 
separately by two-way analyses of variance, to compare non-nodular mucosa with nodular 
tissues. The model fitted was test parameter = sheep + mucosal type + sheep x mucosal 
type, sheep was fitted as a random effect.
7.4.2: Results.
Faecal egg counts, abomasal parasite counts and plasma pepsinogen concentrations are 
detailed in Table 7.3. Faecal egg counts varied from 0 to 1700 epg, with only three animals 
shedding greater than a thousand eggs per gram of faeces. Total worm burdens varied from 
seven hundred to nearly twelve thousand, the majority of worms present at necropsy were
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adult and more adult females were present than males in most animals. More worms were 
generally present at the fourth-larval stage than the fifth. Plasma pepsinogen values were 
mostly mid to high normal concentrations, based on the range for normal animals quoted by 
Paynter (1992). Fifteen of the twenty three animals, for which the parameter was examined, 
had plasma pepsinogen concentrations of 5 iU or less, that would be considered consistent 
with the absence of significant abomasal parasitism.
7.4.2.1: Gross pathology.
Adult worms were seen on the abomasal surface of all animals and a modest number of 
characteristic nodular lesions were scattered throughout the epithelium in all but three 
animals. These animals (Y27, Y166 and Y182) had extensive pathological change since the 
majority of the mucosal surface appeared thickened, was quite rough and pale in colour. In 
animals infected with O. circumcincta the increased cellularity of nodules causes them to 
appear paler than the surrounding mucosa and in very heavy infections the nodules can 
become confluent giving the appearance considered characteristic of Morocco leather. In the 
three exceptional animals the impression was not of a great abundance of individual nodules, 
but rather of a generalised mucosal thickening with few discrete nodular centres. In other 
animals the nodules were generally circular, except where two or three closely abutted each 
other and achieved a degree of confluence. Individual nodules were 5 millimetres across at 
most, were pale and well circumscribed. Oedema and haemorrhage were not observed in the 
abomasa of any of the sheep. One animal (B16) was mildly ascitic. The abomasal pathology 
of this animal was no worse than that of other sheep and no other changes were observed in 
the other visceral organs or elsewhere.
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Table 7.3: Faecal egg counts, worm burdens and plasma pepsinogen concentrations at 
necropsy.
Lamb
FEC
(epg)
Worms
L4 L5 male female Total
Plasma 
Pep. (iU)
02 125 1300 0 750 1100 3150 4.50
Y27 275 1350 550 2750 3700 8350 13.30
Y43 225 1200 100 750 1450 3500 1.20
Y51 675 2200 100 1900 3500 7600 3.00
B60 475 2800 100 1700 2100 6700 1.40
Y6 50 2700 0 850 800 4350 5.00
B69 100 0 0 800 1150 1950 1.20
035 0 6200 400 800 700 8100 5.00
036 0 10400 0 550 550 11500 2.60
062 125 500 150 1400 1250 3300 2.40
B23 400 0 0 800 500 1300 6.83
B27 300 0 0 250 450 700 2.63
B37 200 3500 50 1050 1100 5700 2.89
Y165 1200 4600 0 900 2600 8100 6.30
Y166 100 900 0 300 500 1700 3.41
Y176 500 4600 0 1400 2100 8100 N.D.
Y179 500 2900 50 750 1200 4900 9.71
Y182 1200 7600 200 1600 2000 11400 7.35
B15 350 300 0 1350 1700 3350 2.63
B16 650 2300 100 2000 2900 7300 10.50
B20 250 1400 0 600 300 2300 6.10
B30 600 0 0 1550 2150 3700 0.73
B39 100 1500 0 700 1100 3300 5.61
B41 500 2800 0 500 1300 4600 N.D.
B46 1700 2300 0 1600 1800 5700 N.D.
Y192 650 700 0 1100 1300 4100 0.73
N.D. - not done, due to blood sample clotting.
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1A 2 2 \  Histopathology.
The appearance of the non-nodular areas of mucosa of most animals, in Haematoxylin and 
Eosin stained sections, was largely normal, but there was evidence of slight epithelial 
cytolysis at the superficial tissue margins. In some animals there was also moderate 
hyperplasia o f mucous cells at the level of the upper gland and isthmus, even within the 
intervening areas of grossly normal mucosa. A cellular infiltrate of mainly lymphocytes and 
therefore typical of chronic inflammation was detected, but the level o f infiltration within 
normal areas was slight. The distribution of intraepithelially situated globule leukocytes was 
sporadic with some areas heavily infiltrated by these cells. Parietal cells in these more- 
normal areas appeared histologically and numerically normal. Changes associated with the 
presence of infection were largely confined to nodular areas. Occasional worm larvae were 
seen within nodules, coiled within glands with the epithelium of the surrounding gland often 
floridly hyperplastic and moulded to the worm’s outline. Some nodules contained more than 
one parasitic worm, occupying different glands, and at different stages o f development. At 
the edges of nodules, parietal cell density appeared normal and changes were confined to 
mucous neck cell hyperplasia, so that the pits and glands were straight and tall and with little 
distinction between the two. The edges of many nodules were abrupt, with a step down to the 
adjacent normal mucosa.
At the centre of nodules mucous cells extended towards the mucosal base. Recognisable 
parietal cells and chief cells were absent at all levels. The enlarged pits were wide in many 
instances, almost cigar-shaped (Fig. 7.20). Mitotic figures were more numerous than normal, 
indicative of increased cell divisions, and occurred from just above the base of the glands to 
just below the mucosal surface. Cells lining the enlarged pits were variable in appearance. At 
the mucosal base poorly differentiated cells predominated. The basophilia, characteristic of 
the basal cytoplasm of chief cells, normally predominant at this level of the mucosa, was 
gone. Instead the cytoplasm was pale and eosinophilic, sometimes with an even paler, 
unstained area immediately adjacent to the nucleus. The nuclei themselves appeared larger 
than normal and were pale. Higher up the gland, cells were characterised by the presence of a 
mucus cap of variable size. In some nodules the majority of cells in the pit/glands possessed 
relatively small amounts of mucus, with significant amounts present only in the most 
superficial cells. This was the case in sections from sheep Y27. In contrast Fig. 7.20 shows a 
section of mucosa from animal Y51 and the mucus content of cells at all depths of the
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mucosa was high. Superficial cells were flask-shaped with flattened nuclei at their bases and 
reduced cytoplasmic volume, and their mucin content appeared greater than that of normal 
pit cells. Nodules from other animals were generally at a mid-point between the extremes 
represented by animals Y27 and Y51, since hyperplasia was usually prominent, but the 
massive hypertrophy of mucous cells observed in the nodules present in sheep Y 51 was not 
as marked.
Nodular areas were massively infiltrated by immune cells, sometimes grouped as large 
follicles below the mucosa, occasionally extending upwards through the muscularis into the 
lamina propria. Heavy immune cell infiltration within the mucosa appeared to spread glands 
further apart. Superficially there were often massive numbers o f globule leukocytes situated 
intraepithelially. Eosinophils were an inconsistent feature, but were occasionally seen around 
parasitised glands and scattered within the lamina propria.
An examination of sections stained with PAS reinforced the differences in cell mucin content 
observed in H&E-stained sections. In the more grossly normal mucosa from animal Y27, the 
only difference from a normal mucosal appearance was the presence of PAS-positive 
material at deeper gland levels. This feature was even more prominent in the changed 
mucosa o f Y27 (Fig. 7.21), but the quantity of mucus per cell remained small. The nodular 
mucosa from Y51 (Fig. 7.22) had considerable quantities of mucus contained in many cells 
at all levels, but the most basal cells in glands still contained only small amounts.
In both Y166 and Y182 the similarity of the gross changes reported in these animals to those 
described in Y27 earlier, was not repeated in the histopathological changes. Parietal cells 
were still evident in much of the mucosa, in all sections from both animals, in good numbers. 
Massive mucous cell hyperplasia and parietal cell loss were both apparent, but only as focal 
lesions around parasitised glands and were not generalised as in tissues from Y27. In 
intervening areas a lesser degree of mucous cell hyperplasia was apparent and the mucosae 
from these animals appeared correspondingly thicker. In sheep Y166 chief cells appeared 
abnormal (Fig. 7.23). The basophilia characteristic of the basal cytoplasm of normal chief 
cells was absent and the apical cytoplasm contained few granules. The cytoplasm was 
instead pale, and with a paler perinuclear area on the apical side of the nucleus. Mucus caps 
were not apparent, and in PAS-stained sections these cells were not PAS-positive.
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Fig. 7.21: M arked mucous cell hyperplasia within the abnorm al epithelium of Y27.
Parietal and chief cells are not discernible in the glands and are replaced by cells beginning 
to produce mucus. (PAS stain, x 25).
Fig. 7.22: M arked hypertrophy of mucous cells accompanying the hyperplasia 
associated with nodular lesions in the mucosa of Y51. (PAS stain, x 16).
Fig. 7.23: The appearance of the abnorm al chief cells lining the glands of Y166. (H&E 
stain, x 100).
168
7.4.2.3: Pepsinogen immunolocalisation.
The distribution of pepsinogen within grossly normal mucosae was largely the same as for 
parasite-naive animals. In some animals there was an enhanced degree of staining that could 
be attributed to the slight mucous cell hyperplasia identified at the upper gland/isthmus level. 
This was greatest in animal 02, where pepsinogen-specific staining was also demonstrable in 
the mucous cells o f the pits even superficially. An examination o f the basal portion of some 
glands in the mucosa of 02 also revealed a slight reduction in the pepsinogen content of the 
chief cells. The diminished content of chief cells was also apparent in animals Y27 and 
Y166. Chief cell pepsinogen content was reduced even in the relatively normal mucosa of 
Y27, in areas where parietal cells were still apparent, (Fig. 7.24). In the hyperplastic mucosa 
from animal Y27 no one level of the mucosa stained more intensely than any other (Fig. 
7.25). The chief cells of Y166 that had appeared abnormal in H&E stained sections did stain 
for pepsinogen, but the granule content was reduced (Fig. 7.26).
Figures 7.27 and 7.28 show adjacent sections of the nodule shown previously in Fig. 7.20. 
Within nodules, pepsinogen immunostaining was prominent in the hyperplastic mucous-type 
cells lining the enlarged pit/glands, yet both photomicrographs illustrate the mixed nature of 
adjacent glands that was apparent. The cells lining some pit/glands were relatively free of 
pepsinogen immunostaining whereas adjacent structures were lined by cells strongly positive 
for pepsinogen. Fig. 7.28 shows that parasitised glands (p) were associated with increased 
pepsinogen content of surrounding structures, with an expanded population o f cells positive 
for pepsinogen (Fig. 7.29). Deep within nodules the metaplastic cells replacing the normal 
chief cells at the base of glands did stain for pepsinogen (Fig. 7.30), but the marked 
granularity of chief cells was lost.
Two unusual features were detected in this study. In a section from one animal glandular 
elements at the centre of one nodule were present below the muscularis (Fig. 7.31). Cells 
lining this structure were weakly positive for pepsinogen and therefore assumed to be 
epithelial cells. In another section a direct communication was seen between the sub-mucosal 
structure and the mucosa. The second unusual feature seen in a section from another animal 
was the presence of a number of pepsinogen-positive cells scattered within the lamina
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propria and submucosa. These cells were in an area of considerable mucosal damage with 
glandular degeneration and erosion of the overlying epithelium, surrounded by an 
inflammatory infiltrate of mostly lymphocytes which obliterated the muscularis in this area. 
The pepsinogen-positive cells were either scattered singly within the lamina propria and sub­
mucosa (Fig. 7.32), or were accumulated into thin walled vessels in the sub-mucosa (Fig. 
7.33). These cells were seen in consecutive sections taken from the same block of mucosa, 
but were not seen elsewhere in other sections o f sub-mucosa from the same animal, or in 
similar sites in tissues from any of the other animals.
7.4.2.4: Mucosal wet weights and tissue pepsinogen concentrations.
Tissue wet weights and the tissue pepsinogen concentrations of the first five animals are 
shown in Table 7.4 (Full data is shown in Appendices 19A to C). Not surprisingly the 
mucosal cuts bearing nodules were significantly heavier (p<0.05) than the non-nodular areas. 
Tissues were generally o f similar thickness in all animals and were similarly thickened by 
the presence of nodules (test for the effect of sheep on overall variation in wet weight, by 
ANOVA, p=0.081). Figure 7.34 shows the differences in tissue pepsinogen concentrations 
between nodular and non-nodular areas of mucosa and between individual animals and tissue 
pepsinogen (expressed as peptic units per standard area of mucosa) was found to be 
significantly greater in nodular mucosa (p<0.05), however there was no difference in 
pepsinogen content when calculated as peptic units per gram of wet tissue (p=0.192). The 
mucosal pepsinogen concentrations of the individual sheep were different (p<0.02, by 
ANOVA), but the effect o f the presence of nodules was similar in all animals, as shown by 
Fig. 7.34, where the lines connecting the two mucosal types have similar gradients. The 
interactive terms (sheep x mucosal type) were not significant for all three test parameters 
(p>0.10, 0.50 and 0.25, for wet weights, total tissue pepsinogen and pepsinogen 
concentration respectively).
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Fig. 7.24: Immunolocalisation of pepsinogen in the more norm al mucosa of Y27.
Pepsinogen is present in all cells of the tall and narrow pits and the content of chief cells 
appears reduced (x 25).
Fig. 7.25: Imm unolocalisation of pepsinogen in the changed mucosa of Y27. No one
level of the mucosa dominates in terms of the intensity o f staining (x 10).
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Fig. 7.26: The immunohistochemical localisation of pepsinogen to the abnorm al chief 
cells of Y166. Note that pepsinogen-specific staining is still present, but that granule density 
appears less (x 100).
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Fig. 7.27: Section of the edge of the nodule featured in Fig. 7.20. Pepsinogen 
immunostaining is prominent in hyperplastic mucosal cells at the stepped edge of the lesion
(x 10).
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Fig. 7.28: Mid-section of the nodule featured in Fig. 7.20. Parasitised nodules (p) are 
associated with focal increases in pepsinogen immunostaining, adjacent glands may show 
depletion of stain (arrows)(x 10).
Fig. 7.29: Hyperplasia of mucous cells at a mid-mucosal level. (Pepsinogen immunostain, 
x 100).
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Fig. 7.30: Imm unohistochemical appearance of the metaplastic cell population, 
replacing chief cells in deep mucosal areas within nodules. (Pepsinogen immunostain.
x 100).
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Fig. 7.31: Section showing glandular elements (with pepsinogen content) present in the 
sub-mucosa. (Pepsinogen immunostain, x 13.2).
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Fig. 7.32: Unusual pepsinogen-positive cells scattered in the sub-mucosa below a 
destructive mucosal lesion. (Pepsinogen immunostain, x 50).
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Fig. 7.33: Unusual pepsinogen-positive cells collected in a small calibre vessel in the 
sub-mucosa. (Pepsinogen immunostain, x 250).
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7.4.3: Discussion.
By comparing tissue pepsinogen concentrations expressed as peptic units per area of mucosa, 
the pepsinogen content of parasitic nodules was higher than that of non-nodular mucosa. 
However when pepsinogen content, expressed as pepsinogen per gram of tissue, was 
compared the differences were lost. Thus the observed increase of tissue pepsinogen could 
simply reflect an overall increase in tissue mass, rather than an increase in the pepsinogen 
content of individual cells. However changes in the pepsinogen content of individual cells 
were observed immunohistochemically. Hyperplastic mucous cells within the nodules 
formed an expanded population of pepsinogen-producing cells, but judging by relative 
staining intensities these cells produced less pepsinogen individually than would normal 
chief cells. At the same time mature chief cells became less demonstrable within nodules. 
Both these effects were mirrored by similar changes in the ‘normal’ mucosal areas in some 
animals (such as 02, Y27 and Y166), but to a lesser extent. These findings are similar to the 
observations of Stringfellow and Madden (1981) who reported the depletion of chief cell 
granules following single experimental infections. There is some evidence to suggest that 
prolonged stimulation of pepsinogen release may not involve granule formation (see section 
4.1), and the findings of the present studies could suggest hypersecretion of pepsinogen. The 
actual secretory rates of pepsinogen by mucosae and the peptic activities of the gastric 
contents of individual animals were not assessed, so it is not possible to confirm this 
hypothesis. However the assumption of Stringfellow and Madden (1981), on the basis of the 
appearance of chief cells, that pepsinogen production ceased in infected animals, ignored the 
potential reserve of pepsinogen producing cells that clearly exists within the abomasum.
At the time of necropsy the most severe lesions were in the mucosa of sheep Y27. The 
severity of the pathology in the abomasum of Y27, with generalised hyperplasia and 
subjectively lower parietal cell numbers, was not reflected in clinical illness, and all twenty 
six animals in this study were passing well-formed faeces at the time of necropsy. Severe 
abomasal pathology has been associated with type II disease in cattle (Snider et al, 1983), as 
waves of larvae develop, but although the numbers of L4 in Y27 indicated the existence of an 
inhibited population, they were not greater than L4 numbers present in other sheep.
Two unusual features were seen in tissues from this group of animals. The first feature was 
very similar in appearance to the gastric cystica profunda that have been associated with
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Menetrier’s disease in humans (Van Kruiningen, 1977) and in the stomachs of transgenic 
mice overexpressing TGF-a (Takagi et al, 1992). It is thought that the hyperplasia occurring 
in the pits/glands o f the mucosa encourages the penetration of the muscularis mucosa. The 
muscularis must presumably need to be weakened for this to happen and in the example in 
this study the penetration of the muscularis by the inflammatory infiltrate might have been a 
pre-disposing lesion. The muscularis was also disrupted in association with the second 
unusual feature observed, but here the overlying mucosal lesion was destructive, not 
hyperplastic. The degeneration of chief cells in normal animals is thought to occur by 
necrosis and apoptosis (Karam and Leblond, 1993c). Necrotic chief cells are lost to the 
glandular lumen whereas those undergoing apoptosis are phagocytosed by other chief cells 
or by macrophages that invade the gland from the lamina propria. The pepsinogen-positive 
cells seen in the lamina propria and sub-mucosa in the mucosal lesion could be macrophages 
clearing up the tissue destruction in the epithelium then migrating back to the vascular 
systems. Destructive tissue lesions were uncommon in this study, most lesions were clearly 
hyperplastic, and this may account for the absence of similar cells in other sections and in 
other animals.
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8: THE EFFECTS OF INFECTIONS OF SHEEP WITH HAEMONCHUS 
CONTORTUSON  THE DISTRIBUTION OF TISSUE PEPSINOGEN.
8.1: Introduction.
Haemonchus spp. parasites have a widespread distribution, but are more important as 
parasites of ruminant livestock in tropical and sub-tropical regions (Allonby, 1973). The 
pathology of haemonchosis in cattle and sheep has not been researched as extensively as that 
of ostertagiasis. The life cycle for Haemonchus spp. was first described by Ransom (1906), 
and was followed by a report detailing the precise morphology of the different 
developmental stages (Veglia, 1915). Like Ostertagia spp. the life cycle of Haemonchus spp. 
is direct, with development from ingested L3 to adults taking place within the confines of the 
abomasum. Haemonchus larvae penetrate the gastric pits and undergo the moult to the 
fourth-larval stage. It is at this point, 48 to 60 hours after ingestion, that they leave the glands 
to become ambulatory on the mucosal surface (Veglia, 1915; Silverman and Patterson, 1960; 
Christie et al, 1967; Nicholls et al, 1985), thus the pathology of haemonchosis does not 
remain as focal as that of ostertagiasis. The moult to the fifth-larval stage occurs 10 days 
after initial infection (Veglia, 1915), and from this point the behaviour of Haemonchus spp. 
worms further differs from that of Ostertagia spp. The fifth-larval and adult stages of 
Haemonchus spp. possess a buccal lancet, that is used to penetrate mucosal blood vessels, 
allowing the worms to feed on the resulting haemorrhage. Females are prolific egg layers, 
eggs appearing after two to three weeks. Egg laying has been correlated to blood-feeding 
(Dargie, 1973) and severe blood loss may arise along with the onset of egg production 
(Whitlock, 1966).
Three clinical syndromes of ovine haemonchosis are recognised (Allonby, 1973). 
Hyperacute haemonchosis, characterised by low morbidity, has been associated with massive 
larval challenge and the simultaneous development of blood feeding stages. Up to 35,000 
worms may be responsible for a severe haemorrhagic gastritis and a rapidly fatal severe 
anaemia and sudden death. The acute disease syndrome has been associated with smaller 
numbers of worms (up to ten thousand), a mixed population of different worm stages and a 
lower grade, but persistent, anaemia and hypoproteinaemia. Animals with acute disease may
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show generalised oedema and ‘bottle-jaw’ (marked submandibular oedema). Animals may 
be lethargic, and in poor bodily condition, with wool loss. Agalactia may cause problems for 
suckling lambs. Untreated the condition is likely to prove fatal. In chronic haemonchosis 
smaller worm numbers (perhaps only a thousand) have been associated with chronic, low 
grade blood loss and abomasal dysfunction, leading to lethargy, marked weight loss and 
general poor performance. Anaemia and oedema may not be clinically apparent. The 
abomasal lesions may include severe and generalised hyperplasia and mucous-cell 
metaplasia. The outcome for affected animals may become particularly grave if subjected to 
drought conditions on poor pasture.
The presence of larvae within fundic gastric glands in the first hours of infections was 
associated with small nodules, 1 to 2 millimetres across (Charleston, 1965), generally with a 
central depression lying over the parasite-occupied gland. The edges of the nodules 
displayed mucous cell hyperplasia histologically. Nodules diminished by 6 days after a 
single infection, but from this time on the whole mucosa began to be thicker due to a 
generalised hyperplasia. Hyperplasia was of the foveolar compartment, with little effect on 
the glands themselves. In the studies of Hunter and MacKenzie (1982), following a single 
experimental infection, mucosal depth reached a maximum of close to twice normal, after 
the twelfth day of infection, and subsequently declined, but remained greater than normal at 
least until the thirty-fifth day. Generalised hyperplasia was associated with later larval and 
adult stages moving in and out of the mucosa, and with the onset of blood-feeding after 
approximately the tenth day of infection. The damage caused by later worm stages included 
the disruption of the epithelium at feeding sites and the appearance of honey-comb cells due 
to the loss of the contents of mucous cells on the mucosal surface. The presence of the 
parasites has been shown to provoke typical inflammatory responses involving eosinophils, 
mast cells and globule leukocytes, and lymphocytes (Salman and Duncan, 1984).
Abomasal function can be severely affected by haemonchosis. Doses of one million infective 
larvae resulted in elevated abomasal pH by the third day of infection (Christie et al, 1967). 
The mean abomasal pH of infected lambs rose to 5.5 by the third day of infection in the 
studies of Mapes and Coop (1970), after an identical dose of larvae, and the abomasal pH of 
lambs was still elevated after 19 days of infection. Mapes and Coop (1970) also 
demonstrated a rise in plasma pepsinogen concentration concomitant with the elevation in 
pH. Plasma pepsinogen concentrations returned to normal levels by the nineteenth day of
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infection. Elevations of plasma gastrin have been demonstrated in groups of sheep given 
either fifty thousand or a million larvae (Nicholls et al, 1985), whereas abomasal pH only 
rose in those given the larger larval dose. The timing of the pH rise was similar to that found 
in other studies, with the pH rising, to 6.5, by day three o f infection.
Plasma pepsinogen becomes elevated in both haemonchosis and ostertagiasis. Mucous cell 
hyperplasia is also a feature common to both infections, being generalised in haemonchosis 
after the decline of the initial hyperplastic nodules, but remaining focal for much longer in 
ostertagiasis as worms remain within the gastric glands for a longer period. Therefore, the 
following immunohistological and biochemical studies were designed to establish whether 
changes in abomasal cell populations (chief and mucous cells) associated with experimental 
Haemonchus contortus infection would affect the distribution of tissue pepsinogen, and 
whether infections were associated with an overall increase or decline in mucosal pepsinogen 
content. Experimental haemonchosis was studied in Hampshire Down lambs, a breed 
considered to be relatively parasite-susceptible (Loggins et al, 1965; Preston and Allonby, 
1979). These animals were part of a larger study into the influence of nutrition and dietary 
protein/Nitrogen supplementation on the resistance of sheep to haemonchosis, carried out in 
collaboration with the Department of Veterinary Clinical Studies at Glasgow University 
Veterinary School. Two studies were performed over consecutive years. Tissues were 
obtained from animals killed in the first study to initially assess the histological and 
immunohistochemical changes due to haemonchosis.
8.2: Initial investigations of ovine haemonchosis.
8.2.1: Materials and methods.
8.2.1.1: Animals and experimental design.
Twenty four, five month old, Hampshire Down lambs, that had been reared in helminth-free 
conditions were allocated into four groups (two groups of four, two of eight) by stratified 
random sampling, according to body weight, haemoglobin type and sex. Lambs were fed one 
of two diets which differed in protein content, a basal diet (BD) containing 98g crude protein 
(CP) per kilogram of dry matter (DM), and a soyabean meal supplemented diet (SD) 
containing 173g CP/ kg DM (Wallace et al, 1995). The experimental design was such that
182
half of the lambs received the basal diet, the other half the supplemented diet. Of the twelve 
lambs in each dietary group, eight were infected with larvae of H. contortus (BDI and SDI 
groups). The others remained as uninfected controls (BDC and SDC groups). Two weeks 
after the lambs had been on the diets, animals (BDI and SDI groups) were given an initial 
infecting dose of 100 H. contortus third stage larvae per kilogram of body weight, and then a 
trickle infection regime of 200 L3 three times a week (i.e. a total of 600 per week) for 10 
weeks. All animals were housed on slatted floors and initially fed 1.4 kg fresh matter of the 
allocated diets divided into two equal daily feeds. The amount of food was increased 
fortnightly to maintain the same rate of feeding per kilogram body weight. The infective 
larvae were obtained from the Moredun Institute (Edinburgh, Scotland) and were inoculated 
into the lambs orally. All lambs were killed at the end of the ten week trickle infection 
period.
8.2.1.2: Procedure at, and subsequent to, necropsy.
Lambs were killed by exsanguination following electrical stunning. Blood was collected, as 
the sheep were bled out, into heparinised containers which were later centrifuged at 2,000 g 
in a Beckman GS-6R centrifuge for 10 minutes, plasma was separated and then stored at 
-20°C. Blood was also collected for haematological examination, into evacuated glass tubes 
containing ethylenediamine tetra-acetic acid (EDTA). Faeces was collected from the rectum 
of each animal to allow the determination of faecal egg counts (Gordon and Whitlock, 
1939)(see section 7.4.1). Abomasa were opened along the greater curvature and their 
contents were collected and the mucosa gently washed and then one half o f the mucosa was 
scraped. Worm burdens were determined using standard parasitological techniques (Armour 
et al, 1966)(see section 7.4.1). Mucosal tissue was taken from single sites of the fundus of 
the remaining half of the abomasum and placed in Brunnel’s fixative for routine histology, 
and for pepsinogen immunohistochemistry (see section 7.2) Negative immunostaining 
controls included sections prepared omitting the primary, anti-pepsinogen antiserum, and 
those prepared with the substitution of the primary antiserum by non-immune rabbit serum. 
Total plasma protein and albumin were measured by continuous flow analysis (Standard 
Technicon Auto Analyser II). Plasma pepsinogen was assayed using Paynter’s method 
(1992). Packed cell volumes were measured by microhaematocrit centrifugation.
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Faecal egg counts at necropsy, for infected animals on the basal and supplemented diets were 
compared using a two-sample T-test. Total worm burdens were similarly compared with 
two-sample T-tests. All T-tests were preceded by Bartlett’s test for homogeneity of variance. 
Data for total worm burdens were transformed by taking log10 (worm numbers + 1). Packed 
cell volumes, and the concentrations of total plasma protein, plasma albumin and plasma 
pepsinogen were compared by analyses of variance using general linear models. The model 
fitted was test parameter = diet + infection + diet*infection. When the interactive term, 
diet*infection, showed significance, F-statistics for diet and infection were calculated, 
using sequential sums of squares, with the interactive term as the denominator for the F-test, 
instead of the error term.
8.2.2: Results.
The total worm burdens, numbers of L4, L5, adult male and female worms, and faecal egg 
counts (mean values (± S.E.) for the four groups, BDI, BDC, SDI and SDC) are shown in 
Table 8.1 (full data is recorded in Appendix 20). The worms present in the BDC group were 
due to one individual animal (number 24) that had 200 adult males and 100 adult female 
worms at necropsy. The positive faecal egg count of the SDC group was due to two animals 
that had 100 (animal 15) and 50 (animal 30) strongyle eggs per gram. Mean (± S.E.) packed 
cell volumes, total proteins, plasma albumins, and plasma pepsinogen concentrations for all 
four groups are shown in Table 8.2 (full data is recorded in Appendix 21). Total worm 
burdens of both infected groups were not significantly different (p=0.85). Faecal egg counts 
were however significantly less in animals fed the supplemented diet (p<0.02). Plasma 
pepsinogen concentrations were significantly greater in infected animals (p<0.02) and there 
was no effect o f diet (p>0.50). Packed cell volumes were similar in both control groups, and 
lower in infected animals, with the greatest drop in PCV recorded in the BDI group. For the 
analysis of variance for packed cell volumes the interactive term was significant (p<0.05), 
but the corrected F-statistics for diet and infection were not significant (p=0.36 and 0.28 
respectively). Total plasma protein and albumin concentrations were affected by both diet 
and infection. Both were generally lower in animals fed the basal diet (p<0.01 and 0.001 for 
total protein and albumin respectively) and both parameters were reduced by infection 
(p<0.01 for both); the lowest values were recorded in animals of the BDI group. The 
interactive terms for both parameters were not significant (p>0.05).
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Table 8.2: Mean (± S.E.) values for haematological and biochemical parameters of the 
groups of Hampshire Down lambs.
Group
PCV 
(per cent)
Total Protein 
(g/L)
Albumin
(g/L)
Plasma Peps. 
(iU)
BDC 30 (0.70) 60 (1.80) 29 (0.70) 1.40(1.10)
BDI 23 (1.10) 51 (1.60) 24(1.20) 6.60(1.30)
SDC 30(1.00) 64 (0.90) 32 (0.50) 3.20(1.40)
SDI 28 (0.70) 59 (1.70) 30 (070) 6.40(1.40)
8.2.2.1: Gross pathology.
Abomasa from control animals were grossly normal. Haemorrhage and oedema were not 
observed in any of the abomasa from the infected Hampshire’s. Changes were confined to an 
apparent increase in the thickness of mucosal folds in infected animals. When the mucosae 
were cut, the increase in mucosal fold thickness was apparent and could be seen to be due to 
increases in mucosal thickness and not an increase in sub-mucosal structures.
8.2.2.2: Histology.
The fundic mucosae of all control animals, examined in H&E stained sections, appeared 
normal. The pits were short and lined by surface mucous cells containing moderate amounts 
of mucus. The epithelium was continuous across the mucosal surface. Pits were seldom 
greater than one fifth to one quarter o f the total depth of the mucosa. Pits were also quite 
wide. There appeared to be fewer pits than there were glands, with each pit associated with 
two or three glands at its base. All epithelial cells appeared normal. The height of the glands 
did seem to vary between animals and this factor appeared to be the greatest predictor of 
overall mucosal depth in the control animals. Mitotic figures were rare, as were cells of the 
inflammatory and immune systems. Globule leukocytes were not seen.
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The changes detected in infected animals appeared similar in the two dietary groups, with the 
mucosae from infected animals appearing to be substantially thicker. There was also 
disruption and loss of surface epithelial elements. Increased mucosal depth was 
predominantly due to mucous cell hyperplasia at the mid-point of the depth o f the mucosa. In 
PAS stained sections there was increased staining for mucins apparent in some animals at 
mid-levels of the mucosa (Fig. 8.1), with slight hypertrophy of the hyperplastic cells. Parietal 
cells were either spread thinly within this level, or were confined to deeper gland areas. 
Parietal cell numbers were not quantified in this study, but did not appear greatly affected in 
most instances. Pits became narrower and more tightly packed in the superficial mucosa, so 
that pit/gland junctions were no longer distinct, and there was an apparent increase in the 
number of pits and the pit/gland unit became very straight and tubular. In some animals there 
was a slight increase in size of the zymogenic unit (the most basal gland portion where chief 
cells usually are the most numerous cells), due to an apparent chief cell hyperplasia. These 
changes were most marked in the thickest tissue section examined, that from animal 17 (Fig. 
8.2). Chief cells generally did not appear abnormal in the tissue from animal 17 however 
there was also an extensive area of foveolar hyperplasia and complete gland atrophy, with 
chief and parietal cells being completely replaced by metaplastic mucous cells. Examination 
of the tissue from this animal stained with PAS revealed that cells deep within this lesion 
were full of mucins (Fig. 8.3), even cells immediately adjacent to the muscularis.
Inflammatory cell infiltrates present within mucosae were generalised, with many 
lymphocytes and plasma cells. Eosinophils were seen much less frequently. Globule 
leukocytes were present in massive numbers in some animals, situated intraepithelially, and 
they often accumulated focally in large numbers. Globule leukocytes appeared to be present 
in more animals and in greater numbers in the supplemented diet group, but these differences 
were not quantified.
8.2.2.3: Immunohistochemical studies.
Pepsinogen-specific staining was strongest in chief cells in control animal fundus (Fig. 8.4), 
and the staining pattern was identical to those of other parasite-naive sheep previously 
reported (see section 7.2). The apparent pepsinogen content of mucous neck cells was more 
variable, but they generally stained less than chief cells. One animal, no. 22 (BDC group)
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had very little pepsinogen-specific immunostaining present in any cell type, with only very 
small amounts present in chief cells (Fig. 8.5).
Several animals in both infected groups showed increases in the amount o f staining present 
in the hyperplastic population from the middle of the mucosa towards the surface (Fig. 8.6), 
these changes were generalised, being present in all pit/glands o f the mucosal section o f each 
affected animal. In contrast the quantity of staining present in chief cells at the base of some 
glands appeared reduced. A reduction in the pepsinogen content of basal gland cells was 
most marked within the central lesion in the tissue from animal 17 described earlier (Fig. 
8.7). Poorly staining cells at the base of glands corresponded to those that contained much 
PAS-positive material in other sections (Fig. 8.3). Changes did not appear to be influenced 
by diet.
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8.2.3: Discussion.
The presence of worms and eggs in control animals has not been explained, but might be the 
result of the accidental inoculation of an animal with larvae, or the contamination of samples 
occurring after necropsy.
Infections remained subclinical throughout the whole experiment, however faecal egg counts 
were significantly lower in animals given the supplementary ration, in contrast the numbers 
of worms present in infected animals was unaffected by diet. The presence of a small worm 
population in one animal o f the BDC group (animal 24) and of low faecal egg counts in two 
animals o f the SDC group (animals 15 and 30), have not been explained. Dietary 
supplementation reduced the magnitude of some pathophysiological reactions. Plasma total 
protein and plasma albumin concentrations were higher in infected animals fed the 
supplemented diet, and part o f this effect could be explained by the higher concentrations 
found in control animals fed the same diet. Dietary protein supplementation may have 
enhanced immune responses against the parasites as adult female worms were shorter and 
contained fewer eggs in the supplemented sheep in comparison to the female worms present 
in animals fed the basal diet (Wallace et al, 1995). Plasma pepsinogen concentrations were 
increased in association with infection, but were unaffected by diet. The mean concentrations 
for both control groups (1.40 and 3.20 iU) were both below the 5.0 iU threshold established 
by Paynter (1992) as indicative of abomasal parasitism due to ostertagiasis. The means of 
both infected groups (6.60 and 6.40 iU) were above this figure and were compatible with 
moderate abomasal damage/dysfunction.
Infection resulted in fundic mucosal hyperplasia in animals fed both diets. Some tissues from 
infected animals were approximately twice as thick as those of control animals. Hyperplasia 
was not quantified, but did not appear to be affected by diet. Hyperplasia was predominantly 
of cells at the junction of the pits and glands, and as such parietal cell and chief cell numbers 
appeared little affected as both cells type were mainly confined to the base of glands. 
However in at least one animal hyperplasia was accompanied by total gland atrophy. This 
occurred in the animal with the greatest degree of apparent hyperplasia, and it is therefore 
possible that changes in this animal were more advanced.
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Infection in many animals resulted in an increase in the total number o f cells staining for 
pepsinogen. The hyperplastic cells stained less strongly for pepsinogen than chief cells, but 
the marked increases in their number could lead to increased mucosal content of pepsinogen, 
and could provide evidence of hypersecretion of pepsinogen occurring in infection. In the 
same animals the pepsinogen content of chief cells appeared reduced and this could also be 
evidence of hypersecretion, with pepsinogen being immediately secreted and not stored in 
granules. However the animal with the severest apparent hyperplasia also had an area where 
chief cells were entirely replaced by metaplastic mucus-producing cells, and the reduction in 
the pepsinogen staining o f chief cells could reflect less advanced changes in cell phenotype 
to become more like mucous-type cells.
8.3: Further studies on the effects of Haemonchus contortus on pepsinogen production 
in abomasal tissues.
In the previous study animals infected with H. contortus had thicker abomasal mucosae, due 
to mucous cell hyperplasia. Pepsinogen immunohistochemistry revealed that the expansion 
of mucous-type cells was associated with an overall increase in the number of cells staining 
for pepsinogen. In contrast the pepsinogen content of some chief cells appeared reduced. 
However abomasal changes had been assessed only in single sections of fundus from each 
animal. The abomasal production of pepsinogen was therefore investigated further in a 
subsequent study of haemonchosis in Hampshire Down lambs, to assess whether previous 
histological and immunohistochemical findings were repeatable and quantifiable, whether 
changes affected the whole of the fundic mucosa, and whether the changes in the pattern of 
staining for pepsinogen were reflected in increases in the total tissue content of pepsinogen 
measured biochemically. Animals were again given one of two diets, a basal ration and a 
urea-, non-protein Nitrogen-supplemented ration, and some animals received a trickle 
infection of H. contortus infective, third stage larvae.
8.3.1:Materials and methods.
8.3.1.1: Animals and experimental design.
Twenty four, four month old Hampshire Down lambs were allocated into four groups as in 
the previous study (BDC, BDI, SDC and SDI groups, see section 8.2.1), and given either a
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basal ration (88 g CP/ kg DM) or a urea supplemented diet (149 g CP/ kg DM). Feeding was 
initially at 1.4 kg fresh matter per day of the allocated diet, and feeding was increased at 
fortnightly intervals to maintain the same rate of feeding per kilogram of liveweight. The 
four lambs in both BDC and SDC groups remained uninfected, whereas after two weeks on 
the diets, those in the BDI and SDI groups (8 animals per group) received an identical trickle 
infection of H. contortus third stage larvae as had the lambs in the previous study (section 
8.2.1), the trickle infection was given over the course of ten weeks, at the end of which all 
lambs were killed.
8.3.1.2: Procedure at, and subsequent to, necropsy.
Lambs were killed by exsanguination following electrical stunning. Faeces, whole blood and 
plasma were collected as outlined in section 8.2.1. Abomasal contents and washings were 
collected and one half o f the abomasum was then prepared for the digest method to estimate 
the numbers of tissue dwelling larval stages. Fundic mucosal tissue samples were taken from 
the other abomasal half, using the biopsy punch (see section 7.3.1). Ten tissues were taken 
from the mucosal folds of each animal in a random pattern, five were immediately immersed 
in Brunners fixative, the other five were added to 10 ml plastic tubes and refrigerated (0- 
4°C) until they were later weighed and then homogenised to allow estimation of tissue 
pepsinogen concentration (section 2.3). Faecal egg counts, and worm burdens were 
ascertained using the procedures outlined in section 7.4.1. Blood biochemistry and 
haematological parameters were ascertained as described in section 8.2.1. Plasma pepsinogen 
concentration was measured using Paynter’s method (1992).
8.3.1.3: Immunohistochemistry and computer-aided image analysis.
In addition to routine histological staining (H&E), the five fundic tissues were stained using 
the immunohistochemical procedures outlined in section 7.2.1. Stained sections were 
prepared with or without Haematoxylin counterstain. Negative controls included sections 
prepared omitting the primary, anti-pepsinogen antiserum, and those prepared with the 
substitution of the primary antiserum by non-immune rabbit serum. Those sections that were 
not counterstained were used in computer-aided image analysis in an attempt to quantify the 
amount and distribution o f pepsinogen-specific staining within mucosae.
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Image analysis was performed using the NIH Image (version 1.52) software package 
(National Institutes of Health, Research Services Branch, U.S.A.) and a Sony CCD video 
camera module (model XC-77CE) linked to an Olympus BH2 light microscope. The system 
utilised a captured monochrome image of each mucosal section and would therefore not 
distinguish between pepsinogen-specific diaminobenzidine (DAB) staining and the 
Haematoxylin counterstain, which was therefore omitted. Using a constant illumination 
setting and a constant magnification (xlO objective) the image of each mucosal section was 
projected onto the computer’s television monitor. Pepsinogen-specific immunoreactivity was 
then measured using a standard plot size of 400 by 550 screen pixels. With the mucosa 
running from the top of the screen to the bottom, with the gland bases on the left and the 
luminal surface on the right, the plot was placed on the mucosal image so that the base of the 
plot was adjacent to the base of mucosal glands, in an area where gland bases were at 
equivalent depths in the mucosa, and the glands were seen in longitudinal section. The long 
side of the plot (550 pixels) was sufficient to encompass the total mucosal depth of all 
animals, from base to luminal surface. The width of the plot (400 pixels) was sufficient to 
allow approximately twenty adjacent glands to be scanned (see Fig. 8.8). The computer was 
then able to generate a plot profile that was in essence the average pixel densities of vertical 
columns of four hundred pixels at 550 points along the length of the scan. The data was then 
stored in numerical format in Minitab. Because of the apparent uniformity of the staining 
pattern across the whole of each mucosal cut, a single scan was performed for each of the 
five tissue sections and therefore the overall results represent approximately one hundred 
glands.
To allow easier data handling the 550 separate data points from each scan were condensed to 
55 by taking the mean of every ten consecutive values. Then an overall mean value of the 5 
scans from each animal was obtained. The background pixel density, i.e. the pixel density of 
non-stained areas, was subtracted, and from this data an “area under the curve” (AUC) for 
each animal was calculated by the summation of all data points, that therefore represented 
the total pepsinogen-specific immunoreactivity. Also calculated was the maximal staining 
intensity per animal (Imax), and its position in terms of depth of the mucosa (Pmax)(see Fig. 
8 .8).
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Fig. 8.8: Schematic representation of the method used in the image analysis of 
pepsinogen im m unostaining in fundic mucosal sections, and the forms of results 
obtained.
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8.3.1.4: Statistical analyses.
Faecal egg counts at necropsy, for infected animals on the basal and supplemented diets were 
compared using a two-sample T-test. Total worm burdens were similarly compared with a 
two-sample T-test. All T-tests were preceded by Bartlett’s test for homogeneity of variance. 
Packed cell volumes, and the concentrations of total plasma protein, plasma albumin and 
plasma pepsinogen for individual animals were compared using analyses of variance, using 
general linear models. The model fitted was test parameter = diet + infection + 
diet*infection. When the interactive term, diet*infection, showed significance, F-statistics 
for diet and infection were calculated with the interactive term as the denominator for the F- 
test. Tissue wet weights, tissue pepsinogen concentrations (both iU/area and iU/g), AUC’s, 
Imax and Pmax values were compared by a general linear model analysis of variance, using 
the same model. Because tissue pepsinogen concentration, measured as peptic units per 
mucosal area, and AUC values for the quantity o f immunostaining, were essentially 
measures of the same thing, the two parameters were compared using a Pearson product 
moment correlation. The full image analysis data consisting of all data positions per animal 
were analysed with a multivariate mixed model analysis o f variance using a general linear 
model. The model fitted was staining intensity, positions 1 to 42 = diet + infection + 
diet*infection. This analysis compared staining intensities at each position o f the mucosa 
amongst the four groups, from the deepest (position 1) to the most superficial (position 42). 
Position 42 was the highest positive recorded value for any animal (see Appendices 25A to 
D).
8.3.2: Results.
Mean, total worm burdens, and the numbers of different parasite stages, as well as mean 
faecal egg counts, for each group are given in Table 8.3 (full data is shown in Appendix 22). 
Despite a lower mean faecal egg count in supplemented animals, the difference was not 
significant, by a two-sample T-test (p=0.21). Similarly total worm burdens in the two groups 
of infected animals were not significantly different (p=0.90). Mean (± S.E.) packed cell 
volumes, total protein, plasma albumin, and plasma pepsinogen concentrations for all four 
groups are shown in Table 8.4 (Full data is recorded in Appendix 23). Packed cell volumes 
were significantly lowered by infection (p<0.001), but were not affected by diet (p=0.17). 
Similarly total plasma proteins were reduced by infection (p<0.02), and were also unaffected
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by diet (p=0.14). Albumin levels were affected by both diet (p<0.01) and infection status 
(p<0.001) with lowest values recorded in infected animals on the basal ration. Despite 
increases of plasma pepsinogen concentration in infected animals, the effect of infection was 
only of borderline significance (p=0.061), the effects of diet and of the interactive term were 
not significant (p=0.648 and 0.405 respectively).
Gross pathological changes, as in the previous study, were not readily discerned within 
abomasa or within the carcasses of any animal. On routine histological examination changes 
were confined to mucosal hyperplasia in a similar pattern as reported in the previous study 
(see section 8.2.2), and the presence of typical chronic inflammatory infiltrates. Hyperplasia 
did not appear as marked as in the previous study, and no tissue examined appeared to 
feature any significant parietal cell loss, although parietal cells were not quantified.
8.3.2.1: Tissue pepsinogen concentrations.
Mean group values for tissue wet weights and tissue pepsinogen concentrations are given in 
Table 8.5 (full data is shown in Appendices 24A, B and C). Tissues from infected animals 
were significantly heavier (p<0.02), and this change was unaffected by diet (p=0.11). The 
highest overall mean tissue pepsinogen concentrations (measured as iU/area and as iU/g) 
were recorded in the sheep of the SDC group, and were lowest in the infected animals on the 
same diet (SDI). In contrast the infected animals on the basal diet (BDI) had more 
pepsinogen than the control animals (BDC). This lack of parallelism in the pattern of effects 
is mirrored in the results for the analysis of variance. For tissue pepsinogen, as iU per 
mucosal area and as iU per gram of tissue, the interactive term (diet*infection) was either of 
borderline significance (p=0.068)(for iU/area data) or was significant (p<0.02)(for iU/g 
data), and following corrected F-tests, the effects of both diet and infection on their own 
were not significant. Individual variation between sheep was very great, values ranged from 
a mean (± S.E.) tissue pepsinogen of 172 (100) iU/area for one animal (SDI group) to 10,798 
(744) iU/area for another (SDC).
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Table 8.4: Mean (± S.E.) values for haematological and biochemical parameters of the 
groups of Hampshire Down lambs. Second Study.
Group
PCV
(per cent)
Total Protein
(g/L)
Albumin
(g/L)
Plasma Peps. 
(iU)
BDC 33 (1.14) 65 (1.60) 23 (0.85) 1.84 (0.81)
BDI 24(1.06) 55 (2.46) 18(0.61) 4.08 (0.40)
SDC 33 (1.20) 68 (1.63) 25 (1.25) 2.14(0.40)
SDI 27 (0.90) 58 (1.36) 21 (0.74) 3.04 (0.92)
Table 8.5: Mean (± S.E.) wet weights and tissue pepsinogen concentrations (expressed 
as iU per standard area and as iU per gram of wet weight of tissue) of the Hampshire 
Down lambs.
Group
Wet weight 
(g)
Tissue pepsinogen 
(iU/area)
concentration
(iU/g)
BDC 0.0907 (0.0055) 4,179 (2,345) 42,732 (23,056)
BDI 0.1000 (0.0032) 5,207 (517) 51,719(4,402)
SDC 0.0784 (0.0011) 6,733 (1,362) 86,748 (18,039)
SDI 0.0958 (0.0054) 3,289(851) 31,977 (7,231)
8.3.2.2: Immunohistochemistry and image analysis.
Pepsinogen-specific immunoreactivity in control animals was similar to that reported for 
control animals in the previous study (section 8.2.2.3). The chief cells were the major site of 
staining and were characterised by the presence of large, dense granules packed within the 
apical cytoplasm (Fig. 8.9b). Lesser amounts could be detected within narrow populations of 
mucous neck cells. The changes seen in infected animals were similar to those of the 
previous study, but did not appear as marked, and although many animals featured an 
expanded population of cells staining for pepsinogen at a mid-mucosal level, staining was 
rarely continuous in cells to the luminal surface. The apparent repeatability of
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immunostaining, both in the quantity and in the pattern of distribution, throughout the five 
mucosal sections from each animal, for both infected and control animals, was good. Chief 
cell content in some infected animals appeared lowered, and this was most obvious in cells 
from the animal with the overall greatest increase in mucosal mass, animal number 35 (Fig. 
8.9d). Chief cells in this animal in H&E-stained sections, had paler basal cytoplasm than 
normal, with an even paler perinuclear area, and the eosinophilia of their apical cytoplasm 
was restricted (Fig. 8.9c). As reported in section 8.3.2.1, the quantity of tissue pepsinogen 
varied widely between animals, and this was appreciable in the immunohistochemical 
studies. The quantity o f granules packing the apical cytoplasm of chief cells appeared to be 
the determining factor, and was offset against changes in the hyperplastic mucous cell layer 
in infected animals. Indeed the two animals with the lowest tissue pepsinogen 
concentrations, animals 15 (SDI) and 19 (BDC), with tissue pepsinogen values of 172 (100) 
iU/area and 312 (37) iU/area respectively, both had negligible immunostaining at any level 
of their mucosae (Figs. 8.9f and h). However in H&E-stained sections the chief cells of both 
animals could be seen to contain characteristic eosinophilic granules (Figs. 8.9e and g), but 
these were much less evident in the control animal (number 19).
Quantitative differences in the amount of pepsinogen-specific staining and its distribution 
were investigated using image analysis. The overall mean plot profiles for each animal are 
shown in Figs. 8.10a to d (full data is shown in Appendices 25A to D). The pattern of 
immunostaining in control animals appeared uniform, apart from animal number 19, with the 
greatest staining intensities recorded in the deepest parts of the mucosa, which would 
correspond to the chief cell population. Towards the middle of the mucosa reduced staining 
intensities correspond most likely to mucous neck cells. Greater individual staining 
intensities were recorded in the SDC group (Fig. 8.10b) in comparison to the BDC group, 
and this does agree with the results of the peptic activities of mucosal homogenates. Staining 
intensities were distributed in wider patterns in many infected animals, although some were 
similar to control animal patterns. When overall means for infected and control animals were 
plotted against each other (ignoring diet), the major difference was a much slower decline in 
staining intensity as the mucosa of infected animals was ascended (Fig. 8.11)(full data in 
Appendix 26). In the multivariate analysis of staining intensity in relation to mucosal 
position the following results were obtained (see Appendix 27). At position 1 (mucosal base) 
the interactive term (diet*infection) was significant (p<0.05), but was of borderline 
significance by position 2 (0.05<p<0.10) and was not significant by position 3 (p>0.10). The
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effect of infection became of borderline significance by position 16, and was fully significant 
by position 21 and remained so for many of the other positions.
The mean results for AUC’s, Imax and Pmax for each of the four groups are shown in Table 
8.6 (full data is shown in Appendix 28). The correlation of individual AUC and total tissue 
pepsinogen (iU/area) was positive, but poor (0.200), however certain features were 
consistent. Values for individual AUC’s varied widely (from 0.55 to 9.64) and the lowest 
values, 0.55 and 0.65, as a consequence of negligible detectable immunostaining, were found 
in the two animals with the lowest values of tissue pepsinogen concentration, animals 15 and 
19.
Analysis of variance of the AUC data showed that this parameter was not significantly 
affected by either diet or infection (p>0.05) and that the interactive term was also not 
significant. Similar analyses for Imax and Pmax values data produced identical results.
Table 8.6: Group mean values (± S.E.) for AUC, Imax and Pmax obtained following image 
analysis. Units are arbitrary, but relate ultimately to the pixel density of the scanned images.
Group AUC ^max pA max
BDC 2.49 (0.72) 11.50 (3.28) 5.00 (1.68)
BDI 4.71 (0.98) 14.01 (2.09) 5.87 (1.66)
SDC 4.21 (0.64) 19.10(2.94) 3.25 (0.63)
SDI 4.52 (0.69) 13.90 (2.05) 7.62 (1.88)
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Fig. 8.9: Com parison of the histological appearance of chief cells, in H&E stained 
sections (a,c,e and g) and following pepsinogen immunohistochemistry (b,d,f and h), from a 
control animal (a and b), an infected animal (c and d) and in two animals with negligible 
immunoreactivity, animal 15 (e and f) and animal 19 (g and h).
Ajisuap iaxid
^jisuap jaxid
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8.3.3: Discussion.
Despite slightly higher worm burdens at the end of the trickle infection period in the present 
study, faecal egg counts at necropsy were generally not as high as in the previous year's 
study. Further, the affect of dietary non-protein Nitrogen-supplementation on the fecundity 
o f female worms was not as marked in the latter infection series as it was in the former. 
Plasma pepsinogen concentrations were increased in response to infection, but to a much 
lower extent than in the previous study. Packed cell volumes, plasma total protein and 
plasma albumin concentrations were affected by the presence of infection, but only the 
reductions in plasma albumin concentrations due to infection were significantly ameliorated 
by feeding the supplementary ration.
The differences of the extent of mucosal hyperplasia and of the histopathological and 
immunohistochemical changes between the two studies have not been directly compared, but 
the overall impression was that changes were not as marked in the second infection series. 
The mucosal tissues o f infected animals were significantly heavier, and this was seen to be 
due primarily to hyperplasia of mucous cells occurring at a mid-mucosal level. The 
hyperplastic mucous cells contained pepsinogen, and potentially represented an increase in 
the total number o f cells in the fundus which were capable of secreting pepsinogen. This 
might be expected to have led to an increase in the total mucosal content o f the zymogen, yet 
total tissue pepsinogen concentrations and the overall values of AUC’s calculated from 
measurements of staining intensity were not significantly increased by infection. It was 
considered that in infected animals the pepsinogen content o f chief cells might be reduced, 
and indeed the values for the Imax data, comparing the maximal staining intensity of any one 
level of mucosa and invariably corresponding to the position of the chief cell population, 
were lower for infected animals, but any difference was not significant. Increases in the 
number of cells producing the zymogen might therefore be offset by the reduction of chief 
cell pepsinogen content.
The influence of diet has been less thoroughly illuminated. Comparing only control animals 
dietary Nitrogen supplementation might have increased the demands for peptic digestion and 
this might explain the increased pepsinogen content of control animals fed the supplemented 
ration. Any increases related mostly to the enhanced pepsinogen content o f chief cells.
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Studies of the effects of infection and diet were hampered by the very high degree of 
variation shown by individual animals and it may be that some of the above results had more 
to do with the random assortment of widely different animals than with any real effects of 
diet or infection. To assess the affect of diet more completely, a larger number of uninfected 
animals could be used to overcome the high degree of variation between animals. This might 
also better elucidate the significance of animals that seem to produce very little pepsinogen. 
Abomasal secretion is effectively continuous and the relative absence of pepsinogen from the 
mucosa of some animals is therefore unlikely to result from factors such as differences from 
the time of death to an event such as feeding, but should represent real differences between 
animals in their production of the zymogen. Two animals in the present study had little tissue 
pepsinogen, one was infected, the other was a control animal, one was fed the supplemented 
ration, one the basal diet. There was good agreement between the results for the tissue 
pepsinogen content measured as both the peptic activity present in mucosal homogenates and 
as the quantity of immunostaining. This can be taken as further evidence of the specificity of 
the immunohistochemical techniques employed. Both animals also had low plasma 
pepsinogen concentrations. The biological significance of low tissue pepsinogen is unknown. 
Pepsinogen is known to be of greater importance in the digestion of proteins of animal 
origin, such as collagen, than plant material and more important in animals where 
mastication is limited or absent (Hersey, 1987), and low expression of pepsinogen may 
therefore be no hindrance to herbivorous animals. This work has not examined the secretory 
rates o f the mucosae from these animals for pepsinogen. Pepsinogen secretion in these 
animals might bypass granule formation, yet in other animals a generalised cytoplasmic 
staining of basal cytoplasm implied that forms of pepsinogen are present in non-granular 
structures such as endoplasmic reticulum. Granules were not absent from the two animals 
with low mucosal pepsinogen concentrations, but stained poorly for pepsinogen. The exact 
content of such granules has not been examined.
Mucosal hyperplasia developed in animals by the end of the ten week trickle infection 
period. In other studies similar hyperplastic changes occurred by day twelve following a 
single experimental infection (Hunter and MacKenzie, 1982), and focal hyperplasia, 
associated with the initial larval occupation of the gastric glands, developed within days 
following a single larval inoculum (Charleston, 1965). Clearly the changes in the population 
of cells producing pepsinogen might have important implications for the development of 
increased plasma pepsinogen concentrations.
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EXPERIMENTAL STUDIES - PART 4: GROWTH FACTOR 
IMMUNOHISTOCHEMISTRY.
9: THE ROLE OF TRANSFORMING GROWTH FACTOR-ALPHA IN THE 
PATHOGENESIS OF OSTERTAGIASIS.
9.1: Introduction.
Epidermal Growth Factor (EGF) was identified as a protein present in the secretions of the 
submaxillary salivary gland of the male mouse capable of causing precocious eyelid opening 
and incisor eruption (Cohen, 1960, 1962; Cohen and Elliott, 1963). Part of its biological 
activity was shown to be due to the direct stimulation of the proliferation and keratinisation 
of epidermal tissue. The primary structure of the mature 53 amino acid form of mouse EGF 
was later elucidated by Savage et al (1972). Separately, urogastrone was identified as a 
substance present in the urine of pregnant women that had a beneficial effect on 
experimentally-induced gastric ulcers (Sandweiss et al, 1938) and which inhibited gastric 
acid secretion (Culmer et al, 1939). The structure of urogastrone was reported by Gregory 
(1975) and shown to be identical to the reported structure of human EGF (Cohen and 
Carpenter, 1975). The discovery of Transforming Growth Factor-alpha (TGF-a) led from the 
observation that sarcoma virus-transformed cells showed reduced binding of exogenous EGF 
(Todaro et al, 1976; Todaro and De Larco, 1978). Subsequent experiments showed that 
substances present in media conditioned by virally-transformed fibroblasts competed with 
EGF in binding to the Epidermal Growth Factor receptor (EGF-R)(De Larco and Todaro, 
1978). The observations that similar activities were produced by human tumour cells and by 
chemically transformed cells (Roberts et al, 1980; Todaro et al, 1980) confirmed that the 
substance was a product of cellular and not viral genes. The products of sarcoma virus- 
transformed cells were eventually separated into two subsets (Anzano et al, 1982, 1983), but 
only one component was shown to bind and act through EGF-R, and was identified as 
Transforming Growth Factor-alpha (Carpenter et al, 1983; Massague, 1983).
Epidermal Growth Factor and TGF-a have since been shown to be members of a large 
super-family of peptide growth factors that all bind to the Epidermal Growth Factor receptor.
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Individual members of this group share a signature sequence of 36 to 37 amino acids with 
the following consensus sequence: CX7CX2.3GXCX10CXCX3YXGXRCI (Lee et al, 1995). 
Disulphide bonds formed between the first and third, second and fourth, and fifth and sixth 
cysteines of the consensus sequence result in a compact three-loop structure that is essential 
for high affinity binding to EGF-R. Other mammalian representatives of the group include 
amphiregulin (Shoyab et al, 1988), heparin-binding EGF (Higashiyama et al, 1991), and 
betacellulin (Sasada et al, 1993; Shing et al, 1993).
Pox family viruses encode EGF-R ligands, such as Vaccinia Virus Growth Factor 
(VGF)(Blomquist et al, 1984; Brown et al, 1985; Stroobant et al, 1985). Expressed in 
infected cells in the early stages of infection, secreted VGF may facilitate pox virus infection 
by causing other non-infected host cells to proliferate (Buller et al, 1988). A further member 
of the EGF-R ligand family is the product of the lin-3 gene o f the free-living nematode 
Caenorhabditis elegans (Hill and Sternberg, 1992). The lin-3 gene product binds to the 
nematode EGF-R homologue let-23, and one of its roles is vulval development. The glp-1 
and lin-12 gene products of C. elegans contain numerous EGF-like sequences (Yochem and 
Greenwald, 1989), as does the Notch gene o f Drosophila, but none are likely to be ligands of 
EGF-R or its homologues.
The fully processed TGF-a peptide is fifty amino acids long and EGF and TGF-a share only 
30 per cent homology in amino acid sequence (Marquardt et al, 1984). The activities of 
highly purified recombinant TGF-a and EGF have been compared, but not always using the 
peptides from the same species. Based on studies comparing TGF-a and EGF from the same 
species Ebner and Derynck (1991) demonstrated that both bind to EGF-R with similar 
affinities. In some bioassays TGF-a and EGF are approximately equipotent, for example in 
their abilities to stimulate DNA synthesis in a variety of cell lines (Schreiber et al, 1986) or 
eyelid opening in new-born mice (Smith et al, 1985). In other systems TGF-a appears to be 
the most potent (Derynck, 1988; Lee et al, 1995) and TGF-a has a more widespread 
distribution in tissues (vide infra). Both growth factors have been shown to regulate 
fundamental cell functions such as proliferation, migration, differentiation and gene 
expression, and may consequently be important in foetal development and tissue 
maintenance in adults. Transforming Growth Factor-alpha is a potent mitogen for epithelial
1 - Amino acid abbreviations: C, cysteine, G, glycine, R, arginine, Y, tyrosine, X, unspecified amino acid.
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and mesenchymal cells (Jhappan et al, 1990; Sandgren et al, 1990) and may be involved in 
activities as diverse as angiogenesis (Schreiber et al, 1986), wound healing (Schultz et al, 
1987, 1992) and bone resorption (Ibbotson et al, 1985). Both TGF-a and EGF adversely 
affect hair growth (Moore et al, 1983; Tam, 1985) and EGF has been used to weaken hair 
shafts and allow the sheering of sheep by hand (Moore et al, 1982). Epidermal Growth 
Factor has been shown to stimulate cardiovascular and gastrointestinal smooth muscle 
contraction (Hollenberg, 1994), the physiological significance of which is unknown.
Binding o f ligand induces dimerisation of the EGF-R and concomitant activation of the
receptor’s intrinsic tyrosine kinase. Tyrosine kinase activation is essential for the diverse
2+
effects of ligand binding, including rapid changes in intracellular Ca , changes in 
intracellular pH, and activation of gene transcription and its ultimate effects on cell 
proliferation (Chen et al, 1987). The ligand/receptor complex is then internalised from the 
cell surface after which ligands may be treated differently. In mouse L cells and human 
keratinocytes, Ebner and Derynck (1991) demonstrated that whereas ligand and receptor 
were preferentially recycled to the cell surface from TGF-a/EGF-R complexes, they were 
degraded from complexes of EGF and EGF-R. This may help explain observed differences 
in biological activities in some systems, and prevention of receptor recycling may contribute 
to receptor down-regulation. An important observation of the control of TGF-a gene 
expression was that both EGF and TGF-a were able to enhance TGF-a production by human 
keratinocytes (Coffey et al, 1987). From this important discovery the concept of the 
autocrine function of growth factors was realised; cells producing the factors are potentially 
capable of not only affecting neighbouring cells (paracrine regulation) and distant cells via 
the blood stream (endocrine), but also themselves.
The localisation of Transforming Growth Factor-alpha in the tissues of normal adult 
mammals has been investigated. Normal tissues, including the skin, nervous system, lungs, 
endocrine organs, kidneys, haematopoietic cells and vascular tissues, express the factor in 
varying amounts. Expression of TGF-a in skin keratinocytes was confirmed by Coffey et al 
(1987), expression of EGF-R was however confined to basal cells of the epidermis (Nanney 
et al, 1984). Both TGF-a and EGF-R expression has been confirmed in adipocytes (Luetteke 
et al, 1993), and TGF-a or EGF may prevent adipocyte differentiation and limit the size of 
adipose tissues. Similarly TGF-a may limit the development of muscle and bone (Luetteke 
et al, 1993). The function and distribution of growth factors within the gastrointestinal tract,
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especially in the gastric mucosa, may be of great importance in gastrointestinal parasitism. 
Transforming Growth Factor-alpha mRNA and protein were detected in greatest amounts in 
the parietal cells of human and guinea pig gastric mucosae (Beauchamp et al, 1989). The 
same workers detected little EGF mRNA. Thomas et al (1992) demonstrated that TGF-a 
immunostaining was confined to the differentiated, non-proliferative compartment of 
epithelia from human oesophagus, stomach, small intestine and colon. In the human oxyntic 
mucosa immunoreactivity was strongest in parietal cells and surface mucous cells. Epidermal 
Growth Factor immunostaining was confined to mucous neck cells of the oxyntic mucosa 
and the Brunner’s glands of the duodenum. The receptor for TGF-a and EGF is assumed to 
be confined to the basolateral membranes of gastrointestinal cells of both the proliferative 
and differentiated compartments (Thompson et al, 1994). Beauchamp et al (1989) detected 
highest amounts of EGF-R mRNA in parietal cells of oxyntic mucosae, and smaller amounts 
in chief cell fractions.
It has been hypothesised that both TGF-a and EGF may serve in the maintenance of gastric 
mucosal integrity and in the response to injury, by promoting cell proliferation, migration 
and differentiation, and by inhibiting gastric acid secretion and enhancing mucus production. 
The re-epithelialisation of experimentally-induced gastric ulcers occurred at a rate faster than 
could be accounted for by mitosis alone (Hingson and Ito, 1971; Svanes et al, 1982). 
Epidermal Growth Factor stimulated DNA synthesis and mucosal growth in oxyntic mucosa 
(Johnson and Guthrie, 1980; Konturek et al, 1981, 1988) and both EGF and TGF-a have 
been shown to promote the migration of intestinal epithelial cells and keratinocytes (Blay 
and Brown, 1985; Barrandon and Green, 1987). Both EGF and TGF-a suppressed acid 
production by parietal cells in vivo and in vitro and were probably equipotent in this respect 
(Konturek et al, 1984; Finke et al, 1985; Rhodes et al, 1986; Gregory et al, 1988). Both 
growth factors enhanced mucous secretion (Yoshida et al, 1987; Kelly and Hunter, 1990; 
Romano et al, 1992). Epidermal Growth Factor protected against gastric ulcer formation at 
doses that did not reduce acid secretion (Konturek et al, 1981). Epidermal Growth Factor has 
been detected in saliva (Skinner et al, 1984; Konturek et al, 1988), as has TGF-a (Wu et al, 
1993; Humphreys-Beher et al, 1994), and EGF was detected in milk (Beardmore and 
Richards, 1983; Koldovsky et al, 1991) and considerable interest has been focused on the 
function of growth factors in the gastrointestinal lumen. Some studies have shown that 
intraluminal EGF enhanced enteric mucosal growth and absorptive capacity (Ulshen et al, 
1986; Opleta-Madsen et al, 1991), but in other studies oral EGF was absorbed in suckling
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rats, but not in mature rats, as the ability to process luminal EGF had been lost (Thornburg et 
al, 1987; Rao et al, 1990; Thompson et al, 1994). Using intact mucosal preparations similar 
to the ones used in studies reported earlier in this thesis (section 4.3) both EGF and TGF-a 
have been shown to inhibit histamine-stimulated acid secretion when added to the serosal 
surface, but not when added to the luminal side (Finke et al, 1985; Rhodes et al, 1986). The 
gastric epithelium especially has been shown to be particularly impermeable to a wide 
variety of agents, presumably as further protection against secreted acid (Walsbren et al, 
1994). However luminal EGF has been shown to be important in the maintenance of the 
gastric epithelium of mature animals, since sialoadenectomy (salivary gland removal) 
resulted in gastric mucosal atrophy in rats (Skinner et al, 1984) that could be reversed by the 
oral administration o f EGF (Konturek et al, 1988), but the route of uptake of luminal growth 
factors remains unknown. Both TGF-a and EGF are relatively acid stable proteins (Cohen 
and Carpenter, 1975; Roberts et al, 1980), but EGF has been shown to be degraded by acid 
pH of less than four, to smaller forms (49 and 46 amino acid forms) that are less active 
(Playford et al, 1995).
The role of growth factors in disease is increasingly recognised. Deregulated expression of 
TGF-a and EGF-R has been widely observed in neoplasia in a variety of tissues (Derynck et 
al, 1987, Lee et al, 1995). Diffuse immunostaining for TGF-a was observed in pancreatic 
adenocarcinomas (Barton et al, 1991) and cultured pancreatic tumour cells produced and 
utilised TGF-a as an autocrine growth factor (Smith et al, 1987; Ohmura et al, 1990; Hofer 
et al, 1991). Transforming Growth Factor-alpha has also been implicated in the 
establishment o f cutaneous paraneoplastic syndromes (Ellis et al, 1987). There is also 
evidence of the involvement of TGFa in non-neoplastic conditions; TGF-a mRNA and 
protein are increased in psoriasis (Gottlieb et al, 1988; Elder et al, 1989; Turbitt et al, 1990) 
and overexpression of TGF-a has been implicated in the pathogenesis of Menetrier’s disease 
(Dempsey et al, 1992).
The pathological consequences of overexpression of TGF-a have been investigated using 
transgenic mouse models. Vassar and Fuchs (1991) increased its expression in skin using 
keratin promoters and observed increased epithelial thickness, reductions in hair follicle 
numbers and of hair growth, a propensity to develop benign papillomas, and overall changes 
similar to psoriasis. Sandgren et al (1990) and Jhappan et al (1990) increased TGF-a 
expression in multiple tissues by placing its expression under the control of the zinc-
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inducible metallothionein (MT) promoter. Zinc-fed animals subsequently developed 
epithelial hyperplasia of many gastrointestinal tissues and frank neoplasia in the liver and 
mammary glands. The wet weights of the livers (in the absence of neoplasia), stomachs, and 
small and large intestines were two to three times normal, however the bodyweights of MT- 
TGF-a mice were reduced due to reductions in mesodermally-derived tissues such as fat, 
muscle and bone (Luetteke et al, 1993). In the pancreas o f transgenic animals changes 
included hyperproliferation of connective tissue and acinoductular metaplasia, but there was 
no increase in the frequency of neoplasia in this organ. The changes in the stomachs of 
transgenic mice were also studied by Dempsey et al (1992) and Takagi et al (1992), and 
TGF-a overexpression resulted in many of the changes of Menetrier’s disease of humans, 
changes which were also similar to those associated with ostertagiasis. The major changes 
were hyperplasia o f surface mucous cells (foveolar hyperplasia), coupled with the reduction 
in the number and function of parietal cells. Overexpression of the transgene also blocked 
the maturation o f zymogenic cells and reduced the amounts o f pepsinogen mRNA (Bockman 
et al, 1995).
There is a strong argument to suggest a role for TGF-a in the development of abomasal 
mucous cell hyperplasia in animals with ostertagiasis, and in other helminth infections where 
gastric hyperplasia is prominent, such as infections of rats with T. taeniaformis. The 
following studies were carried out to confirm the presence of a TGF-a-like molecule in the 
gastrointestinal tissues of normal sheep and to investigate whether mucosal concentrations of 
TGF-a are altered by ostertagiasis, and whether such changes support the hypothesis that 
TGF-a is essential to the development of hyperplasia in parasitised abomasa.
9.2: A comparison of the immunohistochemical localisations of EGF and TGF-a in 
gastrointestinal tissues of parasite-naive sheep and in sheep with ostertagiasis.
Immunohistochemical techniques and light microscopy were used to localise TGF-a in 
tissues from parasite-naive and infected animals, and to compare the results with those 
obtained in immunohistochemical studies of EGF localisation in the same tissues. This 
would allow comparison to the published results of other workers on growth factor 
distributions to establish whether growth factor immunoreactivity was specific.
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9.2.1: Materials and methods.
9.2.1.1: Animals.
Tissues were examined for TGF-a and EGF from a total of twenty one parasite-naive 
animals. Further tissues were obtained from multiple sites of the gastrointestinal tracts of 
three parasite-naive Hampshire Down lambs that were killed to provide tissues for 
investigations into the effects of ES products. Tissue was collected from the submandibular 
salivary gland, oesophagus, liver, abomasal fundus and pylorus, proximal duodenum and 
colon from all 3 animals. The immunohistochemical localisation of the two growth factors 
was also investigated in fundic and pyloric mucosal tissues of two parasite-naive Scottish 
Blackface lambs and in fundic mucosa from sixteen Hampshire Down lambs that were the 
parasite-naive controls in the studies of infection with H. contortus. The 
immunohistochemical localisation of both TGF-a and EGF was further investigated in the 
fundic mucosae of twenty six Scottish Blackface lambs that had natural infections of 
predominantly O. circumcincta (section 7.4). Oxyntic gland mucosa was also collected from 
two adult and helminth-free Sprague Dawley rats. The histological sections of rat stomach 
included the stratified squamous epithelium of the gastric cardia.
9.2.1.2: Immunohistochemical techniques.
The immunostaining o f tissues in this section used the same Vectastain ABC kit and similar 
methods as for the studies of pepsinogen in sections 7 and 8 . The primary antisera used were 
raised in rabbits against EGF from mouse submaxillary glands (ICN Pharmaceuticals, Inc., 
Thame, England) and against rat TGF-a (Peninsula Laboratories, Inc., St. Helens, England). 
The staining procedure was identical to that used for pepsinogen, but the trypsin-digestion 
step was omitted. Antisera were used at a 1 in 500 dilution for the anti-EGF sera and 1 in 
1000 for the anti-TGF-a sera. Diaminobenzidine was again used as the chromogen and 
sections were counterstained with haematoxylin. Negative staining controls omitted the 
primary antisera or replaced them with non-immune rabbit serum (Vector Laboratories) at a 
1 in 1000 dilution.
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9.2.2: Results.
9.2.2.1: Tissues from parasite-naive animals.
The results for TGF-a and EGF immunoreactivity showed good similarity between animals 
in the staining patterns for the diverse gastrointestinal tissues examined, and the repeatability 
within each site, when this was examined, was good. No staining was present in any section 
where the primary antiserum had been omitted for either growth factor, but when serum from 
non-immune rabbits was substituted for the primary antiserum, there was a slight degree of 
non-specific reactivity (Fig. 9.1).
Strong immunostaining for both TGF-a and EGF was present in the cytoplasm of the striated 
ducts and larger, intralobular and interlobular ducts of submandibular salivary gland. The 
results for TGF-a are shown in Fig. 9.2. The cytoplasm of duct cells stained uniformly for 
both growth factors. Cells of the mucoserous acini did not stain. Cells lining the larger 
interlobular ducts bore plentiful apical cytoplasm, that was swollen in appearance (Fig. 9.3) 
and which stained intensely for both growth factors. Transforming Growth Factor-alpha was 
localised most strongly to suprabasal keratinocytes of the oesophageal epithelium. Staining 
appeared to be confined to the exterior of cells, but in the stratified squamous epithelium of 
rat cardia, TGF-a immunoreactivity was present throughout the cytoplasm of suprabasal 
cells. Staining of ovine oesophagus and rat cardia for EGF however demonstrated no 
immunoreactivity. In the duodenum the most intense immunoreactivity for TGF-a was in 
enterocytes on the flanks of the villi (Fig. 9.4). Enterocytes showed only weak 
immunoreactivity for EGF and the cells of the Brunner’s glands did not stain for EGF (Fig. 
9.5). In the large intestine TGF-a immunoreactivity was greatest in superficial enterocytes 
and EGF was again not detected.
The examination of the fundic mucosa of all parasite-naive animals revealed consistent 
patterns o f immunoreactivities for both growth factors. Parietal cells in ovine fundus stained 
strongly for TGF-a (Figs. 9.6 and 9.7). Parietal cell cytoplasm stained uniformly. Chief cells 
bore only small amounts of predominantly apical immunoreactivity. Cells at the isthmus 
stained only slightly and the cytoplasm of surface mucous cells o f the pits stained more 
strongly. The apical mucus cap of surface mucous cells did not stain. The distribution of 
EGF-specific staining was identical, but overall EGF immunoreactivity was paler than that
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for TGF-a in most sections from the animals examined. The examination of rat oxyntic 
mucosa revealed an almost identical pattern for both growth factors. In pyloric mucosa TGF- 
a-specific staining was most prominent in the most superficial mucous cells of the pits and 
some cells of the pyloric glands stained strongly at various depths o f the mucosa, but 
adjacent cells did not stain. The muscularis of pyloric mucosa was also stained strongly. 
Little EGF-specific staining could be detected in pyloric mucosa.
The results of TGF-a and EGF immunostaining in rat cardia, ovine oesophagus and ovine 
pylorus and large intestine, as well as the results of EGF immunostaining in ovine salivary 
gland and fundus are shown, for completeness, in Appendices 29-34.
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Fig. 9.2: Subm andibular salivary gland. TGF-a immunoreactivity is confined to duct 
cells, whereas cells of the mucoserous acini do not stain. (Haematoxylin counterstain - 
original magnification x 25).
Fig. 9.3: In terlobular duct of subm andibular salivary gland. The apical cytoplasm of 
duct cells appears swollen and strongly immunoreactive for TGF-a (arrows)(x 50).
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Fig. 9.4: Duodenum immunostained for T G F-a (x 10).
Fig. 9.5: Duodenum immunostained for EGF (x 10).
>»1
Fig. 9.6: Ovine abomasal fundic mucosa immunostained for T G F -a (x 50).
Fig. 9.7: Higher power view of the g landular cells of the abom asal fundus (x 100).
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9.2.2.2: Growth factor immunoreactivity in tissues from animals with infections of 
predominantly O. circumcincta.
An examination of the negative staining controls prepared from infected animal tissues 
showed that, as before no staining was present in sections where the primary antiserum had 
been omitted. There was however a slight non-specific background staining present in some 
slides prepared with normal, non-immune rabbit serum and it was noticeable that parasites 
cut in section in these examples took up some stain (Figs. 9.8 and 9.9).
The most dramatic change in TGF-a immunoreactivity was present in sections from the 
fundic mucosae of infected animals in which there was an obvious increase in the size of the 
foveolar compartments within nodules. Figure 9.10 shows a section of the nodule from 
animal Y51 and featured previously in Fig. 7.20. Despite the expansion of the foveolar 
compartment to almost the base of the mucosa TGF-a immunoreactivity was strongest only 
in the outer half of the mucosa. In contrast to the appearance of parasite-naive fundus the 
number of mucous-type cells strongly positive for the growth factor was clearly increased. 
At higher magnification (Fig. 9.11) immunoreactivity was confined to the cytoplasm of 
surface mucous cells, but the mucus cap did not stain. The loss of parietal cells in this section 
led to a reduction in the apparent immunostaining of the deeper gland structures and the 
metaplastic cells within this area of the nodule remained free of staining even to the extreme 
base of the mucosa (Fig. 9.12). In other sections from other animals deep metaplastic cells 
showed weak cytoplasmic immunoreactivity (Fig. 9.13), but with a pale unstaining 
perinuclear area. Mitotic figures were numerous within nodules, but were mostly confined to 
unstained cells (Fig. 9.14). Mitotic figures were uncommon in the extreme base of the 
mucosa, but occurred in a broad band occupying approximately the middle third of the 
mucosa. The upper limit of this band was the area heavily immunoreactive for TGF-a and 
some mitoses occurred in cells that did seem to be positive for the growth factor (Fig. 9.15). 
The pattern of observed immunoreactivity for EGF in the same sections was similar to that 
for TGF-a, but was generally paler (results not shown). When larval and adult worm stages 
were identified within or lying on the surface of sections, immunoreactivity for both growth 
factors was observed in worm tissues.
Outside nodules the immunohistochemical appearance for both growth factors was nearly 
normal, but where pits were elongated in inter-nodular areas then the band of superficial,
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mucous cell-related immunoreactivity was also wider. Recognisable parietal cells and chief 
cells appeared largely normal.
Occasional cells in the lamina propria were intensely immunoreactive for TGF-a, which, 
judging from their nuclear shape, may well be eosinophils (Fig. 9.16).
Fig. 9.8: Negative control; the appearance of nodular tissue stained using norm al rabbit 
serum. Worms seen in section take up stain (Haematoxylin counterstain - original 
magnification x25).
Fig. 9.9: Negative control; adult worm, free in lumen, can be seen to take up stain
(normal rabbit serum - x 50).
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Fig. 9.14: A mitotic figure present within an expanded population of cells showing little 
im m unoreactivity (TGF-a immunostain - x 100).
Fig. 9.15: A mitotic figure present at the boundary of immunoreactive and non- 
im m unoreactive cells, from the same section as Fig. 9.14, the cytoplasm (arrow) is clearly 
immunoreactive (TGF-a immunostain - x 100).
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9.2.3: Discussion.
The quality of staining in the present experiments was not as good as that observed for the 
immunolocalisation of pepsinogen (sections 7 and 8). Slight non-specific immunoreactivity 
was observed with non-immune rabbit serum and many cell types, including parietal cells 
and cells of the lamina propria and submucosa, were seen to take up stain, albeit weakly. 
Perhaps because chief cells showed strong basophilia with haematoxylin, any non-specific 
staining was masked and these cells appeared largely normal.
Nevertheless in the study of TGF-a immunoreactivity in gastrointestinal tissues from 
parasite-naive animals quite strong staining was seen in an identical pattern as reported in 
humans (Thomas et al 1992), with immunoreactivity confined to the non-proliferative 
compartments of many tissues. Staining was present in suprabasal, but not basal 
keratinocytes, in both rat cardia and sheep oesophagus; TGF-a immunoreactivity was also 
observed in superficial enterocytes in both duodenum and large intestine, but not in crypt 
cells. Transforming growth factor was therefore only present in cells that were differentiated 
to some degree. The results from fundic mucosa support this, with the growth factor present 
in mature surface mucous cells and parietal cells, but the reasons why chief cells (another 
end-stage cell) do not produce it in the same high concentrations remain unknown.
Strong TGF-a-positive immunoreactivity was observed in duct cells of submandibular 
salivary glands, adjacent to cells of the mucoserous acini that were completely free of stain. 
Parietal cell staining was also characteristically strong. Considered alongside the similarity 
between the patterns of TGF-a immunoreactivty in ovine tissues to the results reported in 
humans, and the differences with observed EGF-immunoreactivity in the same ovine tissues, 
there is therefore good evidence to suggest that immunoreactivty strongly reflected growth 
factor distributions and was not necessarily the result of non-specific adsorption of antisera. 
In some tissues EGF and TGF-a co-localised to the same cells (submandibular salivary 
gland and fundus), but the fact that in other tissues (rat cardia, ovine oesophagus, pylorus and 
large intestine) little EGF immunoreactivity was detected suggested that the two anti sera 
recognised different epithelial components.
Unlike the situation in humans (Thomas et al, 1992) Brunner’s glands of ovine duodenum 
showed little immunoreactivity for EGF. The presence of TGF-a and EGF in the ductal cells
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of submandibular salivary glands was similar to the results obtained from mice, rats and 
humans (Gresick et al, 1985; Miettinen et al, 1993; Wu et al, 1993; Humphreys-Beher et al, 
1994). That both growth factors might be secreted into the saliva was supported by the 
finding in the present study of dense immunoreactivity in duct cells of salivary glands. 
Concentrations o f growth factors in saliva have been shown to be important in the 
maintenance of the mass of oxyntic mucosa and in its repair (see section 9.1), but in 
ruminants it is not known whether both growth factors can survive intact through the rumen, 
and this major difference in ruminant anatomy compared to monogastric animals might 
account for the anomalous presence of EGF in ovine fundic mucosal cells, and with the 
production of EGF in the abomasum, then its production in the duodenum is unnecessary.
The presence o f either EGF or TGF-a in cells does not necessarily mean that that cell is 
producing the growth factor for itself, but could represent internalised ligand-receptor 
complexes, and thus to confirm expression of either growth factor by cells would require the 
demonstration o f the respective mRNA’s.
The reasons for the presence of both growth factors in many situations is poorly understood. 
Recent work has shown that a further member of the Epidermal Growth Factor-receptor 
ligand family, Heparin-Binding EGF, is also produced by parietal cells, but little is produced 
by surface mucous cells (Murayama et al, 1995). The differential timing of the production of 
each growth factor in response to injury, and subtly different spectra of activity and 
potencies in diverse epithelial and mesenchymal cell types may account for the continued 
expression of each growth factor by the same cells.
The sections from animals with ostertagiasis were similar in appearance, in terms of the 
presence of foveolar hyperplasia and gland atrophy, to examples of Menetrier’s disease in 
humans (Dempsey et al, 1992) and to the stomachs of transgenic mice overexpressing TGF- 
a  (Takagi et al, 1992), but changes were not as marked. In contrast to the 
immunohistochemical appearance of TGF-a in human examples of Menetrier’s disease 
(Dempsey et al, 1992) the height o f the TGF-a-positive band of mucous cells in the nodules 
of the sheep was less, but nevertheless greater than the normal pits of parasite-naive animals. 
Immature cells normally do not produce the growth factor and a large population of poorly 
differentiated cells associated with little immunoreactivity was present within nodules.
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Transforming Growth Factor-alpha has recently been shown to be produced by eosinophils 
(Todd et al, 1991) and the growth factor-positive cells identified in the lamina propria could 
well represent members of this cell type. Growth factor immunoreactivity within worm 
tissues was probably a result o f the non-specific adsorption of serum, even though nematodes 
do produce and utilise members of the EGF-R ligand family such as the lin-3 gene product 
(Hill and Sternberg, 1992). It is equally difficult to interpret the findings of weak 
immunoreactivity within the deep metaplastic cells in some sections. This might genuinely 
reflect the production of the growth factor by cells under strong stimulation by high 
concentrations o f the growth factor itself or might simply represent a higher non-specific 
reaction than normal. The use of monoclonal antibodies against growth factors, instead of 
polyclonal antisera, may reduce background staining, primarily because much higher 
dilutions can be used, and this could confirm or refute some of the above findings .
The immunohistochemical appearance of nodules from infected animals does not prove that 
TGF-a was the stimulus for hyperplasia. The staining pattern might simply reflect the cell 
changes that occurred due to other reasons, but given the known effects of TGF-a, it must be 
considered as a potential cause of hyperplasia. Transforming Growth Factor-alpha is a potent 
epithelial mitogen, it inhibits parietal cell activity, and prevents the differentiation of parietal 
and chief cells (Dempsey et al, 1992; Bockman et al, 1995). A number o f potential 
hypotheses could explain the role of growth factors in the pathogenesis of ostertagiasis. The 
presence of a motile parasite within the confines of the gastric gland could trigger the 
production of growth factor by mucosal cells, or stretching the lining epithelial cells of the 
gland could allow the absorption of increased amounts of luminal growth factor. 
Alternatively, eosinophils, which are known to be attracted to abomasal mucosa in large 
numbers by the presence of parasites, by a number of mechanisms, could secrete growth 
factor. Whatever the initial cause of increases of growth factor concentration, its known 
ability to increase its own production could quickly account for a considerable increase in 
mucosal concentrations which could then effect the cell changes characteristic of 
ostertagiasis and inhibit parietal cell activity elsewhere. The hyperplastic response itself is 
unlikely to rid the animal of the initial stimulus, i.e. the parasite, but may even promote 
parasite survival, by generating a higher abomasal pH, and by enhancing mucus production.
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10: GENERAL DISCUSSION.
Assay of plasma pepsinogen concentration undoubtedly has a role in the diagnosis and study 
of abomasal helminthoses, and convenient assay methods with lowest intrinsic variability 
will remain the most appropriate for routine use. Comparing four simple assay procedures 
for plasma pepsinogen estimation, the present studies demonstrated that a method, based on 
the work of Paynter (1992) and utilising a glycine-buffered, albumin substrate, was the best. 
The method was acceptably precise, was more proficient with a diverse range of enzyme 
concentrations and o f all the methods had the lowest level of inter-assay variation (variation 
due to the performance of assays on different days). The present studies have also shown that 
two further, potential sources of variation exist and these may warrant further examination. 
Porcine pepsinogen added to ovine plasma produced a solution with lower peptic activity 
than an entirely aqueous solution of the same pepsinogen concentration, but it remains to be 
seen if the same effect would be observed with purified ovine pepsinogen. This finding 
raises the possibility that plasma might contain an inhibitory factor for pepsinogen which 
would influence estimations o f plasma pepsinogen concentration based on measurements of 
the total, acid-stable proteolytic activity of samples. However, despite the putative existence 
of an inhibitory factor, work in humans has shown that the correlation o f total plasma 
proteolytic activity and of plasma pepsinogen concentration measured by immunoassay is 
good (Hirschowitz, 1984). The second potential source of variation arises as a result of the 
intrinsic variability of animals to produce pepsinogen since some sheep were shown to 
produce relatively small amounts of pepsinogen and it is reasonable to argue that these 
animals might generate low plasma pepsinogen concentrations even in the face of a heavy 
abomasal helminth burden.
Excretory/secretory (ES) products of adult O. circumcincta stimulated abomasal glandular 
secretion and smooth muscle contraction, but these responses were identified as 
hypersensitivity responses that occurred only in animals with a history of previous exposure 
to helminth parasites. It is hypothesised that the responses resulted from mast cell 
degranulation following the crosslinking of immunoglobulins, present on sensitised mast cell 
surfaces, by antigens in ES. The in vitro contraction of smooth muscle from sensitised 
animals in response to antigen exposure is well characterised as the Schultz-Dale response
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(section 6 .1) and other experiments have demonstrated secretory and electrical responses in 
sensitised intestinal mucosae in vitro to antigens (Wang et al, 1991; Frieling et al, 1994), but 
the present studies are the first demonstrating enhanced zymogen secretion from the 
stomachs of sensitised animals. There is a known association between hypersensitivty 
responses and elevated plasma pepsinogen concentration, however this has previously been 
ascribed solely to mucosal permeability changes (Yakoob, et al, 1983). There is now clear 
evidence that part of the allergic response also involves increased release of pepsinogen from 
cellular sources.
Mucosal hypersensitivity responses have been considered to be important in the pathology of 
ostertagiasis (Wiggin and Gibbs, 1990). Mast cell degranulation and the release o f numerous 
bioactive compounds can potentially cause permeability changes in mucosal vasculature, 
exacerbating fluid and protein losses, and may also contribute to the accumulation of 
eosinophils, via eosinophil chemotactic factors. The oxidative burst, characteristic of 
activated eosinophils, would almost certainly contribute to tissue damage. Mast cells and 
hypersensitivty reactions have also been associated with immune-mediated expulsion of 
certain helminth infections of the gastrointestinal tract (Miller, 1984; Nawa et al, 1994) and a 
knowledge of the antigenic components of ES involved in the responses demonstrated in the 
present studies may be of use in considering possible vaccine candidates.
Antiserum directed against bovine pepsinogen (PG I) recognised an ovine equivalent, 
presumably ovine PG I, in sheep fundic and pyloric mucosa. The immunohistochemical 
localisation o f pepsinogen in the abomasa of parasite-naive cattle and sheep generally 
reflected patterns observed in other mammalian species (Samloff, 1971; Cybulski and 
Andren, 1990; Yamada et al, 1988), with the fundus being the major source of pepsinogen, 
and the chief cell the most intensely staining cell type. Pepsinogen was localised by 
immunohistochemistry to three cell types in normal bovine fundic mucosa; the chief cell, the 
mucous neck cell and the surface mucous cell, but the presence of pepsinogen in the bovine 
surface mucous cell was variable. Surface mucous cells in normal ovine fundic mucosa did 
not appear to contain pepsinogen.
Abomasal secretion is thought to be effectively continuous thus the granule content of chief 
(and other) cells should be relatively constant, assuming that the rate of granule loss is 
matched by the rate o f production of new granules. A further consequence of the stability of
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granule content is that differences in the pepsinogen content of the abomasa of different 
ruminant animals are likely to be due to definite phenotypic differences of pepsinogen 
production between animals and not the influence of events such as feeding, or other factors 
that might account for temporal changes in granule content in monogastric animals. The 
finding of considerable variation of tissue pepsinogen concentrations in the Hampshire 
Down lambs, in infected (H. contortus) and uninfected animals, is therefore significant, and 
suggests that the rates of pepsinogen secretion in the abomasa of individual animals were 
also markedly different. Although pepsinogen is more important in the digestion of animal 
and not plant protein the consequences for a herbivorous animal not producing pepsinogen 
are unknown.
Hyperplasia of abomasal epithelial cells in response to both ostertagiasis and haemonchosis 
was associated, on the basis of pepsinogen-specific immunoreactivity, with an expanded 
zymogenic population. This occurred in the face of an apparent decline in chief cell staining 
that was demonstrable in both infections. The secretory rates for pepsinogen by infected 
abomasa were not determined in the present studies, but on the basis of the 
immunohistochemical evidence it seems likely that secretion is at least maintained during 
infection, if not increased, as it is unlikely that the hyperplastic mucous cells producing 
pepsinogen are subsequently incapable of secreting it. The present studies have demonstrated 
the existence of a reserve capacity of the abomasum to continue producing pepsinogen, by 
the recruitment o f relatively immature mucous-type cells arising as a result o f hyperplasia. 
These cells may eventually further differentiate to assume the phenotype of mature mucous 
cells, which in the ovine do not produce pepsinogen normally, and pepsinogen production by 
these cells may then cease.
The present immunohistochemical studies did not determine the mechanism of pepsinogen 
secretion or the mechanism whereby pepsinogen gains entry to the blood stream. In the 
present studies all pepsinogen-specific immunoreactivity was intracellular, within epithelia 
and the surrounding lamina propria, confined to the cytoplasm of cells. Plasma pepsinogen 
has been shown to become increased in animals with experimentally induced 
hypergastrinaemia (Fox et al, 1989b). Gastrin was not thought to influence mucosal 
permeability, thus the mechanism of plasma pepsinogen elevation was attributed directly to 
the stimulation of pepsinogen secretion, both to the lumen and also in a retrograde manner to 
the blood stream. On the basis of the present and previous studies (Murray, 1970; Yamada et
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al, 1988; Cybulski and Andren, 1990), the granules of pepsinogen-producing cells lie at their 
apical surfaces. Retrograde secretion may therefore not involve granule formation, although 
Murray (1970) did note the presence of some granules, situated atypically, at the basal 
membranes of mucous neck cells.
The decline of the pepsinogen content of chief cells in some infected animals was a 
consequence of either; accelerated granule loss by these cells in response to strong secretory 
stimuli, or a change of cell phenotype towards that of a non-zymogenic, perhaps mucous- 
type, cell. It is known that gastrin becomes elevated in infected animals, and this could then 
stimulate pepsinogen secretion and deplete granule number. More importantly perhaps, 
mucins (as PAS-positive material) were seen deeper in glands in infected animals than 
normal, so that it is more likely that the decline of chief cell staining is a consequence of 
phenotypic change. The histological appearance of chief cells in the present studies was very 
similar to observations of cells at the deep gland bases of the stomachs of transgenic mice 
overexpressing Transforming Growth Factor-alpha (Bockman et al, 1995). In these animals 
gland cells were prevented from maturing into either parietal or chief cells by the continuous 
presence of high concentrations of growth factor.
Foveolar hyperplasia and complete gland atrophy has been seen focally in both ostertagiasis 
and haemonchosis in the present studies, and is a generalised feature of Menetrier’s disease 
of man. It has also been seen in transgenic mice overexpressing TGF-a (Dempsey et al, 
1992; Takagi et al, 1992) and therefore represents a possible end-stage of disease induced by 
increased expression of, or stimulation by, TGF-a. It is therefore probable that TGF-a has a 
role in the development of the pathology of the gastric helminthoses where hyperplasia is 
prominent. The growth factor has been recognised as a potent inhibitor of parietal cell 
activity and may contribute to the inhibition of parietal cells seen in helminth-infected 
abomasa, which ultimately results in the disappearance of the cells altogether. The 
production of TGF-a in the mammalian gastrointestinal tract and indeed in other tissues is 
confined to the proliferative compartment, hence the strong immunoreactivity observed in 
surface mucous cells and in parietal cells of ovine fundic mucosa, but this does not explain 
the relative paucity of growth factor in normal chief cells, and it is likely that several factors 
are responsible for normal homeostasis in the abomasal epithelium. Gastrin is known to 
increase the numbers of parietal and zymogenic cells in situations where gastrin is elevated 
either artificially (Waldum et al, 1991) or by disease (McGuigan, 1983), and gastrin has been
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shown to partially reverse changes in pancreatic tissues induced by TGF-a overexpression 
(Wang et al, 1993). The increase in gastrin in the mucosae of infected animals could 
stimulate the presence of pepsinogen within the hyperplastic cell population.
The presence of small concentrations of pepsinogen in the plasma of uninfected animals, can 
perhaps be taken as evidence of a continuous, but low grade, leak of the zymogen across the 
epithelial barrier. An identical mechanism might theoretically account for the uptake of 
luminal growth factors that is necessary for the continued maintenance of the gastric 
epithelial mass (see section 9.1). Hyperplastic lesions of the stomach/abomasum are 
associated with increased permeability of the gut wall, due to the poorly formed tight 
junctions that exist between the hyperplastic and immature epithelial cells, and this might 
increase growth factor uptake. Studies of tight junction width and of associated protein loss 
in humans with Menetrier’s disease have shown that treatment with the anti-cholinergic 
agent propantheline bromide reduced tight junction width and concurrently reduced protein 
loss, whereas pentagastrin and bethanechol chloride (gastrin and acetylcholine analogues 
respectively) both increased protein loss, but had no effect on tight junction width (Kelly et 
al, 1982). Treatment of Menetrier’s disease with what would be considered as primarily, 
anti-secretory agents, such as cimetidine (H2-antagonist), is common (Kang et al, 1990; 
Yeaton and Frierson, 1993). That anti-muscarinic and other agents affect epithelial 
permeability could also help explain the reductions in plasma pepsinogen concentrations 
seen in sheep infected with O. circumcincta and given atropine (Mostofa and McKellar, 
1989).
The results of the present work provide a more comprehensive description of some of the 
mechanisms that might operate in ostertagiasis, and, where similarities exist, in 
haemonchosis, than has previously been available. Ingested larvae penetrate the abomasal 
glands and stretch the lining epithelium. At this stage it may be of advantage to the larvae to 
reduce acid secretion within the glands, and larvae could do this in one of three ways. Firstly, 
the larvae might elaborate a chemical capable of directly inhibiting parietal cell activity, and 
some workers have demonstrated the presence of acid-inhibitory factors in the tissues or 
products of Ostertagia spp. parasites (Eiler et al, 1981; Rikihisa and Hammerberg, 1982). 
Secondly, damage to cells of the gland lining may result in the production and release locally 
of a factor, such as TGF-a, which is anti-secretory. Finally, the stretch and disruption of the 
gland lining could allow increased uptake of luminal growth factor. The initial hyperplasia
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that occurs in ostertagiasis and haemonchosis does suggest that TGF-a might be operating at 
this early stage o f infection and with worm growth there is the potential for the production of 
the growth factor by epithelial cells, or its uptake, to be increased. Parietal cell activity may 
consequently become inhibited and the differentiation of new parietal cells prevented. 
Hypergastrinaemia may then be a direct consequence of this inhibition, but the possibility of 
the direct stimulation of G-cells to release gastrin by parasites has not been excluded 
(Anderson et al, 1981).
Plasma pepsinogen concentrations become elevated due to a number of potential 
mechanisms which may include; an increase in mucosal permeability, which may only be a 
transient feature (Holmes and Maclean, 1971), the direct stimulation of pepsinogen secretion 
into the blood by hypergastrinaemia or other stimuli and possible hypersecretion by an 
enhanced zymogenic cell population. Yet the ability of the worms themselves to stimulate 
pepsinogen release cannot be discounted. Plasma pepsinogen concentrations rose rapidly in 
parasite-naive animals following the transplant of adult parasites (McKellar et al, 1986, 
1987), and the present studies (section 6) do not rule out the production o f a pro-secretory 
chemical by adult O. circumcincta in vivo. Hypersensitivity responses induced by parasite 
antigen may further assist in maintaining high plasma pepsinogen concentrations and may 
also affect mucosal permeability.
It is difficult to see how the mucosal hyperplastic response, whether initiated by a growth 
factor such as TGF-a, or by another as yet unidentified mechanism, can eliminate the 
parasites on its own. Mucous hypersecretion and hyposecretion of acid may rather favour 
parasite survival, and it is only the loss of the worm population, whether due to anthelmintic 
treatment, developing immunity, or the gradual senescence of adult worms with no further 
ingestion of infective larvae, that then eliminates the stimulus for the maintenance of the 
mucosa in the hyperplastic state, and allows the restoration o f the normal homeostatic 
control of the abomasal cell population.
241
11: REFERENCES.
Abbott, E.M., Parkins, J.J. & Holmes, P.H. (1986) The effect of dietary protein on the 
pathogenesis of acute ovine haemonchosis. Veterinary Parasitology. 20, 291-306.
Ackert, J.E. & Moldoon, W.E. (1920) Strongylosis (ostertagia) in cattle. Journal o f  the 
American Veterinary Medical Association 58, 138.
Allonby, E.W. (1973) Ovine haemonchosis. Epidemiology, clinical signs and diagnosis. In 
Helminth diseases in cattle sheep and horses in Europe (Edited by Urquhart, G.M. & 
Armour, J.) Robert MacLehose and Company Ltd., Glasgow, Scotland, pp 59-63.
Altounyan, R.E.C. (1967) Inhibition of experimental asthma by a new compound - disodium 
cromoglycate “Intal”. Acta Allergolica 22, 487.
Anderson, N. (1973) Trichostrongylid infections of sheep in a winter rainfall region. II. 
Epizootiological studies in the Western District of Victoria. Australian Journal o f  
Agricultural Research 24, 599-615.
Anderson, N. (1988) Aspects of the biology of Ostertagia ostertagi in relation to the genesis 
of ostertagiasis. Veterinary Parasitology 27, 13-22.
Anderson, N., Armour, J., Jarrett, W.F.H., Jennings, F., Ritchie, J.S.D. & Urquhart, G.M. 
(1965) A field study of parasitic gastritis in cattle. Veterinary Record 77, 1196-1204.
Anderson, N., Hansky, J. & Titchen, D.A. (1981) Effects of Ostertagia circumcincta 
infections on plasma gastrin in sheep. Parasitology 82, 401-410.
Anderson, N., Hansky, J. & Titchen, D.A. (1985) Effects on plasma pepsinogen, gastrin and 
pancreatic polypeptide of Ostertagia spp. transferred directly into the abomasum of sheep. 
International Journal fo r  Parasitology 15, 159-165.
242
Anderson, N., Reynolds, G.W. & Titchen, D.A. (1988) Changes in gastrointestinal mucosal 
mass and mucosal and serum gastrin in sheep experimentally infected with Ostertagia 
circumcincta. International Journal fo r  Parasitology 18, 325-331.
Anderson, R.C. (1984) The origins of zooparasitic nematodes. Canadian Journal o f  Zoology 
62,317-328.
Andervont, H.B. (1939a) Development and genetic characteristics of the adenomatous 
stomach lesion in Strain I mice. Public Health Reports 54, 1851-1855.
Andervont, H.B. (1939b) Studies on some possible causes of spontaneous adenomatous 
lesions o f stomach in mice of Strain I. Public Health Reports 54, 2085-2093.
Andren, A., Bjorck, L. & Claesson, O. (1980) Quantification of chymosin (rennin) and 
pepsin in bovine abomasa by rocket immunoelectrophoresis. Swedish Journal o f  Agriculture 
10,123-130.
Andren, A., Bjorck, L. & Claesson, O. (1982) Immunohistochemical studies on the 
development o f prochymosin- and pepsinogen-containing cells in bovine abomasal mucosa. 
Journal o f  Physiology 327, 247-254.
Anzano, M.A., Roberts, A.B., Meyers, C.A., Komoriya, A., Lamb, L.C., Smith, J.M. & 
Spom, M.B. (1982) Synergistic interaction of two classes of transforming growth factors 
from murine sarcoma cells. Cancer Research 42, 4776-4778.
Anzano, M.A., Roberts, A.B., Smith, J.M., Sporn, M.B. & De Larco, J.E. (1983) Sarcoma 
growth factor from conditioned medium of virally transformed cells is composed of both 
type a  and type P transforming growth factors. Proceedings o f  the National Academy o f  
Sciences o f  the U.S.A. 80, 6264-6268.
Armour, J. (1970) Bovine ostertagiasis: a review. Veterinary R e c o r d s ,  184-190.
243
Armour, J., Bairden, K., Duncan, J.L., Jennings, F.W. & Parkins, J.J. (1979) Observations on 
ostertagiasis in young cattle over two grazing seasons with special reference to plasma 
pepsinogen levels. Veterinary Record 105, 500-503.
Armour, J. & Bruce, R.G. (1974) Inhibited development in Ostertagia ostertagi infections - 
a diapause-like phenomenon in a nematode. Parasitology 69, 161-174.
Armour, J., Jarrett, W.F.H. & Jennings, F.W. (1966) Experimental Ostertagia circumcincta 
infections in sheep: development and pathogenesis of a single infection. American Journal o f  
Veterinary Research 27, 1267-1278.
Armour, J., Jennings, F.W., Murray, M. & Selman, I. (1973) Bovine ostertagiasis. Clinical 
aspects, pathogenesis, epidemiology and control. In Helminth diseases in cattle sheep and 
horses in Europe (Edited by Urquhart, G.M. & Armour, J.) Robert MacLehose and 
Company Ltd., Glasgow, Scotland, pp 11-20.
Armour, J., Jennings, F.W. & Urquhart, G.M. (1967) The possible existence of two strains of 
Ostertagia ostertagi. Veterinary Record 80, 208.
Axelsson, C.K., Axelsen, N.H., Szeczi, P.B. & Foltman, B. (1983) Determination of pepsin 
(EC 3.4.23.1) and gastricsin (EC 3.4.23.3) in gastric juice by rocket immunoelectrophoresis. 
Clinica Chimica Acta 129, 323-331.
Baker, D.G. & Gershwin, L.J. (1993) Immunoglobulin E and type I hypersensitivity in 
bovine ostertagiasis. Veterinary Parasitology 46, 93-102.
Barker, I.K., Van Dreumel, A.A. & Palmer, N. (1993a) The alimentary system. The stomach 
and abomasum. Gastritis. In Pathology o f  Domestic Animals (Edited by Jubb, K.V.F., 
Kennedy, P.C. & Palmer, N.) Academic Press, Ltd., London, England, pp 61-65.
Barker, I.K., Van Dreumel, A.A. & Palmer, N. (1993b) The alimentary system. Infectious 
and parasitic diseases of the gastrointestinal tract. Gastrointestinal helminthosis. In 
Pathology o f Domestic Animals (Edited by Jubb, K.V.F., Kennedy, P.C. & Palmer, N.) 
Academic Press, Ltd.., London, England, pp 258-295.
244
Barker, I.K., Van Dreumel, A.A. & Palmer, N. (1993c) The alimentary system. The stomach 
and Abomasum. Response of the gastric mucosa to injury. In Pathology o f  Domestic Animals 
(Edited by Jubb, K.V.F., Kennedy, P.C. & Palmer, N.) Academic Press, Ltd., London, 
England, pp 54-56.
Barrandon, Y. & Green, H. (1987) Cell migration is essential for sustained growth of 
keratinocyte colonies: the roles of transforming growth factor-a and epidermal growth 
factor. Cell 50, 1131-1137.
Barros, D ’Sa., Bloom, S.R. & Baron, J.H. (1978) Inhibition by somatostatin (growth 
hormone release inhibiting hormone, GH-RIH) of gastric acid and pepsin and G cell release 
of gastrin. Gut 19, 315-320.
Barton, C.M., Hall, P.A., Hughes, C.M., Gullick, W.J. & Lemoine, N.R. (1991) 
Transforming growth factor-alpha and epidermal growth factor in human pancreatic cancer. 
Journal o f  Pathology 163, 111-116.
Basson, M.D., Adrian, T.E. & Modlin, I.M. (1990) Effects of cholecystokinin and 
cholinergic receptor blockade on guinea pig pepsinogen secretion. Scandinavian Journal o f  
Gastroenterology 25, 825-833.
Baudys, M., Erdene, T.G., Kostaka, V., Puvlik, M. & Foltman, B. (1988) Comparison 
between prochymosin and pepsinogen from lamb and calf. Comparative Biochemistry and 
Physiology 89B, 385-391.
Beardmore, J.M. & Richards, R.C. (1983) Concentrations of epidermal growth factor in 
mouse milk throughout lactation. Journal o f  Endocrinology 96, 287-299.
Beauchamp, R.D., Barnard, J.A., McCutchen, C.M., Chemer, J.A. & Coffey, R.J.Jr. (1989) 
Localisation of transforming growth factor-a and its receptor in gastric mucosal cells. 
Implications for a regulatory role in acid secretion and mucosal renewal. Journal o f  Clinical 
Investigation 84, 1017-1023.
245
Berger, S. & Raufman, J.-P. (1985) Prostaglandin-induced pepsinogen secretion from 
dispersed gastric glands from guinea pig stomach. American Journal o f  Physiology 249, 
G595-598.
Berghen, P., Hilderson, H., Vercruysse, J. & Domy, P. (1993) Evaluation of pepsinogen, 
gastrin and antibody response in diagnosing ostertagiasis. Veterinary Parasitology 46, 175- 
196.
Berglindh, T. & Obrink, K.J. (1976) A method for preparing isolated glands from the rabbit 
gastric mucosa. Acta Physiologica Scandinavica 96, 150-159.
Bird, A.F. & Bird, J. (1991). Secretory-excretory system. In The Structure of Nematodes. 
Academic Press Limited, London, England, pp. 167-182.
Bissonnette, E.Y. & Befus, A.D. (1993) Modulation o f mast cell function in the 
gastrointestinal tract. In Immunopharmacology o f  the gastrointestinal system. (Edited by 
Wallace, J.) Academic Press, New York, United States o f America, pp. 95-103.
Blay, J. & Brown, K.D. (1985) Epidermal growth factor promotes the chemotactic migration 
of cultured rat intestinal epithelial cells. Journal o f  Cellular Physiology 124, 107-112.
Bliss, D.H. & Todd, A.C. (1973) Milk production by Wisconsin dairy cattle after deworming 
with Baymix. Veterinary Medicine and Small Animal Clinician 68, 1034-1038.
Bliss, D.H. & Todd, A.C. (1976) Milk production by Vermont dairy cattle after deworming. 
Veterinary Medicine and Small Animal Clinician 71, 1251-1254.
Blomquist, M.C., Hunt, L.T. & Barker, W.C. (1984) Vaccinia virus 19-kiloDalton protein: 
relationship to several mammalian proteins, including two growth factors. Proceedings o f the 
National Academy o f Sciences o f  the U.S.A. 81, 7363-7367.
Bockman, D.E., Sharp, R. & Merlino, G. (1995) Regulation of terminal differentiation of 
zymogenic cells by Transforming Growth Factor-a in transgenic mice. Gastroenterology 
108, 447-454.
246
Bonne, C. & Sandground, J.H. (1939) On the production of gastric tumours bordering on 
malignancy, in Javanese monkeys through the agency o f Nochtia nochti, a parasitic 
nematode. American Journal o f  Cancer 37, 173-185.
Borgsteede, F.H.M. & Eysker, M. (1987) Strains of cattle parasites in The Netherlands with 
different propensities for inhibited larval development. Veterinary Parasitology 24, 93-101.
Bouhours, D., Bouhours, J.-F. & Bryon, P.-A. (1981) Association of glycoproteins and 
pepsinogen in the secretory granules of fundic epithelial cells isolated from guinea pig 
stomach. Biochimica and Biophysica Acta 672, 288-296.
Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 
72, 248-254.
Bremner, K.C. (1982) The pathophysiology of parasitic gastroenteritis o f cattle. In Biology 
and control o f  endoparasites. (Edited by Symonds, L.E.A., Donald, A.D. & Dineen, J.K.) 
Academic Press, Australia, pp 277-289.
Brown, J.P., Twardzik, D.R., Marquardt, H. & Todaro, G.J. (1985) Vaccinia virus encodes a 
peptide homologous to epidermal growth factor and transforming growth factor. Nature 313, 
491-492.
Bryant, C. (1982) The biochemical origins of helminth parasitism. In Biology and control o f  
endoparasites. (Edited by Symonds, L.E.A., Donald, A.D. & Dineen, J.K.) Academic Press, 
Australia, pp 29-52.
Bueno, L., Dorchies. P. & Ruckebusch, Y. (1975) Analyse electromyographique des 
perturbations motrices liees aux strongyloses gastrointestinales chez les ovins. Comptes 
Rendus des Seances de la Societe de Biologie (Paris) 169, 1627-1632.
Bueno, L., Dakkak, A. & Fioramonti, J. (1982a) Gastro-duodenal motor and transit 
disturbances associated to Haemonchus contortus infection in sheep. Parasitology 84, 367- 
374.
247
Bueno, L. & Fioramonti, J. (1979) Rhythms of abomaso-intestinal motility. In Digestive 
physiology and metabolism in ruminants. (Edited by Ruckebusch, Y. & Thivend, P.) MTP 
Press, London, England, pp. 53-80.
Bueno, L., Honde, Ch., Luffau, G. & Fioramonti, J. (1982b) Origin of the early digestive 
disturbances induced by Haemonchus contortus infection in lambs. American Journal o f  
Veterinary Research 43, 1194-1199.
Buller, R.M.L., Chakrabarti, S., Moss, B. & Fredrickson, T. (1988) Cell proliferative 
response to vaccinia virus is mediated by VGF. Virology 164, 182-192.
Canals, A. & Gasbarre, L.C. (1990) Ostertagia ostertagi: isolation and partial 
characterisation of somatic and metabolic antigens. International Journal fo r  Parasitology 
20, 1047-1054.
Canfield, P. & Paraskeva, P. (1992) P-adrenoceptor agonist stimulation of acid secretion by 
rat stomach in vitro is mediated by ‘atypical’ P-adrenoceptors. British Journal o f  
Pharmacology 106, 583-586.
Caprilli, R., Frieri, G. & Vernia, P. (1982) Electrophysiology of intestinal smooth muscle. In 
Mediators and and drugs in gastrointestinal motility I. (Edited by Bertaccini, G.) Springer- 
Verlag, Berlin, Germany, pp. 117-143.
Carpenter, G., Stoscheck, C.M., Preston, Y.A. & DeLarco, J.E. (1983) Antibodies to the 
epidermal growth factor receptor block the biological activities of sarcoma growth factor. 
Proceedings o f  the National Academy o f Sciences o f  the U.S.A. 80, 5627-5630.
Castro, G.A. (1989) Immunophysiology of enteric parasitism. Parasitology Today 5, 11-19
Castro, G.A., Badial-Aceves, F., Smith, J.W., Dudrick, S.J. & Weisbrodt, N.W. (1976) 
Altered small bowel propulsion associated with parasitism. Gastroenterology 71, 620-625.
Chand, N. & Eyre, P. (1978) The Schultz-Dale reaction. A review. Agents and Actions 8, 
171-184
248
Charleston, W.A.G. (1965) Pathogenesis of experimental haemonchosis in sheep, with 
special reference to the development of resistance. Journal o f  Comparative Pathology 75, 
55-67.
Chen, W.S., Lazar, C.S., Poenie, M., Tsien, R.Y., Gill, G.N. & Rosenfeld, M.G. (1987) 
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the 
EGF receptor. Nature 328, 820-823.
Chemer, J.A., Sutliff, V.E., Grybowski, D.M., Jensen, R.T. & Gardner, J.D. (1988) 
Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from 
guinea pig stomach. American Journal o f  Physiology 254, G151-155.
Chew, C.S. (1986) Cholecystokinin, carbachol, gastrin, histamine and forskolin increase
2+[Ca ]j in gastric glands. American Journal o f  Physiology 250, G814-823.
Christie, M.G., Brambell, M.R. & Mapes, C,J. (1967) Effect of young Haemonchus 
contortus on abomasal pH in sheep. Veterinary Record 80, 207-208.
Clark, E.S. (1990) Intestinal motility. In The equine acute abdomen. (Editor White II, N.A.) 
Lea & Febiger, Philadelphia, United States of America, pp. 36-48.
Coad, N.A. & Shah, K.J. (1986) Menetrier’s disease in childhood associated with 
cytomegalovirus infection: a case report and a review of the literature. British Journal o f  
Radiology 59, 615-620.
Coffey, R.J., Derynck, R., Wilcox, J.N., Bringman, T.S., Goustin, A.S., Moses, H.L. & 
Pittelkow, M.R. (1987) Production and auto-induction of transforming growth factor-a in 
human keratinocytes. Nature 328, 817-820.
Cohen, S. (1960) Purification o f a nerve growth promoting protein from the mouse salivary 
gland and its neurocytotoxic antiserum. Proceedings o f  the National Academy o f  Sciences o f  
the U.S.A. 46, 302-311.
249
Cohen, S. (1962) Isolation of a mouse submaxillary gland protein accelerating incisor 
eruption and eyelid opening in the newborn animal. Journal o f  Biological Chemistry 237, 
1555-1562.
Cohen, S. & Carpenter, G. (1975) Human epidermal growth factor. Isolation and chemical 
and biological properties. Proceedings o f  the National Academy o f  Sciences o f  the U.S.A. 72, 
1317-1321.
Cohen, S. & Elliott, G.A. (1963) The stimulation of epidermal keratinisation by a protein 
isolated from the submaxillary gland of the mouse. Journal o f  Investigative Dermatology 40, 
1-5.
Cross, D.A. & Klesius, P.H. (1989) Soluble extracts from Ostertagia ostertagi modulating 
immune function. International Journal for Parasitology 19, 57-61.
Cross, D.A., Klesius, P.H., Hanrahan, L.A. & Haynes, T.B. (1987) Dermal cellular responses 
of helminth-free and Ostertagia ostertagi infected calves to intradermal injections of soluble 
extracts from O.ostertagi L3 larvae. Veterinary Parasitology 23, 257-264.
Cross, D.A., Klesius, P.H. & Haynes, T.B. (1986) Lymphocyte blastogenesis responses of 
calves experimentally infected with Ostertagia ostertagi. Veterinary Parasitology 22, 49-55.
Culmer, C.U., Atkinson, A.J. & Ivy, A.C. (1939) Depression of gastric secretion by the 
anterior pituitary-like fraction of pregnancy urine. Endocrinology 24, 631-637.
Curtain, C.C. & Anderson, N. (1971) Immunocytochemical localisation of the ovine 
immunoglobulins IgA, IgG la and IgG2: effect of gastrointestinal parasitism in the sheep. 
Clinical and Experimental Immunology 8, 151-162.
Cybulski, W. & Andren, A. (1990) Immunohistochemical studies on the development of 
cells containing progastricsin (minor pepsinogen) in comparison to prochymosin and 
pepsinogen in bovine abomasal mucosa. The Anatomical Record 227, 458-463.
250
Dakkak, A. & Khallaayoune, Kh. (1984) Physiopathologie de l’ostertagiose ovine. Effets de 
1’infestation experimentale par Ostertagia circumcincta sur quelques parametres temoins de 
l’etat de fonctionnement de 1’abomasum. Annales des Recherches Veterinaires 15, 319-324.
Dale, H.H. (1913) The anaphylactic reaction of plain muscle in the guinea pig. Journal o f  
Pharmacology and Experimental Therapeutics 4, 167-223.
Dargie, J.D. (1973) Ovine haemonchosis. Pathogenesis. In Helminth diseases in cattle sheep 
and horses in Europe (Edited by Urquhart, G.M. & Armour, J.) Robert MacLehose and 
Company Ltd., Glasgow, Scotland, pp 63-71.
Davey, K.G. & Sommerville, R.I. (1982) Changes in optical path difference in the 
oesophageal region and the excretory cells during exsheathment in Haemonchus contortus. 
International Journal fo r  Parasitology 12, 503-507.
Dawkins, H.J.S., Windon, R.G. & Eagleson, G.K. (1989) Eosinophil responses in sheep 
selected for high and low responsiveness to Trichostrongylus colubriformis. International 
Journal fo r Parasitology 19, 199-205.
Debas, H.T., Konturek, S.J., Walsh, J.H. & Grossman, M.I. (1974) Proof of a pyloro-oxyntic 
reflex for stimulation o f acid secretion. Gastroenterology 66, 526-532.
De Jong, H.R. & Vaandrager, A.B. (1986) The modulation of intestinal ion absorption and 
secretion. In Comparative Veterinary Pharmacology, Toxicology and Therapeutics (Edited 
by Van Miert, A.S.J.P.A.M., Bogaert, M.G. & De Backere, M.) MTP Press Limited, 
Lancaster, England, pp. 331-344.
De Larco, J.E. & Todaro, G.J. (1978) Growth factors from murine sarcoma virus- 
transformed cells. Proceedings o f  the National Academy o f Sciences o f  the U.S.A. 75, 4001 - 
4005.
Dempsey, P.J., Goldenring, J.R., Soroka, C.J., Modlin, I.M., McLure, R.W., Lind, C.D., 
Ahlquist, D.A., Pittelkow, M.R., Lee, D.C., Sandgren, E.P., Page, D.L. & Coffey, R.J.
(1994) Possible role o f transforming growth factor a  in the pathogenesis o f Menetrier’s
251
disease: supportive evidence from humans and transgenic mice. Gastroenterology 103, 1950- 
1963.
Derynck, R., Goeddel, D.V., Ullrich, A., Gutterman, J.U., Williams, R.D., Bingman, T.S. & 
Berger, W.H. (1987) Synthesis of m RNAs for transforming growth factors a  and (3 and the 
epidermal growth factor receptor by human tumours. Cancer Research 47, 707-712.
Derynck, R. (1988) Transforming Growth Factor a . Cell 54, 593-595.
Douch, P.G.C., Harrison, G.B.L., Elliott, D.C., Buchanan, L.L. & Greer, K.S. (1986) 
Relationship of gastrointestinal histology and mucus antiparasite activity with the 
development of resistance to trichostrongyle infections in sheep. Veterinary Parasitology 20, 
315-331.
Douch, P.G.C., Harrison, G.B.L., Buchanan, L.L. & Greer, K.S. (1988) Relationship of 
nematode cholinesterase activity and nematode burdens to the development of resistance to 
trichostrongyle infections in sheep. Veterinary Parasitology 27, 291-308.
Douvres, F.W. (1956) Morphogenesis of the parasitic stages of Ostertagia ostertagi, a 
nematode parasite in cattle. Journal o f  Parasitology 42, 626-635.
Ebner, R. & Derynck, R. (1991) Epidermal growth factor and transforming growth factor-a: 
differential intracellular routing and processing of ligand-receptor complexes. Cell 
Regulation 2, 599-612.
Eckersall, P.D., Macaskill, J., McKellar, Q.A. & Bryce, K.L. (1987) Multiple forms of 
bovine pepsinogen: Isolation and identification in serum from calves with ostertagiasis. 
Research in Veterinary Science 43, 279-283.
Edwards, K.E., Jepson, R.P. & Wood, K.F. (1960) Value of plasma pepsinogen estimation. 
British Medical Journal 1, 30-32.
252
Eiler, H., Baber, W., Lyke, W.A. & Scholtens, R. (1981) Inhibition o f gastric hydrochloric 
acid secretions in the rat given Ostertagia ostertagi (a gastric parasite of cattle) extract. 
American Journal o f  Veterinary Research 42, 498-502.
Elder, J.T., Fisher, G.J., Lindquist, P.B., Bennett, G.L., Pittelkow, M.R., Coffey, R.J.Jr., 
Ellingsworth, L., Derynck, R. & Voorhees, J.J. (1989) Overexpression o f transforming 
growth factor-a in psoriatic epidermis. Science 243, 811-814.
Ellis, D.L., Kafka, S.P., Chow, J.C., Nanney, L.B., Inman, W.H., McCadden, M.E. & King, 
L.E.Jr. (1987) Melanoma, growth factors, acanthosis nigricans, the sign of leser-trelat, and 
multiple acrochordons: a possible role for alpha-transforming growth factor in cutaneous 
paraneoplastic syndromes. New England Journal o f  Medicine 317, 1582-1587.
Else, K.J., Hultner, L. & Grencis, R.K. (1992) Cellular immune responses to the murine 
nematode parasite Trichuris muris. II. Differential induction of Th-cell subsets in resistant 
versus susceptible mice. Immunology 75, 232-237.
Entrocasso, C., McKellar, Q.A., Parkins, J.J., Bairden, K., Armour, J. & Kloosterman, A. 
(1986a) The sequential development of type I and type II ostertagiasis in young cattle with 
special reference to biochemical and serological changes. Veterinary Parasitology 21, 173- 
188.
Entrocasso, C., Parkins, J.J., Armour, J., Bairden, K., & Me William, P.N. (1986b) 
Production, parasitological and carcase evaluation studies in steers exposed to 
trichostrongyle infection and treated with a morantel bolus or fenbendazole in two 
consecutive grazing seasons. Research in Veterinary Science 40, 76-85.
Eysker, M. (1993) The role of inhibited larval development in the epidemiology of 
Ostertagia infections. Veterinary Parasitology 46, 259-269.
Eysker, M. & Kooyman, F.N.J. (1993) Notes on necropsy and herbage processing techniques 
for gastrointestinal parasites of ruminants. Veterinary Parasitology 46, 205-214.
253
Fanning, M.J., Marcander, P., Drzewiecki, G. & Middleton, E. Jr. (1983) Quercetin inhibits 
anaphylactic contraction of guinea pig ileum smooth muscle. International Archives o f  
Allergy and Applied Immunology 71, 371.
Farmer, S.G. & Laniyonu, A.A. (1984) Effects of p-chlorophenylalanine on the sensitivity of 
rat intestine to agonists and on intestinal 5-hydroxytryptamine levels during Nippostrongylus 
brasiliensis infection. British Journal o f  Pharmacology 82, 883-889.
Farquhar, M.G. & Palade, G.E. (1963) Junctional complexes in various epithelia. Journal o f  
Cell Biology 17, 375.
Fewtrell, C.M.S. & Gomperts, B.S. (1977) Quercetin: a novel inhibitor of Ca2+ influx and 
exocytosis in rat peritoneal mast cells. Biochimica et Biophysica Acta 469, 52.
Finke, U., Rutten, M., Murphy, R.A. & Silen, W. (1985) Effects of Epidermal Growth Factor 
on acid secretion from guinea pig gastric mucosa: in vitro analysis. Gastroenterology 88. 
1175-1182.
Foltman, B. & Pederson, V.B. (1976) Comparison of primary structures of acid proteases 
and their zymogens. Advances in Experimental Medicine and Biology 95, 3-22.
Forte, J.G., Forte, T.M. & Machen, T.E. (1975) Histamine-stimulated hydrogen ion secretion 
by in vitro piglet gastric mucosa. Journal o f  Physiology 244, 15-31.
Foster, N., Dean, E.J. & Lee, D.L. (1994) The effect of homogenates and excretory/secretory 
products of Nippostrongylus brasiliensis and of acetylcholinesterase on the amplitude and 
frequency of contraction of uninfected rat intestine in vitro. Parasitology 108, 453-459.
Fox, M.T. (1993) Pathophysiology of infection with Ostertagia ostertagi in cattle. 
Veterinary Parasitology 46, 143-158.
Fox, M.T., Carroll, A.P., Hughes, S.A., Uche, U.E. & Jacobs, D.E. (1993) Gastrin and 
gastrin-related responses to infection with Ostertagia ostertagi in the calf. Research in 
Veterinary Science 54, 384-391.
254
Fox, M.T., Gerrelli, D., Pitt, S.R., Jacobs, D.E., Gill, M. & Gale, D.L. (1989a) Ostertagia 
ostertagi infection in the calf: effects of a trickle challenge on appetite, digestibility, rate of 
passage of digesta and liveweight gain. Research in Veterinary Science 47, 294-298.
Fox, M.T., Gerrelli, D., Pitt, S.R., Jacobs, D.E., Hart, I.C. & Simmonds, A.D. (1987) 
Endocrine effects of a single infection with Ostertagia ostertagi in the calf. International 
Journal fo r  Parasitology 17, 1181-1185.
Fox, M.T., Gerelli, D., Shivalkar, P. & Jacobs, D.E. (1989b) Effect of omeprazole treatment 
on feed intake and blood gastrin and pepsinogen levels in the calf. Research in Veterinary 
Science 46, 280-282.
Frieling, T., Palmer, J.M., Cooke, H.J. & Wood, J.D. (1994) Neuroimmune communication 
in the submucous plexus of guinea pig colon after infection with Trichinella spiralis. 
Gastroenterology 107, 1602-1609.
Gardner, R.C.B. (1911) Parasitic gastritis in sheep and cattle. Journal o f  the South Eastern 
Agricultural College, Wye, Kent 20, 482-493.
Gasbarre, L.C. (1986) Limiting dilution analyses for the quantification of cellular immune 
responses in bovine ostertagiasis. Veterinary Parasitology 20, 133-147.
Gasbarre, L.C., Leighton, E.A. & Davies, C.J. (1993) Influence of host genetics upon 
antibody responses against gastrointestinal nematode infections in cattle. Veterinary 
Parasitology 46, 81 -91.
Gershon, M.D. & Erde, S.M. (1981) The nervous system of the gut. Gastroenterology 80, 
1571-1594.
Gibson, M.E. (1981) The effect of constant and changing temperatures on the development 
rates of the eggs and larvae of Ostertagia ostertagi. Journal o f  Thermal Biology 6, 389-394.
Gordon, H. McL. & Whitlock, H.V. (1939) A new technique for counting nematode eggs in 
sheep faeces. Journal o f  the Council fo r  Scientific and Industrial Research 12, 50.
255
Gottlieb, A.B., Chang, C.K., Posnett, D.N., Fanelli, B. & Tam, J.P. (1988) Detection of 
transforming growth factor-a in normal, malignant and hyperproliferative human 
keratinocytes. Journal o f  Experimental Medicine 167, 670-675.
Gregory, H. (1975) Isolation and structure of urogastrone and its relationship to epidermal 
growth factor. Nature 257, 325-327.
Gregory, H., Thomas, C.E., Young, J.A., Willshire, I.R. & Gamer, A. (1988) The 
contribution o f the C-terminal undecapeptide sequence of urogastrone-epidermal growth 
factor to its biological action. Regulatory Peptides 22, 217-226.
Gregory, P.C. (1985) Parasitic infection and stomach motility: relation to intestinal motility 
and food intake. In Veterinary Research Communication, Vol. 1. The Ruminant Stomach 
(Edited by Ooms, L.A.A., Degryse, A.D. & Marsboom, R.) Janssen Research Foundation, pp 
267-286.
Gresick, E.W., Gubits, R.M. & Barker, T. (1985) In situ localisation of mRNA for epidermal 
growth factor in the submandibular gland of the mouse. Journal o f  Histochemistry and 
Cytochemistry 33, 1235-1240.
Grivel, M.-L. & Ruckebusch, Y. (1972) The propagation of segmental contractions along the 
small intestine. Journal o f  Physiology 227, 611-625.
Grove, D.J., Mahmoud, A.F. & Warren, K.S. (1977) Eosinophils and resistance to 
Trichinella spiralis. Journal o f  Experimental Medicine 145, 755-760
Grundy, D. (1985a) Gastrointestinal smooth muscle. In Gastrointestinal motility: the 
integration o f  physiological mechanisms. MTP Press Limited, Lancaster, England, pp. 1-16.
Grundy, D. (1985b) Extrinsic innervation. In Gastrointestinal motility: the integration o f  
physiological mechanisms. MTP Press Limited, Lancaster, England, pp. 35-56.
256
Grundy, D. (1985c) Neurocrines, endocrines, paracrines. In Gastrointestinal motility: the 
integration o f  physiological mechanisms. MTP Press Limited, Lancaster, England, pp. 57- 
67.
Haot, J., Bogomoletz, W.V., Jouret, A. & Mainguet, P. (1991) Menetrier’s disease with 
lymphocytic gastritis: an unusual association with possible pathogenic implications. Human 
Pathology 22,379-386.
Hargis, A.M., Prieur, D.J. & Blanchard, J.L. (1983) Prevalence, lesions, and differential 
diagnosis of Ollulanis tricuspis infection in cats. Veterinary Pathology 20, 71-79.
Heinova, D., Blahovec, J., Kasafirek, E., Bartik, M. & Rosival, I. (1992) A two-phase 
calorimetric method for the measurement of pepsin activity. Clinica Chimica Acta 213, 103- 
110 .
Herlich, H. & Tromba, F.G. (1982) Vaccine trials with ultraviolet attenuated Ostertagia 
ostertagi in calves. Proceedings o f  the Helminthological Society o f  Washington 49, 71-75.
Hersey, S.J. (1987) Pepsinogen secretion. In Physiology o f  the Gastrointestinal Tract. 2nd 
Edition (edited by Johnson, L.R.) Raven Press, New York, U.S.A. pp 947-957
Hersey, S.J., May, D. & Schyberg, D. (1983a) Stimulation of pepsinogen release from 
isolated gastric glands by cholecystokinin-like peptides. American Journal o f  Physiology 
244,G192-197.
Hersey, S.J., Miller, M., May, D. & Norris, S.H. (1983b) Lack of interaction between acid 
and pepsinogen secretion in isolated gastric glands. American Journal o f  Physiology 245, 
G775-779.
Hersey, S.J., Norris, S.H. & Gibert, A.J. (1984) Cellular control o f pepsinogen secretion. 
Annual Review o f Physiology 46, 393-402.
257
Hertzberg, H., Kohler, L., Deplazes, P., Hacki, W.H. & Eckert, J. (1995) Pathophysiological 
studies of sheep during the build-up of immunity against Ostertagia leptospicularis and after 
a challenge infection. Research in Veterinary Science 58, 14-19.
Higashiyama, S., Abraham, J.A., Miller, J., Fiddes, J.C. & Klagsbrun, M. (1991) A heparin- 
binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251, 
936-939.
Hill, K.J. (1968) Abomasal function. In Handbook o f  Physiology. American Physiological 
Society, Washington D.C., United States of America, pp 2747-2760.
Hill, R.J. & Sternberg, P.W. (1992) The gene lin-3 encodes an inductive signal for vulval 
development in C. elegans. Nature 358, 470-476
Hilderson, H., Berghen, P., Vercruysse, J., Domy, P. & Braem, L. (1989) The diagnostic 
value of pepsinogen for clinical diagnosis. Veterinary Record 125, 376-377.
Hingson, D.J. & Ito, S. (1971) Effect of aspirin and related compounds on the fine structure 
of mouse gastric mucosa. Gastroenterology 61, 156-177.
Hirschowitz, B.I. (1984) Pepsinogen. Postgraduate Medical Journal 60, 743-750.
Hirschowitz, B.I. & Molina, E. (1983) Relation of gastric acid and pepsin secretion to serum 
gastrin levels in dogs given bombesin and gastrin-17. American Journal o f  Physiology 244, 
G546-551.
Hirschowitz, B.I., Molina, E. & Ou Tim, L. (1984) Effects of very low doses of atropine on 
basal acid and pepsin secretion, gastrin and heart rate in normals and DU. Digestive Diseases 
and Sciences 29, 790-796.
Hirst, B.H., Conlon, J.M., Coy, D.H., Holland, J. & Shaw, B. (1982) Comparison of the 
gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and 
somatostatin-14 in cats. Regulatory Peptides 4, 227-237.
258
Hofer, D.R., Sherwood, E.R., Bromberg, W.D., Mendelsohn, J., Lee, C. & Kozlowski. J.M. 
(1991) Autonomous growth of androgen-independent prostatic carcinoma cells: role of 
transforming growth factor-a. Cancer Research 51, 2780-2785.
Hollenberg, M.D. (1994) Tyrosine kinase pathways and the regulation of smooth muscle 
contractility. Trends in Pharmacological Science 15, 108-114.
Holmes, P.H. (1986) Pathophysiology of nematodes. In Parasitology? - Quo vadit. 
Proceedings o f  the Sixth international Congress o f  Parasitology. (Edited by Howell, M.J.) 
Australian Academy of Science. Canberra, Australia, pp 443-451.
Holmes, P.H. & Bremner, K.C. (1971) The pathophysiology of ovine ostertagiasis: water 
balance and turnover studies. Research in Veterinary Science 12, 381-383.
Holmes, P.H. & Maclean, J.M. (1971) The pathophysiology of ovine ostertagiasis: a study of 
the changes in plasma protein metabolism following single infections. Research in 
Veterinary Science 12, 265-271.
Holtenius, P., Uggla, A. & Olsson, G. (1983) Epidemiological studies on Ostertagia 
ostertagi infections in cattle during their first, second and third summer on pasture. Nor disk 
veterinarmedicin 35, 233-238.
Humphreys-Beher, M.G., Macaulery, S.P., Chegini, N., van Setten, G., Purushotham, K., 
Stewart, C., Wheeler, T.T. & Schultz, G.S. (1994) Characterisation of the synthesis and 
secretion of transforming growth factor-alpha from salivary glands and saliva. 
Endocrinology 134, 963-970.
Hunter, A.R. & MacKenzie, G. (1982) The pathogenesis of a single challenge dose of 
Haemonchus contortus in lambs under six months of age. Journal o f  Helminthology 56, 135- 
144.
Huntley, J.F., Newland, G.F.J. & Miller, H.R.P. (1984) The isolation and characterisation of 
globule leukocytes: their derivation from mucosal mast cells in parasitised sheep. Parasite 
Immunology 6, 371-390.
259
Huntley, J.F., Patterson, M., MacKellar, A., Jackson, F., Stevenson, L.M. & Coop, R.L.
(1995) A comparison of the mast cell and eosinophil responses of sheep and goats to 
gastrointestinal nematode infections. Research in Veterinary Science 58, 5-10.
Ibbotson, K.J., Twardzik, D.R., D ’Souza, S.M., Hargreaves, W.R., Todaro, G.J. & Mundy,
G.R. (1985) Stimulation of bone resorption in vitro by synthetic transforming growth factor- 
alpha. Science 228, 1007-1009.
Ichihara, Y., Sogawa, K. & Takahashi, K. (1982) Rat gastric prepepsinogen: In vitro 
synthesis and partial amino-terminal signal sequence. Journal o f  Biochemistry (Tokyo) 92, 
603-606.
Ishaque, M. & Bardhan, K.D. (1978) An assessment of the radial diffusion method for the 
measurement o f pepsin in gastric secretion and its comparison with the haemoglobin 
substrate colorimetric method. Clinica Chimica Acta 87, 259-263.
Jarrett, W.F.H., Miller, H.R.P. & Murray, M. (1967) The relationships between mast cells 
and globule leucokytes in parasitic infections. Veterinary Record 80, 505-596.
Jeffcoate, I.A., Holmes, P.H., Fishwick, G., Boyd, J., Bairden, K. & Armour, J. (1988) 
Effects of trichostrongyle larval challenge on the reproductive performance of immune ewes. 
Research in Veterinary Science 45, 234-239.
Jennings, F.W., Armour, J., Lawson, D.D. & Roberts, R. (1966) Experimental Ostertagia 
ostertagi infections in calves: studies with abomasal cannulas. American Journal o f  
Veterinary Research 27, 1249-1257.
Jensen, P.T. & Nansen, P. (1978) Immunoglobulins in bovine ostertagiasis. Acta Veterinaria 
Scandinavica 19, 601-603.
Jhappan, C., Stahle, C., Harkins, R.N., Fausto, N., Smith, G.H. & Merlino, G.T. (1990) 
TGF-a overexpression in transgenic mice induces liver neoplasia and abnormal development 
of the mammary gland and pancreas. Cell 61, 1137-1146.
260
Johnson, L.R. (1972) Regulation of pepsin secretion by topical acid in the stomach. 
American Journal o f  Physiology 223, G847-850.
Johnson, L.R. & Guthrie, P.D. (1980) Stimulation of rat oxyntic gland mucosal growth by 
epidermal growth factor. American Journal o f  Physiology 238, G45-49.
Kaiser, L., Lamb, V.L., Tithof, P.K., Gage, D.A., Chamberlin, B.A., Watson, J.T. & 
Williams, J.F. (1992) Dirofilaria immitis: do filarial cyclooxygenase products depress 
endothelium-dependant relaxation in the in vitro rat aorta? Experimental Parasitology 75, 
159-167.
Kang, J.Y., Tang, K.F., Goh, A., Sundram, F.X. & Seah, C.S. (1990) Remission of 
Menetrier’s disease associated with ranitidine administration. Australia and New Zealand 
Journal o f  Medicine 20, 716-717.
Karam, S.M. (1993) Dynamics of epithelial cells in the “corpus” of the mouse stomach. IV. 
Bidirectional migration of parietal cells ending in their gradual degeneration and loss. The 
Anatomical Record 236, 314-322.
Karam, S.M. & Leblond, C.P. (1992) Identifying and counting all epithelial cell types 
present in the “corpus” of the mouse stomach. The Anatomical Record 232, 231-246.
Karam, S.M. & Leblond, C.P. (1993a) Dynamics of epithelial cells in the “corpus” of the 
mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cell. 
The Anatomical Record 236, 259-279.
Karam, S.M. & Leblond, C.P. (1993b) Dynamics of epithelial cells in the “corpus” of the 
mouse stomach. II. Outward migration of pit cells. The Anatomical Record 236, 280-296.
Karam, S.M. & Leblond, C.P. (1993c) Dynamics of epithelial cells in the “corpus” of the 
mouse stomach. III. Inward migration of neck cells followed by progressive transformation 
into zymogenic cells. The Anatomical Record 236, 297-313.
261
Karam, S.M. & Leblond, C.P. (1993d) Dynamics of epithelial cells in the “corpus” of the 
mouse stomach. V. Behaviour of entero-endocrine and caveolated cells: General conclusions 
on cell kinetics in the oxyntic epithelium. The Anatomical Record 236, 333-340.
Kaskebar, D.K., Jensen, R.T. & Gardner, J.D. (1983) Pepsinogen secretion from dispersed 
glands from rabbit stomach. American Journal o f  Physiology 244, G392-396.
Kelly, D.G., Miller, L.J., Maldagelada, J.R., Huizenga, K.A. & Markowitz, H. (1982) Giant 
hypertrophic gastropathy (Menetrier’s disease): pharmacologic effects on protein leakage 
and mucosal ultrastructure. Gastroenterology 83, 581-589.
Kelly, S.M. & Hunter, J.O. Epidermal growth factor stimulates synthesis and secretion of 
mucus glycoproteins in human gastric mucosa. Clinical Science 790, 425-427.
Kirkpatrick, C.E., Lok, J.B., Goldschmidt, M.H. & Mellman, S.L. (1987) Gastric 
gnathostomiasis in a cat. Journal o f  the American Veterinary Medical Association 190, 
1437-1439.
Klesius, P.H. (1988) Immunity to Ostertagia ostertagi. Veterinary Parasitology 27, 159-167.
Klesius, P.H. (1993) Regulation of immunity to Ostertagia ostertagi. Veterinary 
Parasitology 46, 63-79.
Klesius, P.H., Haynes, T.B. & Cross, D.A. (1985) Chemotactic factors for eosinophils in 
soluble extracts of L3 stages of Ostertagia ostertagi. International Journal fo r  Parasitology 
15,517-522.
Klesius, P.H., Snider, III, T.G., Horton, L.W. & Crowder, C.H. (1989) Visualisation of 
eosinophil chemotactic factor in abomasal tissue of cattle by immunoperoxidase staining 
during Ostertagia ostertagi infection. Veterinary Parasitology 31, 49-56.
Klesius, P.H., Washburn, S.M., Ciordia, H., Haynes, T.B. & Snider, III, T.G. (1984) 
Lymphocyte reactivity to Ostertagia ostertagi L3 antigen in type I ostertagiasis. American 
Journal o f Veterinary Research 45, 230-233.
262
Kloosterman, A., Borgsteede, F.H.M. & Eysker, M. (1984) The effect of experimental 
Ostertagia ostertagi infections in stabled milking cows on egg output, serum pepsinogen 
levels, antibody titres and milk production. Veterinary Parasitology 17, 299-308.
Koelz, H.R., Hersey, S.J., Sachs, G. & Chew, C.S. (1982) Pepsinogen release from isolated 
gastric glands. American Journal o f  Physiology 243, G218-225.
Koldovsky, O., Bedrick, A. & Rao, R.K. (1991) Role of milk-borne prostaglandins and 
epidermal growth factor for the suckling mammal. Journal o f  the American College o f  
Nutritionists 10, 17-23.
Komorowski, R.A. & Caya, J.G. (1991) Hyperplastic gastropathy. Clinicopathologic 
correlation. American Journal o f  Surgical Pathology 15, 577-585.
Konturek, S.J., Birenat, J., Kwiecien, N. & Oleksy, J. (1975) Effect of glucagon on meal- 
induced gastric secretion in man. Gastroenterology 68, 448-454.
Konturek, S.J. Cieszkowski, M., Jaworek, J., Konturek, J., Brzozowski, T. & Gregory, H. 
(1984) Effects of epidermal growth factor on gastrointestinal secretions. American Journal o f  
Physiology 246, G580-586.
Konturek, S.J., Dembinski, A., Warzecha, Z., Brzozowski, T. & Gregory, H. (1988) Role of 
epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. 
Gastroenterology 94, 1300-1307.
Konturek, S.J., Radecki, T., Brzozowski, T., Piastucki, I., Dembinski, A., Dembinska-Kiec, 
A., Zmuda, A., Gryglewski, R. & Gregory, H. (1981) Gastric cytoprotection by epidermal 
growth factor. Gastroenterology 81, 438-443.
Langley, J.N. (1881) On the histology and physiology of pepsin-forming glands. 
Philosophical Transcripts o f  the Royal Society o f  London B, 172, 664-711.
263
Leblanc, B., Fox, J.G., Le Net, J.L., Masson, M.T. & Picard, A. (1993) Hyperplastic gastritis 
with intraepithelial Campylobacter-like organisms in a Beagle dog. Veterinary Pathology 30, 
391-394.
Lee, D.C., Fenton, S.E., Berkowitz, E.A. & Hissong, M.A. (1995) Transforming Growth 
Factor-a: expression, regulation, and biological activities. Pharmacological Reviews 47, 51- 
85.
Lee, D.L. (1970).The fine structure of the excretory system in adult Nippostrongylus 
brasiliensis (Nematoda) and a suggested function for the ‘excretory glands’. Tissue Cell 2, 
225.
Leland., S.E. Jr, Drudge, J.H., Wyant, Z.N. & Elam, G.W. (1961) Studies on 
Trichostrongylus axei (Cobbold, 1879). VII. Some quantitative and pathologic aspects of 
natural and experimental infections in the horse. American Journal o f  Veterinary Research 
22, 128-138.
Leyva, V., Henderson, A.E. & Sykes, A.R. (1982) Effect of daily infection with Ostertagia 
circumcincta larvae on food intake, milk production and wool growth. Journal o f  
Agricultural Science 99, 249-259.
Loggins, P.E., Swanson, L.E. & Koger, M. (1965) Parasite levels in sheep as affected by 
heredity. Journal o f  Animal Science 24 (abstract), 286-287.
Luetteke, N.C., Lee, D.C., Palmiter, R.D., Brinster, R.L. & Sandgren, E.P. (1993) Regulation 
of fat and muscle development by TGF-a in transgenic mice and cultured cells. Cell Growth 
and Differentiation 4,203-213.
Lushbaugh, C.C. (1947) Experimental hyperplastic gastritis and gastric polyposis in 
monkeys. Journal o f  the National Cancer Institute 7, 313-320.
MAFF/ADAS (1984a) Determination of plasma pepsinogen. In Manual o f  laboratory 
investigation, laboratory techniques, Vol 2, 3rd edition. Reference book no. 390, HMSO, pp 
47-48.
264
MAFF/ADAS (1984b) Nematode faecal egg counts. In Manual o f  laboratory investigation, 
laboratory techniques, Vol 2, 3rd edition. Reference book no. 390, HMSO, pp 162-165.
Maizels, R.M., Blaxter, M.L., Robertson, B.D. & Selkirk, M.E. (1991) Protein determination 
by the Bradford method. In Parasite antigens Parasite genes. A Laboratory Manual for  
Molecular Parasitology. Cambridge University Press, Cambridge, England, pp 17-18.
Mamber, L. & Gershon, M.O. (1979) A reciprocal adrenergic-cholinergic axoaxonic synapse 
in the mammalian gut. American Journal o f  Physiology 236, E73 8-745.
Mapes, C.J. & Coop, R.L. (1970) The interaction of infections of Haemonchus contortus and 
Nematodirus battus in lambs. Journal o f  Comparative Pathology 80, 123-136.
Marom, A. & Casale, T.B. (1983) Mast cells and their mediators. Annales Allergy 50, 367- 
370.
Marquardt, H., Hunkapiller, M.W., Hood, L.E. & Todaro, G.J. (1984) Rat transforming 
growth factor type 1: structure and relation to epidermal growth factor. Science 223, 1079- 
1082.
Martin, W.B., Thomas, B.A.C. & Urquhart, G.M. (1957) Chronic diarrhoea in housed cattle 
due to atypical parasitic gastritis. Veterinary Record 69, 736-739.
Massague, J. (1983) Epidermal growth factor-like transforming growth factor. II. Interaction 
with epidermal growth factor receptors in human placental membranes and A431 cells. 
Journal o f  Biological Chemistry 258, 13614- 13620.
McGuigan, J.E. (1983) Zollinger-Ellison syndrome. In Gastrointestinal Disease (edited by 
Sleisinger, M.H. & Fordtran, J.S.) Vol 1. 3rd Edn. WB Saunders Co. pp 693-707.
McKellar, Q.A. & Bogan, J.A. (1987) Effect of sodium cromoglycate on the response to 
Ostertagia circumcincta in adult sheep. Research in Veterinary Science 43, 157-159.
265
McKellar, Q.A., Duncan, J.L., Armour, J., Lindsay, F.E.F. & McWilliam, P. (1987) Further 
studies on the response to transplanted adult Ostertagia ostertagi in calves. Research in 
Veterinary Science 42, 29-34.
McKellar, Q.A., Duncan, J.L., Armour, J. & McWilliam, P. (1986) Response to transplanted 
adult Ostertagia ostertagi in calves. Research in Veterinary Science 40, 367-371.
McKellar, Q.A., Mostofa, M. & Eckersall P.D. (1990a) Effect of Ostertagia ostertagi 
secretions and various putative secretagogues and inhibitors on aminopyrine accumulation in 
dispersed bovine abomasal gland cells. Research in Veterinary Science 49, 323-326.
McKellar, Q.A., Mostofa, M. & Eckersall P.D. (1990b) Stimulated pepsinogen secretion 
from dispersed abomasal glands exposed to Ostertagia spp. secretions. Research in 
Veterinary Science 48, 6-11.
McLaren, D.J., Burt, J.S. & Ogilvie, B.M. (1974) The anterior glands o f adult Necator 
americanus (Nematoda; Strongyloidea) - II cytochemical and functional studies.. 
International Journal fo r  Parasitology 4, 39.
McLeay, L.M., Anderson, N., Bingley, J.B. & Titchen, D.A. (1973) Effects on abomasal 
function o f Ostertagia circumcincta infections in sheep. Parasitology 66, 241-257.
McClure, S.J., Emery, D.L., Wagland, B.M. & Jones, W.O. (1992) A serial study of 
rejection of Trichostrongylus colubriformis by immune sheep. International Journal o f  
Parasitology 22, 227-234.
Michel, J.F., Lancaster, M.B. & Hong, C. (1973) Ostertagia ostertagi: protective immunity 
in calves. The development in calves of a protective immunity to infection with Ostertagia 
ostertagi. Experimental Parasitology 33, 179-186.
Michel, J.F., Lancaster, M.B., Hong, C. & Berrett, S. (1978) Plasma pepsinogen levels in 
some experimental infections o f Ostertagia ostertagi in cattle. Veterinary Record 103, 370- 
373.
266
Miettinen, P.J. (1993) Transforming growth factor-alpha and epidermal growth factor 
expression in human foetal gastrointestinal tract. Paediatric Research 33, 481-486.
Miller, H.R.P. (1984) The protective mucosal response against gastrointestinal nematodes in 
ruminants and laboratory animals. Veterinary Immunology and Immunopathology 6, 167- 
259.
Miller, H.R.P., Jackson, F., Newlands, G. & Appleyard, W.T. (1983) Immune exclusion, a 
mechanism of protection against the ovine nematode Haemonchus contortus. Research in 
Veterinary Science 35, 357.
Moore, G.P.M., Panaretto, B.A. & Robertson, D. (1982) Inhibition of wool growth in merino 
sheep following administration of mouse epidermal growth factor and a derivative. 
Australian Journal o f  Biological Science 35, 163-172.
Moore, G.P.M., Panaretto, B.A. & Robertson, D. (1983) Epidermal growth factor delays the 
development of the epidermis and the hair follicles of mice during growth of the first coat. 
Anatomical Record 205, 47-55.
Mostofa, M. (1989a) Biological studies on abomasal acid protease precursors in domestic 
ruminants. PhD Thesis. University of Glasgow, pp 31-32.
Mostofa, M. (1989b) Biological studies on abomasal acid protease precursors in domestic 
ruminants. PhD Thesis. University of Glasgow, pp 8-11.
Mostofa, M. & McKellar, Q.A. (1989) Effect of an anti-muscarinic drug on the plasma 
pepsinogen activity o f sheep infected with Ostertagia circumcincta. Research in Veterinary 
Science 47, 208-211.
Mostofa, M., McKellar, Q.A. & Eckersall, P.D. (1990a) Comparison of pepsinogen forms in 
cattle, sheep and goats. Research in Veterinary Science 48, 33-37.
267
Mostofa, M., McKellar, Q.A., Eckersall, P.D. & Gray, D. (1990b) Pepsinogen types in 
worm-free sheep and in sheep infected with Ostertagia circumcincta and Haemonchus 
contortus. Research in Veterinary Science 48, 108-111.
Murayama, Y., Miyagawa, J.-I., Higashiyama, S., Kondo, S., Yabu, M., Isozaki, K., 
Kayanoki, Y., Kanayama, S., Shinomura, Y., Taniguchi, N. & Matsuzawa, Y. (1995) 
Localisation of heparin-binding epidermal growth factor-like growth factor in human gastric 
mucosa. Gastroenterology 109, 1051-1059.
Murray, M. (1969) Structural changes in bovine ostertagiasis associated with increased 
permeability of the bowel wall to macromolecules. Gastroenterology 56, 763-772.
Murray, M. (1970) The fine structure of bovine gastric epithelia. Research in Veterinary 
Science 11, 411-416
Murray, M., Jennings, F.W. & Armour, J. (1970) Bovine ostertagiasis: structure, function 
and mode of differentiation of the bovine gastric mucosa and kinetics of the worm loss. 
Research in Veterinary Science 11, 417-427.
Nair, K.P.C. & Damodoran, S. (1969) Chronic hypertrophic gastritis in equines. Indian 
Journal o f  Animal Health 8, 137-139.
Nanney, L.B., Magid, M., Stoscheck, C.M. & King, L.E. (1984) Comparison of epidermal 
growth factor binding and receptor distribution in normal human epidermis and appendages. 
Journal o f  Investigative Dermatology 83, 385-393.
Nawa, Y., Ishikawa, N., Tsuchiya, K., Horii, Y., Abe, T., Khan, A.I., Bing-Shi, Itoh, H., Ide, 
H. & Uchiyama, F. (1994) Selective effector mechanisms for the expulsion of intestinal 
helminths. Parasite Immunology 16, 333-338.
Nelson, F.K., Albert, P.S. & Riddle, D.L. (1983) Fine structure of the Caenorhabditis 
elegans Secretory-Excretory system. Journal o f  Ultrastructure Research 82, 156-171.
268
Nicholls, C.D., Lee, D.L. & Sharpe, M.J. (1985) Scanning electron microscopy of biopsy 
specimens removed by a colonoscope from the abomasum of sheep infected with 
Haemonchus contortus. Parasitology 90, 357-363.
Occena, R.O., Taylor, S.F., Robinson, C.C. & Sokol, R.J. (1993) Association of 
cytomegalovirus with Menetrier’s disease in childhood: report o f two new cases with a 
review of literature. Journal o f  Paediatric Gastroenterology and Nutrition 17, 217-224.
Oderda, G., Cinti, S., Cangiotti, A.M., Fomi, M. & Ansaldi, N. (1990) Increased tight 
junction width in two children with Menetrier’s disease. Journal o f  Paediatric 
Gastroenterology and Nutrition 11, 123-127.
Ogilvie, B.M., Rothwell, T.L., Bremner, K.D., Schnitzerling, H.J., Nolan, J. & Keith, R.K. 
(1973) Acetylcholinesterase secretion by parasitic nematodes. I. Evidence for secretion of the 
enzyme by a number of species. International Journal fo r  Parasitology 3, 589-597.
Ohmura, E., Okada, M., Onoda, N., Kamiya, Y., Murakami, H., Tsushima, T. & Shizume, K. 
(1990) Insulin-like growth factor I and transforming growth factor-a as autocrine growth 
factors in human pancreatic cancer cell growth. Cancer Research 50, 103-107.
Opleta-Madsen, K., Hardin, J. & Gall, D.G. (1991) Epidermal growth factor upregulates 
intestinal electrolyte and nutrient transport. American Journal o f  Physiology 260, G807-814.
Opperman, C.H. & Chang, S. (1992) Nematode acetylcholinesterases: molecular forms and 
their potential role in nematode behaviour. Parasitology Today 8, 406-411.
Osborne, J.C., Batte, E.G. & Bell, R.R. (1960) The pathology following single infections of 
Ostertagia ostertagi in calves. Cornell Veterinarian 50, 223-235.
Ostertag, R. (1890) Eine neue strongylus-art im labmagen des rindes. Zeitschrift fu r  Fleisch. 
unt Milchyg 1, 4.
269
Palmer, J.M. & Castro, G.A. (1986) Anamnestic stimulus-specific myoelectric responses 
associated with intestinal immunity in the rat. American Journal o f  Physiology 250, G266- 
273.
Palmer, J.M., Weisbrodt, N.W. & Castro, G.A. (1984) Trichinella spiralis: intestinal 
myoelectric activity during enteric infection in the rat. Experimental Parasitology 57, 132- 
141.
Pandey, V.S. (1972a) Effect of temperature on the development of the free-living stages of 
Ostertagia ostertagi. Journal o f  Parasitology 58, 1037-1041.
Pandey, V.S. (1972b) Effect of temperature on the survival o f the free-living stages of 
Ostertagia ostertagi. Journal o f  Parasitology 58, 1042-1046.
Parkins, J.J., Bairden, K. & Armour, J .( l982) Ostertagia ostertagi in calves: a growth, 
nitrogen balance and digestibility study conducted during winter feeding following 
thiabendazole anthelmintic therapy. Journal o f  Comparative Pathology 92, 219-227.
Parkins, J.J. & Holmes, P.H. (1989) Effects of gastrointestinal helminth parasites on 
ruminant nutrition. Nutrition Research Reviews 2, 227-246.
Patel, M. & Spraggs, C.F. (1992) Functional comparisons of gastrin/cholecystokinin 
receptors in isolated preparations of gastric mucosa and ileum. British Journal o f  
Pharmacology 106, 275-282.
Paul, W.E., Seder, R.A. & Plaut, M. (1993) Lymphokine and cytokine production by FceR1+ 
cells. Advances in Immunology 53, 1-29.
Paynter, D.I. (1992) In Australian standard diagnostic techniques fo r  animal diseases, 
Standing Committee of Agriculture, CSIRO, Australia.
Perdue, M.H. & McKay, D.M. (1993) Immunomodulation of the gastrointestinal epithelium. 
In Immunopharmacology o f  the gastrointestinal system. (Edited by Wallace, J.) Academic 
Press, New York, United States of America, pp. 14-39.
270
Plaut, M., Pierce, J.H., Watson, C.J., Hankey-hyde, J., Nordan, R.P. & Paul, W.E. (1989) 
Mast cell lines produce lymphokines in response to cross-linkage of FceRI or to calcium 
ionophores. Nature 339, 64-67.
Playford, R.J., Marchbank, T., Calnan, D.P., Calam, J., Royston, P., Batten, J.J. & Hansen,
H.F. (1995) Epidermal growth factor is digested to smaller, less active forms in acidic gastric 
juice. Gastroenterology 108, 92-101.
Preston, J.M. & Allonby, E.W. (1979) The influence of breed on the susceptibility of sheep 
to Haemonchus contortus infections in Kenya. Research in Veterinary Science 26, 134-139.
Pritchard, D.I. (1993) Points in question. Why do some parasitic nematodes secrete 
acetylcholinesterase (AChE)? International Journal fo r  Parasitology 23, 549-550.
Ransom, B.H. (1906) The life history of the twisted wire worm {Haemonchus contortus) of 
sheep, cattle and other ruminants. Circular 93, U.S.D.A. Bureau Animal Industry, 1-7.
Ransom, B.H. (1911) The nematodes parasitic in the alimentary tract of cattle, sheep and 
other ruminants. United States Department o f  Agriculture Bulletin 127, p 132
Rao, R.K., Koldovsky, O., Korc, M., Pollack, P.F., Wright, S. & Davis, T.P. (1990) 
Processing and transfer of epidermal growth factor in developing rat jejunum and ileum. 
Peptides 11, 1093-1102.
Raufman, J.-P., Kaskebar, D.K., Jensen, R.T., & Gardner, J.D. (1983) Potentiation of 
pepsinogen secretion from dispersed glands from rat stomach. American Journal o f  
Physiology 245, G525-530.
Raufman, J.-P., Sutliff, V.E., Kaskebar, D.K., Jensen, R.T., & Gardner, J.D. (1984) 
Pepsinogen secretion from dispersed chief cells from guinea pig stomach. American Journal 
o f  Physiology 247, G95-104.
271
Raynaud, J.P. & Bouchet, A. (1976) Bovine ostertagiosis, a review. Analysis of types and 
syndromes found in France by post mortem examinations and total worm counts. Annales 
des Recherches Veterinaires 7, 253-280.
Reid, J.F.S. & Murray, M. (1973) Ovine parasitic gastro-enteritis. Clinical aspects and 
pathology. In Helminth diseases in cattle sheep and horses in Europe (Edited by Urquhart, 
G.M. & Armour, J.) Robert MacLehose and Company Ltd., Glasgow, Scotland, pp 32-35.
Reindel, J.F., Trapp, A.L., Armstrong, P.J. & Stickle, R.L. (1987) Recurrent plasmacytic 
stomatitis-pharyngitis, fibrosing gastritis and gastric nematodiasis. Journal o f  the American 
Veterinary Medical Association 190, 65-67.
Reiner, S.L. (1994) Parasites and T helper cell development: some insights. Parasitology 
Today 10, 485-488.
Reynolds, G.W., Anderson, N., Stiffe, G., Hansky, J. & Titchen, D.A. (1979) Ovine tissue 
and serum gastrin in ostertagiasis. Annales des Recherches Veterinaires 10, 341-343.
Rhodes, J.A., Tam, J.P., Finke, U., Saunders, M., Bemanke, J., Silen, W. & Murphy, R.A.
(1986) Transforming growth factor a  inhibits secretion of gastric acid. Proceedings o f  the 
National Academy o f  Sciences o f  the U.S.A. 83, 3844-3846.
Rikihisa, Y. & Hammerberg, B. (1982) Stimulation of hypersecretion in stomach mucosal 
cells of rats by in vitro products of ostertagia larvae. Proceedings o f  the American 
Association o f  Veterinary Parasitologists (Abstract), 17.
Ritchie, J.D.S., Anderson, N., Armour, J., Jarrett, W.F.H., Jennings, F.W. & Urquhart, G.M. 
(1966) Experimental Ostertagia ostertagi infections in calves: parasitology and pathogenesis 
of a single infection. American Journal o f  Veterinary Research 27, 659-667.
Roberts, A.B., Lamb, L.C., Newton, D.L., Spom, M.B., De Larco, J.E. & Todaro, G.J. 
(1980) Transforming growth factors: isolation of polypeptides from virally and chemically 
transformed cells by acid/ethanol extraction. Proceedings o f  the National Academy o f  
Sciences o f  the U.S.A. 77, 3494-3498.
272
Romano, M., Polk, W.H., Awad, J.A., Arteaga, C.L., Nanney, L.B., Wargovich, M.J., Kraus, 
E.R., Boland, C.R. & Coffey, R.J. (1992) Transforming growth factor-a protection against 
drug-induced injury to the rat gastric mucosa in vivo. Journal o f  Clinical Investigation 90, 
2409-2421.
Rose, J.H. (1961) Some observations on the free-living stages of Ostertagia ostertagi, a 
stomach worm of cattle. Parasitology 85, 21-25.
Ross, J.G. & Dow, C. (1965) The course and development of the abomasal lesions in calves 
experimentally infected with the nematode parasite Ostertagia ostertagi. British Veterinary 
Journal 121, 228-233.
Ross, J.G. & Todd, J.R. (1965) Biochemical, serological and haematological changes 
associated with infections in calves with the nematode parasite Ostertagia ostertagi. British 
Veterinary Journal 121, 55-64.
Rothwell, T.L.W. & Dineen, J.K. (1972) Cellular reactions in guinea pigs following primary 
and challenge infection with Trichostrongylus colubriformis with special reference to the 
roles played by eosinophils and basophils in rejection of the parasite. Immunology 22, 733- 
745.
Ruckebusch, Y. (1970) The electrical activity of the digestive tract o f the sheep as an 
indication of the mechanical event in various regions. Journal o f  Physiology. 210, 857-882.
Ruckebusch, Y. (1981) Motor functions of the intestine. Advances in Veterinary Science and 
Comparative Medicine 25, 345-369.
Sack, J. & Spenney, J.G. (1982) Aminopyrine accumulation by mammalian gastric glands: 
an analysis of the technique. American Journal o f  Physiology 243, G 313-319.
Salman, S.K. & Duncan, J.L. (1984) The abomasal histology of worm-free sheep given 
primary and challenge infections of Haemonchus contortus. Veterinary Parasitology 16, 43- 
54.
273
Samloff, I.M. (1971a) Pepsinogens, pepsins and pepsin inhibitors. Gastroenterology 60, 586- 
604.
Samloff, I.M. (1971b) Cellular localisation of group I pepsinogens in human gastric mucosa 
by immunofluorescence. Gastroenterology 61, 185-188.
Samloff, I.M. (1983) In Pepsinogens and pepsins in gastrointestinal disease. Smith, Kline 
and French International Company, England pp. 60.
Samloff, I.M. & Liebman, W.M. (1972) Purification and immunochemical characterization 
of group II pepsinogens in human seminal fluid. Clinical and Experimental Immunology 11, 
405-414.
Samloff, I.M. & Liebman, W.M. (1973) Cellular localisation of the group II pepsinogens in 
human stomach and duodenum. Gastroenterology 65, 36-42.
Sanders, M.J., Amirian, D.A., Ayalon, A. & Soil, A. (1983) Regulaion of pepsinogen release 
from canine chief cells in primary monolayer culture. American Journal o f  Physiology 254, 
G641-646.
Sandgren, E.P., Luetteke, N.C., Palmiter, R.D., Brinster, R.L. & Lee, D.C. (1990) 
Overexpression of TGF-a in transgenic mice: induction of epithelial hyperplasia, pancreatic 
metaplasia, and carcinoma of the breast. Cell 61, 1121-1135.
Sandweiss, D.J., Saltzstein, H.C. & Farbman, A. (1938) The prevention or healing of 
experimental peptic ulcer in Mann-Williamson dogs with the anterior pituitary-like hormone 
(Antuitrin-S). American Journal Digestive Diseases 5, 24-30.
Sasada, R., Ono, Y., Taniyama, Y., Shing, Y., Folkman, J. & Igarashi, K. (1993) Cloning 
and expression of cDNA encoding human betacellulin, a new member of the EGF family. 
Biochemical and Biophysical Research Communications 190, 1173-1179.
Savage, C.R.Jr., Inagimi, T. & Cohen, S. (1972) The primary structure of epidermal growth 
factor. Journal o f  Biological Chemistry 247, 7612-7621.
274
Schanbacher, L.M., Nations, J.K., Weisbrodt, N.W. & Castro, G.A. (1978) Intestinal 
myoelectric activity in parasitised dogs. American Journal o f  Physiology 234, R188-195.
Schmidt, W.E., Schenk, S., Nustede, R., Holst, J.J., Folsch, U.R. & Creutzfeldt, W. (1994) 
Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of 
gastrin in humans. Gastroenterology 107, 1610-1620.
Schreiber, A.B., Winkler, M.E. & Derynck, R. (1986) Transforming growth factor-a: a more 
potent angiogenic mediator than epidermal growth factor. Science 232, 1250-1253.
Schugerman, R.P., Hirschowitz, B.I., Bhown. A.S., Schronkenloher, R.E. & Spenney, J.G. 
(1982) A unique “mini” pepsinogen isolated from bullfrog esophageal glands. Journal o f  
Biological Chemistry 257, 795-798.
Schultz, G.S., White, M., Mitchell, R., Brown. G., Lynch, J., Twardzik, D.R. & Todaro, G.J. 
(1987) Epithelial wound healing enhanced by transforming growth factor-a and vaccinia 
growth factor. Science 235, 350-352.
Schultz, G.S., Chegini, N., Grant, M., Khaw, P. & MacKay, S. (1992) Effects of growth 
factors on corneal wound healing. Acta Ophthalmologica 70, 60-66.
Schultz, W.H. (1910) Physiological studies in anaphylaxis. I. The reaction of smooth muscle 
of guinea pig sensitised with horse serum. Journal o f  Pharmacology and Experimental 
Therapeutics 1, 549-567.
Schwartz, L.B. (1984) Structure and function of the chemical mediators of mast cells. 
Progress in Allergy 34, 271-321
Shapiro, S.S. & Wilk, M.B. (1965) An analysis of variance test for normality (complete 
samples). Biometrika 52, 591-611.
Shing, Y., Christofori, G., Hanahan, D., Ono, Y., Sasada, R., Igarashi, K. & Folkman, J. 
(1993) Betacellulin: a mitogen from pancreatic (3 cell tumours. Science 259, 1604-1607.
275
Shirakawa, T. & Hirschowitz, B.I. (1986) Seasonal fluctuations in pepsinogen secretion from 
frog esophageal peptic glands. American Journal o f  Physiology 250, G484-488.
Shoyab, M., McDonald, V.L., Bradley, J.G. & Todaro, G.J. (1988) Amphiregulin: a 
bifunctional growth-modulating glycoprotein produced by the phorbol 12-myrisate- 13- 
acetate-treated human breast adenocarcinoma cell line MCF-7. Proceedings o f  the National 
Academy o f Sciences o f  the U.S.A. 85, 6528-6532.
Silverman, P.H. & Patterson, J.E. (1960) Histotrophic (parasitic) stages of Haemonchus 
contortus. Nature 185, 54-55.
Sinski, E., Bairden, K., Duncan, J.L., Eisler, M.C., Holmes, P.H., McKellar, Q.A., Murray, 
M. & Stear, M.J. (1995) Local and plasma antibody responses to the parasitic larval stages of 
the abomasal nematode Ostertagia circumcincta. Veterinary Parasitology 59, 107-118.
Skinner, K.A., Soper, B.D. & Tepperman. B.L. (1984) Effect of sialoadenectomy and 
salivary gland extracts on gastrointestinal mucosal growth and gastrin levels in the rat. 
Journal o f  Physiology 35, 1-12.
Smith, J.J., Derynck, R. & Korc, M. (1987) Production of transforming growth factor-a in 
human pancreatic carcinoma cells: evidence for a superagonist autocrine cycle. Proceedings 
o f the National Academy o f  Sciences o f  the U.S.A. 84, 7567-7570.
Smith, J.M., Spom, M.B., Roberts, A.B., Derynck, R., Winkler, M.E. & Gregory, H. (1985) 
Human transforming growth factor-alpha causes precocious eyelid opening in newborn mice. 
Nature 315, 515-516.
Smith, W.D., Jackson, F., Jackson, E. & Williams, J. (1983) Local immunity and Ostertagia 
circumcincta: changes in the gastric lymph of immune sheep after a challenge infection. 
Journal o f Comparative Pathology 93, 479-488.
Smith, W.D., Jackson, F., Jackson, E. & Williams, J. (1985) Age immunity to Ostertagia 
circumcincta: comparison o f the local immune responses of 4 1/2 and 10 month old lambs. 
Journal o f Comparative Pathology 95, 235-245.
276
Smithy W.D., Jackson, F., Jackson, E., Williams, J. & Miller, H.R.P. (1984) Manifestations 
of resistance to ovine ostertagiasis associated with immunological responses in the gastric 
lymph. Journal o f  Comparative Pathology 94,591-601.
Snedecor, G. W. & Cochran, W.G. (1980) In Statistical methods. Iowa State University 
Press, Ames. 7th edition, pp 393-413.
Snider, III, T.G., Ochoa, R. & Williams, J.C. (1983) Menetrier’s disease. Pre-type II and 
type II ostertagiosis in cattle. American Journal o f  Pathology 113, 410-412.
Snider, III, T.G., Klesius, P.H. & Haynes, T.B. (1985a) Dermal responses to Ostertagia 
ostertagi and Cooperia punctata-mfzcted calves. American Journal o f  Veterinary Research 
46, 887-890.
Snider, III, T.G., Williams, J.C., Karns, P.A., Romaire, T.L., Trammel, H.E. & Kearney, 
N.T. (1986) Immunosuppression of lymphocyte blastogenesis in cattle infected with 
Ostertagia ostertagi and/or Trichostrongylus axei. Veterinary Immunology and 
Immunopathology 11, 251-264.
Snider, III, T.G., Williams, J.C., Karns, P.A., Markovits, J.E. & Romaire, T.L. (1988) High 
concentration of serum gastrin immunoreactivity and abomasal mucosal hyperplasia in 
calves infected with Ostertagia ostertagi and/or Trichostrongylus axei. American Journal o f  
Veterinary Research 49, 2101-2104.
Sogawa, K., Fujii-Kuriyama, Y., Mizukami, Y., Ichihara, Y. & Takahashi, K. (1983) 
Primary structure of human pepsinogen gene. Journal o f  Biological Chemistry 258, 5306- 
5311.
Soil, A.H. & Berglindh, T. (1987) Physiology of isolated gastric glands and parietal cells: 
Receptors and effectors regulating function. In Physiology o f  the Gastrointestinal Tract. 2nd 
Edition (edited by Johnson, L.R.) Raven Press, New York. U.S.A. pp 883-906
277
Stead, R.H., Tomioka, M., Quinonez, G., Simon, G.T., Feltsen, S.Y. & Bienenstock, J.
(1987) Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in 
intimate contact with peptidergic nerves. Proceedings o f  the National Academy o f  Sciences 
o f the USA 84, 2975-2979.
Stead, R.H., Kosecka-Janiszewska, U., Oestreicher, A.B., Dixon, M.F. & Bienenstock, J. 
(1991) Remodelling of B-50 Gap-43 and NSE-immunoreactive mucosal nerves in the 
intestines of rats infected with Nippostrongylus brasiliensis. Journal o f  Neuroscience 11, 
3809-3821.
Stear, M.J., Bairden, K., Duncan, J.L., Gettinby, G., McKellar, Q.A., Murray, M. & Wallace, 
D.S. (1995a) The distribution of faecal nematode egg counts in Scottish Blackface lambs 
following natural, predominantly Ostertagia circumcincta infection. Parasitology 110, 573- 
581.
Stear, M.J., Bishop, S.C., Doligalska, M., Duncan, J.L., Holmes, P.H., McCririe, L., 
McKellar, Q.A., Sinski, E. & Murray, M. (1995b) Regulation of egg production, worm 
burden, worm length and worm fecundity by host responses in sheep infected with 
Ostertagia circumcincta. Parasite Immunology 17, 643-652.
Steel, J.W., Jones, W.O. & Symons, L.E.A. (1982) Effects of a concurrent infection of 
Trichostrongylus colubriformis on the productivity and physiological and metabolic 
responses of lambs infected with Ostertagia circumcincta. Australian Journal o f  
Agricultural Research 33, 131-140.
Steel, R.G.D. & Torrie, J.H. (1980) In Principles and procedures o f  statistics. A biometrical 
approach. 2nd edition, McGraw-Hill Book Company, p 471.
Stewart, D.F. (1953) Studies on resistance of sheep to infection with Haemonchus contortus 
and Trichostrongylus spp. and on the immunological reactions of sheep exposed to 
infestation V. The nature of the self cure phenomenon. Australian Journal o f  Agricultural 
Research 4, 100-117.
Stewart, D.F. (1955) ‘Self-cure’ in nematode infestations of sheep. Nature 176, 1273.
278
Stewart, H.L. (1941) Hyperplastic and neoplastic lesions of the stomach in mice. Journal o f  
the National Cancer Institute 1, 489-509.
Stewart, H.L. & Andervont, H.B. (1938) Pathologic observations on the adenomatous lesion 
in the stomach in mice of strain I. Archives o f  Pathology 26, 1009-1022.
Stewart, W.L. & Crofton, H.D. (1941) Parasitic gastritis in cattle. Veterinary Record 53, 
619-621.
Stiles, C.W. (1900-1901) Verminous diseases of cattle, sheep and goats in Texas. United 
States Department o f  Agriculture 17th Annual Report, pp 356-357.
Stockdale, P.H.G. (1974) The pathogenesis of Hyostrongylus rubidus in growing pigs. 
British Veterinary Journal 130, 366-373.
Stringfellow, F. & Madden, P.A. (1979) Effects of Ostertagia ostertagi on pepsinogen 
granules of chief cells from calf abomasum correlated with selected plasma and abomasal 
proteins. Proceedings o f  the Helminthological Society o f  Washington 46, 233-239.
Stroobant, P., Rice, A.P., Gullick, W.J., Cheng, D.J., Kerr, I.M. & Waterfield, M.D. (1985) 
Purification and characterisation of vaccinia virus growth factor. Cell 42, 383-393.
Svanes, K., Ito, S., Takeuchi, K. & Silen, W. (1982) Restitution of the surface epithelium of 
the in vitro frog gastric mucosa after damage with hyperosmolar sodium chloride. 
Gastroenterology 82, 1409- 1426.
Sykes, A.R. & Coop, R.L. (1976) Intake and utilisation of food by growing sheep with 
parasitic damage to the small intestine caused by daily dosing with Trichostrongylus 
colubriformis larvae. Journal o f  Agricultural Science 86, 507-515.
Sykes, A.R. & Coop, R.L. (1977) Intake and utilisation of food by growing sheep with 
abomasal damage caused by daily dosing with Ostertagia circumcincta larvae. Journal o f  
Agricultural Science 88, 671-677.
279
Sykes, A.R., Coop, R.L. & Angus, K.W. (1977) The influence of chronic Ostertagia 
circumcincta infection on the skeleton of growing sheep. Journal o f  Comparative Pathology 
87, 521-529.
Symons, L.E.A. (1989) Gastrointestinal endogenous proteins, plasma albumin concentration 
and albumin metabolism. In Pathophysiology o f  endoparasitic infection compared with 
ectoparasitic infestation and microbial infection. Academic Press, Inc., London, England, pp 
128-143.
Szurszewski, J.H. (1969) Migrating electric complex of the canine small intestine. American 
Journal o f Physiology 217, 1757-1763.
Takagi, H., Jhappan, C., Sharp, R. & Merlino, G. (1992) Hypertrophic gastropathy 
resembling Menetrier’s disease in transgenic mice overexpressing transforming growth 
factor-alpha in the stomach. Journal o f  Clinical Investigation 90, 1161-1167.
Tam, J.P. (1985) Physiological effects of transforming growth factor in the newborn mouse. 
Science 229, 673-675.
Tamura, K., Palmer, J.M. & Wood, J.D. (1987) Presynaptic inhibition produced by histamine 
at nicotinic synapses in enteric ganglia. Neuroscience 25, 171-179.
Tang, J. (1979) Evolution in the structure and function of carboxyl proteases. Molecular and 
Cellular Biochemistry 26, 93-109.
Taylor, L.M., Parkins, J.J., Armour. J., Bairden, K., Holmes, P.H. & McWilliam, P.N. 
(1989) Pathophysiological and parasitological studies on Ostertagia ostertagi infections in 
calves. Research in Veterinary Science 46, 218-225.
Tazi-Saad, K., Chariot, J., Del Tacca, M. & Roze, C. (1992) Effect of a 2-adrenoceptor 
agonists on gastric pepsin and acid secretion in the rat. British Journal o f  Pharmacology 106, 
790-796.
280
Thatcher, E.F., Gershwin, L.J. & Baker, N.F. (1989) Levels of serum IgE in response to 
gastrointestinal nematodes in cattle. Veterinary Parasitology 32, 153-162.
Thode-Jensen, P. (1977) A simple method for the determination of pepsinogen in bovine 
serum and plasma. Acta Veterinaria Scandinavica 18, 10-14.
Thomas, D.M., Nasim, M.M., Gullick, W.J. & Alison, M.R. (1992) Immunoreactivity of 
transforming growth factor-alpha in the normal adult gastrointestinal tract. Gut 33, 628-631.
Thompson, J.F., Van den Berg, M. & Stokkers, P.C.F. (1994) Developmental regulation of 
epidermal growth factor receptor kinase in rat intestine. Gastroenterology 107, 1278-1287.
Thornburg, W., Rao, R.K., Matrisian, L.M., Magun, B.E. & Koldovsky, O. (1987) Effect of 
maturation on gastrointestinal absorption of epidermal growth factor in rats. American 
Journal o f  Physiology 253, G68-71.
Titchen, D.A. & Anderson, N. (1977) Aspects of the physio-pathology of parasitic gastritis 
in the sheep. Australian Veterinary Journal 53, 369-373.
Todaro, G.J., De Larco, J.E. & Cohen, S. (1976) Transformation by murine and feline 
sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature 264, 
26-31.
Todaro, G.J. & De Larco, J.E. (1978) Growth factors produced by sarcoma virus- 
transformed cells. Cancer Research 38, 4147-4154.
Todaro, G.J., Fryling, C. & De Larco, J.E. (1980) Transforming growth factors produced by 
certain human tumour cells: polypeptides that interact with epidermal growth factor 
receptors. Proceedings o f  the National Academy o f  Sciences o f  the U.S.A. 77, 5258-5262.
Todd, R., Donoff, B.R., Chiang, T., Chou, M.Y., Elovic, A., Gallagher, G.T. & Wong,
D.T.W. (1991) The eosinophil as a cellular source of transforming growth factor-alpha in 
healing cutaneous wounds. American Journal o f  Pathology 138, 1307-1313.
281
Turbitt, M.L., Akhurst, R.J., White, S.I. & MacKie, R.M. (1990) Localisation of elevated 
transforming growth factor-a in psoriatic epidermis. Journal o f  Investigative Dermatology 
95, 229-232.
Turner, J.C. & Shanks, V. (1982) An enzyme-linked immunoassay for pepsinogen in sheep 
plasma. Veterinary Parasitology 10, 79-86.
Ulshen, M.H., Lyn-Cook, L.E. & Raasch, R.H. (1986) Effects of intraluminal epidermal 
growth factor on mucosal proliferation in the small intestine of adult rats. Gastroenterology 
91, 1134-1140.
Urquhart, G.M., Armour, J., Duncan, J.L., Dunn, A.M. & Jennings, F.W. (1987) In 
Veterinary parasitology. Longman Scientific & Technical, Longman Group UK Ltd., Essex, 
England, pp 10-32.
Vagne, M., Roche, C., Chayvialle, J.A. & Gespach, C. (1982) Effect of somatostatin on the 
secretin-induced gastric secretions of pepsin and mucus in cats. Regulatory Peptides 3, 183- 
191.
van der Gaag, I., Happe, R.P. & Wolvekamp, W.Th.C. (1974) Investigation of the dog 
stomach. Netherlands Small Animal Veterinary Association Proceedings 5, 60-73.
van der Gaag, I., Happe, R.P. & Wolvekamp, W.Th.C. (1976) A Boxer dog with chronic 
gastritis resembling Menetrier’s disease in man. Veterinary Pathology 13, 172-185.
van Kruiningen, H.J. (1977) Giant hypertrophic gastritis of Basenji dogs. Veterinary 
Pathology 14, 19-28.
Vassar, R. & Fuchs, E. (1991) Transgenic mice provide new insights into the role of TGF-a 
during epidermal development and differentiation. Genes and Development 5, 714-727.
Veglia, F. (1915) The anatomy and life history of the Haemonchus contortus. Report 
Veterinary Research University o f  South Africa, 3&4, 347-500.
282
Vermillion, D.L. & Collins, S.M. (1988) Increased responsiveness of jejunal longitudinal 
muscle in Trichinella-mfectQd rats. American Journal o f  Physiology 254. G124-129.
Vial, J.D. & Orrego, H. (1963) Electron microscope observations on the fine structure of 
parietal cells. Exploratory Cell Research 30, 232.
Waldum, H.I., Lehy, T., Brenna, E., Sandvik, A.K., Petersen, H., Schulze Sognen, B., 
Bonfils, S. & Lewin, M.J.M. (1991) Effect of the histamine-1 antagonist astemizole alone or 
with omeprazole on rat gastric mucosa. Scandinavian Journal o f  Gastroenterology 26, 23- 
35.
Wallace, D.S., Bairden, K., Duncan, J.L., Fishwick, G., Gill, M., Holmes, P.H., McKellar, 
Q.A., Murray, M., Parkins, J.J. & Stear, M.J. (1995) Influence of supplementation with 
dietary soyabean meal on resistance to haemonchosis in Hampshire down lambs. Research in 
Veterinary Science 58, 232-237.
Walsbren, S.J., Gelbel, J.P., Modlin, I.M. & Boron, W.F. (1994) Unusual permeability 
properties of gastric gland cells. Nature 368, 332-335.
Wang, T.C., Bonner-Weir, S., Oates, P.S., Chulak, M., Simon, B., Merlino, G.T., Schmidt,
E.V. & Brand, S.J. (1993) Pancreatic gastrin stimulates islet differentiation of transforming 
growth factor-a-induced ductular precursor cells. Journal o f  Clinical Investigation 92, 1349- 
1356.
Wang, Y.-Z., Palmer, J.M. & Cooke, H.J. (1991) Neuro-immune regulation of colonic 
secretion in guinea pigs. American Journal o f  Physiology 260, G3 07-314.
Ward, C.W. & Wagland, B.M. (1990) Gut hypersensitivity reactions in guinea pigs
following vaccination or infection with Trichostrongylus colubriformis. International 
Archives o f  Allergy and Applied Immunology 92, 183-188.
Warner, A.C.I. & Stacy, B.D. (1968) The fate of water in the rumen. 2. Water balances
throughout the feeding cycle in sheep. British Journal o f  Nutrition 22, 389-410.
283
Washburn, S.M. (1984) Cellular and humoral immune responses to Ostertagia ostertagi in 
type I infection. PhD. Thesis, Auburn University, Alabama, U.S.A., pp 1-111.
Washburn, S.M. & Klesius, P.H. (1984) Leukokinesis in bovine ostertagiasis: stimulation of 
leukocyte migration by Ostertagia. American Journal o f  Veterinary Research 45, 1095- 
1098.
Wasserman, S.I. (1979) The mast cell and the inflammatory response. In The Mast Cell 
(edited by Peyys, E.) Pitman, Bath, England, pp 9-20.
Wedrychowicz, H. (1986) Studies on the antigens of Ostertagia circumcincta. III. Somatic 
and metabolic antigens of adult nematodes. Acta Parasitologica Polonica 30, 317-326.
Weyns, A., Ooms, L.A.A., Verhofstad, A., Peeters, Th., Degryse, A.D., van Nassauw, L. & 
Krediet, P. (1987) Neurotransmitters/neuromodulators in the motor and secretory functions 
of the ruminant stomach: a histochemical, radioimmunological, immunocytochemical and 
functional approach. In Physiological and pharmacological aspects o f  the reticulo-rumen. 
(Edited by Ooms, L.A.A., Degryse, A.D. & van Miert, A.S.J.P.A.M.) MTP Press Limited, 
Lancaster, England, pp. 43-112.
Wharton, D.A. & Sommerville, R.I. (1984) The structure of the excretory system of the 
infective larvae of Haemonchus contortus. International Journal fo r  Parasitology 14, 591
Whitlock, J.H. (1966) In Biology o f parasites (Edited by Soulsby, E.J.L.) Academic Press, 
London, England, pp. 185-197.
Wiggin, C.J. & Gibbs, H.C. (1987) Pathogenesis of simulated natural infections with 
Ostertagia ostertagi in calves. American Journal o f  Veterinary Research 48, 274-280.
Wiggin, C.J. & Gibbs, H.C. (1990) Adverse immune reactions and the pathogenesis of 
Ostertagia ostertagi infections in calves. American Journal o f  Veterinary Research 51 825- 
832.
284
Wilson, W.D. & Field, A.C. (1983) Absorption and secretion of calcium and phosphorus in 
the alimentary tract of lambs infected with daily doses of Trichostrongylus colubriformis or 
Ostertagia circumcincta larvae. Journal o f  Comparative Pathology 93, 61-71.
Wolfsen, H.C., Carpenter, H.A. & Talley, N.J. (1993) Menetrier’s disease: a form of 
hypertrophic gastropathy or gastritis? Gastroenterology 104, 1310-1319.
Wu, H.H., Kawamata, H., Wang, D.D. & Oyasu, R. (1993) Immunohistochemical 
localisation of transforming growth factor-alpha in the major salivary glands of male and 
female rats. Histochemistry Journal 25, 613-618.
Yakoob, A., Holmes, P.H. & Armour, J. (1983) The pathophysiology of gastrointestinal 
trichostrongyles in sheep: plasma losses and changes in plasma pepsinogen levels associated 
with parasitic challenge of immune animals. Research in Veterinary Science 34, 305-309.
Yamada, J., Andren, A., Kitamure, N. & Yamashita, T. (1988) Electron 
immunocytochemical co-localization of prochymosin and pepsinogen in chief cells, mucous 
neck cells and transitional mucous neck/chief cells of the calf fundic glands. Acta Anatomica 
132, 246-252.
Yeaton, P. & Frierson, H.F. Jr. (1993) Octreotide reduces enteral protein losses in 
Menetrier’s disease. American Journal o f  Gastroenterology 88, 95-98.
Yochem, J. & Greenwald, I. (1989) glp-1 and lin-12, genes implicated in distinct cell-cell 
interactions in C. elegans, encode similar transmembrane proteins. Cell 58, 553-563.
Yoshida, S., Kasuga, S., Hirao, Y., Fuwa, T. & Nakagawa, S. (1987) Effect of biosynthetic 
human epidermal growth factor on the synthesis and secretion of mucin glycoprotein from 
primary culture of rabbit fundal mucosa cells. In Vitro Cell and Developmental Biology 23, 
460-464.
Young, R.R., Nicholson, R.M., Tweedie, R.L. & Schul, H.J. (1980) Quantitative modelling 
and prediction of development times of the free-living stages of Ostertagia ostertagi under 
controlled and field conditions. Parasitology 81, 439-505.
285
11: APPENDICES.
Contents.
Appendix Page
1A Replicate analyses of the 5 plasma standards by method 1. 292
IB Replicate analyses of the 5 plasma standards by method 2. 293
1C Replicate analyses of the 5 plasma standards by method 3. 294
ID Replicate analyses of the 5 plasma standards by method 4. 295
2 The peptic activity of porcine pepsinogen standards with time; a 296
comparison with tyrosine standards.
3 Replicate analyses of plasma from the eleven sheep, 297
experimentally infected with O. circumcincta, assayed for plasma 
pepsinogen concentration by Paynter’s method.
4A Zone diameters for blank plasma, and for plasma and water 299
standards with identical concentrations of added porcine 
pepsinogen.
4B Change in optical densities (AO.D.560nm), over three hours of 299
incubation, for blank plasma, and for plasma and water standards 
with identical concentrations of added porcine pepsinogen.
5 A Gland counts and pepsinogen secretion during exposure of isolated 300
gastric glands to different doses of carbachol.
5B Gland counts and the pepsinogen concentrations released during 301
two experiments investigating the effects of likely supramaximal 
doses of carbachol
6A Pepsinogen release from individual tissues of, and mean values for, 302
sheep 1 in time course of the cholinergic response experiments.
6B Pepsinogen release from individual tissues of, and mean values for, 303
sheep 2 in time course of the cholinergic response experiments.
6C Pepsinogen release from individual tissues of, and mean values for, 304
sheep 3 in time course of the cholinergic response experiments.
7A Pepsinogen release from individual tissues of, and mean values for, 305
sheep 1 in carbachol dose response studies using intact mucosal 
sheets.
7B
1C
7D
7E
8A
8B
8C
8D
9A
9B
9C
9D
9E
10A
10B
286
Pepsinogen release from individual tissues of, and mean values for, 305 
sheep 2 in carbachol dose response studies using intact mucosal 
sheets.
Pepsinogen release from individual tissues of, and mean values for, 306
sheep 3 in carbachol dose response studies using intact mucosal 
sheets.
Pepsinogen release from individual tissues of, and mean values for, 306
sheep 4 in carbachol dose response studies using intact mucosal 
sheets.
Pepsinogen release from individual tissues of, and mean values for, 307
sheep 5 in carbachol dose response studies using intact mucosal 
sheets.
Responses of individual muscle strips and mean values for sheep 1 307
in carbachol cumulative dose response experiments.
Responses o f individual muscle strips and mean values for sheep 2 308
in carbachol cumulative dose response experiments.
Responses of individual muscle strips and mean values for sheep 3 308
in carbachol cumulative dose response experiments.
Responses of individual muscle strips and mean values for sheep 4 308
in carbachol cumulative dose response experiments.
Responses o f individual muscle strips and mean values for sheep 1 309
in histamine cumulative dose response experiments.
Responses of individual muscle strips and mean values for sheep 2 309
in histamine cumulative dose response experiments.
Responses of individual muscle strips and mean values for sheep 3 309
in histamine cumulative dose response experiments.
Responses of individual muscle strips and mean values for sheep 2 310
in serotonin cumulative dose response experiments.
Responses of individual muscle strips and mean values for sheep 3 310
in histamine cumulative dose response experiments.
Individual and mean values of pepsinogen release (total units) for 311
ES studies using intact mucosal preparations from abattoir-derived 
sheep.
Individual and mean values of pepsinogen release (total units) for 311
ES studies using intact mucosal preparations from abattoir-derived 
sheep.
IOC Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10D Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10E Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10F Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10G Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10H Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
101 Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10J Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10K Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10L Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
10M Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
ION Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
100 Individual and mean values of pepsinogen release (total units) for
ES studies using intact mucosal preparations from abattoir-derived
sheep.
287
312
312
313
313
314
314
315
315
316
316
317 
317
288
10P
10Q
10R
11A 
1 IB 
11C 
1 ID
h e
1 IF 
11G 
11H 
111  
11J 
1 IK 
11L 
11M
Individual and mean values of pepsinogen release (total units) for 318
ES studies using intact mucosal preparations from abattoir-derived 
sheep.
Individual and mean values of pepsinogen release (total units) for 319
ES studies using intact mucosal preparations from abattoir-derived 
sheep.
Individual and mean values of pepsinogen release (total units) for 319
ES studies using intact mucosal preparations from abattoir-derived 
sheep.
Responses of smooth muscle strips, obtained from abattoir-derived 320
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 320
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 320
sheep, to ES doses.
Responses o f smooth muscle strips, obtained from abattoir-derived 321
sheep, to ES doses.
Responses o f smooth muscle strips, obtained from abattoir-derived 321
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 321
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 322
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 322
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 322
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 323
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 323
sheep, to ES doses.
Responses of smooth muscle strips, obtained from abattoir-derived 323
sheep, to ES doses.
Responses o f smooth muscle strips, obtained from abattoir-derived 324
sheep, to ES doses.
289
1 IN Responses of smooth muscle strips, obtained from abattoir-derived 324
sheep, to ES doses.
110 Responses of smooth muscle strips, obtained from abattoir-derived 324
sheep, to ES doses.
1 IP Responses of smooth muscle strips, obtained from abattoir-derived 325
sheep, to ES doses.
1 IQ Responses of smooth muscle strips, obtained from abattoir-derived 325
sheep, to ES doses.
12 Pepsinogen and LDH release from intact mucosal preparations 326
from one animal.
13 Pepsinogen and LDH release from individual tissues in response to 327
the addition of ES and carbachol.
14 Pepsinogen and LDH release from individual tissues in response to 328
the addition of ES and carbachol.
15A Pepsinogen release from individual tissues from sheep 1 in time 329
course of the response to ES experiment.
15B Pepsinogen release from individual tissues from sheep 2 in time 330
course of the response to ES experiment.
16A Pepsinogen release from individual tissues of parasite-naive 331
animals in response to ES: animal 1.
16B Pepsinogen release from individual tissues of parasite-naive 331
animals in response to ES: animal 2.
16C Pepsinogen release from individual tissues of parasite-naive 332
animals in response to ES: animal 3.
16D Pepsinogen release from individual tissues of parasite-naive 332
animals in response to ES: animal 4.
16E Pepsinogen release from individual tissues of parasite-naive 333
animals in response to ES: animal 5.
16F Pepsinogen release from individual tissues of parasite-naive 333
animals in response to ES: animal 6.
16G Pepsinogen release from individual tissues o f parasite-naive 334
animals in response to ES: animal 7.
16H Pepsinogen release from individual tissues o f parasite-naive 334
animals in re:sp(onse to ES: animal 8.
290
17A Responses of individual muscle strips of parasite-naive animals to 335
carbachol and ES: animal 1.
17B Responses of individual muscle strips of parasite-naive animals to 335
carbachol and ES: animal 2.
17C Responses of individual muscle strips of parasite-naive animals to 336
carbachol and ES: animal 3.
17D Responses of individual muscle strips of parasite-naive animals to 336
carbachol and ES: animal 4.
17E Responses of individual muscle strips of parasite-naive animals to 336
carbachol and ES: animal 5.
17F Responses of individual muscle strips of parasite-naive animals to 337
carbachol and ES: animal 6.
17G Responses of individual muscle strips of parasite-naive animals to 337
carbachol and ES: animal 7.
17H Responses of individual muscle strips of parasite-naive animals to 337
carbachol and ES: animal 8.
18A Total tissue pepsinogen (iU/ standard area) of fundic mucosal 338
pieces of cattle and sheep.
18B Tissue wet weights (g) of fundic mucosal pieces of cattle and 338
sheep.
19A Tissue wet weights (g) of mucosal pieces from ovine fundus 339
comparing nodular and non-nodular mucosa.
19B Tissue pepsinogen (iU/ area) of mucosal pieces from ovine fundus 339
comparing nodular and non-nodular mucosa.
19C Tissue pepsinogen (iU/g) of mucosal pieces from ovine fundus 340
comparing nodular and non-nodular mucosa.
20 Individual faecal egg counts (epg) and worm burdens o f sheep in 341
the initial study of the effects of haemonchosis.
21 Individual packed cell volumes (PCV), and the concentrations of 342
total plasma protein (T.P.), plasma albumin and plasma pepsinogen
(P.peps.) of sheep in the initial study of the effects of 
haemonchosis.
22 Individual faecal egg counts (epg) and worm burdens o f sheep in 343
the second study of the effects of haemonchosis.
291
23
24A
24B
24C
25A
25B
25C
25D
26
27
28
29
30
31
32
33
34
Individual packed cell volumes (PCV), and the concentrations of 344
total plasma protein (T.P.), plasma albumin and plasma pepsinogen 
(P.peps.) of sheep in the initial study of the effects of 
haemonchosis.
Individual and mean (± S.E.) values for wet weights of mucosal 345
cuts from the Hampshire’s in the second haemonchosis study.
Individual and mean (± S.E.) values for pepsinogen concentrations 346
(iU/area) of mucosal cuts from the Hampshire’s in the second 
haemonchosis study.
Individual and mean (± S.E.) values for pepsinogen concentrations 347
(iU/g) of mucosal cuts from the Hampshire’s in the second 
haemonchosis study.
Individual plot profiles for the image analysis o f the pepsinogen 348
immunohistochemistry of animals from the BDC group.
Individual plot profiles for the image analysis of the pepsinogen 349
immunohistochemistry of animals from the BDI group.
Individual plot profiles for the image analysis of the pepsinogen 350
immunohistochemistry of animals from the SDC group.
Individual plot profiles for the image analysis of the pepsinogen 351
immunohistochemistry of animals from the SDI group.
Overall mean (± S.E.) plot profiles for control (8 animals) and 352
infected (16 animals) Hampshire Down lambs.
Level of significance (probability) for factors influencing staining 353
intensity at different mucosal positions.
Individual values of AUC, Imax and Pmax following image 354
analysis of the pepsinogen immunohistochemistry for the second 
study of haemonchosis in Hampshire Down lambs.
TGF-a (a) and EGF (b) immunostaining in rat gastric cardia. 355
TGF-a (a) and EGF (b) immunostaining in ovine oesophagus. 356
EGF immunostaining in ovine sub-mandibular salivary gland. 357
EGF immunostaining in ovine abomasal fundus. 357
TGF-a (a) and EGF (b) immunostaining in ovine pylorus. 358
TGF-a (a) and EGF (b) immunostaining in ovine colon. 359
Appendix 1A: Replicate analyses of the 5 plasma standards by method 1.
(results in iU, figures in parentheses are mean values ± S.E. for day one data only).
Std.
Day
1 2 3 4 5
1 5.94 
7.16
5.94 
6.85 
6.04
(6.39 ± 0.26)
7.42 6.33 6.34 5.47
2 10.64
13.08
10.95
12.16
12.57
(11.88 ±0 .50)
11.66 13.81 10.12 9.8
3 14.42
14.72
15.53
15.84
15.13
(15.12 ±0 .26)
11.75 16.63 13.65 16.87
4 22.98
24.30
24.50 
23.89
24.50
(24.03 ± 0.30)
27.90 26.30 24.21 26.21
5 32.72
31.50
34.55
31.71
32.82
(32.66 ± 0.54)
27.28 36.24 31.77 35.47
Appendix IB: Replicate analyses of the 5 plasma standards by method 2.
(results in iU, figures in parentheses are mean values ± S.E. for day one data only).
Std.
Day
1 2 3 4 5
1 1.77
1.82
1.82
1.85
1.88
(1.83 ± 0.02)
1.77 1.61 1.29 1.78
2 2.65
2.73
2.72
2.47
2.75
(2.66 ± 0.05)
2.73 2.63 2.13 3.09
3 3.38
3.57
3.52
3.66
3.51
(3.53 ± 0.04)
3.52 3.42 3.29 4.03
4 4.93
5.29
5.14
4.97
5.16
(5.10 ±0 .07)
4.99 5.20 4.94 5.23
5 6.40
6.79
6.43
6.62
6.59
(6.57 ± 0.07)
6.60 6.76 6.37 7.17
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Appendix 1C: Replicate analyses of the 5 plasma standards by method 3.
(results in iU, figures in parentheses are mean values ± S.E. for day one data only).
Std.
Day
1 2 3 4 5
1 1.26 
1.85 
1.52 
1.63 
1.77 
(1.61 ± 0 .10)
1.53 1.10 1.34 1.02
2 2.44
3.33
2.92
3.14
3.22
(3.01 ±0 .16)
2.22 2.13 2.43 1.47
3 3.07
3.36
3.62
3.33
3.40
(3.57 ± 0.09)
2.75 2.83 3.19 2.33
4 5.80
6.40
5.73
5.95
5.99
(5.97 ± 0 .12)
4.05 4.35 4.97 3.76
5 7.06
7.32
7.28
6.84
7.39
(7.18 ±0 .10)
4.56 6.08 6.29 5.22
Appendix ID: Replicate analyses of the 5 plasma standards by method 4.
(results in ng/ml, figures in parentheses are mean values ± S.E. for day one data only).
Std.
Day
1 2 3 4 5
1 0.55
0.67
0.57
0.44
0.46
(0.54 ± 0.04)
0.79 0.74 1.03 0.67
2 0.58
0.71
0.69
0.66
0.55
(0.64 ± 0.03)
1.49 0.89 1.21 0.71
3 0.93
1.19
0.81
0.81
0.84
(0.92 ± 0.07)
2.54 1.47 1.19 0.93
4 1.44
1.34
1.44
1.35 
1.79
(1.47 + 0.08)
2.75 1.75 1.95 1.44
5 2.04
2.07
1.71
2.23
1.68
(1.95 ± 0 .11)
5.37 2.57 2.65 2.07
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Appendix 2: The peptic activity of porcine pepsinogen standards with time; a 
comparison with tyrosine standards.
Date
lng/m l is 
equivalent to: (iU)
1 u/ml is equivalent 
to: (iU)
12/03/93 48.03 15.37
07/09/93 43.03 13.77
12/09/93 31.72 10.15
30/11/93 31.37 10.04
08/12/93 33.19 10.62
10/01/94 31.31 10.02
25/01/94 29.75 9.52
18/02/94 32.00 10.24
08/03/94 45.72 14.63
09/03/94 42.25 13.52
08/04/94 29.75 9.52
12/04/94 33.09 10.59
19/04/94 29.28 9.37
21/04/94 29.87 9.56
22/04/94 42.81 13.70
28/04/94 26.53 8.49
04/05/94 49.37 15.80
10/05/94 30.94 9.90
18/08/94 23.87 7.64
12/09/95 22.87 7.32
13/01/95 38.59 12.35
Mean (± S.E.) 34.50 (1.70) 11.00(0.50)
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Appendix 3: Replicate analyses of plasma from the eleven sheep, experimentally infected 
with O. circumcincta, assayed for plasma pepsinogen concentration by Paynter’s 
method.
(results in iU, figures in parentheses are mean values, ± S.E. for day one data only).
Sheep No. DAI*
Day
1 2 3 4 5
1 NI 0.16
0.22
0.00
1.26
0.11
(0.35 ± 0.23)
0.56 2.80 2.19 0.81
2 28 1.10
0.88
1.15
0.88
2.47
(1.30 ±0.30)
2.08 3.73 2.89 0.91
3 NI O c
2.75 
5.11 
2.64
2.75
(3.32 ± 0.46)
4.17 5.34 4.77 2.72
4 14 3.63
3.35
5.16
4.45
4.56
(4.23 ± 0.33)
7.78 8.05 6.25 5.95
5 NI 1.26
2.53
0.93
0.99
1.43
(1.43±0.29)
0.76 1.61 1.00 0.71
6 7 5.60
2.80
3.40
2.20
4.78
(3.76 ± 0.63)
2.50 4.41 3.28 2.32
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7 7 5.00
4.35
3.39
3.71
3.55
(4.00 ± 0.30)
4.37 5.17 4.61 4.04
8 14 5.56 
5.08
5.56 
8.71 
7.42
(6.47 ± 0.69)
5.42 6.19 6.41 6.40
9 21 12.34
13.31
12.26
16.29
13.71
(13.58 ±0.73)
11.74 11.86 12.58 10.59
10 28 6.05
6.69
5.08
4.68
4.84
(5.47 ± 0.39)
4.86 4.83 5.94 3.13
11 21 8.39
8.63
9.03
9.35
9.52
(8.98 ±0.0.21)
6.87 6.19 13.00 8.78
* DAI - status at necropsy - days after infection with 15,000 O. circumcincta L3. NI - 
uninfected controls.
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Appendix 4A: Zone diameters for blank plasma, and for plasma and water standards 
with identical concentrations of added porcine pepsinogen, figures are in mm, adjusted 
means are mean values for water and plasma standards minus the mean diameter of the 
plasma blank (equivalent to well diameter).
1 2 3 4 5 6 7 8 9
Plasma blank 7.70 7.70 7.70 7.70 7.70
Water Std. 14.75 14.32 14.18 14.08 14.33 14.22 14.73 14.37 14.02
Plasma Std. 14.31 13.50 13.60 13.09 13.32 13.74 13.77 13.28 12.99
Appendix 4B: Change in optical densities (AO.D.560nm), over three hours of incubation, 
for blank plasma, and for plasma and water standards with identical concentrations of 
added porcine pepsinogen.
1 2 3 4 5 6 7 8 9
Plasma blank 
Water Std. 
Plasma Std.
0.003
0.306
0.167
0.000
0.315
0.152
0.003
0.271
0.205
0.002
0.266
0.187
0.283
0.198
0.328
0.184
0.250
0.186
0.289
0.196
0.232
0.203
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Appendix 5B: Gland counts and the pepsinogen concentrations released during two 
experiments investigating the effects of likely supramaximal doses of carbachol,
pepsinogen concentrations are in u/ml, and represent the differences between pre-sample 
concentrations and those of samples collected after 30 minutes of incubation in the presence 
or absence (controls) of ImM carbachol.
sheep 1
control ImM Carbachol
sheep 2
control ImM Carbachol
gland counts
(glands/ml) 8,000 8,000 18,000 18,000
replicate 1 0.70 0.06 0.93 1.50
2 0.32 0.19 0.75 1.54
3 0.31 0.32 0.00 0.00
4 0.33 0.13 0.66 2.66
5 0.00 0.24 0.99 0.89
6 0.04 0.57 1.41 0.82
7 0.23 0.01
8 0.38 0.00
9 0.58 0.00
10 0.00 0.10
Mean (± S.E.) 0.29 (0.07) 0.16 (0.06) 0.79 (0.19) 1.23 (0.37)
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Appendix 6A: Pepsinogen release from individual tissues of, and mean values for,
sheep 1 in time course of the cholinergic response experiments.
Time (min)
Tissue
A B
Mean (± S.E.) 
u/ml
Mean (± S.E.) 
Secretion/basal
5 5.93 6.39 6.16 (0.23) 1.64 (0.06)
10 4.13 3.88 4.00 (0.12) 1.06 (0.03)
15 2.67 4.68 3.67 (1.00) 0.98 (0.27)
20 3.66 3.53 3.59 (0.06) 0.95 (0.02)
25 3.49 4.13 3.81 (0.32) 1.01 (0.08)
30 4.82 2.70 3.76 (1.06) 1.00 (0.28)
35 13.26 11.62 12.44 (0.82)* 3.31 (0.22)
40 17.27 17.30 17.28 (0.01)* 4.60 (0.00)
45 17.73 17.85 17.79 (0.06)* 4.73 (0.02)
50 13.88 13.55 13.71 (0.16)* 3.65 (0.04)
55 10.82 14.49 12.65 (1.84)* 3.36(0.49)
60 7.76 11.64 9.70 (1.94)* 2.58 (0.52)
65 9.46 7.40 8.43 (1.03)* 2.24 (0.27)
70 6.60 5.95 6.27 (0.32) 1.67 (0.09)
75 6.94 5.63 6.28 (0.65) 1.67 (0.17)
80 5.24 5.25 5.24 (0.00) 1.39 (0.00)
Notes:
* - secretion significantly different from basal (t30), based on ANOVA and Dunnetf s test of 
log i0-transformed data (p<0.05).
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Appendix 6B: Pepsinogen release from individual tissues of, and mean values for, sheep
2 in time course of the cholinergic response experiments.
Time
Tissue
A B C D E
Mean (±S.E.) 
u/ml
Mean (±S.E.) 
secn./basal
(min)5 1.64 2.51 2.90 1.21 1.64 1.98 (0.31) 1.01 (0.16)
10 2.96 2.35 3.00 1.06 1.48 2.17 (0.39) 1.10(0.20)
15 2.12 1.34 2.05 1.31 1.32 1.63 (0.19) 0.83 (0.09)
20 1.55 1.14 1.89 0.24 2.02 1.37 (0.32) 0.70 (0.16)
25 2.17 0.91 2.32 0.67 2.75 1.76 (0.41) 0.90 (0.21)
30 2.01 0.86 2.66 0.91 3.38 1.96 (0.49) 1.00 (0.25)
35 2.22 2.24 3.34 2.11 4.10 2.80 (0.39) 1.43 (0.20)
40 2.55 2.48 3.39 2.59 3.12 2.83 (0.18) 1.44 (0.09)
45 2.72 2.86 9.49 4.89 4.93 4.98 (1.22) 2.54 (0.62)
50 6.99 7.54 13.32 5.42 7.48 8.15 (1.35)* 4.15 (0.69)
55 9.29 7.25 12.83 4.89 8.83 8.62 (1.30)* 4.39 (0.66)
60 5.53 5.99 12.05 3.15 6.14 6.57 (1.47)* 3.34 (0.75)
65 8.19 6.09 15.20 2.42 8.41 8.06 (2.08)* 4.10(1.06)
70 7.65 6.79 14.85 1.84 7.19 7.66 (2.08)* 3.90 (1.06)
75 6.55 5.77 13.40 1.69 4.76 6.43 (1.93)* 3.27 (0.98)
Notes:
* - secretion significantly different from basal (t30), based on ANOVA and Dunnetf s test of 
logI0-transformed data (p<0.05).
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Appendix 6C: Pepsinogen release from individual tissues of, and mean values for,
sheep 3 in time course of the cholinergic response experiments.
Time
Tissue
A B C D E
M ean (±S.E.) 
u/ml
M ean (±S.E.) 
secn./basal
(min)5 1.44 1.57 1.86 1.60 1.69 1.63 (0.07) 1.26 (0.05)
10 1.64 1.07 1.11 1.37 1.15 1.27 (0.11) 0.98 (0.08)
15 1.49 1.07 1.50 1.37 0.90 1.27 (0.12) 0.98 (0.09)
20 1.05 0.72 1.21 1.15 1.00 1.03 (0.08) 0.79 (0.06)
25 1.51 0.67 1.11 1.15 0.95 1.08 (0.14) 0.83 (0.11)
30 2.29 0.67 1.21 1.04 1.27 1.30 (0.27) 1.00 (0.21)
35 4.71 4.14 7.42 3.34 5.13 4.95 (0.69)* 3.82 (0.53)
40 7.50 5.40 7.17 j A j 4.97 5.63 (0.79)* 4.35 (0.61)
45 5.17 4.72 5.56 3.81 4.29 4.71 (0.31)* 3.63 (0.24)
50 6.27 5.49 6.57 4.96 4.34 5.53 (0.41)* 4.27 (0.32)
55 5.40 3.90 6.26 5.01 3.60 4.83 (0.50)* 3.73 (0.38)
60 4.31 4.13 5.54 5.07 4.49 4.71 (0.26)* 3.63 (0.20)
65 3.13 3.94 5.83 4.44 2.72 4.01 (0.54)* 3.09 (0.42)
70 3.13 3.26 6.32 4.01 3.17 3.98 (0.61)* 3.07 (0.47)
75 3.33 2.19 3.97 2.70 2.55 2.95 (0.31)* 2.27 (0.24)
80 3.74 3.49 4.36 3.41 2.96 3.59 (0.23)* 3.05 (0.18)
Notes:
* - secretion significantly different from basal (t30), based on ANOVA and Dunnett’s test of 
log10-transformed data (p<0.05).
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Appendix 7A: Pepsinogen release from individual tissues of, and mean values for,
sheep 1 in carbachol dose response studies using intact mucosal sheets.
Time (min) 
[carb]1
Tissue
A B C D E
Mean (±S.E.) 
u/ml
Mean (±S.E.) 
secn./basal
20 5.19 4.06 3.68 4.20 6.91 4.81 (0.58) 1.01 (0.30)
40 8.66 9.87 3.36 5.04 3.21 6.03 (1.37) 1.00 (0.00)
60 (-9) 8.31 9.18 4.16 6.72 9.64 7.60 (0.99) 1.49 (0.38)
80 (-8) 8.66 7.79 3.20 5.71 4.66 6.00 (1.00) 1.06 (0.11)
100 (-7) 8.77 10.73 8.80 8.23 7.71 8.85 (0.51) 1.75 (0.33)
120 (-6) 30.13 20.95 16.32 10.59 21.85 19.97 (3.23)* 3.87 (0.89)
140 (-5) 27.70 13.51 13.28 10.59 23.94 17.80 (3.37)* 3.62 (1.06)
Notes:
* - secretion significantly different from basal (t40), based on ANOVA and Dunnetf s test of 
logiQ-transformed data (p<0.05).
1 - Carbachol concentration, 10n molar.
Appendix 7B: Pepsinogen release from individual tissues of, and mean values for, sheep
2 in carbachol dose response studies using intact mucosal sheets.
Time (min) 
[carb]1
Tissue
A B C D E
Mean (±S.E.) 
u/ml
Mean (±S.E.) 
secn./basal
20 5.59 5.20 4.39 3.55 5.80 4.91 (0.42) 1.13(0.07)
40 5.33 5.30 3.95 2.58 5.10 4.45 (0.53) 1.00 (0.00)
60 (-9) 6.46 4.57 4.66 J. /J 6.60 5.20 (0.57) 1.20 (0.10)
80 (-8) 4.89 4.75 1.61 2.93 3.70 3.58 (0.61) 0.82 (0.12)
100 (-7) 3.41 4.57 4.48 1.24 3.60 3.46 (0.60) 0.76 (0.11)
120 (-6) 7.42 12.97 6.46 6.04 9.30 8.44 (1.26) 1.93 (0.20)
140 (-5) 17.03 21.28 12.11 6.75 12.70 13.97 (2.45)* 3.08 (0.27)
Notes:
* - secretion significantly different from basal (t40), based on ANOVA and Dunnetf s test of 
log10-transformed data (p<0.05).
1 - Carbachol concentration, 10" molar.
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Appendix 7C: Pepsinogen release from individual tissues of, and mean values for,
sheep 3 in carbachol dose response studies using intact mucosal sheets.
Time (min) 
[carbl1
Tissue
A B C D E
Mean (±S.E.) 
u/ml
Mean (±S.E.) 
secn./basal
20 18.41 17.31 23.10 23.68 25.08 21.52 (1.54) 1.14(0.09)
40 18.41 11.94 25.63 26.24 20.32 20.51 (2.62) 1.00 (0.00)
60 (-9) 12.70 8.66 3.38 11.20 13.97 9.98 (1.87) 0.54 (0.11)
80 (-8) 17.46 12.24 9.86 15.04 17.46 14.41 (1.49) 0.77 (0.12)
100 (-7) 22.86 15.82 4.51 19.84 20.63 16.73 (3.26) 0.92 (0.20)
120 (-6) 97.78 71.94 43.66 48.64 73.97 67.20 (9.75)* 3.74 (0.86)
140 (-5) 51.43 43.58 30.42 27.20 49.52 40.43 (4.94) 2.24 (0.48)
Notes:
* - secretion significantly different from basal (t40), based on ANOVA and Dunnetf s test of 
logI0-transformed data (p<0.05).
1 - Carbachol concentration, 10n molar.
Appendix 7D: Pepsinogen release from individual tissues of, and mean values for, 
sheep 4 in carbachol dose response studies using intact mucosal sheets.
Time (min) 
[carb]1
Tissue
A B C D E
Mean (±S.E.) 
u/ml
Mean (±S.E.) 
secn./basal
20 10.53 16.78 21.98 17.06 22.02 17.67 (2.11) 1.43 (0.08)
40 6.53 10.34 16.76 12.18 18.16 12.79 (2.12) 1.00 (0.00)
60 (-9) 1.26 1.17 5.59 5.89 5.87 3.96 (1.12) 0.29 (0.06)
80 (-8) 12.00 15.02 20.72 21.93 21.10 18.15 (1.96) 1.50(0.14)
100 (-7) 16.21 17.76 18.92 24.97 19.63 19.50 (1.49) 1.69 (0.27)
120 (-6) 59.37 64.39 69.37 61.73 35.60 58.09 (5.86)* 5.30(1.18)
140 (-5) 45.89 30.83 40.00 25.99 26.42 33.83 (3.93)* 3.20 (0.10)
Notes:
* - secretion significantly different from basal (t40), based on ANOVA and Dunnetf s test of 
log10-transformed data (p<0.05).
1 - Carbachol concentration, 10" molar.
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Appendix 7E: Pepsinogen release from individual tissues of, and mean values for, sheep
5 in carbachol dose response studies using intact mucosal sheets.
Time (min) 
[carb]1
Tissue
A B C D E
Mean (±S.E.) 
u/ml
Mean (±S.E.) 
secn./basal
20 8.44 10.09 6.55 4.49 1.47 6.21 (1.51) 1.15(0.22)
40 7.05 6.96 5.54 2.81 4.77 5.43 (0.78) 1.00 (0.00)
60 (-9) 6.35 5.04 5.93 5.96 1.93 5.04 (0.81) 1.04 (0.29)
80 (-8) 7.05 5.33 6.10 2.81 2.11 4.68 (0.95) 0.86 (0.12)
100 (-7) 21.08 9.39 8.36 8.21 5.96 10.60 (2.68) 2.00 (0.39)
120 (-6) 14.92 18.26 12.20 13.19 6.42 13.00 (1.94)* 2.59 (0.56)
140 (-5) 8.44 7.88 5.08 6.46 2.57 6.09 (1.06) 1.22 (0.29)
Notes:
* - secretion significantly different from basal (t40), based on ANOVA and Dunnetf s test of 
logio-transformed data (p<0.05).
1 - Carbachol concentration, 10n molar.
Appendix 8A: Responses of individual muscle strips and mean values for sheep 1 in 
carbachol cumulative dose response experiments. Data as a proportion of the maximum 
response obtained in each tissue (1.00 = maximum).
[carbachol]
moles
Tissue
A B c D Mean (± S.E.)
10'9 0.00 0.00 0.00 0.00 0.00 (0.00)
10'8 0.00 0.03 0.04 0.03 0.02 (0.01)
10'7 0.12 0.20 0.23 0.38 0.23 (0.05)
10° 0.50 0.67 0.68 0.88 0.68 (0.08)
1 0 5 0.87 1.00 1.00 1.00 0.97 (0.03)
104 1.00 1.00 0.91 1.00 0.97 (0.03)
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Appendix 8B: Responses of individual muscle strips and mean values for sheep 2 in
carbachol cumulative dose response experiments. Data as a proportion of the maximum
response obtained in each tissue (1.00 = maximum).
[carbachol]
moles
Tissue
A B c D Mean (± S.E.)
10‘9 0.00 0.00 0.00 0.00 0.00 (0.00)
10‘8 0.00 0.00 0.00 0.00 0.00 (0.00)
10'7 0.11 0.08 0.04 0.17 0.10(0.03)
10° 0.69 0.62 1.00 0.67 0.74 (0.09)
10 s 1.00 1.00 0.88 1.00 0.97 (0.03)
104 0.77 0.50 0.80 0.83 0.72 (0.08)
Appendix 8C: Responses of individual muscle strips and mean values for sheep 3 in 
carbachol cumulative dose response experiments. Data as a proportion of the maximum 
response obtained in each tissue (1.00 = maximum).
[carbachol]
moles
Tissue
A B C D Mean (± S.E.)
10'9 0.08 0.00 0.08 * 0.05 (0.03)
10'8 0.19 0.14 0.19 0.17(0.02)
10'' 0.42 0.54 0.53 0.50 (0.04)
10° 0.77 0.91 0.83 0.84 (0.04)
103 1.00 1.00 1.00 1.00 (0.00)
10'4 1.00 0.82 0.97 0.93 (0.06)
*- Tissue not responsive.
Appendix 8D: Responses of individual muscle strips and mean values for sheep 4 in 
carbachol cumulative dose response experiments. Data as a proportion of the maximum 
response obtained in each tissue (1.00 = maximum).
[carbachol]
moles
Tissue
A B c D E F
Mean 
(± S.E.)
10'9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (0.00)
10 s 0.05 0.05 0.02 0.06 0.04 0.00 0.04 (0.01)
10'7 0.34 0.36 0.26 0.41 0.43 0.25 0.34 (0.03)
104’ 0.76 0.81 0.63 0.77 0.83 0.89 0.78 (0.03)
10 s 0.94 1.00 0.95 1.00 1.00 1.00 0.82 (0.16)
10'4 1.00 1.00 1.00 1.00 0.96 0.93 0.98 (0.01)
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Appendix 9A: Responses of individual muscle strips and mean values for sheep 1 in
histamine cumulative dose response experiments. Data as a proportion of the maximum
response obtained in each tissue to 100 micromolar carbachol (1.00 = maximum).
[histamine]
moles
Tissue
A B Mean (± S.E.)
i o 9 0.00 0.00 0.00 (0.00)
10'8 0.00 0.00 0.00 (0.00)
10'7 0.00 0.00 0.00 (0.00)
10" 0.00 0.00 0.00 (0.00)
10° 0.00 0.00 0.00 (0.00)
10‘4 0.00 0.00 0.00 (0.00)
Appendix 9B: Responses of individual muscle strips and mean values for sheep 2 in 
histamine cumulative dose response experiments. Data as a proportion of the maximum 
response obtained in each tissue to 100 micromolar carbachol (1.00 = maximum).
[histamine]
moles
Tissue
A B c D Mean (± S.E.)
10 * 0.00 0.00 0.00 0.00 0.00 (0.00)
10'8 0.00 0.00 0.00 0.00 0.00 (0.00)
10'7 0.00 0.00 0.00 0.00 0.00 (0.00)
10" 0.00 0.00 0.00 0.00 0.00 (0.00)
10'5 0.02 0.02 0.01 0.00 0.01 (0.00)
Id 4 0.07 0.09 0.07 0.25 0.12(0.04)
Appendix 9C: Responses of individual muscle strips and mean values for sheep 3 in 
histamine cumulative dose response experiments. Data as a proportion of the maximum 
response obtained in each tissue to 100 micromolar carbachol (1.00 = maximum).
[histamine]
moles
Tissue
A B c D Mean (± S.E.)
10'9 0.00 0.00 0.00 0.00 0.00 (0.00)
10'8 0.00 0.00 0.00 0.00 0.00 (0 .00)
10'7 0.00 0.00 0.00 0.00 0.00 (0.00)
10° 0.00 0.00 0.00 0.00 0.00 (0.00)
10 s 0.00 0.00 0.00 0.00 0.00 (0 .00)
10'4 0.00 0.00 0.00 0.00 0.00 (0 .00)
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Appendix 9D: Responses of individual muscle strips and mean values for sheep 2 in
serotonin cumulative dose response experiments. Data as a proportion of the maximum
response obtained in each tissue to 100 micromolar carbachol (1.00 = maximum).
[serotonin]
moles
Tissue
A B C D Mean (± S.E.)
io'9 0.00 0.00 0.00 0.00 0.00 (0.00)
10'8 0.02 0.05 0.02 0.00 0.02 (0.01)
IO'7 0.12 0.18 0.09 0.08 0.12(0.02)
10° 0.18 0.32 0.11 0.19 0.20 (0.04)
10 s 0.18 0.32 0.12 0.21 0.21 (0.04)
Appendix 9E: Responses of individual muscle strips and mean values for sheep 3 in 
serotonin cumulative dose response experiments. Data as a proportion of the maximum 
response obtained in each tissue to 100 micromolar carbachol (1.00 = maximum).
[serotonin]
moles
Tissue
A B c D Mean (± S.E.)
10‘9 0.00 0.00 0.00 0.00 0.00 (0.00)
10'8 0.00 0.00 0.00 0.00 0.00 (0.00)
1 0 7 0.00 0.00 0.00 0.00 0.00 (0.00)
10" 0.05 0.10 0.04 0.12 0.08 (0.02)
10° 0.07 0.13 0.04 0.18 0.10(0.03)
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Appendix 10A: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E.
Mean 
(± S.E.)
20 3.15 3.03 2.65 3.55 4.12 3.30(0.25)
40 (Blank) 3.95 2.69 3.12 1.79 2.25 2.76 (0.37)
60 (ES) 3.91 2.99 4.33 4.59 2.88 3.74 (0.35)
80 (carb) 5.95 3.63 5.58 6.45 6.45 5.61* (0.52)
Notes;
Blank - 100 jj.1 RPMI 1640 blank medium - mean response to blank is 0 .84  times secretion in 
preceding twenty minutes (t20).
ES - 100 pi Batch 27/10/93 (1st culture) - mean response to ES is 1.35 times response to
Blank medium.
carb - 1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05).
Appendix 10B: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 1.41 1.00 0.74 1.05 (0.97)
40 (Blank) 1.00 1.70 0.21 0.97 (0.43)
60 (ES) 1.21 0.53 1.70 1.15 (0.34)
80 (carb) 7.44 5.32 5.21 5.99* (0.73)
Notes;
Blank - 100 pi RPMI 1640 blank medium - mean response to blank is 0.92 times secretion in 
preceding twenty minutes (t20).
ES - 100 pi Batch 03/11/93 (1st culture) - mean response to ES is 1.18 times response to
Blank medium.
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05).
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Appendix IOC: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 0.00 0.00 0.36 0.00 0.10(0.10)
40 0.32 0.00 0.00 0.00 0.10(0.10)
60 (Blank) 0.16 0.07 0.00 0.00 0.10(0.04)
80 (ES) 1.85 0.00 0.00 0.00 0.46 (0.46)
100 (carb) 2.58 6.14 5.27 6.35 5.08* (0.87)
Notes;
Blank - 100 pi RPMI 1640 blank medium - mean response to blank is 1.00 times secretion in 
preceding twenty minutes (t40).
ES - 100 pi Batch 03/11/93 (1st culture) - mean response to ES is 4.60 times response to
Blank medium.
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10(x+l) transformation.
Appendix 10D: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 6.45 7.61 13.75 9.69 9.89 9.50 (1.25)
40 9.93 7.87 16.87 11.09 9.18 11.00(1.56)
60 (Blank) 9.81 6.97 11.41 10.61 8.89 9.50 (0.80)
80 (ES) 23.23 20.64 33.59 33.98 17.92 25.9* (3.30)
100 (carb) 26.71 35.94 38.75 37.42 34.69 34.7* (2.10)
Notes;
Blank - 100 pi RPMI 1640 blank medium - mean response to blank is 0.87 times secretion in 
preceding twenty minutes (t40).
ES - 100 pi Batch 27/10/93 (2nd culture) - mean response to ES is 2.70 times response to
Blank medium.
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05).
Appendix 10E: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 0.51 1.50 2.17 1.55 1.40 (0.34)
40 1.48 1.66 2.04 1.48 1.66 (0.13)
60 (ES) 2.32 2.24 2.58 2.24 2.35 (0.08)
80 (carb) 3.47 3.32 4.09 3.42 3.58* (0.17)
Notes;
ES - 100 pi Batch 27/10/93 (1st culture) - mean response to ES is 1.42 times basal secretion 
(I40)
carb -0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05).
Appendix 10F: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 0.86 0.67 1.02 0.66 0.80 (0.10)
40 1.00 0.65 0.68 0.77 0.80 (0.10)
60 (ES) 1.17 2.12 1.41 1.10 1.44* (0.24)
80 (carb) 2.02 3.26 1.64 2.13 2.26* (0.35)
Notes;
ES - 100 pi Batch 27/10/93 (1st culture) - mean response to ES is 1.80 times basal secretion 
(*40)
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10(x+l) transformation.
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Appendix 10G: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 0.83 0.34 0.21 0.03 0.28 0.34 (0.13)
40 0.42 0.34 0.60 0.20 0.60 0.43 (0.10)
60 (ES) 1.10 1.82 2.44 1.44 3.08 1.98* (0.35)
80 (carb) 1.02 0.99 0.23 0.76 2.36 1.10(0.35)
Notes;
ES - 100 pi Batch 27/10/93 (2nd culture) - mean response to ES is 4.60 times basal secretion 
( U o )
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10(x+l) transformation.
Appendix 10H: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 15.55 8.20 11.82 17.88 11.34 13.0(1.70)
40 16.68 5.65 12.42 11.21 8.95 11.0(1.80)
60 (ES) 19.79 10.74 26.67 22.69 24.48 20.9* (2.80)
80 (carb) 61.62 36.36 47.58 51.04 47.46 48.8* (4.05)
Notes;
ES - 100 pi Batch 27/10/93 (2nd culture) - mean response to ES is 1.90 times basal secretion 
(I40)
carb -0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10 transformation.
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Appendix 101: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 10.81 10.16 15.24 10.52 19.51 13.25 (1.82)
40 9.52 8.06 11.43 11.07 13.98 10.81 (0.99)
60 (ES) 11.45 13.52 19.81 11.76 15.00 14.31 (1.52)
80 (carb) 31.77 63.43 40.19 20.07 35.00 38.1* (7.14)
Notes;
ES - 100 pi Batch 27/10/93 (2nd culture) - mean response to ES is 1.32 times basal secretion 
(Uo)
carb -0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10 transformation.
Appendix 10J: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 4.96 5.64 5.99 5.00 7.30 5.80 (0.43)
40 5.49 6.85 6.89 5.08 11.43 7.15 (1.13)
60 (ES) 11.24 12.42 12.96 9.67 23.17 13.9* (3.39)
80 (carb) 20.88 24.11 25.09 18.61 37.46 25.2* (3.27)
Notes;
ES - 100 pi Batch 27/10/93 (2nd culture) - mean response to ES is 1.94 times basal secretion 
(Uo)
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10 transformation.
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Appendix 10K: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 8.83 6.00 7.89 9.47 12.62 9.00(1.09)
40 6.00 3.83 5.79 7.37 10.05 6.60(1.03)
60 (ES) 22.17 8.50 15.44 13.16 35.93 19.0* (4.80)
80 (carb) 25.50 15.00 15.96 9.47 27.38 18.7* (3.40)
Notes;
ES - 100 pi Batch 28/10/93 (1st culture) - mean response to ES is 2.88 times basal secretion 
(I40)
carb -0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10 transformation.
Appendix 10L: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 8.77 10.04 5.65 5.13 12.40 8.40 (3.04)
40 8.70 9.66 6.99 3.69 8.68 7.54 (2.36)
60 (ES) 8.33 9.37 7.81 6.47 4.79 7.35 (1.77)
80 (carb) 27.73 23.34 16.58 11.24 19.75 19.7* (6.30)
Notes;
ES - 100 pi Batch 03/11/93 (1st culture) - mean response to ES is 0.97 times basal secretion 
(I40)
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10 transformation.
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Appendix 10M: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 3.32 4.75 1.11 1.03 4.70 2.98 (0.82)
40 2.26 3.17 0.95 1.66 2.74 2.16(0.39)
60 (ES) 6.79 8.38 2.37 5.77 4.70 5.60(1.01)
80 (carb) 21.06 21.73 6.56 7.25 11.47 13.6* (3.29)
Notes;
ES - 100 pi Batch 27/10/93 (1st culture) - mean response to ES is 2.60 times basal secretion
(W
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log,0 transformation.
Appendix 10N: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 7.70 4.23 5.70 6.64 7.07 6.27 (0.60)
40 4.85 3.96 5.70 4.34 5.98 5.00 (0.39)
60 (ES) 5.52 5.29 6.32 5.84 6.47 5.89 (0.23)
80 (carb) 20.92 19.82 19.04 24.60 20.00 20.9* (1.00)
Notes;
ES - 100 jl iI  Batch 06/10/94 (1st culture) - mean response to ES is 1.18 times basal secretion 
(I40)
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log]0 transformation.
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Appendix 100: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 3.18 2.12 3.27 3.61 3.17 3.07 (0.25)
40 3.40 2.28 3.04 3.50 2.59 2.96 (0.23)
60 (ES) 3.96 3.23 4.91 7.28 3.04 4.84* (0.77)
80 (carb) 2.34 2.23 2.54 4.59 2.07 2.75 (0.46)
Notes;
ES - 100 pi Batch 06/10/94 (1st culture) - mean response to ES is 1.63 times basal secretion
(W
carb -0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following logi0 transformation.
Appendix 10P: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 3.09 3.91 4.84 3.85 3.57 3.85 (0.29)
40 3.39 2.42 4.04 4.09 3.23 3.43 (0.31)
60 (ES) 5.24 4.75 7.80 8.45 6.70 6.59* (0.71)
80 (carb) 9.44 10.78 13.56 12.33 14.23 12.1* (0.88)
Notes;
ES - 100 pi Batch 06/10/94 (1st culture) - mean response to ES is 1.92 times basal secretion 
(I40)
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following logj0 transformation.
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Appendix 10Q: Individual and mean values of pepsinogen release (total units) for ES
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 4.28 3.88 3.72 3.96 (0.17)
40 2.24 2.74 5.88 3.62(1.14)
60 (ES) 4.08 3.92 8.24 5.41 (1.31)
80 (carb) 37.96 34.12 33.72 27.1* (1.46)
Notes;
ES - 100 pi Batch 05/10/94 (1st culture) - mean response to ES is 1.49 times basal secretion
(W
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following logi0 transformation.
Appendix 10R: Individual and mean values of pepsinogen release (total units) for ES 
studies using intact mucosal preparations from abattoir-derived sheep.
Time (min) Tissue
A B C D E
Mean 
(± S.E.)
20 2.57 0.61 0.92 1.37(0.13)
40 2.84 1.97 0.15 1.65 (0.79)
60 (ES) 18.64 9.85 17.86 15.4* (2.81)
80 (carb) 12.58 15.30 17.56 15.1* (1.44)
Notes;
ES - 100 pi Batch 05/10/94 (1st culture) - mean response to ES is 9.30 times basal secretion 
O40)
carb - 0.1 mM carbachol
* significantly different from secretion in second period (t40) by ANOVA and Dunnett’s test 
(p<0.05) following log10 transformation.
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Appendix 11 A: Responses of smooth muscle strips, obtained from abattoir-derived
sheep, to ES doses, data expressed as a proportion o f  the m axim al response obtained to 0.1
m M  carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES/10 0.32 0.32 0.30 0.34 0.32 (0.02)
100 pi ES raw 0.37 0.53 0.37 0.35 0.41 (0.08)
Notes;
ES - Batch 27/10/93 (1st culture). 
ES/10 - 1 in 10 dilution of raw ES.
Appendix 11B: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B c D
Mean 
(± S.E.)
100 pi ES/100 0 0 0 0 0.00 (0.00)
100 pi ES/10 0.06 0 0 0 0.01 (0.03)
100 pi ES raw 0.20 0 0.02 0.09 0.08 (0.08)
Notes;
ES - Batch 28/10/93 (1st culture).
ES/100 - 1 in 100 dilution of raw ES.
ES/10 - 1 in 10 dilution of raw ES.
Appendix 11C: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES * 0.19 0.09 0.00 0.09 (0.05)
Notes;
ES - Batch 28/10/93 (1st culture).
* - Tissue unresponsive to carbachol.
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Appendix 11D: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1
mM carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES 0.04 0.29 0.09 * 0.14(0.13)
Notes;
ES - Batch 28/10/93 (1st culture).
* - Tissue unresponsive to carbachol.
Appendix 11E: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B c D
Mean 
(± S.E.)
100 pi ES 0.00 0.00 0.00 0.00 0.00 (0.00)
Notes;
ES - Batch 03/11//93 (1st culture).
Appendix 11F: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B c D E F G
Mean 
(± S.E.)
100 pi 
ES/10 0.00 0.00 0.10 0.06 0.00 0.08 0.21 0.06 (0.08)
100 pi 
ES raw 0.07 0.00 0.20 0.25 0.06 0.10 0.25 0.13 (0.10)
Notes;
ES - Batch 27/10/93 (1st culture). 
ES/10 - 1 in 10 dilution of raw ES.
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Appendix 11G: Responses of smooth muscle strips, obtained from abattoir-derived
sheep, to E S doses, data expressed as a proportion o f  the m axim al response obtained to 0.1
m M  carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES 0.69 0.74 0.90 0.78 (0.11)
Notes;
ES - Batch 27/10/93 (1st culture).
Appendix 11H: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES + INDO* 0.73 0.60 1.23 0.86 0.85 (0.27)
100 pi ES-INDO 0.28 0.08 0.29 0.43 0.27 (0.14)
Notes;
ES - Batch 27/10/93 (1st culture).
* - presence or absence of 3 micromolar Indomethacin.
Appendix 111: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES 0.52 0.63 0.83 1.07 0.76 (0.12)
Notes;
ES - Batch 06/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
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Appendix 11J: Responses of smooth muscle strips, obtained from abattoir-derived
sheep, to E S doses, data expressed as a proportion o f  the m axim al response obtained to 0.1
m M  carbachol.
ES dose
Tissue
A B c D
Mean 
(± S.E.)
100 pi ES/100 0.00 0.00 0.11 0.14 0.06 (0.04)
100 pi ES/10 0.22 0.21 0.28 0.43 0.28 (0.05)
100 pi ES raw 0.22 0.21 0.28 0.49 0.30 (0.06)
Notes;
ES - Batch 27/10/93 (2nd culture).
ES/100 - 1 in 100 dilution of raw ES.
ES/10 - 1 in 10 dilution of raw ES.
All tissues given 3 micromolar Indomethacin.
Appendix 11K: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B
Mean 
(± S.E.)
100 pi ES 0.66 0.70 0.68 (0.02)
Notes;
ES - Batch 06/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
Appendix 11L: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B
Mean 
(± S.E.)
100 pi ES 2.14 * 2.14(0.00)
Notes;
ES - Batch 06/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
* - Tissue not responsive to carbachol.
324
Appendix 11M: Responses of smooth muscle strips, obtained from abattoir-derived
sheep, to ES doses, data expressed as a proportion o f  the m axim al response obtained to 0.1
mM  carbachol.
ES dose
Tissue
A B c D
Mean 
(± S.E.)
100 pi ES 0.96 1.00 0.92 1.13 1.00 (0.09)
Notes;
ES - Batch 06/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
Appendix 11N: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B c D
Mean 
(± S.E.)
100 nl E S /10“ 0.00 0.00 0.00 0.00 0.00 (0.00)
100 nl E S /10J 0.00 0.00 0.00 0.00 0.00 (0.00)
100 h1 ES/ 10^ 0.00 0.00 0.00 0.00 0.00 (0.00)
100 Hi ES/ 10 0.31 0.17 0.15 0.29 0.23 (0.08)
100 Hi ES 0.19 0.07 0.15 0.21 0.15 (0.06)
Notes;
ES - Batch 06/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
Appendix llO : Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B C D
Mean 
(± S.E.)
100 pi ES 0.56 0.54 0.54 0.60 0.56 (0.03)
Notes;
ES - Batch 06/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
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Appendix IIP: Responses of smooth muscle strips, obtained from abattoir-derived
sheep, to E S doses, data expressed as a proportion o f  the m axim al response obtained to 0.1
m M  carbachol.
ES dose
Tissue
A B c D
M ean 
(± S.E.)
100 jil ES/ 10J 0.00 0.01 0.00 0.00 0.00 (0.00)
100 nl ES/ 10z 0.01 0.04 0.02 0.06 0.03 (0.01)
100 |il E S /10 0.03 0.09 0.03 0.09 0.06 (0.02)
100 nl ES 0.04 0.11 0.06 0.12 0.08 (0.02)
Notes;
ES - Batch 05/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
Appendix 11Q: Responses of smooth muscle strips, obtained from abattoir-derived 
sheep, to ES doses, data expressed as a proportion of the maximal response obtained to 0.1 
mM carbachol.
ES dose
Tissue
A B C D
M ean 
(± S.E.)
100 pi ES 0.21 0.75 0.07 0.00 0.26 (0.17)
Notes;
ES - Batch 05/10/94 (1st culture).
All tissues given 3 micromolar Indomethacin.
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Appendix 12: Pepsinogen and LDH release from intact mucosal preparations from one 
animal, pepsinogen release is expressed as the total units (u) released per 20 minutes and as 
pepsinogen release over basal (40 min)(figures in parentheses).
Time (min) Tissue
A B c D E
Mean 
(± S.E.)
Peps
20 1.59
(0.95)
3.77
(1.17)
2.36
(0.80)
3.45
(1.36)
1.51
(0.72) (1.00 (0.12))
40 1.67
(1.00)
3.23
(1.00)
2.94
(1.00)
2.54
(LOO)
2.10
(1.00) (1.00 (0.00))
60 (ES) 2.80
(1.68)
4.84
(1.50)
4.15
(1.41)
4.84
(L90)
2.99
(1.42) (1.58 (0.09))
80 (carb) 2.23
(1.33)
4.14
(1.28)
3.07
(1.04)
4.49
(1.77)
3.04
(1.45) (1.37(0.12))
LDH (U) 
20 0.000 0.010 0.014 0.017 0.010 0.010(0.003)
40 0.007 0.014 0.014 0.007 0.014 0.011 (0.002)
60 (ES) 0.007 0.010 0.010 0.010 0.010 0.009 (0.001)
80 (carb) 0.014 0.007 0.010 0.010 0.014 0.011 (0.001)
ES - 100 pi Batch 27/10/93 (1st culture), 
carb - 1 mM carbachol.
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Appendix 13: Pepsinogen and LDH release from individual tissues in response to the 
addition of ES and carbachol. All data are expressed as the total units released per twenty 
minute period. Included are the total tissue content of pepsinogen and LDH at the end of the 
experiment.
Group 1 Group 2
Time Tissue
(min) A B C D E F
Peps (u)
20 3.33 2.22 3.52 2.52 1.96 3.43
40 1.97 2.35 3.77 2.52 3.36 3.00
60 (ES) 3.83 3.46 3.40 4.65 2.52 2.86
80 (carb) 22.10 27.41 27.67 23.50 17.06 25.00
Tissue 192.59 208.80 249.06 162.24 195.80 200.00
LDH (U)
20 0.007 0.000 0.007 0.000 0.007 0.007
40 0.000 0.007 0.014 0.007 0.007 0.014
60 (ES) 0.000 0.000 0.007 0.014 0.000 0.000
80 (carb) 0.000 0.007 0.000 0.007 0.000 0.007
Tissue 1.44 1.58 1.51 1.52 1.58 1.70
Group 1 tissues (tissues A to C), Group 2 tissues (tissues D to F).
ES - 100 pi Batch 27/10/93 (2nd culture) - given to group 1 tissues only, 
carb - 0.1 mM carbachol, given to all six tissues.
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Appendix 14: Pepsinogen and LDH release from individual tissues in response to the 
addition of ES and carbachol to tissues in the presence and absence of Indomethacin*.
All data are expressed as the total units released per twenty minute period. Included are the 
total tissue content of pepsinogen and LDH at the end of the experiment. The mean (± S.E.) 
results for pepsinogen for groups 1 and 2 are given in parentheses.
Time
(min)
Tissue
A
Group 1 
B C D
Group 2
E F
Peps (u) 
20 7.72 7.41 8.89 4.32 3.13 3.17
40 9.20 7.90
(8.0(0.45))
8.11 4.00 3.35
(3.5 (0.40)) 
4.40
60 (ES) 9.96 11.20
(8.4 (0.40)) 
9.30 6.11 5.30
(3.9 (0.31)) 
5.51
80 9.29 9.66
(10.1 (0.60)) 
7.70 5.30 4.46
(5.6 (0.24)) 
4.51
100 (carb) 12.23 11.83
(8.9(0.60))
15.30 13.03 11.09
(4.8 (0.27)) 
8.63
Tissue 291.07 271.83
(13.1 (1.10)) 
266.67 300.54 257.38
(10.9(1.27))
306.41
LDH (U) 
20 0.007 0.007 0.000 0.007 0.000 0.007
40 0.000 0.000 0.000 0.000 0.000 0.007
60 (ES) 0.007 0.014 0.000 0.007 0.000 0.000
80 0.000 0.000 0.014 0.000 0.000 0.007
100 (carb) 0.000 0.000 0.007 0.000 0.000 0.007
Tissue 2.296 1.836 1.553 1.688 1.728 1.458
* - Indomethacin (3 micromolar) given to group 2 tissues only. 
Group 1 tissues (tissues A to C), Group 2 tissues (tissues D to F). 
ES - 100 pi Batch 27/10/93 (2nd culture), given to all six tissues, 
carb -0.1 mM carbachol, given to all six tissues.
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Appendix 15A: Pepsinogen release from individual tissues from sheep 1 in time course 
of the response to ES experiment. Pepsinogen release expressed as the total units released 
per 10 minute period, and the mean values are also given as secretion over basal (figures in 
parentheses and bold script).
Time (min)
Tissue
A B C Mean (± S.E.)
10 4.32 4.44 1.76 3.51 (0.87) 
(0.87 (0.22))
20 4.64 4.60 3.23 4.16(0.46) 
(1.03 (0.11))
30 2.88 4.60 4.63 4.04 (0.58) 
(1.00 (0.14))
40 (ES) 25.28 27.94 25.74 26.32 (0.82) 
(6.52 (0.20))
50 4.60 10.15 9.44 8.06(1.74) 
(2.00 (0.43))
60 (ES) 3.49 2.35 4.07 3.30 (0.50) 
(0.82 (0.12))
70 2.06 3.97 0.37 2.13 (1.04) 
(0.53 (0.26))
80 1.90 3.82 2.41 2.71 (0.57) 
(0.67 (0.14))
90 (carb) 21.90 12.35 12.96 15.74 (3.09) 
(3.90 (0.76))
100 6.35 4.70 3.15 4.73 (0.92) 
(1.17 (0.23))
ES - 1 OOjlxI Batch 27/10/93 (2nd culture), added to submucosal solutions in the 31st and 51st 
minutes. Tissues exposed to ES for forty minutes.
carb - 0.1 mM carbachol, added in 81st minute, tissues exposed to carbachol for twenty 
minutes.
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Appendix 15B: Pepsinogen release from individual tissues from sheep 2 in time course 
of the response to ES experiment. Pepsinogen release expressed as the total units released 
per 10 minute period, and the mean values are also given as secretion over basal (figures in 
parentheses and bold script).
Time
(min)
Tissue
A B C D E
Mean 
(± S.E.)
10 2.69 1.30 1.84 3.02 2.54 2.28 (0.31) 
(0.86 (0.12))
20 2.34 1.66 2.05 2.21 2.98 2.25 (0.22) 
(0.85 (0.08))
30 2.98 1.80 2.05 2.73 3.66 2.64 (0.33) 
(1.00 (0.13))
40 (ES) 3.90 2.74 1.34 2.66 3.43 2.81 (0.43) 
(1.06 (0.16))
50 3.90 2.67 6.01 4.65 4.78 4.40 (0.55) 
(1.66 (0.21))
60 (ES) 1.77 1.15 1.84 0.37 3.28 1.68 (0.48) 
(0.64 (0.18))
70 1.70 1.59 1.98 1.84 3.73 2.17(0.40) 
(0.82 (0.15))
80 0.92 1.08 1.77 1.33 2.69 1.56 (0.32) 
(0.59 (0.12))
90 (carb) 8.58 9.67 12.93 9.89 13.06 10.83 (0.91) 
(4.09 (0.34))
ES - lOOpl Batch 05/10/94 (1st culture), added to submucosal solutions in the 31st and 51st 
minutes. Tissues exposed to ES for forty minutes.
carb - 0.1 mM carbachol, added in 81st minute, tissues exposed to carbachol for ten minutes.
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Appendix 16A: Pepsinogen release from individual tissues of parasite-naive animals in
response to ES: animal 1. Pepsinogen release expressed as the total in each tw enty minute
period.
Time (min)
Tissue
A B C D E
Mean 
(± S.E.)
20 0.82 0.58 1.32 1.06 1.31 1.02 (0.14)
40 1.18 0.79 0.99 0.64 1.31 0.98 (0.12)
60 1.47 0.99 0.51 0.54 0.70 0.84 (0.18)
80 (ES-1) 0.82 0.65 0.81 0.96 1.08 0.86 (0.07)
100 (ES-2) 0.55 0.36 0.79 0.22 1.18 0.62 (0.17)
120 (carb) 3.25 J.J / 7.12 5.76 4.02 4.70*(0.75)
ES-1 - 100 pi Batch 06/10/94.
ES-2 - 100 pi Batch 27/10/93 (1st culture), 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated time period (t60) by ANOVA and 
Dunnetf s test (p<0.05) following log|0(x+l) transformation.
Appendix 16B: Pepsinogen release from individual tissues of parasite-naive animals in 
response to ES: animal 2. Pepsinogen release expressed as the total in each twenty minute 
period.
Time (min)
Tissue
A B C D E
Mean 
(± S.E.)
20 4.84 5.05 15.16 10.54 9.89 9.10(1.92)
40 5.68 5.89 12.69 15.27 7.10 9.33 (1.96)
60 (ES) 5.89 5.26 11.61 9.89 9.98 8.53 (1.25)
80 (carb) 31.58 20.84 46.88 50.54 30.66 36.1 *(5.51)
E S -100  pi Batch 06/10/94. 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated time period (t40) by ANOVA and 
Dunnetf s test (p<0.05) following logi0-transformation.
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Appendix 16C: Pepsinogen release from individual tissues of parasite-naive animals in
response to ES: animal 3. Pepsinogen release expressed as the total in each twenty minute
period.
Time (min)
Tissue
A B C D E
Mean 
(± S.E.)
20 7.67 7.10 8.70 9.60 8.18 8.25*(0.43)
40 6.60 6.01 5.87 4.64 4.24 5.47 (0.44)
60 (ES) 5.82 4.03 3.72 3.49 2.42 3.90 (0.55)
80 (carb) 3.59 3.29 2.59 4.17 5.17 3.76*(0.43)
ES - 100 pi Batch 06/10/94. 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated time period (t40) by ANOVA and 
Dunnetf s test (p<0.05) following log]^transformation.
Appendix 16D: Pepsinogen release from individual tissues of parasite-naive animals in 
response to ES: animal 4. Pepsinogen release expressed as the total in each twenty minute 
period.
Time (min)
Tissue
A B C D E
Mean 
(± S.E.)
20 4.12 5.30 4.12 2.66 4.72 4.18(0.44)
40 J.J / 3.91 2.82 1.75 4.23 3.22 (0.44)
60 (ES) 3.30 4.73 2.03 0.58 3.62 2.85 (0.71)
80 (carb) 2.12 3.42 2.89 2.29 2.72 2.69 (0.23)
E S -100  pi Batch 06/10/94. 
carb -0.1 mM carbachol.
* significantly different from secretion in last untreated tim e period (t40) by A N O V A  and
D u n netf s test (p<0.05) fo llow in g  log|^transform ation.
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Appendix 16E: Pepsinogen release from individual tissues of parasite-naive animals in
response to ES: animal 5. Pepsinogen release expressed as the total in each twenty minute
period.
Time (min)
Tissue
A B C D E
M ean 
(± S.E.)
20 1.55 1.23 5.09 6.04 5.43 3.87 (1.02)
40 1.37 1.23 5.46 8.99 2.82 3.97 (1.47)
60 (ES) 2.19 1.23 J). / J 4.03 3.49 2.93 (0.53)
80 (carb) 13.97 9.77 34.41 39.87 17.05 23.0*(5.94)
ES - 100 pi Batch 06/10/94. 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated time period (t40) by ANOVA and 
Dunnetf s test (p<0.05) following log|^transformation.
Appendix 16F: Pepsinogen release from individual tissues of parasite-naive animals in 
response to ES: animal 6. Pepsinogen release expressed as the total in each twenty minute 
period.
Time (min)
Tissue
A B C D E
Mean 
(± S.E.)
20 0.57 0.57 0.00 1.65 1.69 0.90 (0.33)
40 1.00 0.28 0.28 3.03 0.56 1.03 (0.52)
60 (ES) 0.00 0.69 0.96 1.97 2.53 1.23 (0.45)
80 (carb) 32.03 12.69 25.79 27.89 36.48 27.0*(4.01)
ES - 100 pi Batch 06/10/94. 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated tim e period (t40) by A N O V A  and
D unnetf s test (p <0.05) fo llow ing lo g !0(x+ l)-transform ation.
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Appendix 16G: Pepsinogen release from individual tissues of parasite-naive animals in
response to ES: animal 7. Pepsinogen release expressed as the total in each tw enty minute
period.
Time (min)
Tissue
A B C D E
M ean 
(± S.E.)
20 2.49 1.48 0.77 1.58 (0.50)
40 2.15 0.84 0.97 1.32(0.42)
60 (ES) 2.72 1.34 1.04 1.70 (0.52)
80 (carb) 35.21 24.61 41.37 38.8*(0.79)
ES - 100 pi Batch 06/10/94. 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated time period (t40) by ANOVA and 
Dunnetf s test (p<0.05) following log ^ -transformation.
Appendix 16H: Pepsinogen release from individual tissues of parasite-naive animals in 
response to ES: animal 8. Pepsinogen release expressed as the total in each twenty minute 
period.
Time (min)
Tissue
A B C D E F
M ean 
(± S.E.)
20 13.85 1 o n -> 11.03 5.03 3.71 8.77 9.20 (1.73)
40 11.41 5.53 6.22 5.69 5.83 9.85 7.42(1.04)
60 (ES) 9.36 5.26 4.24 5.43 6.77 7.23 6.38 (0.74)
80 (carb) 40.39 40.64 38.94 36.56 40.15 36.31 38.8*(0.79)
ES - 100 pi Batch 05/10/94 (1st culture), 
carb - 0.1 mM carbachol.
* significantly different from secretion in last untreated tim e period (t40) by A N O V A  and
D u n n etf s test (p < 0 .05) fo llow in g  log,^transform ation.
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Appendix 17A: Responses of individual muscle strips of parasite-naive animals to
carbachol and ES: animal 1. R esponses are expressed as grams of tension per gram of wet
w eigh t o f  tissue.
Treatment
Tissue
A B c D
Mean 
(± S.E.)
long. mm.
carbachol 127.7 173.9 208.3 500.0 252.5 (84.1)
ES-1 0.00 0.00 0.00 0.00 0.00 (0.00)
ES-2 0.00 0.00 0.00 0.00 0.00 (0.00)
ES-4 0.00 0.00 0.00 0.00 0.00 (0.00)
circ. mm.
carbachol 265.6 371.0 100.0 71.4 202.0 (70.7)
ES-1 0.00 0.00 0.00 0.00 0.00 (0.00)
ES-4 0.00 0.00 0.00 0.00 0.00 (0.00)
ES-1* 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol - 0.1 mM.
ES-1 - 100 pi Batch 06/10/94.
ES-2 - 27/10/93 (1st culture).
ES-3 - 05/10/94 (2nd culture).
ES-4 - 05/10/94 (1st culture).
* - tissues preincubated with 3 micromolar Indomethacin before addition of ES.
Appendix 17B: Responses of individual muscle strips of parasite-naive animals to 
carbachol and ES: animal 2. Responses are expressed as grams of tension per gram of wet 
weight of tissue.
Treatment
Tissue
A B c D E F
Mean 
(± S.E.)
carb 69.5 172.4 27.4 40.9 41.7 60.8 68.8(21.6)
ES 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (0.00)
ES* 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol - 0.1 mM.
E S -100  pi Batch 06/10/94.
* - tissues preincubated with 3 micromolar Indomethacin before addition of ES.
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Appendix 17C: Responses of individual muscle strips of parasite-naive animals to
carbachol and ES: animal 3. R esponses are expressed as grams o f  tension  per gram o f  wet
w eight o f  tissue.
Treatment
Tissue
A B c D
Mean 
(± S.E.)
carbachol 181.0 224.4 188.3 246.8 210.1 (15.5)
ES 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol -0.1 mM. 
E S -100  pi Batch 06/10/94.
Appendix 17D: Responses of individual muscle strips of parasite-naive animals to 
carbachol and ES: animal 4. Responses are expressed as grams of tension per gram of wet 
weight of tissue.
Treatment
Tissue
A B C D
Mean 
(± S.E.)
carbachol 50.33 155.56 186.27 155.34 136.9 (29.7)
ES 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol -0.1 mM.
ES -100 pi Batch 06/10/94.
Appendix 17E: Responses of individual muscle strips of parasite-naive animals to 
carbachol and ES: animal 5. Responses are expressed as grams of tension above basal.
Treatment
Tissue
A B c D
Mean 
(± S.E.)
carbachol 4.00 4.00 2.10 2.80 3.22 (0.47)
ES 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol - 0.1 mM. 
ES -100 pi Batch 06/10/94.
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Appendix 17F: Responses of individual muscle strips of parasite-naive animals to 
carbachol and ES: animal 6. Responses are expressed as grams of tension above basal.
Treatment
Tissue
A B c D
Mean 
(± S.E.)
carbachol 1.00 1.20 1.25 0.60 1.01 (0.15)
ES 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol - 0.1 mM.
E S -1 0 0  pi Batch 06/10/94.
Appendix 17G: Responses of individual muscle strips of parasite-naive animals to 
carbachol and ES: animal 7. Responses are expressed as grams of tension above basal.
Treatment
Tissue
A B c D
Mean 
(± S.E.)
carbachol 2.80 3.00 1.70 1.65 2.29 (0.36)
ES 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol - 0.1 mM.
ES - 100 pi Batch 05/10/94 (1st culture).
Appendix 17H: Responses of individual muscle strips of parasite-naive animals to 
carbachol and ES: animal 8. Responses are expressed as grams of tension above basal.
Treatment
Tissue
A B C D
Mean 
(± S.E.)
carbachol 1.85 1.55 0.40 0.74 1.13 (0.34)
ES 0.00 0.00 0.00 0.00 0.00 (0.00)
carbachol - 0.1 mM.
ES - 100 pi Batch 05/10/94 (1st culture).
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Appendix 18A: Total tissue pepsinogen (iU/ standard area) of fundic mucosal pieces of 
cattle and sheep.
Site
Calf
1 2 3 4 5
Sheep
1 2 3
1 4319 8082 2974 2724 2965 753 2877 3245
2 7447 8336 4392 2771 2307 1228 2877 2673
3 6764 7130 3706 2511 2557 1060 1996 3588
4 7606 6685 3901 3243 1890 894 2553 3145
5 6876 6876 3169 2613 2557 976 2083 3673
6 4891 4633 4439 3141 4244 726 2436 3659
7 4478 7304 3299 3299 1946 502 2923 2709
8 6034 4764 4392 3456 2984 753 2826 2330
9 5208 6907 2483 3632 3660 670 2631 2830
10 5129 7146 4346 4096 3456 880 2143 4224
Appendix 18B: Tissue wet weights (g) of fundic mucosal pieces of cattle and sheep.
Site
Calf
1 2 3 4 5
Sheep
1 2 3
1 0.1144 0.1111 0.0802 0.0901 0.1130 0.0872 0.1090 0.0585
2 0.1099 0.1477 0.1304 0.1006 0.1022 0.0866 0.1013 0.0684
3 0.1344 0.1189 0.0905 0.1047 0.0852 0.0937 0.1154 0.0675
4 0.1222 0.1000 0.0981 0.1069 0.0992 0.0768 0.0893 0.0717
5 0.1195 0.1041 0.0908 0.0757 0.0798 0.0999 0.0948 0.0697
6 0.1350 0.0834 0.1011 0.0913 0.1136 0.0899 0.0842 0.0667
7 0.1230 0.1372 0.1008 0.1029 0.0916 0.0733 0.0780 0.0687
8 0.1077 0.1032 0.0926 0.0950 0.1020 0.0728 0.0885 0.0680
9 0.1368 0.1256 0.0600 0.1047 0.0949 0.0682 0.0880 0.0544
10 0.1283 0.0882 0.0886 0.0834 0.1070 0.0702 0.0810 0.0775
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Appendix 19A: Tissue wet weights (g) of mucosal pieces from ovine fundus comparing 
nodular and non-nodular mucosa.
Sheep
Site
1 2 3 4
Y27 nodular 0.1019 0.1195 0.1235 0.1116
nodular 0.1201 0.1043 0.1131 0.1153
02 nodular 0.0982 0.1341 0.1023 0.1069
non-nodular 0.0859 0.0800 0.0981 0.0835
Y43 nodular 0.1095 0.1315 0.1249 0.1322
non-nodular 0.1227 0.0886 0.0939 0.0919
Y51 nodular 0.0860 0.0897 0.0809 0.0891
non-nodular 0.0755 0.0807 0.0685 0.0819
B60 nodular 0.1033 0.1025 0.0850 0.0916
non-nodular 0.0853 0.0933 0.0962 0.0869
Appendix 19B: Tissue pepsinogen (iU/ area) of mucosal pieces from ovine fundus 
comparing nodular and non-nodular mucosa.
Sheep
Site
1 2 3 4
Y27 nodular 2984 3505 3993 4301
nodular 2761 1731 3324 4163
02 nodular 3048 7615 7285 3940
non-nodular 4014 4768 3961 3770
Y43 nodular 4025 3568 2793 2538
non-nodular 1858 1572 1476 1625
Y51 nodular 2825 2283 4057 3781
non-nodular 2517 2634 2145 2145
B60 nodular 2814 1912 2007 1338
non-nodular 2475 945 1561 1338
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Appendix 19C: Tissue pepsinogen (iU/g) of mucosal pieces from ovine fundus 
comparing nodular and non-nodular mucosa.
Sheep
Site
1 2 3 4
Y27 nodular 29,290 29,343 32,359 38,582
nodular 22,950 16,567 29,417 36,076
02 nodular 31,021 56,753 71,196 36,904
non-nodular 46,675 59,546 40,388 45,103
Y43 nodular 36,735 27,113 22,408 19,169
non-nodular 15,176 17,767 15,739 17,650
Y51 nodular 32,826 25,456 50,126 42,427
non-nodular 33,304 32,582 31,329 26,199
B60 nodular 27,240 16,036 23,640 14,666
non-nodular 29,078 10,078 16,280 15,452
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Appendix 20: Individual faecal egg counts (epg) and worm burdens of sheep in the
initial study of the effects of haemonchosis.
Animal Group FEC L4 L5 Adults* Total
14 SDI 3900 200 1400 2900/1300 5800
20 8500 0 100 1350/1400 2850
21 2550 0 50 700/550 1300
25 1450 0 0 400/500 900
28 50 0 0 0/0 0
32 200 200 0 100/100 400
33 2250 400 50 150/300 900
34 30700 50 150 1100/900 2200
15 SDC 100 0 0 0/0 0
19 0 0 0 0/0 0
29 0 0 0 0/0 0
30 50 0 0 0/0 0
16 BDI 29000 350 300 350/350 1350
17 16300 100 750 450/450 1750
18 27700 200 300 100/400 1000
26 62600 0 200 100/1100 1400
27 16200 0 300 1400/1500 3200
31 14300 0 150 750/300 1200
35 18400 100 100 350/250 800
36 20600 0 300 1100/700 2100
22 BDC 0 0 0 0/0 0
24 0 0 0 200/100 300
37 0 0 0 0/0 0
38 0 0 0 0/0 0
* - adult worm  burdens are given  as numbers o f  m ales/ number o f  fem ales.
342
Appendix 21: Individual packed cell volumes (PCV), and the concentrations of total
plasma protein (T.P.), plasma albumin and plasma pepsinogen (P.peps.) of sheep in the
initial study of the effects of haemonchosis.
Animal Group
PCV 
(per cent)
T.P.
(g/L)
Albumin
(g/L)
P. peps. 
(iU)
14 SDI 30 60 30 5.03
20 27 48 26 2.19
21 28 59 31 3.06
25 28 58 30 15.10
28 30 65 31 5.49
32 28 61 5.44
33 27 59 30 8.04
34 24 61 30 7.09
15 SDC 32 66 32 0.66
19 28 63 31 2.63
29 32 63 JJ 7.09
30 30 66 33 2.52
16 BDI 26 56 28 14.22
17 20 52 24 2.63
18 21 53 25 5.25
26 22 45 23 4.80
27 19 45 19 4.35
31 21 51 20 3.89
35 28 51 28 9.46
36 24 58 27 8.27
22 BDC 32 65 31 0.00
24 30 60 31 4.58
37 29 58 28 0.00
38 29 57 29 0.95
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Appendix 22: Individual faecal egg counts (epg) and worm burdens of sheep in the
second study of the effects of haemonchosis.
Animal Group FEC L4 L5 Adults* Total
10 SDI 6900 750 100 1350/950 3150
11 9200 100 0 1300/1100 2500
15 7500 50 150 1000/700 1900
17 8700 0 200 950/950 2100
20 5900 0 150 1100/950 2200
23 50 0 100 1750/1550 3400
33 7600 0 200 1000/850 2050
35 5900 0 0 700/500 1200
7 SDC 650 0 0 0/0 0
16 500 0 0 0/0 0
26 0 0 0 0/0 0
36 0 0 0 0/0 0
9 BDI 15600 50 500 1350/850 2750
21 6300 0 450 1350/1100 2900
25 3300 50 150 1350/550 2100
29 21500 0 250 350/250 850
32 10600 100 0 1050/1150 2300
37 4300 150 200 1400/1000 2750
41 6400 0 500 1750/950 3200
42 9500 0 0 650/600 1250
18 BDC 0 0 0 0/0 0
19 0 0 0 0/0 0
28 0 0 0 0/0 0
38 0 0 0 0/0 0
* - adult worm burdens are g iven  as numbers o f  m ales/ num ber o f  fem ales.
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Appendix 23: Individual packed cell volumes (PCV), and the concentrations of total
plasma protein (T.P.), plasma albumin and plasma pepsinogen (P.peps.) of sheep in the
second study of the effects of haemonchosis.
Animal Group
PCV 
(per cent)
T.P.
(g/L)
Albumin
(g/L)
P. peps. 
(iU)
10 SDI 25 58 19 3.05
11 27 53 23 0.97
15 29 58 24 0.97
17 27 58 23 1.79
20 26 57 20 2.07
23 26 60 21 3.45
33 24 83 18 9.08
35 32 65 21 2.94
7 SDC 34 64 25 1.66
16 29 68 22 1.38
26 35 68 28 3.20
36 •">JJ 72 24 2.34
9 BDI 21 53 16 4.30
21 28 60 19 3.87
25 27 60 19 5.21
29 21 44 15 4.67
32 22 48 17 5.87
37 24 63 19 2.73
41 22 62 20 2.99
42 27 53 18 2.99
18 BDC 30 66 22 2.49
19 31 60 23 0.97
28 35 67 25 0.13
38 34 66 21 3.77
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Appendix 24A: Individual and mean (± S.E.) values for wet weights of mucosal cuts 
from the Hampshire’s in the second haemonchosis study.
Sheep Group
Tissue
A B C D E
Mean 
(± S.E.)
10 SDI 0 .0655 0.0851 0.1052 0.0812 0 . 095 2 0 . 08 6 4  (0 .0070)
11 0 . 096 8 0.0791 0.0892 0 .0856 0 . 076 2 0 . 0 8 54  (0 .0037)
15 0 . 089 4 0.1061 0 .1057 0 .1020 0 . 104 2 0 . 1015  (0 .0031)
17 0 .0745 0 .0926 0.0917 0 .0724 0 .0845 0.0831 (0 .0042)
20 0 . 087 6 0 .0767 0.0840 0 .1065 0.0701 0 . 08 5 0  (0 .0062)
23 0.0981 0.1093 0.1041 0.1093 0 . 0988 0 . 1 0 3 9 ( 0 . 0 0 2 4 )
33 0 .0 94 4 0 .0840 0 .0899 0 .1014 0 .0953 0 .0 9 3 0  (0 .0029)
35 0 . 106 9 0 .1314 0 .1220 0 .1409 0 .1413 0 . 1285  (0 .0065)
7 SDC 0 . 071 6 0.0775 0.0893 0 .0710 0 .073 2 0 . 0765  (0 .0034)
16 0 . 073 9 0 .0696 0.0870 0.0793 0 . 0 8 34 0 . 0 7 8 6 ( 0 . 0 0 3 1 )
26 0 .0723 0 .0998 0.0921 0.0785 0 .0643 0 . 0 8 57  (0 .0056)
36 0 .0885 0.0681 0.0852 0.0805 0 . 064 0 0 .0773  (0 .0048)
9 BDI 0 . 088 6 0 .0790 0 .0760 0.0902 0 .0823 0 . 0 8 3 2  (0 .0027)
21 0 .0923 0 .0804 0 .0976 0 .0900 0.1011 0 .090 3  (0 .0041)
25 0 . 103 7 0 .1056 0.1002 0.1013 0 .1 05 0 0 . 1 0 3 2 ( 0 . 0 0 1 0 )
29 0 .089 0 0 .0930 0.1128 0 .1046 0 . 099 0 0 . 09 9 7  (0 .0042)
32 0 .1053 0 .1107 0 .1239 0.1133 0 . 105 0 0.11 16 (0 .0035)
37 0 . 102 6 0 .1026 0 .0964 0 .0988 0.0883 0 . 0 9 77  (0 .0026)
41 0 .0963 0 .1032 0.0975 0 .1034 0.1201 0.1041 (0 .0043)
42 0 .1215 0.1131 0.1113 0.0993 0 . 0958 0 . 108 2  (0 .0047)
18 BDC 0 .0870 0 .0950 0.1060 0.0795 0 . 0790 0 .0893  (0 .0051)
19 0 .0 670 0 .0860 0.0803 0.0715 0 . 0738 0 . 0 7 57  (0 .0033)
28 0 .0895 0.1113 0.1011 0.1008 0 . 0902 0 . 0 9 86  (0 .0046)
38 0 .0 937 0 .1089 0.0999 0 .0927 0 . 1018 0 .0 9 94  (0 .0029)
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Appendix 24B: Individual and mean (± S.E.) values for pepsinogen concentrations
(iU/area) of mucosal cuts from the Hampshire’s in the second haemonchosis study.
Sheep Group
Tissue
A B C D E
Mean 
(± S.E.)
10 SDI 3757 2837 2785 2 9 50 3 084 3083 (176)
11 1876 2 216 1601 1748 1695 1 8 2 7 ( 1 0 7 )
15 0 8 94.3 223 537 1 7 2 ( 1 0 0 )
17 4163 4488 5594 3 32 2 4415 4 39 6  (364)
20 3023 2403 3000 3 77 0 8612 41 6 2  (1133)
23 4 147 3783 4077 3453 35 08 3 7 9 4 ( 1 4 2 )
33 1106 571 938 857 1420 978 (140)
35 10011 12283 5578 8388 5911 7892  (1377)
7 SDC 11211 11415 13019 8 790 9555 10798 (744)
16 3 699 5389 7527 5 937 5586 5 6 2 8 ( 6 1 2 )
26 5811 5151 7409 44 72 4 734 55 16  (525)
36 5468 6579 4884 3 44 0 4721 5 0 1 8 ( 5 1 2 )
9 BDI 2 777 2748 3846 3935 3629 3 38 7  (260)
21 4 640 5036 8237 3823 5363 5420  (750)
25 7884 6477 8329 3 7 7 0 8612 7 0 1 4 ( 8 9 0 )
29 4 559 4323 6741 8106 4603 5667  (751)
32 496 8 5059 7739 5565 7530 6172  (606)
37 430 7 436 2 3817 5761 43 07 4511 (328)
41 2743 4 106 2416 2963 2 60 7 2 96 7  (298)
42 7061 8096 7265 4 7 0 6 5452 6 5 1 6 ( 6 2 3 )
18 BDC 1847 2078 1669 1944 1433 1 7 9 4 ( 1 1 2 )
19 375 252 419 288 225 3 1 2 ( 3 7 )
28 5059 14662 1 1651 12256 10726 10871 (1592)
38 29 47 46 40 3757 3851 3595 3758  (271)
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Appendix 24C: Individual and mean (± S.E.) values for pepsinogen concentrations
(iU/g) of mucosal cuts from the Hampshire’s in the second haemonchosis study.
Sheep Group
Tissue
A B C D E
Mean 
(± S.E.)
10 SDI 57360 33343 26474 36331 3 2 3 9 2 3 7 1 8 0  (5 292)
11 19379 28022 17946 20415 2 2 2 4 6 2 1 6 0 2  (1 751)
15 0 74 892 2183 5 1 5 4 1661 (958)
17 55882 484 67 61000 458 8 6 52 245 5 2 6 96  (2 679)
20 34515 31324 35713 25831 356 93 3 2 6 1 5 ( 1 8 7 6 )
23 42278 34614 39162 31593 3 5 5 0 8 36631 (1 857)
33 11712 6799 10433 8449 14901 10459 (1392)
35 93648 93475 45721 40313 41831 6 2 9 9 8 ( 1 2 5 0 9 )
7 SDC 156578 147295 145787 123804 130535 140800  (5959)
16 50060 77433 86520 74866 6 6 9 7 6 71171 (6131)
26 80356 51612 80449 56972 7 3 6 2 9 6 8 6 0 8  (6034)
36 61785 96605 57320 42 73 4 7 3 7 6 9 6644 3  (9029)
9 BDI 31345 34790 50607 43 628 44091 4 0 8 9 2  (3468)
21 50271 62632 84398 42473 53 048 58565  (7218)
25 76023 61332 83124 372 18 8 20 18 679 43  (8607)
29 51222 464 84 59763 77498 4 6 4 9 8 56293  (5 829)
32 47175 4570 2 62466 49 1 16 71713 5 5 2 3 4  (5085)
37 41981 425 1 7 39599 58314 4 8 7 8 0 4 6 2 3 8  (3379)
41 28485 3978 2 24776 28658 2 1 7 0 6 28681  (3059)
42 58114 71581 65276 47 387 56913 5 9 8 5 4  (4087)
18 BDC 21231 21 87 0 15745 24453 18141 2 0 2 8 8  (1516)
19 5592 2925 5220 4031 3053 4 1 6 4  (545)
28 56528 131730 115244 121591 118917 108802  (133 52)
38 31456 426 08 37608 415 47 3531 1 3 7 7 0 6  (2 044)
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Appendix 25A: Individual plot profiles for the image analysis of the pepsinogen
immunohistochemistry of animals from the BDC group, results are mean values o f  the
condensed data from five scans per animal.
Animal
18 19 28 38
4.2 0.2 6.8 4.2
11.0 1.0 10.8 14.6
12.8 0.8 13.2 15.4
15.6 1.2 10.0 12.2
15.4 1.2 8.4 10.2
13.8 1.2 7.8 10.2
12.8 1.0 6.2 10.6
12.4 1.2 4.6 10.8
11.6 1.0 3.4 10.2
9.4 1.8 3.0 9.2
7.6 1.4 2.4 9.4
7.6 1.2 2.4 8.4
8.0 1.2 2.8 6.8
7.6 0.8 3.4 5.6
7.2 1.0 2.8 4.2
5.8 1.0 3.2 3.4
6.0 1.0 2.6 3.6
5.4 1.2 2.2 3.4
4.6 1.2 1.6 3.4
3.6 1.2 1.4 2.6
2.8 0.8 1.6 2.2
2.0 1.2 1.2 1.8
1.0 1.0 0.8 1.8
0.8 0.8 0.6 1.6
0.8 0.8 0.2 0.6
0.8 0.8 0.0 0.6
0.6 0.6 0.2
1.0 0.6 0.6
1.0 0.0 0.0
0.6 0.4
0.2 0.6
0.2 0.6
0.0 0.4
0.2
0.2
0.4
0.4
0.4
0.4
0.0
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Appendix 25B: Individual plot profiles for the image analysis of the pepsinogen
immunohistochemistry of animals from the BDI group, results are mean values o f  the
condensed data from five scans per animal.
mimal
10 11 15 17 20 23 33 35
5.0 3.6 0.8 2.4 10.0 3.6 2.4 0.0
13.8 12.4 1.2 6.8 18.2 12.2 11.8 3.8
14.0 16.8 1.2 10.0 19.2 14.2 15.8 6.6
14.6 17.0 1.6 10.2 17.4 15.4 17.2 6.0
14.0 16.8 1.6 10.4 19.0 16.2 14.8 5.6
14.4 14.8 1.4 8.8 20.2 16.4 12.2 7.4
12.4 13.4 1.0 7.6 20.8 15.8 10.8 7.2
11.8 14.0 1.0 7.2 20.2 12.6 10.0 7.6
9.2 14.2 1.2 6.2 20.6 10.6 7.0 8.4
8.6 13.2 1.2 6.6 20.8 11.4 8.6 8.6
7.6 13.2 1.4 6.4 16.2 11.0 6.4 8.8
7.8 11.8 1.0 6.4 14.2 11.6 4.2 11.8
8.8 10.2 1.2 9.2 12.2 11.8 5.4 12.0
9.0 7.8 1.2 10.0 9.6 11.6 4.6 12.0
8.0 6.6 1.4 10.4 9.4 11.6 5.6 12.4
7.4 5.2 1.2 9.8 7.8 12.6 6.0 10.6
5.6 4.4 1.2 11.2 7.4 13.2 6.2 8.4
4.6 3.6 0.8 9.6 7.6 14.0 7.6 8.0
4.4 3.2 0.8 8.2 6.6 12.2 8.2 8.8
3.6 2.8 0.8 8.0 5.6 10.6 8.0 8.0
3.2 2.4 0.8 7.0 5.4 10.0 7.8 7.6
3.0 1.8 0.8 6.2 5.6 10.2 7.4 7.8
2.4 1.4 0.6 5.8 5.6 10.2 7.4 7.6
2.2 0.8 0.6 4.2 5.0 10.8 6.4 6.4
1.8 0.4 0.4 4.2 4.0 9.4 6.0 6.6
1.6 0.0 0.4 4.0 3.4 8.2 5.2 6.2
1.2 0.4 3.0 2.6 7.2 4.4 5.8
1.2 0.2 2.8 2.4 5.8 4.0 5.0
0.8 0.0 2.2 2.4 6.0 3.0 4.8
0.6 1.6 2.2 4.8 2.0 5.4
0.8 0.8 1.6 4.2 1.8 6.4
0.6 0.6 0.8 4.6 1.2 5.8
0.0 0.6 0.4 3.4 0.8 4.2
0.0 0.2
0.6
0.0
2.6
2.6
1.4
0.4
0.6
0.2
0.0
0.2
0.0
3.0
2.0 
1.2 
0.6 
0.2 
0.2 
0.0
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Appendix 25C: Individual plot profiles for the image analysis of the pepsinogen
immunohistochemistry of animals from the SDC group, results are m ean values o f  the
condensed  data from five scans per animal.
Animal
7 16 26 36
9.6 5.8 6.6 12.2
17.6 19.4 10.6 21.0
21.6 19.8 9.4 23.6
19.0 16.2 9.2 19.8
22.4 15.0 8.6 22.0
22.2 14.8 7.0 20.0
21.0 10.6 6.8 16.8
16.6 9.0 7.6 15.4
15.8 7.4 7.2 15.6
13.8 8.6 5.8 14.0
13.6 8.6 6.4 12.2
13.0 7.6 5.6 10.2
11.4 6.2 4.8 9.0
11.2 6.0 3.8 7.6
9.6 6.4 2.8 5.8
6.8 6.0 2.6 3.8
5.4 6.4 2.4 2.8
4.6 7.0 2.2 2.0
2.8 7.4 1.8 1.6
1.8 6.2 1.6 1.4
1.4 5.0 1.6 1.2
1.2 3.6 1.4 0.8
0.8 3.2 1.4 0.6
1.0 2.4 1.2 0.6
0.8 2.4 0.8 0.4
0.6 1.6 0.6 0.2
0.6 0.8 0.4 0.2
0.4 0.8 0.2 0.4
0.2 0.4 0.0 0.0
0.2 0.0
0.0
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Appendix 25D: Individual plot profiles for the image analysis of the pepsinogen
immunohistochemistry of animals from the SDI group, results are m ean values o f  the
condensed data from five scans per animal.
mimal
9 21 25 29 32 37 41 42
5.0 8.0 0.4 6.6 5.0 7.6 4.2 4.6
15.4 16.4 2.4 10.8 17.0 10.4 6.0 12.4
14.6 20.2 4.0 9.6 16.2 12.0 7.7 13.6
17.0 18.2 3.8 8.8 14.0 11.6 8.7 14.2
12.4 17.0 2.4 10.4 15.0 13.6 8.0 14.2
11.4 16.6 2.2 10.0 14.4 12.8 8.0 17.2
11.0 14.4 2.8 9.8 12.4 13.8 6.5 15.8
10.4 14.6 2.8 8.4 12.6 13.0 6.0 13.4
10.4 13.2 2.1 9.6 12.6 13.0 6.2 13.4
10.4 13.4 2.6 oo bo 10.6 13.8 6.5 13.4
9.8 11.8 2.4 7.6 9.0 14.6 6.0 14.4
11.8 11.0 2.8 7.2 8.2 12.4 5.0 14.4
12.6 13.4 3.4 6.0 7.0 9.8 5.0 13.2
8.2 19.4 2.6 5.0 7.2 11.4 4.6 13.2
6.6 22.8 2.4 3.6 6.8 11.6 4.2 10.8
6.6 20.4 1.6 2.8 7.2 11.6 3.0 9.4
5.6 18.6 1.6 2.2 7.0 11.0 2.7 9.6
4.6 18.6 1.4 2.0 7.8 9.8 3.0 8.0
3.6 18.0 0.8 1.8 9.4 9.2 2.2 8.0
4.0 19.6 1.0 1.4 9.2 8.4 2.0 7.8
3.6 18.0 1.0 1.4 9.4 8.0 2.0 6.8
3.0 16.0 1.0 1.0 11.0 6.8 2.0 5.8
2.6 14.0 0.6 0.8 10.0 6.0 1.7 5.0
2.4 11.8 0.6 0.6 11.6 4.6 1.5 4.0
1.6 12.2 0.2 0.4 11.0 3.8 1.2 3.6
0.8 12.4 0.0 0.2 11.8 3.4 1.2 2.6
0.4 9.8 0.0 10.6 2.4 1.5 1.6
0.0 7.6 9.0 1.8 1.2 1.0
6.8 8.4 1.4 1.0 0.8
7.8 7.6 1.2 0.5 0.6
7.4 6.0 1.2 0.2 0.6
7.0 5.2 0.6 0.5 0.6
6.2 4.4 0.4 0.2 0.0
* 4.6 4.0 0.2 0.0
3.8 3.2 0.0
3.0 2.0
2.4 2.4
1.6 2.0
1.8 2.0
1.4 2.0
0.6 0.8
0.0 0.2
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Appendix 26: Overall mean (± S.E.) plot profiles for control (8 animals) and infected 
(16 animals) Hampshire Down lambs.
Position Control Infected
1 6.20 (1.28) 4.32 (0.70)
2 13.25 (2.26) 10.69(1.31)
o 14.57(2.61) 12.23 (1.34)
4 12.90 (2.16) 12.23 (1.30)
5 12.90 (2.56) 11.96(1.30)
6 12.13 (2.47) 11.76(1.31)
7 10.73 (2.23) 10.97 (1.27)
8 9.70 (1.85) 10.35 (1.19)
9 9.02 (1.89) 9.87(1.21)
10 8.20 (1.59) 9.91 (1.17)
11 7.70(1.51) 9.16(1.06)
12 7.00 (1.37) 8.85 (1.03)
13 6.28(1.17) 8.82 (0.94)
14 5.75 (1.12) 8.59(1.13)
15 4.97 (0.99) 8.39 (1.29)
16 4.07 (0.69) 7.70(1.21)
17 3.77 (0.69) 7.24(1.17)
18 3.50(0.71) 6.94(1.18)
19 3.05 (0.74) 6.59(1.16)
20 2.47 (0.60) 6.30(1.20)
21 2.07 (0.47) 5.90(1.12)
22 1.65 (0.31) 5.59 (1.07)
23 1.32 (0.30) 5.11 (1.00)
24 1.12 (0.22) 4.59 (0.98)
25 0.85 (0.23) 4.17(0.97)
26 0.65 (0.17) 3.84 (1.00)
27 0.42 (0.10) 3.18(0.86)
28 0.50(0.11) 2.62 (0.72)
29 0.20 (0.12) 2.35 (0.68)
30 0.15 (0.08) 2.14(0.68)
31 0.10(0.08) 1.94 (0.64)
32 0.10(0.05) 1.72 (0.60)
o ^2> J 0.05 (0.05) 1.29 (0.51)
34 0.02 (0.02) 0.92 (0.40)
35 0.02 (0.02) 0.76 (0.33)
36 0.05 (0.05) 0.47 (0.23)
37 0.05 (0.05) 0.36 (0.20)
38 0.05 (0.05) 0.27 (0.16)
39 0.05 (0.05) 0.26 (0.16)
40 0.00 (0.00) 0.21 (0.15)
41 0.00 (0.00) 0.09 (0.06)
42 0.00 (0.00) 0.01 (0.01)
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Appendix 27: Level of significance (probability) for factors influencing staining 
intensity at different mucosal positions. Figures in bold script are of borderline 
significance (0.05<p<0.10)+ or are significant (p<0.05)*.
Position
1 2 3 4 5
Model 0.0449* 0.1606 0.2309 0.4437 0.2506
Diet 0.2271 0.1773 0.1272 0.1703 0.1819
Infection 0.1350 0.2814 0.3644 0.7790 0.7050
Diet*Inf. 0.0151* 0.0627+ 0.1261 0.2230 0.1390
6 7 8 9 10 11
0.3101 0.4747 0.5630 0.5550 0.4436 0.3332
0.1115 0.1837 0.2282 0.3039 0.2603 0.2340
0.8834 0.9183 0.7636 0.7804 0.4040 0.4268
0.1463 0.2280 0.3038 0.2313 0.2481 0.1378
12 13 14 15 16 17
0.3646 0.2876 0.3634 0.3653 0.2942 0.3215
0.3016 0.3266 0.5788 0.6409 0.7523 0.8155
0.3016 0.1246 0.1384 0.1086 0.0675+ 0.0717"
0.1930 0.3416 0.3491 0.5026 0.6552 0.7790
18 19 20 21 22 23
0.3382 0.3081 0.2485 0.1906 0.1466 0.1347
0.7939 0.8653 0.9573 0.9306 0.9331 0.8995
0.0767+ 0.0659" 0.0512+ 0.0360* 0.0244* 0.0214*
0.8250 0.8334 0.7282 0.7280 0.8368 0.9189
24 25 26 27 28 29
0.1696 0.1941 0.2406 0.2421 0.3045 0.2530
0.9299 0.9064 0.9412 0.9810 1.000 1.000
0.0289* 0.0349* 0.0469* 0.0464* 0.0633" 0.0489*
0.8834 0.8271 0.8376 0.8903 0.9272 0.9233
30 31 32 33 34 35
0.3086 0.3266 0.3840 0.4558 0.4953 0.5151
0.8704 0.9283 0.8970 0.8330 0.7439 0.7848
0.0651" 0.0702" 0.0892" 0.1195 0.1517 0.1553
0.9759 0.9080 0.9294 0.9354 0.8063 0.8620
36 37 38 39 40 41 42
0.5553 0.3918 0.4279 0.3469 0.2657 0.2603 0.6012
0.5664 0.3381 0.3284 0.2661 0.3140 0.3107 0.4981
0.2297 0.2988 0.3284 0.3654 0.3140 0.3107 0.4981
0.7736 0.5294 0.5840 0.4870 0.3140 0.3107 0.4981
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Appendix 28: Individual values of AUC, Imax and Pmax following image analysis of 
the pepsinogen immunohistochemistry for the second study of haemonchosis in 
H am pshire Down lambs.
Animal Group AUC Imax Pmax
10 SDI 4.08 14.6 4
11 4.24 17.0 4
15 0.55 1.6 4
17 4.17 11.2 17
20 6.50 20.8 7
23 7.02 16.4 6
*■> n
J J 4.61 17.2 4
35 4.98 12.4 15
7 SDC 5.34 22.4 5
16 4.29 19.8 oJ >
26 2.41 10.6 2
36 4.82 23.6 3
9 BDI 4.12 17.0 4
21 9.64 22.8 15
25 0.98 4.0 3
29 2.74 10.8 2
32 6 . 8 6 17.0 2
37 5.46 14.6 11
41 2.40 8.7 4
42 5.48 17.2 6
18 BDC 3.88 15.6 4
19 0.65 1.8 10
28 2.07 13.2 J
38 rJ . J O 15.4 J
Appendix 29: TG F-a (a) and EGF (b) im m unostaining in ra t gastric cardia.
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Appendix 30: TGF-a (a) and EGF (b) immunostaining in ovine oesophagus.
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Appendix 31: EGF immunostaining in ovine sub-mandibular salivary gland.
Appendix 32: EGF im munostaining in ovine abom asal fundus.
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Appendix 33: TGF-a (a) and EGF (b) immunostaining in ovine pylorus.
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Appendix 34: TGF-a (a) and EGF (b) immunostaining in ovine colon.
*4 OF* Ifl iT ^
# iJtL W 1
'
*  A  if?  i* . -*> ^
. .  ' •'
^  * -* G a
l b *•»* '’i#* ■■ ''Z jc + fr? ' ■ *1
f  *► , . ’flT * ;*  •*
T*f V. V& ,x , W ; ,/  'V *g i* ,>• k- * '  *. I  t S f  T *  * F# .3 * i
**pr*v
